"Molecule ChEMBL ID";"Molecule Name";"Molecule Max Phase";"Molecular Weight";"#RO5 Violations";"AlogP";"Compound Key";"Smiles";"Standard Type";"Standard Relation";"Standard Value";"Standard Units";"pChEMBL Value";"Data Validity Comment";"Comment";"Uo Units";"Ligand Efficiency BEI";"Ligand Efficiency LE";"Ligand Efficiency LLE";"Ligand Efficiency SEI";"Potential Duplicate";"Assay ChEMBL ID";"Assay Description";"Assay Type";"BAO Format ID";"BAO Label";"Assay Organism";"Assay Tissue ChEMBL ID";"Assay Tissue Name";"Assay Cell Type";"Assay Subcellular Fraction";"Assay Parameters";"Assay Variant Accession";"Assay Variant Mutation";"Target ChEMBL ID";"Target Name";"Target Organism";"Target Type";"Document ChEMBL ID";"Source ID";"Source Description";"Document Journal";"Document Year";"Cell ChEMBL ID";"Properties";"Action Type";"Standard Text Value"
"CHEMBL3953318";"";"None";"433.45";"0";"2.47";"BDBM208507";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2cc(-c3ccc(F)cc3)cn2)n1";"IC50";"'='";"112.4";"nM";"6.95";"";"368544";"UO_0000065";"16.03";"0.30";"4.48";"7.64";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3426153";"";"None";"407.47";"0";"3.59";"6e";"CC(C)OC(=O)c1ccccc1C(=O)N1C[C@H](Oc2cc(C#N)ccn2)CC[C@H]1C";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3667577";"";"None";"496.43";"0";"4.52";"BDBM154951";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1";"IC50";"'='";"68.0";"nM";"7.17";"";"297242";"UO_0000065";"14.44";"0.30";"2.65";"9.47";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1080905";"";"None";"484.57";"1";"5.25";"30, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1cccc(C(F)(F)F)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1911744";"";"None";"393.89";"0";"3.73";"1g";"C[C@@H]1COc2ccc(S(C)(=O)=O)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"4700.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL4083024";"";"None";"474.95";"0";"4.09";"14e";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc(-c5cccc(Cl)c5)co4)C[C@@H]3C2)c1";"IC50";"'='";"2787.0";"nM";"5.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3426154";"";"None";"387.39";"0";"3.63";"Table 3, R7C1";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1OC(F)F";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3667583";"";"None";"396.42";"0";"2.77";"BDBM154957";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(F)c(F)c2)cc1";"IC50";"'='";"136.0";"nM";"6.87";"";"297248";"UO_0000065";"17.32";"0.35";"4.10";"9.07";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1348119";"";"None";"398.45";"1";"5.27";"SID17515708";"O=C(Nc1nnc(-c2ccccc2)o1)c1cc(-c2cccs2)nc2ccccc12";"IC50";"";"8500.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1571807";"";"None";"353.43";"1";"5.44";"SID17415295";"O=[N+]([O-])c1cccc(-c2nc(-c3cccs3)c(-c3cccs3)[nH]2)c1";"IC50";"";"28800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1355104";"";"None";"310.36";"0";"3.49";"SID49826124";"Cn1c2ccccc2c(=O)c2cc(C#Cc3ccccn3)ccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1080686";"";"None";"430.60";"0";"4.54";"22, diastereoisomeric mixtures";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1ccc(C)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080723";"";"None";"434.56";"0";"4.37";"28, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1ccccc1F";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL3980961";"";"None";"402.46";"0";"3.91";"BDBM221307";"Cc1ccc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc1";"IC50";"'='";"1040.0";"nM";"5.98";"";"387440";"UO_0000065";"14.87";"0.27";"2.07";"6.11";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892023";"";"None";"388.47";"0";"4.63";"BDBM202968";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2cccnc2)c1";"IC50";"'='";"249.0";"nM";"6.60";"";"360494";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937786";"";"None";"392.40";"0";"3.81";"BDBM203038";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)F)nc1";"IC50";"'='";"621.0";"nM";"6.21";"";"360578";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3622324";"";"None";"411.90";"0";"2.76";"19";"Cc1ncc(Cl)c(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667599";"";"None";"451.39";"0";"4.17";"BDBM154973";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C)cc2Br)c1";"IC50";"'='";"82.0";"nM";"7.09";"";"297264";"UO_0000065";"15.70";"0.36";"2.92";"10.66";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4062883";"";"None";"462.94";"0";"3.57";"14f";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H]3CN(Cc4nc5cc(Cl)ccc5o4)C[C@H]3C2)c1";"IC50";"'='";"1822.0";"nM";"5.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL337367";"";"None";"444.53";"0";"3.63";"8";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)CC2";"IC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"15.09";"0.28";"3.08";"9.89";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1084949";"";"None";"413.49";"0";"2.95";"9";"C[C@@H]1CCN(c2ncc3ccccc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL343786";"";"None";"402.56";"0";"3.85";"26";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccsc1)C(C)(C)C)CC2";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"18.52";"0.36";"3.61";"14.68";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3667593";"";"None";"392.91";"0";"3.75";"BDBM154967";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)cc2)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"297258";"UO_0000065";"19.08";"0.39";"3.74";"11.27";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3113755";"";"None";"447.56";"1";"5.83";"55";"COc1ccc2nc(C)oc2c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113753";"";"None";"409.51";"0";"4.48";"53";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113752";"";"None";"416.48";"1";"5.25";"52";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113748";"";"None";"403.48";"0";"4.41";"48";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113745";"";"None";"402.49";"1";"5.02";"45";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3112601";"";"None";"376.46";"0";"4.51";"36";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113539";"";"None";"437.46";"1";"5.64";"21";"CCOc1cccc(OCC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113775";"";"None";"423.43";"1";"5.25";"15";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3667585";"";"None";"392.45";"0";"2.93";"BDBM154959";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)ccc2F)cc1";"IC50";"'='";"26.0";"nM";"7.58";"";"297250";"UO_0000065";"19.33";"0.38";"4.66";"10.02";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL140504";"";"None";"325.41";"0";"3.22";"3";"COc1cc2c(cc1OC)CN(C(=O)CCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL524440";"";"None";"390.51";"0";"3.07";"20";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(OC)cc1";"IC50";"'='";"661.0";"nM";"6.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL497404";"";"None";"385.49";"0";"2.93";"23";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(C#N)cc1";"IC50";"'='";"1187.0";"nM";"5.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL467577";"";"None";"374.51";"0";"3.37";"25";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccccc1C";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL468969";"";"None";"378.47";"0";"3.20";"27";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccccc1F";"IC50";"'='";"3372.0";"nM";"5.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL495963";"";"None";"479.60";"0";"2.84";"35";"CCN(CC)C(=O)CN(c1cc(N(C)C)ccc1OC)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"239.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL497595";"";"None";"510.06";"1";"4.02";"44";"CCN(CC)C(=O)CN(c1cc(N2CCCC2)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"1606.0";"nM";"5.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL497596";"";"None";"506.02";"1";"4.21";"45";"CCN(CC)C(=O)CN(c1cc(-n2cccc2)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"1161.0";"nM";"5.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL486747";"";"None";"454.59";"0";"4.35";"25";"COc1ccc(OCCCN(CC(=O)NCc2ccccc2)Cc2cccs2)cc1OC";"IC50";"'='";"131.83";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3426131";"";"None";"377.45";"0";"3.04";"5b";"Cc1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL493427";"";"None";"546.66";"1";"4.68";"11";"COc1ccc2c(c1)C(NC(=O)CN1CCc3cc(OC)c(OC)cc3C1Cc1ccc(OC)c(OC)c1)CC2";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"12.80";"0.24";"2.32";"8.91";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3742341";"";"None";"460.60";"1";"5.72";"(+/-)-1";"CCn1cc(C(=O)N2CCc3ccsc3C2Cc2ccc(OC)c(OC)c2)c2ccccc21";"IC50";"'='";"1.4";"nM";"8.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL139117";"";"None";"382.50";"0";"4.12";"13";"COc1cc2c(cc1OC)CN(C(=O)C(Nc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"14.84";"0.28";"1.56";"11.18";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL2004183";"";"None";"334.43";"0";"3.20";"SID14737405";"COc1ccc(/C=N/Nc2snc(SC)c2C#N)cc1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1463349";"";"None";"316.41";"0";"3.45";"SID14744997";"CCSc1nnc(NC(=O)c2ccc3ccccc3n2)s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1983843";"";"None";"388.28";"1";"5.45";"SID17512000";"O=C(N/N=C/c1c(Cl)[nH]c2ccccc12)c1sc2ccccc2c1Cl";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1093724";"";"None";"443.49";"0";"3.15";"rac-15";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CC2CCN3c2ncc3cc(F)ccc3n2)c1";"IC50";"'='";"3700.0";"nM";"5.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL4794408";"";"None";"471.52";"0";"4.12";"56";"COC(=O)c1nc([C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)oc1-c1ccccc1";"IC50";"'='";"1589.0";"nM";"5.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL4081382";"";"None";"447.50";"0";"3.14";"31";"C[C@@H]1CC[C@@H](Oc2nccc3c2C(=O)OC3(C)C)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4090932";"";"None";"464.98";"0";"4.05";"14a";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(Cl)ccc5s4)C[C@@H]3C2)c1";"IC50";"'='";"1185.0";"nM";"5.93";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4101007";"";"None";"425.50";"0";"2.73";"14d";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4ncnc5ccccc45)C[C@@H]3C2)c1";"IC50";"'='";"1685.0";"nM";"5.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL1911937";"";"None";"401.49";"0";"2.73";"3";"O=C(Nc1ccccc1)N1CCC2(CC1)OCCN2S(=O)(=O)c1ccccc1";"IC50";"'='";"710.0";"nM";"6.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1091111";"";"None";"425.50";"0";"2.87";"9";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CC2CN(c2ncc4ccccc4n2)C3)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL139157";"";"None";"416.52";"0";"4.12";"22";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccccc1)c1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1438796";"";"None";"307.42";"0";"4.09";"SID49677881";"CN(C)c1ccc(NC(=S)c2ccc3ccccc3n2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342119";"";"None";"257.31";"0";"3.68";"SID4254756";"COc1ccc(-c2nc3ccccc3s2)cc1O";"IC50";"";"56000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1521545";"";"None";"330.39";"0";"3.70";"SID7972582";"c1ccc(N2CCN(c3ncnc4c3oc3ccccc34)CC2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1709502";"";"None";"412.43";"0";"3.81";"SID57262856";"Cc1ccccc1NC(=O)C1CCCN1S(=O)(=O)c1ccccc1C(F)(F)F";"IC50";"";"10100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1505044";"";"None";"387.46";"1";"5.87";"SID17433998";"O=[N+]([O-])c1ccc(-c2c[nH]c(SC(c3ccccc3)c3ccccc3)n2)cc1";"IC50";"";"29700.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1503548";"";"None";"247.30";"0";"3.76";"SID7972454";"CCn1c2ccccc2c2nc3ccccc3nc21";"IC50";"";"35200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3920668";"";"None";"408.54";"0";"4.95";"BDBM202874";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(N2CCCCC2)c1";"IC50";"'='";"46.0";"nM";"7.34";"";"360392";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918055";"";"None";"468.32";"0";"3.76";"BDBM221431";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3ncc(Br)cn3)c2)c1";"IC50";"'='";"1160.0";"nM";"5.94";"";"387562";"UO_0000065";"12.67";"0.27";"2.18";"5.36";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893455";"";"None";"455.52";"1";"5.14";"BDBM221325";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccc(C)c(C)c4)cn3)c2c1";"IC50";"'='";"51.0";"nM";"7.29";"";"387458";"UO_0000065";"16.01";"0.29";"2.15";"7.44";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977377";"";"None";"495.46";"1";"5.54";"BDBM221339";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(C(F)(F)F)c4)cn3)c2c1";"IC50";"'='";"16.0";"nM";"7.80";"";"387472";"UO_0000065";"15.73";"0.30";"2.26";"7.96";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409872";"";"None";"417.46";"0";"4.44";"BDBM203175";"COc1cccc(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"360736";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409870";"";"None";"419.45";"1";"5.41";"BDBM203185";"COc1cccc(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"1.0";"nM";"9.00";"";"360746";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409871";"";"None";"435.91";"1";"5.68";"BDBM203187";"COc1cccc(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"360748";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936553";"";"None";"461.59";"1";"6.08";"BDBM203257";"CCc1nc2ccc(OC)c(C3CCCC(=O)N3Cc3cccc(-c4csc(C)n4)c3)c2o1";"IC50";"'='";"33.0";"nM";"7.48";"";"360821";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409857";"";"None";"431.36";"0";"4.71";"BDBM50074105";"COc1cccc(OC)c1C1CC(F)(F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"133.0";"nM";"6.88";"";"360635";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113764";"";"None";"409.40";"0";"4.71";"BDBM203083";"COc1cccc(OC)c1[C@@H]1C[C@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"126.0";"nM";"6.90";"";"360638";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113756";"";"None";"411.38";"0";"3.70";"BDBM50447800";"COc1cccc(OC)c1C1COCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"86.0";"nM";"7.07";"";"360645";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936973";"";"None";"411.42";"1";"6.12";"BDBM203108";"O=C1CCC(c2ccccc2-c2ccccc2)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"585.0";"nM";"6.23";"";"360666";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933940";"";"None";"435.78";"0";"4.95";"BDBM203138";"COc1c(F)ccc(F)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1410.0";"nM";"5.85";"";"360696";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976423";"";"None";"417.79";"0";"4.81";"BDBM203142";"COc1cc(F)ccc1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2150.0";"nM";"5.67";"";"360702";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892186";"";"None";"431.81";"1";"5.20";"BDBM203146";"CCOc1c(F)cccc1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1760.0";"nM";"5.75";"";"360706";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409855";"";"None";"413.37";"0";"4.41";"25";"COc1cccc(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409871";"";"None";"435.91";"1";"5.68";"41";"COc1cccc(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1419029";"";"None";"540.64";"1";"3.23";"SID24833540";"Cc1c(NS(=O)(=O)c2cccc(C(=O)OCC(=O)N(C)C3CCCCC3)c2)c(=O)n(-c2ccccc2)n1C";"IC50";"";"1200.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1326648";"";"None";"457.32";"0";"3.51";"SID49717191";"O=C(CN1C(=O)/C(=C\c2cccc(Br)c2)Oc2ccccc21)NCC1CCCO1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1308855";"";"None";"447.49";"0";"4.85";"SID17509208";"Cc1ccc(C(=O)N/C(=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)C(=O)NC(C)(C)C)cc1";"IC50";"";"27900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3597958";"";"None";"417.56";"0";"3.42";"54";"C[C@@H]1CC[C@@H](c2csc(C(C)(C)O)n2)CN1C(=O)c1cscc1-n1nccn1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598905";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced Ca2+ flux preincubated for 5 mins followed by orexin-A induction measured 1 sec interval for 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3740670";"";"None";"418.50";"0";"3.71";"11";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)ccc2-c2ncccn2)cc1OC";"IC50";"'='";"71.0";"nM";"7.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3742079";"";"None";"457.00";"1";"5.64";"24";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(Cl)c2)cc1OC";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1911746";"";"None";"350.25";"0";"4.98";"1i";"C[C@@H]1COc2ccc(Cl)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"730.0";"nM";"6.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3426150";"";"None";"399.45";"0";"3.48";"6b";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-c1ncccn1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426142";"";"None";"442.32";"0";"3.50";"5k";"C[C@@H]1CC[C@@H](Oc2cc(Br)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426136";"";"None";"387.44";"0";"2.72";"5e";"C#Cc1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3985601";"";"None";"449.36";"0";"3.94";"BDBM185274";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ncccc1OC(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"334191";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3934220";"";"None";"452.39";"0";"3.72";"BDBM185283";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1cc(F)cc(F)c1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334200";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3912836";"";"None";"449.41";"0";"3.37";"BDBM185287";"CC1(Nc2ncc(C(F)(F)F)cc2F)CCCC1NC(=O)c1ncccc1-n1nccn1";"IC50";"'='";"7897.0";"nM";"5.10";"";"334204";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL2413082";"";"None";"433.53";"0";"3.67";"62";"CN(Cc1ccccc1)C(=O)Cn1nc(S(=O)(=O)Cc2ccccc2)c2ccccc21";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2413375";"";"None";"432.55";"0";"4.27";"61";"CN(Cc1ccccc1)C(=O)Cn1cc(S(=O)(=O)Cc2ccccc2)c2ccccc21";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3597952";"ACT-462206";"1.0";"388.49";"0";"3.10";"21, ACT-462206";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598897";"Antagonist activity at recombinant orexin-2 receptor (unknown origin) expressed in CHO cells assessed as inhibition of orexin-A-induced Ca2+ flux preincubated for 120 mins followed by orexin-A induction measured every 1 sec by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409857";"";"None";"431.36";"0";"4.71";"27";"COc1cccc(OC)c1C1CC(F)(F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3426144";"";"None";"393.45";"0";"2.74";"5m";"COc1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426140";"";"None";"381.41";"0";"2.87";"5i";"C[C@@H]1CC[C@@H](Oc2cc(F)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426139";"";"None";"434.50";"0";"2.44";"5h";"C[C@@H]1CC[C@@H](Oc2cc(C(=O)N(C)C)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"95.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL1572758";"";"None";"340.85";"0";"4.05";"SID17516815";"Cc1cc(-c2ccc(N3CCOCC3)cc2)nc2ccccc12.Cl";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1307031";"";"None";"249.27";"0";"0.77";"SID857884";"CN1C(=O)C2(N=c3ccccc3=N2)c2ccccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1721724";"";"None";"356.45";"0";"3.99";"SID47200781";"Cc1cccc(OCCSc2nc3ccccc3n2CCC(=O)O)c1";"IC50";"";"88200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493746";"";"None";"455.01";"1";"6.21";"SID17516553";"C=CCn1c(SCc2csc(-c3ccc(Cl)cc3)n2)nnc1-c1ccccc1OC";"IC50";"";"18500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4755979";"";"None";"409.49";"0";"3.20";"13";"Cc1oc([C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)nc1C(C)(C)O";"IC50";"'='";"12.8";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL3235253";"";"None";"403.46";"0";"3.40";"5a";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235254";"";"None";"385.47";"0";"3.26";"5b";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccccn3)CC[C@H]2C)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235259";"";"None";"415.50";"0";"2.76";"5g";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccc(CO)cn3)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3740186";"";"None";"452.58";"0";"4.99";"26";"COc1ccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc(OC)c(OC)c2)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1911942";"";"None";"479.53";"0";"2.70";"4f";"COc1ccc(S(=O)(=O)N2CCOC23CCN(C(=O)Nc2ccccc2)CC3F)cc1OC";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL519258";"";"None";"434.54";"0";"3.90";"15";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccccc2)cc1OC";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL498618";"";"None";"548.07";"1";"3.77";"48";"CCN(C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1cnc(C)cn1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL1432793";"";"None";"353.39";"0";"3.40";"SID24792652";"O=c1c2ccccc2nc2c3ccccc3c(NCc3ccccn3)nn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1440953";"";"None";"568.93";"2";"6.24";"SID24782357";"O=C(CSc1ccc(Br)c2cccc(Cl)c12)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"";"31500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1507474";"";"None";"303.41";"0";"2.78";"SID3714103";"Nn1c(-c2cccs2)nc2sc3c(c2c1=O)CCCC3";"IC50";"";"31200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714761";"";"None";"429.35";"1";"5.17";"SID49645954";"O=C(Nc1ccccc1)[C@@H]1CC=C[C@@H]2CCN(Cc3ccc(Cl)c(Cl)c3)C(=O)[C@@H]21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1405608";"";"None";"461.43";"0";"4.02";"SID14736873";"CSc1cccc(NC(=O)C2CCCN2S(=O)(=O)c2ccc(Br)s2)c1";"IC50";"";"400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714024";"";"None";"450.00";"0";"4.19";"SID57261318";"CC(NC(C)c1ccccc1Cl)C(=O)Nc1cccc(S(=O)(=O)N2CCCCC2)c1";"IC50";"";"18900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1967103";"";"None";"395.44";"0";"2.39";"SID14740945";"COc1ccc(/C=c2\sc3nc(-c4ccccc4OC)nn3c2=O)c(OC)c1";"IC50";"";"33500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418004";"";"None";"312.35";"0";"4.06";"SID24798232";"Oc1ccc(NC(=S)N=Nc2c(O)[nH]c3ccccc23)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1487872";"";"None";"263.30";"0";"3.19";"SID4257347";"Cc1ccc(NC(=O)c2ccc3ccccc3n2)nc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1476869";"";"None";"406.89";"0";"3.50";"SID49671047";"COc1cc(CN2CC(=O)N(c3ccccc3Cl)C2=S)cc(OC)c1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1583293";"";"None";"322.18";"0";"4.07";"SID7976136";"Nc1c(C(=O)c2ccc(Br)s2)oc2ccccc12";"IC50";"";"30700.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1170179";"";"None";"457.51";"0";"3.54";"16b";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CC[C@H]2CCN3c2ncc3ccc(F)cc3n2)c1";"IC50";"'='";"740.0";"nM";"6.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1409773";"";"None";"302.18";"0";"3.78";"SID47200842";"Cc1cc(C)n2nc(-c3cccc(Br)c3)cc2n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714525";"";"None";"351.40";"0";"3.95";"SID85200171";"Cc1c(C(=O)OC(C)C(=O)N(C)Cc2ccccc2)oc2ccccc12";"IC50";"";"9600.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL454133";"";"None";"487.01";"0";"3.71";"141";"Cc1cccc(-c2sc(N)nc2C(=O)N2CC[C@H]2CNC(=O)c2c(Cl)nc3sccn23)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3933550";"";"None";"390.48";"0";"4.90";"BDBM202933";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"1041.0";"nM";"5.98";"";"360459";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894604";"";"None";"416.52";"1";"5.41";"BDBM202940";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2cccnc2)c1";"IC50";"'='";"46.0";"nM";"7.34";"";"360466";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL199868";"";"None";"301.35";"0";"2.60";"SID26667288";"CCN(CC)c1ccc(/C=N/NC(=O)c2ccco2)c(O)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386871";"";"None";"254.29";"0";"2.97";"SID4259383";"CCOC(=O)c1c(C)nc2c3ccccc3ccn12";"IC50";"";"30000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1582623";"";"None";"385.36";"1";"5.38";"SID47195785";"COc1cccc(OP(=O)(Nc2ccccc2)Oc2cccc(OC)c2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1720286";"";"None";"374.98";"0";"4.43";"SID47195899";"Cl.c1ccc(CN2CCN(C3CCCSc4ccccc43)CC2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342119";"";"None";"257.31";"0";"3.68";"SID4254756";"COc1ccc(-c2nc3ccccc3s2)cc1O";"IC50";"";"9410.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1357156";"";"None";"340.38";"1";"5.05";"SID57268664";"Cc1nc2ccc(NC(=O)c3oc4ccc(F)cc4c3C)cc2s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418095";"";"None";"374.44";"1";"5.08";"SID17511678";"CCn1c2ccccc2c2cc(NC(=O)c3cc(OC)cc(OC)c3)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1302355";"";"None";"361.49";"0";"4.51";"SID49818091";"Cc1ccc(NC2CCCN(C(=O)c3cn(C)c4ccccc34)C2)cc1C";"IC50";"";"1640.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1511752";"";"None";"300.70";"0";"4.17";"SID49641421";"O=[N+]([O-])c1c(O)nc2ccc(Cl)cc2c1-c1ccccc1";"IC50";"";"1500.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502109";"";"None";"398.91";"0";"4.84";"SID24785310";"OCC1(Cc2cccc(Cl)c2)CCCN(Cc2ccc3cc(F)ccc3n2)C1";"IC50";"";"25100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4633255";"";"None";"449.52";"0";"3.19";"(-)-3f";"Cc1ccc(-n2nccn2)c(C(=O)N2CSC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"13.1";"nM";"7.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4645946";"";"None";"447.47";"0";"2.86";"(+)-3h";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"274.0";"nM";"6.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4634034";"";"None";"448.46";"0";"2.26";"(-)-7";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2ncc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"1.88";"nM";"8.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3954363";"";"None";"431.42";"0";"3.23";"BDBM185332";"CC1(Nc2ccc(C(F)(F)F)cn2)CCCC1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334250";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4633205";"";"None";"445.50";"0";"3.67";"(+)-3b";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCC[C@@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"52.4";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4647913";"";"None";"433.45";"0";"2.47";"(+)-3c";"Cc1ccc(-n2nccn2)c(C(=O)N2CCO[C@@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"2320.0";"nM";"5.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4633683";"";"None";"433.45";"0";"2.47";"(-)-3d";"Cc1ccc(-n2nccn2)c(C(=O)N2COC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL491468";"";"None";"481.55";"0";"3.17";"(+/-)-100";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccno2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.38";"0.20";"1.83";"5.25";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL138717";"";"None";"410.51";"0";"3.43";"(+/-)-39";"COc1cc2c(cc1OC)CN(C(=O)C(NC(=O)c1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL342583";"";"None";"396.53";"0";"3.79";"42";"COc1cc2c(cc1OC)CN(C(=O)[C@H](NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL140559";"";"None";"444.53";"0";"3.63";"(+/-)-32";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)NC(=O)c1ccccc1)CC2";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL140504";"";"None";"325.41";"0";"3.22";"(+/-)-28";"COc1cc2c(cc1OC)CN(C(=O)CCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3951651";"";"None";"416.41";"0";"3.44";"BDBM185302";"O=C(N[C@H]1CCC[C@@H]1Nc1cc(C(F)(F)F)ccn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334219";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3113741";"";"None";"396.51";"0";"4.88";"BDBM50447815";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2sc(C)nc2c1";"IC50";"'='";"13.0";"nM";"7.89";"";"360379";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936665";"";"None";"406.49";"0";"3.93";"BDBM202956";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"86.0";"nM";"7.07";"";"360482";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1172519";"";"None";"457.51";"0";"3.40";"14a";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H]3CC[C@@H]2CN(c2ncc4ccc(F)cc4n2)C3)c1";"IC50";"'='";"370.0";"nM";"6.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1171594";"";"None";"457.51";"0";"3.54";"8a, enantiomer";"Cc1ccc(-n2nccn2)c(C(=O)N2C3CCC2CN(c2ncc4ccc(F)cc4n2)CC3)c1";"IC50";"'='";"136.0";"nM";"6.87";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1171595";"";"None";"457.51";"0";"3.40";"14b";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CC[C@H]2CN(c2ncc4ccc(F)cc4n2)C3)c1";"IC50";"'='";"790.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1171767";"";"None";"457.51";"0";"3.54";"15b";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]3CC[C@@H]2CN3c2ncc3ccc(F)cc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1091110";"";"None";"425.50";"0";"2.87";"8c, enantiomer-B";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CC(C2)N(c2ncc4ccccc4n2)C3)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL451281";"";"None";"554.65";"1";"4.75";"119";"COc1cc2c(cc1OC)C(Cc1ccc(Oc3ncccn3)c(OC)c1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"11.94";"0.22";"1.87";"6.97";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL521579";"";"None";"474.56";"0";"3.89";"115";"COc1cc2c(cc1OC)C(Cc1ccc3c(c1)OCO3)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489289";"";"None";"460.57";"0";"4.17";"113";"COc1cccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL522786";"";"None";"484.64";"1";"5.27";"111";"COc1cc2c(cc1OC)C(Cc1ccc(C)c(C)c1)N(CC(=O)NC1CCc3ccccc31)CC2";"IC50";"'='";"4198.0";"nM";"5.38";"";"";"UO_0000065";"11.09";"0.20";"0.11";"10.58";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL522957";"";"None";"504.63";"1";"4.22";"93";"COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CCN2CC(=O)NCCc2ccccc2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.91";"0.18";"0.78";"7.22";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL462433";"";"None";"464.59";"0";"4.38";"145";"CCc1nc(OC)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C)c(F)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL461773";"";"None";"480.60";"1";"5.21";"144";"CCn1nc(C)c2c1CCCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1cc(F)c(C)c(F)c1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL507557";"";"None";"479.63";"0";"4.48";"142";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@@H](NC(=O)c3c(C)nc4sccn34)C2)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL454132";"";"None";"535.70";"1";"3.95";"140";"Cc1cccc(-c2sc(CCCO)nc2C(=O)N2C[C@H]3C[C@H]3[C@H]2CNC(=O)c2c(C)nc3sccn23)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL509417";"";"None";"491.64";"0";"4.48";"139";"Cc1cccc(-c2sc(C)nc2C(=O)N2[C@H](CNC(=O)c3c(C)nc4sccn34)C[C@@H]3C[C@@H]32)c1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3933744";"";"None";"429.48";"0";"2.24";"BDBM183986";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cncn3)c2)c1";"IC50";"'='";"4780.0";"nM";"5.32";"";"332050";"UO_0000065";"12.39";"0.23";"3.08";"5.85";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1978117";"";"None";"390.47";"0";"3.70";"SID17509557";"Cc1nn(-c2ccccc2)c(C)c1/C=N/NC(=O)c1cc(-c2cccs2)[nH]n1";"IC50";"";"37000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1464571";"";"None";"353.36";"1";"5.98";"SID49676248";"Cc1ccc(C)c(NP(=O)(Oc2ccccc2)Oc2ccccc2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559065";"";"None";"420.47";"0";"4.37";"SID26729595";"Cc1ccc(C)n1-c1nn(S(=O)(=O)c2cccc3cccnc23)c2cccc(F)c12";"IC50";"";"29340.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1382624";"";"None";"408.52";"0";"3.59";"SID4254993";"CSc1cccc(NC(=O)C2CCCN(S(=O)(=O)c3ccc(F)cc3)C2)c1";"IC50";"";"8400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979607";"";"None";"279.34";"0";"3.65";"SID7974141";"Cc1nn(C)c(C)c1/N=C/c1c(O)ccc2ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1372776";"";"None";"598.50";"1";"4.64";"SID14728003";"Cc1cc(Br)cc2c1NC(=O)C2(c1c(C)n(C)n(-c2ccccc2)c1=O)c1c(C)n(C)n(-c2ccccc2)c1=O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1479951";"";"None";"492.56";"0";"3.83";"SID852774";"O=C(c1ccco1)N1CCCC(c2nc(-c3ccc(S(=O)(=O)NCc4ccccc4)cc3)no2)C1";"IC50";"";"39300.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1548353";"";"None";"249.27";"0";"3.41";"SID863264";"CNc1oc(-c2cccc3ccccc23)nc1C#N";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502109";"";"None";"398.91";"0";"4.84";"SID24785310";"OCC1(Cc2cccc(Cl)c2)CCCN(Cc2ccc3cc(F)ccc3n2)C1";"IC50";"";"6700.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1386871";"";"None";"254.29";"0";"2.97";"SID4259383";"CCOC(=O)c1c(C)nc2c3ccccc3ccn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1501952";"";"None";"416.54";"0";"3.74";"SID49727331";"CCOc1ccc(S(=O)(=O)N2CCCC(C(=O)Nc3cc(C)cc(C)c3)C2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL489485";"";"None";"499.44";"1";"5.47";"13";"COc1cc2c(cc1OC)C(Cc1ccc(Cl)c(Cl)c1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'='";"281.0";"nM";"6.55";"";"";"UO_0000065";"13.12";"0.26";"1.08";"12.90";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL528990";"";"None";"452.53";"0";"4.04";"16";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccc(F)cc2)cc1OC";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3113767";"";"None";"397.35";"0";"4.30";"67";"COc1cccc(OC)c1C1COC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"771.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113542";"";"None";"311.38";"0";"3.96";"25";"COc1cccc(OC)c1C1CCCC(=O)N1c1ccccc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113541";"";"None";"325.41";"0";"3.96";"24";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccccc1";"IC50";"'='";"416.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3739704";"";"None";"406.53";"0";"4.92";"(+/-)-2";"CCn1cc(C(=O)N2CCCCC2Cc2ccc(OC)c(OC)c2)c2ccccc21";"IC50";"'='";"102.0";"nM";"6.99";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3742247";"";"None";"434.54";"0";"4.22";"(+/-)-5";"COc1ccc(CCC2CCCCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3981385";"";"None";"427.51";"0";"3.39";"BDBM183960";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"332085";"UO_0000065";"20.35";"0.37";"5.31";"10.64";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3947667";"";"None";"442.52";"0";"3.15";"BDBM184151";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3cccn3)ccc2C)c(-n2nccn2)c1";"IC50";"'='";"1090.0";"nM";"5.96";"";"332220";"UO_0000065";"13.47";"0.25";"2.81";"7.64";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3930630";"";"None";"462.49";"0";"3.16";"BDBM184143";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncon3)ccc2F)c(-n2nccn2)c1C";"IC50";"'='";"1567.0";"nM";"5.80";"";"332212";"UO_0000065";"12.55";"0.23";"2.64";"5.85";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3338864";"";"None";"444.50";"0";"3.19";"23";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2cnn(C)c2)nc1OC";"IC50";"'='";"167.0";"nM";"6.78";"";"";"UO_0000065";"15.25";"0.28";"3.59";"6.51";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3409872";"";"None";"417.46";"0";"4.44";"42";"COc1cccc(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409874";"";"None";"423.87";"1";"5.81";"44";"COc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1082024";"";"None";"430.60";"0";"4.54";"20, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1ccccc1C";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1081209";"";"None";"446.60";"0";"4.24";"23, diastereoisomeric mixtures";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1ccc(OC)cc1";"IC50";"'='";"219.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080883";"";"None";"458.65";"1";"5.35";"26(S;R)";"CCn1nc(C)c2c1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(C)C)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080722";"";"None";"458.65";"1";"5.35";"27(R;R)";"CCn1nc(C)c2c1CCN([C@@H](C(=O)NC)c1ccccc1)[C@@H]2CCc1ccc(C(C)C)cc1";"IC50";"'='";"179.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080924";"";"None";"470.54";"0";"4.86";"34, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2Cc1ccc(C(F)(F)F)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL2031504";"";"None";"491.59";"1";"5.82";"48";"Cc1nc(C(=O)N2[C@H](CNC(=O)c3cccc4occc34)CCC[C@@H]2C)c(-c2ccc(F)cc2)s1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3960536";"";"None";"403.53";"1";"6.88";"BDBM203106";"O=C1CCC(c2ccccc2-c2ccccc2)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"533.0";"nM";"6.27";"";"360664";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921925";"";"None";"417.79";"0";"4.81";"BDBM203126";"COc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"96.0";"nM";"7.02";"";"360684";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919179";"";"None";"431.81";"1";"5.45";"BDBM203253";"CCOc1cccc(Cl)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"31.0";"nM";"7.51";"";"360815";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936904";"";"None";"449.80";"1";"5.34";"BDBM203256";"CCOc1cc(F)cc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"63.0";"nM";"7.20";"";"360818";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113754";"";"None";"426.52";"1";"6.07";"BDBM50447802";"COc1ccc2nc(C)oc2c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"91.0";"nM";"7.04";"";"360819";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891971";"";"None";"458.50";"0";"3.74";"BDBM208517";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cn2cc(-c3ccc(F)cc3)cn2)n1";"IC50";"'='";"4544.3";"nM";"5.34";"";"368554";"UO_0000065";"11.65";"0.21";"1.60";"6.21";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1735531";"";"None";"498.00";"1";"5.55";"SID56463406";"COc1ccc([C@@H]2CC=C(C(=O)O)[C@H](c3cccc(Cl)c3)N2S(=O)(=O)c2ccccc2C)cc1";"IC50";"";"3320.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1481716";"";"None";"408.52";"0";"3.77";"SID49716568";"Cc1ccc(/C=C2/Sc3ccccc3N(CC(=O)NCC3CCCO3)C2=O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1336039";"";"None";"345.40";"0";"3.50";"SID3711499";"O=C(OC1CCOC1=O)c1ccc(-c2nc3ccccc3s2)s1";"IC50";"";"11400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1459180";"";"None";"359.38";"0";"4.29";"SID17506820";"COc1ccc(C(=O)ON=C2c3ccccc3-c3ccccc32)cc1OC";"IC50";"";"2780.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1581581";"";"None";"363.39";"0";"4.53";"SID14725892";"O=C(OCC#CCSc1nc2ccccc2o1)c1cc2ccccc2o1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1721971";"";"None";"394.88";"0";"3.14";"SID85199502";"COc1ccccc1NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"6280.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1487872";"";"None";"263.30";"0";"3.19";"SID4257347";"Cc1ccc(NC(=O)c2ccc3ccccc3n2)nc1";"IC50";"";"2350.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1967103";"";"None";"395.44";"0";"2.39";"SID14740945";"COc1ccc(/C=c2\sc3nc(-c4ccccc4OC)nn3c2=O)c(OC)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1988282";"";"None";"447.46";"1";"1.64";"SID49820287";"COc1cccc(/C=N/NC(=O)c2nnn(-c3nonc3N)c2CN(C)c2ccccc2)c1";"IC50";"";"5390.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1326648";"";"None";"457.32";"0";"3.51";"SID49717191";"O=C(CN1C(=O)/C(=C\c2cccc(Br)c2)Oc2ccccc21)NCC1CCCO1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335338";"";"None";"363.44";"0";"2.83";"SID24828913";"O=c1cc(CN2CC(O)Cc3ccc4ccccc4c32)nc2sccn12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3740088";"";"None";"440.54";"1";"5.12";"23";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2ccc(F)cc2)cc1OC";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1583293";"";"None";"322.18";"0";"4.07";"SID7976136";"Nc1c(C(=O)c2ccc(Br)s2)oc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1344555";"";"None";"271.35";"0";"3.53";"SID24782548";"CN(C)c1ccc(-c2nnc(-c3cccs3)o2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3932552";"";"None";"414.47";"0";"2.54";"BDBM183979";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"1822.0";"nM";"5.74";"";"332043";"UO_0000065";"13.85";"0.25";"3.20";"7.35";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922611";"";"None";"440.51";"0";"3.12";"BDBM183980";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncccn3)c2)c1";"IC50";"'='";"396.0";"nM";"6.40";"";"332044";"UO_0000065";"14.53";"0.26";"3.28";"7.44";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3981448";"";"None";"415.42";"0";"3.82";"BDBM185206";"O=C(NC1CCCC1Cc1cc(C(F)(F)F)ccn1)c1ccccc1-n1nccn1";"IC50";"'='";"6160.0";"nM";"5.21";"";"334123";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3954414";"";"None";"408.42";"0";"3.97";"BDBM185213";"CCOc1ccc(C)cc1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334130";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4087451";"";"None";"405.44";"0";"2.75";"5b";"Cc1ccc(-n2nccn2)c(C(=O)N(C)CCn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"51.7";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3398466";"";"None";"419.46";"0";"3.14";"1";"CCN(CCn1ccc(-c2ccc(F)cn2)n1)C(=O)c1cc(C)ccc1-n1nccn1";"IC50";"'='";"2.81";"nM";"8.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4091475";"";"None";"434.48";"0";"3.86";"9f";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"2.73";"nM";"8.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4080357";"";"None";"435.46";"0";"3.25";"18";"CCN(C(=O)c1nc(C)ccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"40.5";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4059968";"";"None";"434.48";"0";"2.92";"9g";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"2.57";"nM";"8.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL485716";"";"None";"504.96";"1";"4.83";"21";"COc1ccc(OCCN(CC(=O)NCc2ccccc2Cl)Cc2ccc(F)c(F)c2)cc1OC";"IC50";"'='";"81.28";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3896431";"";"None";"460.93";"0";"3.46";"BDBM184156";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1ccc(Cl)c(-c2ncccn2)c1";"IC50";"'='";"2257.0";"nM";"5.65";"";"332225";"UO_0000065";"12.25";"0.23";"2.19";"6.56";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL495770";"";"None";"484.02";"0";"3.49";"39";"CCN(CC)C(=O)CN(c1cc(Cl)ccc1N(C)C)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL498014";"";"None";"561.09";"1";"4.92";"51";"CCN(C(=O)CN(c1cc2c(C)nsc2cc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1ccccn1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3964256";"";"None";"465.90";"0";"3.66";"BDBM240194";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2cc(Cl)c(C)cc2-n2nccn2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"419036";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953989";"";"None";"455.31";"0";"4.52";"BDBM240202";"Cc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2ccc(Cl)cc2-n2nccn2)no1";"IC50";"'='";"13.0";"nM";"7.89";"";"419044";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3597964";"";"None";"480.91";"0";"3.88";"BDBM50108622";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3OC)n2)c(-n2nccn2)cc1C";"IC50";"'='";"0.7";"nM";"9.15";"";"419048";"UO_0000065";"";"";"";"";"1";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964868";"";"None";"449.87";"0";"4.88";"BDBM240209";"Cc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2cc(F)ccc2-c2ncccn2)no1";"IC50";"'='";"122.0";"nM";"6.91";"";"419052";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946899";"";"None";"385.43";"0";"2.95";"BDBM240215";"Cc1ccc(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3)[nH]2)c(-n2nccn2)c1";"IC50";"'='";"322.0";"nM";"6.49";"";"419058";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984374";"";"None";"430.47";"0";"2.74";"BDBM240217";"CCOc1ncccc1-c1nnc([C@@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)[nH]1";"IC50";"'='";"316.0";"nM";"6.50";"";"419060";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930758";"";"None";"422.51";"0";"4.80";"BDBM203274";"COc1ccc2c(c1C1CCCC(=O)N1Cc1csc(-c3ccccc3)n1)OCO2";"IC50";"'='";"40.0";"nM";"7.40";"";"360838";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1970286";"";"None";"384.44";"0";"3.64";"SID17414402";"Cc1nn(-c2ccccc2)c(C)c1/C=N/NC(=O)c1cc(-c2ccccc2)[nH]n1";"IC50";"";"18800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4079714";"";"None";"462.94";"0";"4.11";"6";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CCCN(c4nc5cc(Cl)ccc5o4)C3C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4060141";"";"None";"428.50";"0";"3.23";"14k";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(C)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"211.0";"nM";"6.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4087734";"";"None";"484.89";"0";"3.76";"15a";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@]3(F)CN(c4nc5cc(Cl)ccc5o4)C[C@@]3(F)C2)c1";"IC50";"'='";"639.0";"nM";"6.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4079757";"";"None";"469.55";"0";"4.35";"22";"CC(=O)Nc1ccc(-c2ccccc2)c(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL342583";"";"None";"396.53";"0";"3.79";"17";"COc1cc2c(cc1OC)CN(C(=O)[C@H](NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"2900.0";"nM";"5.54";"";"";"UO_0000065";"13.97";"0.26";"1.75";"10.90";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3910868";"";"None";"403.48";"0";"4.41";"BDBM202910";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"95.0";"nM";"7.02";"";"360434";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938749";"";"None";"399.49";"1";"5.38";"BDBM203094";"O=C1CCCC(c2cccc3c2OCCO3)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"296.0";"nM";"6.53";"";"360652";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901793";"";"None";"443.55";"1";"5.39";"BDBM203097";"COc1cncc(OC)c1C1CCCCC(=O)N1Cc1ccc2c(c1)c1ccccc1n2C";"IC50";"'='";"222.0";"nM";"6.65";"";"360655";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948876";"";"None";"395.38";"0";"3.74";"BDBM203130";"COc1cccc(C)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"887.0";"nM";"6.05";"";"360688";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3597960";"";"None";"440.48";"0";"2.50";"56";"C[C@@H]1CC[C@@H](Oc2nccc(C(C)(C)O)c2F)CN1C(=O)c1ccccc1-n1ncnn1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598905";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced Ca2+ flux preincubated for 5 mins followed by orexin-A induction measured 1 sec interval for 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3597963";"";"None";"464.91";"0";"4.18";"59";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)cc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598907";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced calcium flux preincubated for 120 mins followed by orexin-A induction measured every 1 sec by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL525010";"";"None";"547.08";"1";"4.38";"47";"CCN(C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1cccc(C)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3113772";"";"None";"413.42";"0";"4.38";"2";"COc1cccc(OC)c1C1SCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3962055";"";"None";"426.48";"0";"2.81";"BDBM183981";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"1892.0";"nM";"5.72";"";"332045";"UO_0000065";"13.42";"0.24";"2.91";"6.65";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3903093";"";"None";"435.39";"0";"2.98";"BDBM185237";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cccc(F)c1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334154";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3338865";"";"None";"447.52";"0";"3.92";"24";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2nccs2)nc1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.42";"0.33";"3.88";"7.87";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3961204";"";"None";"501.44";"1";"3.09";"BDBM184100";"O=C(c1ccc(C(F)(F)F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"159.0";"nM";"6.80";"";"332169";"UO_0000065";"13.56";"0.26";"3.71";"7.47";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3398472";"";"None";"419.46";"0";"3.14";"6b";"CCN(CCn1cc(-c2ccc(F)cn2)cn1)C(=O)c1cc(C)ccc1-n1nccn1";"IC50";"'='";"14.2";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4089060";"";"None";"435.46";"0";"3.25";"9d";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cn2)n1";"IC50";"'='";"11.3";"nM";"7.95";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4070565";"";"None";"445.50";"0";"4.73";"13";"CCN(C(=O)c1cc(C)ccc1-c1ncccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"8.85";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4099210";"";"None";"439.43";"0";"3.08";"14";"CCN(C(=O)c1cc(F)ccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cn2)n1";"IC50";"'='";"887.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4098384";"";"None";"446.49";"0";"4.13";"19";"CCN(C(=O)c1nc(C)ccc1-c1ncccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"254.0";"nM";"6.59";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3398476";"";"None";"405.44";"0";"2.75";"5a";"Cc1ccc(-n2nccn2)c(C(=O)N(C)CCn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"11.9";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4085017";"";"None";"391.41";"0";"2.40";"4b";"Cc1ccc(-n2nccn2)c(C(=O)NCCn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"1460.0";"nM";"5.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3740773";"";"None";"441.00";"1";"5.94";"20";"COc1ccc(Cl)c(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(C)c2)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3741767";"";"None";"445.42";"1";"6.58";"22";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"66.0";"nM";"7.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1355104";"";"None";"310.36";"0";"3.49";"SID49826124";"Cn1c2ccccc2c(=O)c2cc(C#Cc3ccccn3)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1494796";"";"None";"302.77";"0";"3.11";"SID49649438";"CNc1nc(Nc2ccc(C)c(Cl)c2)c2cnn(C)c2n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532928";"";"None";"260.30";"0";"4.35";"SID3711653";"Cc1ccnc2ccc(-c3nc4ccccc4o3)cc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1720383";"";"None";"279.28";"0";"3.16";"SID49679688";"Fc1cccc(Nc2nc3ccccc3n3cnnc23)c1";"IC50";"";"2130.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1432793";"";"None";"353.39";"0";"3.40";"SID24792652";"O=c1c2ccccc2nc2c3ccccc3c(NCc3ccccn3)nn12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1505044";"";"None";"387.46";"1";"5.87";"SID17433998";"O=[N+]([O-])c1ccc(-c2c[nH]c(SC(c3ccccc3)c3ccccc3)n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1716146";"";"None";"382.44";"0";"3.07";"SID49817708";"O=C(c1cccc(N2CCNC2=O)c1)N1CCCC(Nc2cccc(F)c2)C1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1363571";"";"None";"452.92";"0";"3.53";"SID24806388";"NS(=O)(=O)c1ccc(CNC(=O)c2cc(-c3ccccn3)nc3ccc(Cl)cc23)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1331281";"";"None";"457.56";"0";"4.61";"SID4258307";"CCn1c(SCC(=O)Nc2ccc3c(c2)c2ccccc2n3CC)nnc1-c1cnccn1";"IC50";"";"23100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1548353";"";"None";"249.27";"0";"3.41";"SID863264";"CNc1oc(-c2cccc3ccccc23)nc1C#N";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502107";"";"None";"430.90";"1";"5.33";"SID17387640";"Cc1cccc(NC(=O)NNC(=O)c2cc(-c3ccccc3Cl)nc3ccccc23)c1";"IC50";"";"27100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1555841";"";"None";"547.05";"2";"5.87";"SID85148927";"COC(=O)C1=C(c2ccccc2OCc2ccccc2)C[C@@H]2CC[C@H]1N2C(=O)NCCOc1ccccc1Cl";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1575576";"";"None";"344.41";"1";"5.08";"SID17408655";"CCn1c2ccccc2c2cc(NC(=O)c3cccc(OC)c3)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1333250";"";"None";"426.48";"0";"3.55";"SID49724792";"O=C(O)c1ccccc1NS(=O)(=O)c1cccc(-n2sc3ccccc3c2=O)c1";"IC50";"";"3450.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1709502";"";"None";"412.43";"0";"3.81";"SID57262856";"Cc1ccccc1NC(=O)C1CCCN1S(=O)(=O)c1ccccc1C(F)(F)F";"IC50";"";"2340.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1399289";"";"None";"308.37";"0";"3.53";"SID861745";"COc1ccc(-c2nn3c(-c4ccccc4)nnc3s2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1498924";"";"None";"484.95";"1";"5.49";"SID17507690";"C=CCSC1=C(C#N)C(c2ccccc2Cl)C(C(=O)c2cccs2)C(O)(C(F)(F)F)N1";"IC50";"";"15200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1328144";"";"None";"403.46";"0";"2.58";"SID3712546";"COC(=O)c1ccccc1NC(=O)CSc1nc(O)cc(=O)n1C1CCCC1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1558506";"";"None";"350.38";"0";"3.01";"SID17504004";"COc1ccc(/C=C/c2nc(N)nc(-c3ccccc3O)n2)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1977808";"";"None";"383.40";"0";"2.97";"SID26665718";"COc1ccc(OC)c(/C=N/NC(=O)c2cc3c(OC)cc(OC)cc3[nH]2)c1";"IC50";"";"6900.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1978117";"";"None";"390.47";"0";"3.70";"SID17509557";"Cc1nn(-c2ccccc2)c(C)c1/C=N/NC(=O)c1cc(-c2cccs2)[nH]n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1313229";"";"None";"494.62";"0";"4.59";"SID14725701";"Cc1cc(NC(=O)CCC(=O)N(Cc2cccs2)C(C(=O)NC2CCCC2)c2ccccc2)no1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1433931";"";"None";"733.91";"2";"6.83";"SID87345519";"CC[C@]12c3[nH]c4cc(-c5ccco5)ccc4c3CCN1C(=O)[C@@H](CC(=O)NC/C=C(\C)CCC=C(C)C)C[C@@H]2C(=O)N1CCN(C(=O)c2ccco2)CC1";"IC50";"";"2050.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1301892";"";"None";"377.44";"0";"3.77";"SID49735429";"CCOc1ccccc1C(=O)Nc1ccc2nc3n(c(=O)c2c1)CCCCC3";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1706330";"";"None";"482.00";"1";"5.84";"SID85301960";"Cc1ccc([C@@H]2CC=C(C(=O)O)[C@H](c3cccc(Cl)c3)N2S(=O)(=O)c2ccccc2C)cc1";"IC50";"";"670.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418004";"";"None";"312.35";"0";"4.06";"SID24798232";"Oc1ccc(NC(=S)N=Nc2c(O)[nH]c3ccccc23)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979607";"";"None";"279.34";"0";"3.65";"SID7974141";"Cc1nn(C)c(C)c1/N=C/c1c(O)ccc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1526293";"";"None";"447.50";"0";"2.32";"SID17509626";"COCCCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1559065";"";"None";"420.47";"0";"4.37";"SID26729595";"Cc1ccc(C)n1-c1nn(S(=O)(=O)c2cccc3cccnc23)c2cccc(F)c12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1337585";"";"None";"522.95";"2";"5.56";"SID49646422";"COc1ccc(CN2CC[C@H]3C=CC[C@@H](C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)[C@H]3C2=O)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377656";"";"None";"501.54";"2";"5.36";"SID22410795";"O=C(Nc1cccc(S(=O)(=O)NCc2ccco2)c1)c1cc(-c2ccc(F)cc2)nc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1713886";"";"None";"217.27";"0";"2.96";"SID14725848";"CCOC(=O)c1ccc2[nH]c(C)c(C)c2c1";"IC50";"";"13500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3113764";"";"None";"409.40";"0";"4.71";"21";"COc1cccc(OC)c1[C@@H]1C[C@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409867";"";"None";"438.45";"0";"4.01";"37";"COc1cccc(OC)c1[C@@H]1C[C@H](N(C)C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"8300.0";"nM";"5.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2031481";"";"None";"477.56";"1";"5.43";"7";"Cc1nc(C(=O)N2CCCCC2CNC(=O)c2cccc3occc23)c(-c2ccc(F)cc2)s1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031494";"";"None";"465.55";"0";"4.30";"29";"O=C(NC[C@@H]1C[C@H](O)CCN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"62.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3984746";"";"None";"480.36";"1";"6.06";"BDBM221409";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cc(Cl)c(Cl)cc43)c2)c1";"IC50";"'='";"81.0";"nM";"7.09";"";"387540";"UO_0000065";"14.76";"0.29";"1.03";"9.11";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904374";"";"None";"445.91";"1";"5.41";"BDBM221410";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cc(Cl)ccc43)c2)c1";"IC50";"'='";"507.0";"nM";"6.29";"";"387541";"UO_0000065";"14.12";"0.27";"0.88";"8.08";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915925";"";"None";"445.45";"0";"4.66";"BDBM221330";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccccc4F)cn3)c2c1";"IC50";"'='";"7.0";"nM";"8.15";"";"387463";"UO_0000065";"18.31";"0.34";"3.49";"8.32";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945060";"";"None";"475.48";"0";"4.60";"BDBM221337";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4ccccc4F)cn3)c2cc1OC";"IC50";"'='";"287.0";"nM";"6.54";"";"387470";"UO_0000065";"13.76";"0.26";"1.94";"6.79";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947113";"";"None";"462.51";"0";"3.93";"BDBM221371";"CCOc1cc(OC)nc(CCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"84.0";"nM";"7.08";"";"387502";"UO_0000065";"15.30";"0.28";"3.15";"6.04";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914646";"";"None";"444.46";"0";"2.95";"BDBM221397";"COc1ncnc2c1ncn2CCn1cc(NC(=O)c2ncoc2-c2cccc(C)c2)cn1";"IC50";"'='";"1081.0";"nM";"5.97";"";"387528";"UO_0000065";"13.42";"0.25";"3.02";"4.74";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975373";"";"None";"441.49";"0";"4.76";"BDBM221407";"COc1ccc2c(ccn2CCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)c1";"IC50";"'='";"784.0";"nM";"6.11";"";"387538";"UO_0000065";"13.83";"0.25";"1.35";"7.01";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915643";"";"None";"457.49";"0";"4.53";"BDBM221329";"COc1ccc(-c2ocnc2C(=O)Nc2cnn(CCc3c[nH]c4ccc(OC)cc34)c2)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"387462";"UO_0000065";"16.30";"0.30";"2.93";"6.96";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951547";"";"None";"511.46";"2";"5.42";"BDBM221338";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(OC(F)(F)F)c4)cn3)c2c1";"IC50";"'='";"13.0";"nM";"7.89";"";"387471";"UO_0000065";"15.42";"0.29";"2.47";"7.36";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890903";"";"None";"503.56";"2";"6.19";"BDBM221341";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(-c5ccccc5)c4)cn3)c2c1";"IC50";"'='";"73.0";"nM";"7.14";"";"387474";"UO_0000065";"14.17";"0.26";"0.95";"7.28";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890113";"";"None";"442.48";"0";"4.16";"BDBM221382";"COc1ccnc2c1ccn2CCn1cc(NC(=O)c2ncoc2-c2cccc(C)c2)cn1";"IC50";"'='";"548.0";"nM";"6.26";"";"387513";"UO_0000065";"14.15";"0.26";"2.10";"6.26";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL140700";"";"None";"513.42";"1";"4.94";"10";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)cc(Cl)c1)CC2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"14.65";"0.29";"2.58";"11.08";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3667596";"";"None";"436.56";"0";"2.50";"BDBM154970";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(S(C)(=O)=O)cc2)c1";"IC50";"'='";"197.0";"nM";"6.71";"";"297261";"UO_0000065";"15.36";"0.32";"4.21";"6.66";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2396834";"";"None";"540.96";"2";"5.87";"35";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1cc(F)c(C(F)(F)F)cc1F";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396833";"";"None";"540.96";"2";"5.87";"34";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)c(F)c1F";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396869";"";"None";"539.43";"2";"6.25";"32";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)c(Cl)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2031479";"";"None";"488.59";"1";"5.23";"5";"Cc1nc(C(=O)N2CCCCC2CNC(=O)c2cccc3cccnc23)c(-c2ccc(F)cc2)s1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3907587";"";"None";"458.50";"0";"3.60";"BDBM208526";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cc2cnn(-c3ccc(F)cn3)c2)c1";"IC50";"'='";"20.4";"nM";"7.69";"";"368563";"UO_0000065";"16.77";"0.31";"4.09";"8.94";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933616";"";"None";"463.50";"1";"5.15";"BDBM185252";"COc1cccc(OC)c1C(=O)N(C1CCC1)[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1";"IC50";"'='";"1610.0";"nM";"5.79";"";"334169";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3971276";"";"None";"431.42";"0";"3.23";"BDBM185266";"CC1(Nc2cnc(C(F)(F)F)cn2)CCCC1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"7541.0";"nM";"5.12";"";"334183";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3958239";"";"None";"434.40";"0";"3.58";"BDBM185282";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1cccc(F)c1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334199";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3957094";"";"None";"446.43";"0";"4.01";"BDBM185324";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@]2(C)Nc2cnc(C(F)(F)F)cn2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334241";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3981788";"";"None";"457.46";"0";"3.67";"BDBM185329";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334246";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3975164";"";"None";"456.47";"0";"4.28";"BDBM185330";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334247";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3113751";"";"None";"408.52";"1";"5.08";"BDBM50447805";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"360414";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899904";"";"None";"389.50";"1";"5.50";"BDBM202928";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"32.0";"nM";"7.50";"";"360454";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3622327";"";"None";"421.51";"0";"2.42";"6";"COc1nc(N2CC[C@@H](C)N(C(=O)c3cc(C)ccc3-n3nccn3)CC2)ncc1C";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622334";"";"None";"465.87";"0";"3.47";"14";"C[C@@H]1CCN(c2nc(Cl)ncc2C(F)(F)F)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3963320";"";"None";"465.87";"0";"3.88";"BDBM185276";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1cc(Cl)ccc1-n1nccn1";"IC50";"'='";"5569.0";"nM";"5.25";"";"334193";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3896682";"";"None";"431.42";"0";"3.23";"BDBM185277";"CC1(Nc2ncc(C(F)(F)F)cn2)CCCC1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334194";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3949049";"";"None";"495.30";"0";"4.21";"BDBM185290";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1Br)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334207";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3961425";"";"None";"453.38";"0";"3.08";"BDBM185307";"O=C(NC1CC(F)(F)CC1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334228";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3975071";"";"None";"463.41";"0";"4.60";"BDBM185318";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1cc(F)ccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334235";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3970006";"";"None";"393.44";"0";"3.93";"BDBM202988";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2noc(C)n2)c1";"IC50";"'='";"547.0";"nM";"6.26";"";"360515";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926769";"";"None";"430.23";"0";"3.42";"BDBM185212";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ncccc1Br";"IC50";"'>'";"10000.0";"nM";"";"";"334129";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL1485217";"";"None";"403.48";"0";"3.87";"SID49648089";"COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCc1c[nH]c2ccccc12";"IC50";"";"6410.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518566";"";"None";"341.42";"0";"4.57";"SID3714377";"Cc1cnc(NC(=O)c2ccc(-c3nc4ccccc4s3)o2)s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1572758";"";"None";"340.85";"0";"4.05";"SID17516815";"Cc1cc(-c2ccc(N3CCOCC3)cc2)nc2ccccc12.Cl";"IC50";"";"19300.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3909195";"";"None";"474.95";"0";"3.85";"BDBM184075";"C[C@@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)[C@H](Cc2cccc(-c3ncccn3)c2)CO1";"IC50";"'='";"110.0";"nM";"6.96";"";"332144";"UO_0000065";"14.65";"0.28";"3.11";"8.09";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3972319";"";"None";"461.50";"0";"2.77";"BDBM184102";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-n3ccnn3)ccc2F)c1";"IC50";"'='";"1110.0";"nM";"5.96";"";"332171";"UO_0000065";"12.90";"0.24";"3.18";"6.55";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3893458";"";"None";"443.51";"0";"2.63";"BDBM184129";"Cc1ccc(-n2nccn2)c(C(=O)N2CCO[C@H](C)[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"2382.0";"nM";"5.62";"";"332198";"UO_0000065";"12.68";"0.23";"2.99";"6.18";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942007";"";"None";"484.35";"0";"3.24";"BDBM184132";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1Cl";"IC50";"'='";"451.0";"nM";"6.35";"";"332201";"UO_0000065";"13.10";"0.26";"3.11";"6.98";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3976034";"";"None";"429.48";"0";"2.32";"BDBM184062";"C[C@@H]1CN(C(=O)c2ccccc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"289.0";"nM";"6.54";"";"332131";"UO_0000065";"15.23";"0.28";"4.22";"7.19";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922707";"";"None";"440.51";"0";"3.20";"BDBM184070";"C[C@@H]1CN(C(=O)c2ccccc2-n2nccn2)[C@H](Cc2cccc(-c3ncccn3)c2)CO1";"IC50";"'='";"855.0";"nM";"6.07";"";"332139";"UO_0000065";"13.78";"0.25";"2.87";"7.05";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3965827";"";"None";"463.93";"0";"2.89";"BDBM184087";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2Cl)c1";"IC50";"'='";"626.0";"nM";"6.20";"";"332156";"UO_0000065";"13.37";"0.26";"3.31";"6.82";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3944222";"";"None";"461.50";"0";"2.69";"BDBM184056";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)c1C";"IC50";"'='";"3578.0";"nM";"5.45";"";"332125";"UO_0000065";"11.80";"0.22";"2.76";"5.99";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3910889";"";"None";"450.89";"0";"3.05";"BDBM184048";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"2652.0";"nM";"5.58";"";"332117";"UO_0000065";"12.37";"0.24";"2.53";"5.62";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943141";"";"None";"443.51";"0";"2.63";"BDBM184059";"Cc1cccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-n3nccn3)c2)c1-n1nccn1";"IC50";"'='";"237.0";"nM";"6.62";"";"332128";"UO_0000065";"14.94";"0.27";"4.00";"7.28";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL138101";"";"None";"460.41";"1";"5.26";"1";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccc(Br)cc1)C(C)(C)C)CC2";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"12.38";"0.27";"0.44";"14.70";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1911745";"";"None";"333.79";"0";"4.46";"1h";"C[C@@H]1COc2ccc(F)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"3000.0";"nM";"5.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3897767";"";"None";"436.43";"0";"2.68";"BDBM221310";"COc1cc(OC)nc(OCCn2cc(NC(=O)c3ncoc3-c3ccccc3)cn2)n1";"IC50";"'='";"29.0";"nM";"7.54";"";"387443";"UO_0000065";"17.27";"0.32";"4.86";"5.96";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904325";"";"None";"453.43";"0";"2.85";"BDBM221356";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(F)c3)cn2)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"387486";"UO_0000065";"16.77";"0.31";"4.75";"5.88";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986532";"";"None";"489.54";"0";"3.58";"BDBM221444";"COc1cc(OC)nc(N2CCCC2Cn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"320.0";"nM";"6.50";"";"387575";"UO_0000065";"13.27";"0.25";"2.91";"5.39";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925325";"";"None";"388.43";"0";"4.18";"BDBM221302";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ccccc3)c2)c1";"IC50";"'='";"984.0";"nM";"6.01";"";"387435";"UO_0000065";"15.46";"0.28";"1.83";"7.31";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982244";"";"None";"471.59";"1";"5.61";"BDBM221345";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncsc4-c4ccc(C)c(C)c4)cn3)c2c1";"IC50";"'='";"225.0";"nM";"6.65";"";"387478";"UO_0000065";"14.10";"0.27";"1.04";"7.84";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935412";"";"None";"463.50";"0";"3.33";"BDBM221353";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3ccc(C)c(C)c3)cn2)n1";"IC50";"'='";"51.0";"nM";"7.29";"";"387483";"UO_0000065";"15.73";"0.29";"3.96";"5.64";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971841";"";"None";"441.49";"0";"4.83";"BDBM221363";"COc1ccc2c(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c[nH]c2c1";"IC50";"'='";"1655.0";"nM";"5.78";"";"387493";"UO_0000065";"13.09";"0.24";"0.95";"5.90";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917673";"";"None";"406.42";"0";"4.32";"BDBM221385";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cccc(F)c3)c2)c1";"IC50";"'='";"931.0";"nM";"6.03";"";"387516";"UO_0000065";"14.84";"0.27";"1.71";"7.34";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907321";"";"None";"403.44";"0";"3.88";"BDBM221390";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cccc(C)n3)c2)c1";"IC50";"'='";"794.0";"nM";"6.10";"";"387521";"UO_0000065";"15.12";"0.28";"2.22";"6.42";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946423";"";"None";"444.52";"0";"4.82";"BDBM221419";"Cc1cccc(-c2scnc2C(=O)Nc2cnn(CCNc3nc4ccccc4o3)c2)c1";"IC50";"'='";"237.0";"nM";"6.62";"";"387550";"UO_0000065";"14.90";"0.28";"1.81";"6.77";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898816";"";"None";"455.55";"0";"4.62";"BDBM221420";"Cc1cccc(-c2scnc2C(=O)Nc2cnn(CCNc3cnc4ccccc4n3)c2)c1";"IC50";"'='";"129.0";"nM";"6.89";"";"387551";"UO_0000065";"15.12";"0.29";"2.27";"7.06";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930525";"";"None";"463.50";"0";"3.41";"BDBM221433";"COc1cc(OC)nc(NCCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"57.0";"nM";"7.24";"";"387564";"UO_0000065";"15.63";"0.29";"3.83";"5.61";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909122";"";"None";"404.43";"0";"3.28";"BDBM221437";"Cc1cnc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc1";"IC50";"'='";"869.0";"nM";"6.06";"";"387568";"UO_0000065";"14.99";"0.28";"2.78";"5.61";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943770";"";"None";"477.53";"0";"3.43";"BDBM221442";"CCN(CCn1cc(NC(=O)c2ncoc2-c2cccc(C)c2)cn1)c1nc(OC)cc(OC)n1";"IC50";"'='";"631.0";"nM";"6.20";"";"387573";"UO_0000065";"12.98";"0.24";"2.77";"5.15";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969869";"";"None";"441.50";"0";"4.10";"BDBM221443";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3nc4ccccc4n3C)c2)c1";"IC50";"'='";"909.0";"nM";"6.04";"";"387574";"UO_0000065";"13.68";"0.25";"1.94";"5.88";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894227";"";"None";"455.52";"1";"5.15";"BDBM221446";"COc1ccc2c(ccn2CCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)c1";"IC50";"'='";"891.0";"nM";"6.05";"";"387577";"UO_0000065";"13.28";"0.24";"0.90";"6.95";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983080";"";"None";"485.39";"0";"3.86";"BDBM185238";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(C(F)(F)F)ccc1-n1ccnn1";"IC50";"'>'";"10000.0";"nM";"";"";"334155";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3905669";"";"None";"410.40";"0";"3.28";"BDBM185218";"COc1cccc(OC)c1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334135";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3949103";"";"None";"434.40";"0";"3.58";"BDBM185230";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(F)cccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334147";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3938981";"";"None";"447.47";"0";"2.38";"BDBM184024";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"404.0";"nM";"6.39";"";"332093";"UO_0000065";"14.29";"0.26";"4.01";"7.03";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968942";"";"None";"463.47";"0";"2.08";"BDBM184040";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1F";"IC50";"'='";"528.0";"nM";"6.28";"";"332109";"UO_0000065";"13.54";"0.25";"4.20";"6.27";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901849";"";"None";"451.44";"0";"2.21";"BDBM184053";"O=C(c1cc(F)c(F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"612.0";"nM";"6.21";"";"332122";"UO_0000065";"13.76";"0.26";"4.00";"6.83";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946474";"";"None";"443.51";"0";"2.63";"BDBM184058";"Cc1ccc(C(=O)N2C[C@H](C)OC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"390.0";"nM";"6.41";"";"332127";"UO_0000065";"14.45";"0.27";"3.78";"7.05";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3950474";"";"None";"449.90";"0";"2.59";"BDBM184088";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1Cl";"IC50";"'='";"1480.0";"nM";"5.83";"";"332157";"UO_0000065";"12.96";"0.25";"3.24";"6.41";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3907193";"";"None";"465.46";"0";"2.52";"BDBM184094";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1F";"IC50";"'='";"1170.0";"nM";"5.93";"";"332163";"UO_0000065";"12.74";"0.24";"3.41";"6.52";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3964366";"";"None";"447.47";"0";"2.38";"BDBM184145";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2F)c(-n2nccn2)c1";"IC50";"'='";"2130.0";"nM";"5.67";"";"332214";"UO_0000065";"12.67";"0.23";"3.29";"6.24";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3934350";"";"None";"430.53";"0";"4.08";"BDBM184009";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2cccs2)c1";"IC50";"'='";"163.0";"nM";"6.79";"";"332073";"UO_0000065";"15.77";"0.30";"2.71";"11.27";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936154";"";"None";"460.93";"0";"3.46";"BDBM184014";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"229.0";"nM";"6.64";"";"332078";"UO_0000065";"14.41";"0.27";"3.18";"7.72";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2396861";"";"None";"504.98";"2";"5.59";"24";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1cccc(C(F)(F)F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1171594";"";"None";"457.51";"0";"3.54";"8a, enantiomer";"Cc1ccc(-n2nccn2)c(C(=O)N2C3CCC2CN(c2ncc4ccc(F)cc4n2)CC3)c1";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3113773";"";"None";"395.38";"0";"4.47";"1";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1911750";"";"None";"381.81";"0";"4.93";"1m";"C[C@@H]1COc2ccc(OC(F)F)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1911641";"";"None";"315.80";"0";"4.32";"1b";"C[C@@H]1COc2ccccc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"6400.0";"nM";"5.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1911748";"";"None";"383.80";"1";"5.34";"1k";"C[C@@H]1COc2ccc(C(F)(F)F)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"270.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL493427";"";"None";"546.66";"1";"4.68";"(+/-)-104";"COc1ccc2c(c1)C(NC(=O)CN1CCc3cc(OC)c(OC)cc3C1Cc1ccc(OC)c(OC)c1)CC2";"IC50";"'='";"101.0";"nM";"7.00";"";"";"UO_0000065";"12.80";"0.24";"2.32";"8.91";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL523963";"";"None";"516.64";"1";"4.15";"(+/-)-103";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC2Cc3ccccc3C2)cc1OC";"IC50";"'='";"1098.0";"nM";"5.96";"";"";"UO_0000065";"11.53";"0.21";"1.81";"8.60";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3260827";"";"None";"445.53";"0";"3.47";"33";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4c(C)c(C)oc4n3)CC[C@H]2C)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"16.56";"0.31";"3.91";"7.92";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3260828";"";"None";"447.57";"0";"3.63";"34";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4c(C)csc4n3)CC[C@H]2C)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"16.66";"0.32";"3.83";"9.32";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3260836";"";"None";"448.56";"0";"2.90";"42";"Cc1csc2nc(N3CC[C@@H](C)N(C(=O)c4ccccc4-n4nccn4)CC3)nc(N)c12";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"16.80";"0.32";"4.64";"7.11";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL337159";"";"None";"397.52";"0";"3.19";"50";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccccn1)C(C)(C)C)CC2";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3409859";"";"None";"411.38";"0";"3.44";"29";"COc1cccc(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409862";"";"None";"425.40";"0";"4.09";"32";"COc1cccc(OC)c1[C@@H]1C[C@@H](OC)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"6940.0";"nM";"5.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2347598";"";"None";"548.63";"1";"4.34";"24";"CCc1nc(S(C)(=O)=O)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347601";"";"None";"527.59";"1";"4.30";"27";"CCc1nc(C(=O)NC)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347609";"";"None";"470.54";"0";"4.94";"10, diastereomeric mixture";"CCc1ncc2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"194.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1091112";"";"None";"443.49";"0";"3.15";"rac-14";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC3CC2CN3c2ncc3cc(F)ccc3n2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1466997";"";"None";"246.27";"0";"4.04";"SID4260863";"c1ccc2nc(-c3nc4ccccc4o3)ccc2c1";"IC50";"";"6.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1365949";"";"None";"392.50";"0";"2.27";"SID843476";"O=S(=O)(NC1CC1)c1ccc(S(=O)(=O)N2CCCc3ccccc32)cc1";"IC50";"";"6620.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1401331";"";"None";"431.50";"0";"3.08";"SID17509899";"CCCCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351110";"";"None";"310.78";"0";"4.13";"SID49680724";"Cc1cc(C(=O)NCc2cccc(Cl)c2)c2ccccc2n1";"IC50";"";"7590.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1983843";"";"None";"388.28";"1";"5.45";"SID17512000";"O=C(N/N=C/c1c(Cl)[nH]c2ccccc12)c1sc2ccccc2c1Cl";"IC50";"";"6880.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3398466";"";"None";"419.46";"0";"3.14";"2";"CCN(CCn1ccc(-c2ccc(F)cn2)n1)C(=O)c1cc(C)ccc1-n1nccn1";"IC50";"'='";"2.81";"nM";"8.55";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4634476";"";"None";"462.46";"0";"3.57";"(-)-14";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCCO[C@H]1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"4.58";"nM";"8.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3965859";"";"None";"453.43";"0";"2.85";"BDBM221357";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3ccccc3F)cn2)n1";"IC50";"'='";"41.0";"nM";"7.39";"";"387487";"UO_0000065";"16.29";"0.31";"4.54";"5.72";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908974";"";"None";"428.45";"0";"4.35";"BDBM221425";"Cc1cccc(-c2ocnc2C(=O)Nc2cn(CCNc3nc4ccccc4o3)cn2)c1";"IC50";"'='";"2775.0";"nM";"5.56";"";"387556";"UO_0000065";"12.97";"0.24";"1.21";"5.01";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903587";"";"None";"450.46";"0";"2.99";"BDBM221435";"COc1cc(OC)nc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"25.0";"nM";"7.60";"";"387566";"UO_0000065";"16.88";"0.31";"4.61";"6.01";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986090";"";"None";"426.48";"0";"4.46";"BDBM221305";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3c(C)nc4ccccc43)c2)c1";"IC50";"'='";"176.0";"nM";"6.75";"";"387438";"UO_0000065";"15.84";"0.29";"2.29";"7.44";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986786";"";"None";"455.52";"0";"4.84";"BDBM221364";"COc1ccc2c(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)cn(C)c2c1";"IC50";"'='";"665.0";"nM";"6.18";"";"387494";"UO_0000065";"13.56";"0.25";"1.34";"7.09";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954046";"";"None";"403.45";"0";"3.31";"BDBM221417";"Cc1cnc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc1";"IC50";"'='";"2610.0";"nM";"5.58";"";"387548";"UO_0000065";"13.84";"0.25";"2.27";"5.04";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1083358";"";"None";"431.48";"0";"3.09";"38";"C[C@@H]1CCN(c2ncc3cc(F)ccc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"17.54";"0.32";"4.48";"9.46";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3667554";"";"None";"406.53";"0";"3.21";"21";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(SC)c2)cc1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772009";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL1171766";"";"None";"457.51";"0";"3.54";"15a";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@@H]3CC[C@H]2CN3c2ncc3ccc(F)cc3n2)c1";"IC50";"'='";"1450.0";"nM";"5.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3597964";"";"None";"480.91";"0";"3.88";"60";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3OC)n2)c(-n2nccn2)cc1C";"IC50";"'='";"0.7";"nM";"9.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598907";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced calcium flux preincubated for 120 mins followed by orexin-A induction measured every 1 sec by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667559";"";"None";"455.40";"0";"3.96";"BDBM154932";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2cccc(Br)c2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"297223";"UO_0000065";"19.10";"0.46";"4.74";"13.09";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426141";"";"None";"397.87";"0";"3.39";"5j";"C[C@@H]1CC[C@@H](Oc2cc(Cl)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426129";"";"None";"377.45";"0";"3.04";"3";"Cc1cccc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)n1";"IC50";"'='";"33.0";"nM";"7.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL337159";"";"None";"397.52";"0";"3.19";"27";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccccn1)C(C)(C)C)CC2";"IC50";"'='";"1400.0";"nM";"5.85";"";"";"UO_0000065";"14.73";"0.28";"2.66";"9.19";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3891723";"";"None";"434.40";"0";"3.58";"BDBM185194";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1cc(F)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334111";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3973456";"";"None";"417.39";"0";"3.41";"BDBM185204";"O=C(N[C@H]1CCC[C@@H]1Oc1cc(C(F)(F)F)ccn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334121";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3260831";"";"None";"448.56";"0";"2.90";"37";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc(N)c4ccsc4n3)CC[C@H]2C)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.65";"0.32";"4.57";"7.04";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3260834";"";"None";"448.56";"0";"2.90";"40";"Cc1cc2c(N)nc(N3CC[C@@H](C)N(C(=O)c4ccccc4-n4nccn4)CC3)nc2s1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"16.65";"0.32";"4.57";"7.04";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL344622";"";"None";"402.56";"0";"3.85";"25";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1cccs1)C(C)(C)C)CC2";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"18.88";"0.37";"3.75";"14.96";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3113771";"";"None";"396.51";"0";"4.73";"71, Stereoisomeric mixture";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2sc(C)nc2c1";"IC50";"'='";"122.0";"nM";"6.91";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113762";"";"None";"437.46";"1";"5.49";"62";"COc1cccc(OC)c1C1CC(C)(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1080.0";"nM";"5.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113543";"";"None";"339.44";"0";"4.00";"26";"COc1cccc(OC)c1C1CCCC(=O)N1CCc1ccccc1";"IC50";"'='";"1331.0";"nM";"5.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113535";"";"None";"393.40";"1";"5.16";"17";"COc1cccc(C)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"268.0";"nM";"6.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113758";"";"None";"424.42";"0";"3.62";"58";"COc1cccc(OC)c1C1CN(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL497403";"";"None";"378.47";"0";"3.20";"22";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(F)cc1";"IC50";"'='";"346.0";"nM";"6.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL1333250";"";"None";"426.48";"0";"3.55";"SID49724792";"O=C(O)c1ccccc1NS(=O)(=O)c1cccc(-n2sc3ccccc3c2=O)c1";"IC50";"";"6800.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1458435";"";"None";"311.41";"0";"3.72";"SID26664038";"Cc1ccc(NC2=NC(=O)/C(=C/c3cccn3C)S2)cc1C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1512498";"";"None";"247.30";"0";"3.58";"SID49648071";"Cc1cccc2c3nc4ccccc4nc3n(C)c12";"IC50";"";"11000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1375038";"";"None";"482.59";"0";"3.01";"SID56316493";"CSc1cccc(N2CC(C(=O)NCCN3C(=O)S/C(=C\c4cccnc4)C3=O)CC2=O)c1";"IC50";"";"20600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1526729";"";"None";"252.30";"0";"2.87";"SID24821640";"N#Cc1cccn1-c1nccc(-c2cccs2)n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1606494";"";"None";"428.56";"0";"4.60";"SID14744388";"CN(C(=O)CSc1nc(-c2ccccc2)cn1N)C(c1ccccc1)c1ccccc1";"IC50";"";"20900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1555841";"";"None";"547.05";"2";"5.87";"SID85148927";"COC(=O)C1=C(c2ccccc2OCc2ccccc2)C[C@@H]2CC[C@H]1N2C(=O)NCCOc1ccccc1Cl";"IC50";"";"3900.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1980584";"";"None";"294.31";"0";"2.55";"SID7970886";"Cc1ccc2nc(Nc3ccccc3)c(/C=N/O)c(=O)n2c1";"IC50";"";"32500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1539105";"";"None";"267.72";"0";"3.93";"SID7964632";"Cn1c2ccc(Cl)cc2c2nc3ccccc3nc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1528787";"";"None";"352.37";"0";"2.97";"SID22408543";"O=C(OCc1cc(=O)n2c(n1)sc1ccccc12)c1cccc(O)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1590005";"";"None";"395.46";"0";"4.76";"SID85146492";"C=CCn1c2ccccc2c(=O)c2cc(C#Cc3cc(OC)cc(OC)c3)ccc21";"IC50";"";"11000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979083";"";"None";"560.59";"0";"2.88";"SID74373450";"CCSc1ccc([C@@H]2[C@H]3C(=O)N(CC)C(=O)[C@H]3[C@]3(C(=O)OC)CCCCN23)cc1OC.O=C(O)C(F)(F)F";"IC50";"";"6400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1448743";"";"None";"354.46";"0";"4.41";"SID14745046";"Cc1cnc(NC(=O)c2cc3c(C)nn(-c4ccccc4)c3s2)s1";"IC50";"";"60400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1406761";"";"None";"239.27";"0";"3.50";"SID24823971";"CCOC(=O)c1ccc2[nH]c3ccccc3c2c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1416951";"";"None";"336.39";"0";"3.83";"SID845346";"Cc1c(C(=O)Nc2ccc(N3CCOCC3)cc2)oc2ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1357156";"";"None";"340.38";"1";"5.05";"SID57268664";"Cc1nc2ccc(NC(=O)c3oc4ccc(F)cc4c3C)cc2s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1553774";"";"None";"337.44";"0";"3.99";"SID85146636";"COc1ccc2sc(-c3ccc(N(C)C)cc3)c(C#CCO)c2c1";"IC50";"";"37400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3667595";"";"None";"402.52";"0";"3.41";"BDBM154969";"COc1ccc(C)cc1S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"297260";"UO_0000065";"20.86";"0.41";"4.99";"11.09";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667592";"";"None";"402.52";"0";"3.41";"BDBM154966";"COc1cc(C)ccc1S(=O)(=O)N1CCC[C@H]1C(=O)Nc1cc(C)cc(C)c1";"IC50";"'='";"168.0";"nM";"6.78";"";"297257";"UO_0000065";"16.83";"0.33";"3.36";"8.95";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667561";"";"None";"455.40";"0";"3.96";"BDBM154934";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)cc2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"297225";"UO_0000065";"17.57";"0.42";"4.04";"12.03";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2385132";"";"None";"454.55";"0";"3.04";"EMPA";"CCN(Cc1cccnc1)C(=O)CN(c1ccc(OC)nc1)S(=O)(=O)c1ccccc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"19.14";"0.37";"5.66";"9.38";"0";"CHEMBL2390635";"Antagonist activity at OX2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2384932";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3667587";"";"None";"429.33";"0";"3.79";"BDBM154961";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(Cl)c(Cl)c2)cc1";"IC50";"'='";"58.0";"nM";"7.24";"";"297252";"UO_0000065";"16.86";"0.37";"3.45";"9.56";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL489884";"";"None";"458.60";"0";"4.78";"118";"COc1cc2c(cc1OC)C(Cc1ccc(C)c(C)c1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'='";"1161.0";"nM";"5.93";"";"";"UO_0000065";"12.94";"0.24";"1.16";"11.68";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490675";"";"None";"492.57";"0";"4.93";"110";"COc1cc2c(cc1OC)C(Cc1ccc(F)c(F)c1)N(CC(=O)NC1CCc3ccccc31)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL455137";"";"None";"416.59";"0";"4.36";"128";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL461772";"";"None";"460.62";"0";"4.55";"143";"CCc1nc(OC)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C)c(C)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL453915";"";"None";"561.10";"1";"4.37";"131";"CCN(Cc1cccc(C)n1)C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL344622";"";"None";"402.56";"0";"3.85";"48";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1cccs1)C(C)(C)C)CC2";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489284";"";"None";"504.60";"1";"4.80";"109";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC2CCc3ccccc32)cc1F";"IC50";"'='";"2686.0";"nM";"5.57";"";"";"UO_0000065";"11.04";"0.21";"0.77";"9.28";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL524093";"";"None";"456.59";"0";"4.65";"105";"COc1cc2c(cc1OC)C(Cc1ccccc1)N(CC(=O)NC1CCc3ccccc31)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3932131";"";"None";"430.47";"0";"2.71";"BDBM184045";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncon3)c2)c1-n1nccn1";"IC50";"'='";"403.0";"nM";"6.39";"";"332114";"UO_0000065";"14.86";"0.27";"3.68";"6.45";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3932799";"";"None";"430.47";"0";"1.64";"BDBM184015";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)n1";"IC50";"'='";"1630.0";"nM";"5.79";"";"332079";"UO_0000065";"13.45";"0.25";"4.15";"5.57";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4789372";"";"None";"470.58";"0";"4.39";"66";"C[C@@H]1CC[C@@H](c2nc(CN(C)C)c(-c3ccccc3)o2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"983.0";"nM";"6.01";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL2004183";"";"None";"334.43";"0";"3.20";"SID14737405";"COc1ccc(/C=N/Nc2snc(SC)c2C#N)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2003606";"";"None";"481.51";"0";"1.59";"SID57262163";"CCN(C(=O)CO/N=C/c1ccc(OC)cc1OC)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O";"IC50";"";"1770.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2006840";"";"None";"350.38";"0";"3.32";"SID24800864";"COc1cccc(/C=N/Nc2cc(C)nc(-c3ccccc3O)n2)c1O";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3742089";"";"None";"420.51";"0";"3.83";"(+/-)-4";"COc1ccc(CC2CCCCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1OC";"IC50";"'='";"3.3";"nM";"8.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3740506";"";"None";"406.49";"0";"3.44";"7";"COc1ccc(C[C@@H]2CCCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1OC";"IC50";"'='";"8.4";"nM";"8.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3740565";"";"None";"405.50";"0";"4.05";"9";"COc1ccc(C[C@@H]2CCCN2C(=O)c2cc(C)ccc2-n2cccn2)cc1OC";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3967139";"";"None";"439.52";"0";"3.72";"BDBM183991";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ccncc3)c2)c1";"IC50";"'='";"2107.0";"nM";"5.68";"";"332055";"UO_0000065";"12.91";"0.23";"1.96";"7.76";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3960556";"";"None";"433.45";"0";"2.07";"BDBM183999";"O=C(c1ccc(F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"889.0";"nM";"6.05";"";"332063";"UO_0000065";"13.96";"0.26";"3.98";"6.65";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921296";"";"None";"446.49";"0";"2.98";"BDBM183984";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cccn3)c2)c1F";"IC50";"'='";"1649.0";"nM";"5.78";"";"332048";"UO_0000065";"12.95";"0.24";"2.80";"7.41";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3945071";"";"None";"440.47";"0";"1.80";"BDBM183994";"N#Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"360.0";"nM";"6.44";"";"332058";"UO_0000065";"14.63";"0.27";"4.64";"5.62";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3890975";"";"None";"418.34";"0";"4.28";"BDBM185246";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1C(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"334163";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3929344";"";"None";"400.35";"0";"4.20";"BDBM185249";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1C(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"334166";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3891082";"";"None";"409.53";"0";"4.34";"BDBM202888";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(N2CCCCC2)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"360407";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926196";"";"None";"447.38";"1";"5.87";"BDBM203052";"COc1cccc(C(F)(F)F)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2950.0";"nM";"5.53";"";"360602";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3961144";"";"None";"411.47";"0";"4.75";"BDBM221375";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4ccccc43)c2)c1";"IC50";"'='";"86.0";"nM";"7.07";"";"387506";"UO_0000065";"17.17";"0.31";"2.32";"9.07";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935229";"";"None";"443.43";"0";"3.50";"BDBM185331";"CC1(Nc2ncc(C(F)(F)F)cn2)CCCC1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334248";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3954363";"";"None";"431.42";"0";"3.23";"BDBM185332";"CC1(Nc2ccc(C(F)(F)F)cn2)CCCC1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334249";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3909403";"";"None";"474.46";"0";"4.42";"BDBM185336";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1cc(F)ccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334253";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3942105";"";"None";"420.48";"1";"5.16";"BDBM202870";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccc(F)cc2)n1";"IC50";"'='";"142.0";"nM";"6.85";"";"360385";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957144";"";"None";"402.49";"1";"5.02";"BDBM202873";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccncc2)c1";"IC50";"'='";"64.0";"nM";"7.19";"";"360388";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890634";"";"None";"379.38";"0";"4.85";"BDBM203035";"CCOc1ccccc1C1CCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"240.0";"nM";"6.62";"";"360574";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953208";"";"None";"392.40";"0";"3.81";"BDBM203041";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccnc(OC(F)F)c1";"IC50";"'='";"923.0";"nM";"6.04";"";"360581";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113761";"";"None";"437.46";"1";"5.49";"BDBM50447795";"COc1cccc(OC)c1C1CCC(C)(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1291.0";"nM";"5.89";"";"360594";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113759";"";"None";"423.43";"1";"5.10";"BDBM50447797";"COc1cccc(OC)c1C1CCC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"894.0";"nM";"6.05";"";"360595";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890497";"";"None";"415.36";"0";"4.93";"BDBM203161";"CCOc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"360721";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915484";"";"None";"420.53";"1";"5.14";"BDBM203093";"Cc1nc(-c2cccc(CN3C(=O)CCCC3c3cccc4c3OCCO4)c2)cs1";"IC50";"'='";"229.0";"nM";"6.64";"";"360651";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1911743";"";"None";"340.81";"0";"4.20";"1f";"C[C@@H]1COc2ccc(C#N)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"8200.0";"nM";"5.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL2031485";"";"None";"473.60";"1";"5.54";"20";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccccc2)s1";"IC50";"'='";"8.7";"nM";"8.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031497";"";"None";"500.62";"1";"4.72";"32";"CO[C@@H]1CCN(C(=O)c2sc(C)nc2-c2ccccc2)[C@H](CNC(=O)c2cccc3cccnc23)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3902305";"";"None";"465.47";"1";"2.72";"BDBM221359";"COc1ccc(-c2ocnc2C(=O)Nc2cnn(CCNc3nc(OC)cc(OC)n3)c2)cc1";"IC50";"'='";"100.0";"nM";"7.00";"";"387489";"UO_0000065";"15.04";"0.28";"4.28";"5.06";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667603";"";"None";"386.52";"0";"3.71";"BDBM154977";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C)cc2C)c1";"IC50";"'='";"108.0";"nM";"6.97";"";"297268";"UO_0000065";"18.02";"0.35";"3.26";"10.48";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968919";"";"None";"438.60";"1";"7.12";"BDBM203269";"O=C1CCCCC(c2ccccc2-c2ccccc2)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"77.0";"nM";"7.11";"";"360833";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3741221";"";"None";"474.59";"0";"4.64";"(+/-)-3";"COc1ccc(CC2c3sccc3CCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1OC";"IC50";"'='";"428.0";"nM";"6.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL490885";"";"None";"504.63";"1";"4.74";"(+/-)-94";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC(C)c2ccccc2)cc1OC";"IC50";"'='";"9499.0";"nM";"5.02";"";"";"UO_0000065";"9.95";"0.19";"0.28";"7.25";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL453916";"";"None";"550.08";"1";"3.40";"132";"CCN(Cc1ccn(C)n1)C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL139083";"";"None";"381.52";"0";"4.49";"2";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"19.01";"0.35";"2.76";"18.70";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3930962";"";"None";"448.46";"0";"3.75";"BDBM240105";"CCOc1c(F)cccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"418946";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971174";"";"None";"450.95";"1";"5.72";"BDBM240153";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-c2ccccc2)s1";"IC50";"'='";"133.0";"nM";"6.88";"";"418995";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894582";"";"None";"479.99";"1";"5.48";"BDBM240154";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2nc(N(C)C)sc2-c2ccccc2)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"418996";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959783";"";"None";"431.46";"0";"3.01";"BDBM240185";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)no1";"IC50";"'='";"2.0";"nM";"8.70";"";"419027";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4071046";"";"None";"443.51";"0";"3.80";"11";"COc1ccc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(-c2ccncc2)n1";"IC50";"'='";"65.0";"nM";"7.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4755620";"";"None";"439.58";"0";"2.38";"18";"CNS(=O)(=O)N[C@H]1C[C@@H](C)N(C(=O)OC)[C@H]1CO[C@H]1CC[C@@H](c2ccccc2)CC1";"IC50";"'='";"0.5";"nM";"9.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL1560993";"";"None";"336.39";"0";"4.14";"SID85146499";"C=CCn1c2ccccc2c(=O)c2cc(C#Cc3ccccn3)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1334210";"";"None";"249.27";"0";"3.68";"SID14723730";"Cc1nc2cc(-c3nc4ccccc4o3)ccc2[nH]1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1571807";"";"None";"353.43";"1";"5.44";"SID17415295";"O=[N+]([O-])c1cccc(-c2nc(-c3cccs3)c(-c3cccs3)[nH]2)c1";"IC50";"";"3200.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1715597";"";"None";"378.88";"0";"3.44";"SID85268585";"Cc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)cc2)c1";"IC50";"";"370.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1978193";"";"None";"446.54";"1";"5.81";"SID24791433";"Sc1nnc(-c2cc(-c3ccccc3)[nH]n2)n1/N=C/c1c2ccccc2cc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1539105";"";"None";"267.72";"0";"3.93";"SID7964632";"Cn1c2ccc(Cl)cc2c2nc3ccccc3nc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1513765";"";"None";"462.55";"0";"3.36";"SID49733432";"CN(Cc1ccccc1)C(=O)c1[nH]cnc1C(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1485238";"";"None";"457.55";"0";"3.16";"SID49731791";"COc1ccc(N(CC(=O)NCCc2cccc(C)c2)S(=O)(=O)c2c(C)noc2C)cc1";"IC50";"";"2270.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1540610";"";"None";"323.40";"0";"2.44";"SID864606";"COC(=O)c1ccccc1NC(=O)c1sc(=S)n(C)c1N";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1406761";"";"None";"239.27";"0";"3.50";"SID24823971";"CCOC(=O)c1ccc2[nH]c3ccccc3c2c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1434457";"";"None";"465.58";"0";"3.85";"SID57256579";"CCOc1ccccc1N1CCN(C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)CC1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1540815";"";"None";"433.49";"0";"4.30";"SID22406208";"COc1ccccc1NS(=O)(=O)c1cccc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1731389";"";"None";"428.51";"0";"3.38";"SID51085667";"COc1ccc(OC)c(S(=O)(=O)NCC(c2ccco2)N2CCc3ccccc32)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3897277";"";"None";"390.42";"0";"4.48";"BDBM221303";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCc3cccc(F)c3)c2)c1";"IC50";"'='";"1780.0";"nM";"5.75";"";"387436";"UO_0000065";"14.73";"0.27";"1.27";"7.88";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL139634";"";"None";"397.52";"0";"3.19";"51";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1cccnc1)C(C)(C)C)CC2";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL435826";"";"None";"402.58";"0";"4.17";"(+/-)-45";"COc1cc2c(cc1OC)CN(C(=O)C(NCC1CCCCC1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490681";"";"None";"476.57";"0";"4.50";"(+/-)-92";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)Nc2ccccc2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.49";"0.20";"0.50";"7.22";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490484";"";"None";"516.64";"1";"4.67";"(+/-)-102";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC2CCc3ccccc32)cc1OC";"IC50";"'='";"679.0";"nM";"6.17";"";"";"UO_0000065";"11.94";"0.22";"1.50";"8.91";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3667582";"";"None";"424.91";"0";"3.15";"BDBM154956";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(Cl)ccc2OC)cc1";"IC50";"'='";"209.0";"nM";"6.68";"";"297247";"UO_0000065";"15.72";"0.33";"3.53";"7.86";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4635632";"";"None";"431.48";"0";"3.28";"(+)-3a";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC[C@@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"313.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4645246";"";"None";"447.47";"0";"2.51";"(-)-3g";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4638046";"";"None";"447.47";"0";"2.86";"(-)-3h, ORN0829";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"1.27";"nM";"8.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3898332";"";"None";"402.45";"0";"4.35";"BDBM221308";"COc1cccc(CCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)c1";"IC50";"'='";"399.0";"nM";"6.40";"";"387441";"UO_0000065";"15.90";"0.29";"2.05";"7.79";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924741";"";"None";"418.46";"0";"3.61";"BDBM221316";"COc1ccnc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)c1";"IC50";"'='";"254.0";"nM";"6.59";"";"387449";"UO_0000065";"15.76";"0.29";"2.99";"6.16";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940453";"";"None";"457.56";"1";"5.30";"BDBM221331";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncsc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"30.0";"nM";"7.52";"";"387464";"UO_0000065";"16.44";"0.31";"2.22";"8.87";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917373";"";"None";"464.91";"0";"4.18";"BDBM240205";"COc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2cc(C)c(C)cc2-n2nccn2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"419047";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937139";"";"None";"450.89";"0";"3.87";"BDBM240212";"COc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)no1";"IC50";"'='";"4.0";"nM";"8.40";"";"419055";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL140559";"";"None";"444.53";"0";"3.63";"7";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)NC(=O)c1ccccc1)CC2";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"13.60";"0.25";"2.42";"8.91";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3937551";"";"None";"456.51";"0";"2.82";"BDBM183970";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1cccnn1";"IC50";"'='";"6090.0";"nM";"5.21";"";"332034";"UO_0000065";"11.42";"0.21";"2.40";"5.47";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940436";"";"None";"439.52";"0";"3.72";"BDBM183988";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3cccnc3)c2)c1";"IC50";"'='";"1400.0";"nM";"5.85";"";"332052";"UO_0000065";"13.32";"0.24";"2.13";"8.00";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3904485";"";"None";"463.93";"0";"2.89";"BDBM184067";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(Cl)cc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"101.0";"nM";"7.00";"";"332136";"UO_0000065";"15.08";"0.29";"4.11";"7.69";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3971116";"";"None";"447.47";"0";"2.38";"BDBM184108";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(F)cc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"282.0";"nM";"6.55";"";"332177";"UO_0000065";"14.64";"0.27";"4.17";"7.20";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931945";"";"None";"458.50";"0";"3.34";"BDBM184110";"C[C@@H]1CN(C(=O)c2ccccc2-n2nccn2)[C@H](Cc2cc(-c3ncccn3)ccc2F)CO1";"IC50";"'='";"1935.0";"nM";"5.71";"";"332179";"UO_0000065";"12.46";"0.23";"2.37";"6.64";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936920";"";"None";"463.93";"0";"2.89";"BDBM184082";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2Cl)c(-n2nccn2)c1";"IC50";"'='";"531.0";"nM";"6.28";"";"332151";"UO_0000065";"13.53";"0.26";"3.38";"6.90";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4794726";"";"None";"386.49";"0";"4.02";"27";"CCOc1ccccc1C(=O)N1C[C@H](c2nc(C(C)(C)O)c(C)o2)CC[C@H]1C";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL3338857";"";"None";"441.49";"0";"3.86";"16";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2ccccn2)nc1OC";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"16.86";"0.31";"3.58";"7.51";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3940216";"";"None";"392.46";"0";"3.54";"BDBM202907";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2cccn2)n1";"IC50";"'='";"213.0";"nM";"6.67";"";"360430";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969830";"";"None";"423.54";"0";"4.78";"BDBM202909";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"360433";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113753";"";"None";"409.51";"0";"4.48";"BDBM50447803";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"360435";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946040";"";"None";"393.45";"0";"2.93";"BDBM202920";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"156.0";"nM";"6.81";"";"360446";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919120";"";"None";"422.57";"1";"5.34";"BDBM202941";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(N2CCCCC2)c1";"IC50";"'='";"58.0";"nM";"7.24";"";"360467";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966965";"";"None";"408.54";"0";"4.95";"BDBM202946";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(N2CCCC2)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"360472";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915110";"";"None";"391.47";"0";"4.14";"BDBM203017";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(-n2cccn2)cc1";"IC50";"'='";"453.0";"nM";"6.34";"";"360547";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975065";"";"None";"392.40";"0";"3.95";"BDBM203031";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(OC(F)F)ccn1";"IC50";"'='";"484.0";"nM";"6.32";"";"360567";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113775";"";"None";"423.43";"1";"5.25";"BDBM50447781";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"66.0";"nM";"7.18";"";"360572";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946821";"";"None";"446.49";"0";"3.47";"BDBM208519";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cn2cc(-c3ccc(F)cc3)cn2)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"368556";"UO_0000065";"20.16";"0.37";"5.53";"11.53";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970371";"";"None";"449.47";"0";"3.02";"BDBM221413";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"19.0";"nM";"7.72";"";"387544";"UO_0000065";"17.18";"0.32";"4.70";"5.98";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890024";"";"None";"392.46";"0";"3.54";"BDBM202883";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2cncn2)c1";"IC50";"'='";"471.0";"nM";"6.33";"";"360402";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955148";"";"None";"388.47";"0";"4.63";"BDBM202973";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccnc(-c2ccccc2)c1";"IC50";"'='";"121.0";"nM";"6.92";"";"360499";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667602";"";"None";"420.96";"0";"4.37";"BDBM154976";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2cc(C)c(Cl)cc2C)c1";"IC50";"'='";"171.0";"nM";"6.77";"";"297267";"UO_0000065";"16.08";"0.33";"2.40";"10.18";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3338851";"";"None";"441.49";"0";"3.86";"10";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)nnc2-c2ccccc2)nc1OC";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"15.33";"0.28";"2.91";"6.83";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL4783256";"";"None";"457.57";"0";"2.52";"25";"CNS(=O)(=O)N[C@H]1C[C@@H](C)N(C(=O)OC)[C@H]1CO[C@H]1CC[C@@H](c2cccc(F)c2)CC1";"IC50";"'='";"0.27";"nM";"9.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL469146";"";"None";"413.49";"0";"2.87";"1";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCN(c3ncc4ccccc4n3)CC2)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3667604";"";"None";"451.39";"0";"4.17";"BDBM154978";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)cc2C)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"297269";"UO_0000065";"16.96";"0.39";"3.49";"11.52";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667580";"";"None";"400.50";"0";"2.98";"BDBM154954";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc3c(c2)CCC3)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"297245";"UO_0000065";"19.78";"0.39";"4.94";"10.46";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1720286";"";"None";"374.98";"0";"4.43";"SID47195899";"Cl.c1ccc(CN2CCN(C3CCCSc4ccccc43)CC2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1584180";"";"None";"483.55";"1";"5.23";"SID22409822";"O=C(Nc1cccc(S(=O)(=O)NCc2ccco2)c1)c1cc(-c2ccccc2)nc2ccccc12";"IC50";"";"16900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1485238";"";"None";"457.55";"0";"3.16";"SID49731791";"COc1ccc(N(CC(=O)NCCc2cccc(C)c2)S(=O)(=O)c2c(C)noc2C)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1480014";"";"None";"426.52";"0";"4.72";"SID14726667";"Cc1ccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)cc1";"IC50";"";"24900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1399289";"";"None";"308.37";"0";"3.53";"SID861745";"COc1ccc(-c2nn3c(-c4ccccc4)nnc3s2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1977763";"";"None";"271.28";"0";"2.77";"SID17506339";"CN(/N=C/c1cc([N+](=O)[O-])ccc1O)c1ccccc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418095";"";"None";"374.44";"1";"5.08";"SID17511678";"CCn1c2ccccc2c2cc(NC(=O)c3cc(OC)cc(OC)c3)ccc21";"IC50";"";"21650.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1588256";"";"None";"455.49";"0";"3.65";"SID17504815";"CC(NS(=O)(=O)c1ccc(OCC(=O)Nc2cccc([N+](=O)[O-])c2)cc1)c1ccccc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1541192";"";"None";"447.52";"0";"2.78";"SID7967149";"O=C(C1CCCN1S(=O)(=O)c1cccc2cccnc12)N1CCn2c1nc1ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532928";"";"None";"260.30";"0";"4.35";"SID3711653";"Cc1ccnc2ccc(-c3nc4ccccc4o3)cc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1502107";"";"None";"430.90";"1";"5.33";"SID17387640";"Cc1cccc(NC(=O)NNC(=O)c2cc(-c3ccccc3Cl)nc3ccccc23)c1";"IC50";"";"16400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1409330";"";"None";"300.43";"0";"4.95";"SID3711668";"N#CC(=C1SC=CS1)c1nc(-c2ccccc2)cs1";"IC50";"";"6655.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1422276";"";"None";"324.41";"0";"3.88";"SID24821268";"Cc1cc(O)n2nc(-c3sccc3-n3c(C)ccc3C)cc2n1";"IC50";"";"53400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1384723";"";"None";"420.48";"0";"2.84";"SID24840225";"C=Cn1ccnc1P(=S)(c1c(C)nn(-c2ccccc2)c1C)c1nccn1C=C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1481716";"";"None";"408.52";"0";"3.77";"SID49716568";"Cc1ccc(/C=C2/Sc3ccccc3N(CC(=O)NCC3CCCO3)C2=O)cc1";"IC50";"";"29800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1334210";"";"None";"249.27";"0";"3.68";"SID14723730";"Cc1nc2cc(-c3nc4ccccc4o3)ccc2[nH]1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1379934";"";"None";"397.50";"0";"3.01";"SID49674112";"Cc1ccc(S(=O)(=O)N2CCCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1";"IC50";"";"29400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1731389";"";"None";"428.51";"0";"3.38";"SID51085667";"COc1ccc(OC)c(S(=O)(=O)NCC(c2ccco2)N2CCc3ccccc32)c1";"IC50";"";"10500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3597952";"ACT-462206";"1.0";"388.49";"0";"3.10";"BDBM154947";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"297238";"UO_0000065";"21.37";"0.42";"5.20";"10.96";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1421498";"";"None";"486.41";"0";"3.62";"SID49642404";"CCOc1cc(C(=S)N2CCOCC2)cc(Br)c1OS(=O)(=O)c1ccccc1";"IC50";"";"6200.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1556254";"";"None";"314.39";"0";"4.26";"SID14725382";"Cc1nc2c(-c3ccccc3)c(C)nn2c(N)c1-c1ccccc1";"IC50";"";"24900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1481095";"";"None";"281.34";"0";"4.32";"SID17409133";"COc1ccc2c(c1)nc(O)c1sc3ccccc3c12";"IC50";"";"5500.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1612190";"";"None";"312.42";"0";"4.18";"SID24816433";"O=C(CSc1ccc(-c2ccccc2)nn1)c1cccs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1721971";"";"None";"394.88";"0";"3.14";"SID85199502";"COc1ccccc1NC(=O)[C@@H]1CCCN1S(=O)(=O)c1ccc(Cl)cc1";"IC50";"";"11000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2031484";"";"None";"502.62";"2";"5.48";"19";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccc(F)cc2)s1";"IC50";"'='";"658.0";"nM";"6.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3962710";"";"None";"428.50";"0";"2.85";"BDBM183985";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"318.0";"nM";"6.50";"";"332049";"UO_0000065";"15.16";"0.28";"3.65";"8.32";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957752";"";"None";"439.52";"0";"3.72";"BDBM183987";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ccccn3)c2)c1";"IC50";"'='";"1030.0";"nM";"5.99";"";"332051";"UO_0000065";"13.62";"0.25";"2.27";"8.19";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1080882";"";"None";"444.62";"0";"4.79";"25(R;R)";"CCc1ccc(CC[C@@H]2c3c(C)nn(CC)c3CCN2[C@@H](C(=O)NC)c2ccccc2)cc1";"IC50";"'='";"174.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080724";"";"None";"434.56";"0";"4.37";"29, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1cccc(F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL4077821";"";"None";"420.45";"0";"3.55";"17";"CCN(C(=O)c1ccccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"11.6";"nM";"7.94";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL2413368";"";"None";"476.60";"0";"3.90";"54";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC2CNC(=O)c2cccc3c2OCCN3C)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2413367";"";"None";"518.65";"2";"5.13";"34, ACT-335827";"COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CCN2[C@@H](C(=O)NC(C)C)c2ccccc2)cc1OC";"IC50";"'='";"417.0";"nM";"6.38";"";"";"UO_0000065";"12.30";"0.23";"1.25";"9.21";"0";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL1911742";"";"None";"361.89";"1";"5.05";"1e";"CSc1ccc2c(c1)[C@H](C)N(C(=O)c1ccc(Cl)cc1)[C@H](C)CO2";"IC50";"'='";"6.4";"nM";"8.19";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3667549";"";"None";"461.43";"0";"4.02";"BDBM154922";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)s2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"297213";"UO_0000065";"17.34";"0.44";"3.98";"12.03";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3983952";"";"None";"464.46";"0";"3.37";"BDBM240183";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(F)c3OC)n2)c(-n2nccn2)cc1C";"IC50";"'='";"0.6";"nM";"9.22";"";"419025";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985158";"";"None";"519.87";"1";"4.20";"BDBM240225";"COc1cc(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c(-n2nccn2)cc1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"419068";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975171";"";"None";"391.47";"0";"4.14";"BDBM202887";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2ccnc2)c1";"IC50";"'='";"181.0";"nM";"6.74";"";"360406";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974746";"";"None";"429.48";"0";"2.24";"BDBM183978";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3ccnn3)c2)c1";"IC50";"'='";"3160.0";"nM";"5.50";"";"332042";"UO_0000065";"12.81";"0.23";"3.26";"6.05";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3906721";"";"None";"431.36";"0";"4.10";"BDBM203248";"CCOc1cc(F)cc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"255.0";"nM";"6.59";"";"360810";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113760";"";"None";"423.43";"1";"5.10";"BDBM50447796";"COc1cccc(OC)c1C1CC(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"297.0";"nM";"6.53";"";"360552";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963425";"";"None";"392.40";"0";"3.95";"BDBM203027";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(OC(F)F)n1";"IC50";"'='";"64.0";"nM";"7.19";"";"360562";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113773";"";"None";"395.38";"0";"4.47";"BDBM50447783";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"158.0";"nM";"6.80";"";"360575";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909846";"";"None";"409.40";"0";"4.71";"BDBM203039";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"108.0";"nM";"6.97";"";"360579";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934693";"";"None";"449.41";"0";"3.00";"BDBM185259";"CN(c1cnc(C(F)(F)F)cn1)[C@H]1CCC[C@@H]1NC(=O)c1c(F)cccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334176";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3949639";"";"None";"460.46";"0";"4.18";"BDBM185328";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1nc(C)no1";"IC50";"'>'";"10000.0";"nM";"";"";"334245";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3944614";"";"None";"443.43";"0";"3.42";"BDBM185337";"Cc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334254";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3950867";"";"None";"440.51";"0";"3.12";"BDBM184003";"Cc1ccnc(-c2cccc(C[C@@H]3COCCN3C(=O)c3ccccc3-n3nccn3)c2)n1";"IC50";"'='";"762.0";"nM";"6.12";"";"332067";"UO_0000065";"13.89";"0.25";"3.00";"7.11";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3926167";"";"None";"426.48";"0";"2.81";"BDBM184011";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2cccnn2)c1";"IC50";"'='";"4440.0";"nM";"5.35";"";"332075";"UO_0000065";"12.55";"0.23";"2.54";"6.22";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3953726";"";"None";"457.54";"0";"2.94";"BDBM184061";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1C";"IC50";"'='";"1223.0";"nM";"5.91";"";"332130";"UO_0000065";"12.92";"0.24";"2.97";"6.50";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3982996";"";"None";"463.93";"0";"2.89";"BDBM184068";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(Cl)cc(-n3nccn3)c2)c1-n1nccn1";"IC50";"'='";"335.0";"nM";"6.47";"";"332137";"UO_0000065";"13.96";"0.27";"3.58";"7.12";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL497402";"";"None";"439.38";"0";"3.82";"21";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(Br)cc1";"IC50";"'='";"142.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL495974";"";"None";"512.07";"1";"4.27";"42";"CCN(CC)C(=O)CN(c1cc(N(CC)CC)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"2405.0";"nM";"5.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL486116";"";"None";"470.52";"0";"4.18";"17";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccc(F)c(F)c2)cc1OC";"IC50";"'<'";"30.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3667564";"";"None";"429.33";"0";"3.79";"BDBM154937";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(Cl)cc(Cl)c2)cc1";"IC50";"'='";"20.0";"nM";"7.70";"";"297228";"UO_0000065";"17.93";"0.39";"3.91";"10.17";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4087320";"";"None";"435.47";"0";"2.31";"26";"CCN(C(=O)c1nc(C)ccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4096898";"";"None";"446.49";"0";"3.19";"27";"CCN(C(=O)c1nc(C)ccc1-c1ncccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"1310.0";"nM";"5.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL2031499";"";"None";"508.62";"1";"3.89";"43";"O=C(NC[C@@H]1CCC(NCCO)CN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"137.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3667576";"";"None";"424.91";"0";"3.15";"BDBM154950";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(OC)ccc2Cl)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"297241";"UO_0000065";"16.22";"0.34";"3.74";"8.11";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL138101";"";"None";"460.41";"1";"5.26";"(+/-)-26";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccc(Br)cc1)C(C)(C)C)CC2";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3910286";"";"None";"472.52";"0";"3.64";"BDBM184127";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-c3cccnn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"1296.0";"nM";"5.89";"";"332196";"UO_0000065";"12.46";"0.23";"2.25";"6.84";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3938872";"";"None";"463.93";"0";"2.89";"BDBM184153";"Cc1ccc(-n2nccn2)cc1C[C@@H]1COCCN1C(=O)c1ccc(Cl)cc1-n1nccn1";"IC50";"'='";"1040.0";"nM";"5.98";"";"332222";"UO_0000065";"12.90";"0.25";"3.09";"6.58";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL485915";"";"None";"448.56";"0";"4.29";"23";"COc1ccc(OCCCN(CC(=O)NCc2ccccc2)Cc2ccccc2)cc1OC";"IC50";"'='";"51.29";"nM";"7.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL486542";"";"None";"484.54";"0";"4.57";"24";"COc1ccc(OCCCN(CC(=O)NCc2ccccc2)Cc2ccc(F)c(F)c2)cc1OC";"IC50";"'='";"107.15";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3942262";"";"None";"459.51";"0";"2.25";"BDBM184000";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1C";"IC50";"'='";"209.0";"nM";"6.68";"";"332064";"UO_0000065";"14.54";"0.27";"4.43";"6.67";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL140260";"";"None";"401.51";"0";"4.62";"4";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)c1ccccc1)CC2";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"15.95";"0.29";"1.78";"16.52";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3940457";"";"None";"403.48";"0";"4.41";"BDBM202895";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)n1";"IC50";"'='";"87.0";"nM";"7.06";"";"360417";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900745";"";"None";"406.43";"0";"4.26";"BDBM202922";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc(OC(F)F)c(C)c1";"IC50";"'='";"77.0";"nM";"7.11";"";"360448";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959981";"";"None";"416.52";"1";"5.41";"BDBM202935";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccccc2)n1";"IC50";"'='";"26.0";"nM";"7.58";"";"360461";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921650";"";"None";"380.42";"0";"3.52";"BDBM203179";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"87.0";"nM";"7.06";"";"360740";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409869";"";"None";"401.46";"1";"5.47";"BDBM50074060";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"20.0";"nM";"7.70";"";"360506";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895679";"";"None";"402.49";"0";"4.88";"BDBM202989";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ccccc2)n1";"IC50";"'='";"29.0";"nM";"7.54";"";"360517";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926581";"";"None";"391.47";"0";"4.00";"BDBM202995";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cnn(-c2ccccc2)c1";"IC50";"'='";"318.0";"nM";"6.50";"";"360523";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951832";"";"None";"391.41";"0";"4.56";"BDBM203014";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)F)cc1";"IC50";"'='";"31.0";"nM";"7.51";"";"360544";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954157";"";"None";"429.37";"0";"3.58";"BDBM203132";"COc1ccc(F)c(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"742.0";"nM";"6.13";"";"360690";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934631";"";"None";"419.32";"0";"4.68";"BDBM203280";"COc1c(F)ccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"405.0";"nM";"6.39";"";"360700";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409859";"";"None";"411.38";"0";"3.44";"BDBM203082";"COc1cccc(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"59.0";"nM";"7.23";"";"360637";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915167";"";"None";"375.47";"1";"5.11";"BDBM202876";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc2ccccc12";"IC50";"'='";"23.0";"nM";"7.64";"";"360394";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1440341";"";"None";"357.49";"0";"4.88";"SID14737997";"CSc1nc2ccc3nc(NC(=O)c4ccccc4)sc3c2s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1463349";"";"None";"316.41";"0";"3.45";"SID14744997";"CCSc1nnc(NC(=O)c2ccc3ccccc3n2)s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1460004";"";"None";"501.07";"1";"5.06";"SID24818007";"COc1ccc(OCc2n(CC(=O)OC3CC(C)CCC3C(C)C)c3ccccc3[n+]2C)cc1.[Cl-]";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1520702";"";"None";"311.34";"1";"5.09";"SID49648838";"O=c1c2ccccc2oc2cc(-c3ccc4[nH]ccc4c3)ccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1448743";"";"None";"354.46";"0";"4.41";"SID14745046";"Cc1cnc(NC(=O)c2cc3c(C)nn(-c4ccccc4)c3s2)s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1409773";"";"None";"302.18";"0";"3.78";"SID47200842";"Cc1cc(C)n2nc(-c3cccc(Br)c3)cc2n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1562279";"";"None";"408.45";"0";"2.76";"SID49716630";"COc1cccc(/C=C2/Oc3ccccc3N(CC(=O)NCC3CCCO3)C2=O)c1";"IC50";"";"960.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1542157";"";"None";"321.41";"0";"4.33";"SID17410557";"Cc1[nH]c2ccccc2c1C(=O)CSc1nc2ccccc2[nH]1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1364699";"";"None";"322.41";"0";"4.84";"SID4259189";"CCN(CC)c1ccc(NC(=O)c2cc3ccccc3o2)c(C)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1445904";"";"None";"374.39";"0";"1.77";"SID49817991";"CCOC(=O)C1=C(COC(=O)/C=C/c2cccc(OC)c2)NC(=O)NC1C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979083";"";"None";"560.59";"0";"2.88";"SID74373450";"CCSc1ccc([C@@H]2[C@H]3C(=O)N(CC)C(=O)[C@H]3[C@]3(C(=O)OC)CCCCN23)cc1OC.O=C(O)C(F)(F)F";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1438796";"";"None";"307.42";"0";"4.09";"SID49677881";"CN(C)c1ccc(NC(=S)c2ccc3ccccc3n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1503548";"";"None";"247.30";"0";"3.76";"SID7972454";"CCn1c2ccccc2c2nc3ccccc3nc21";"IC50";"";"6650.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1702133";"";"None";"342.42";"0";"3.68";"SID47201161";"O=C(O)CCn1c(SCCOc2ccccc2)nc2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1372776";"";"None";"598.50";"1";"4.64";"SID14728003";"Cc1cc(Br)cc2c1NC(=O)C2(c1c(C)n(C)n(-c2ccccc2)c1=O)c1c(C)n(C)n(-c2ccccc2)c1=O";"IC50";"";"990.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1476869";"";"None";"406.89";"0";"3.50";"SID49671047";"COc1cc(CN2CC(=O)N(c3ccccc3Cl)C2=S)cc(OC)c1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1557141";"";"None";"386.48";"0";"2.54";"SID24816259";"CCOC(=O)N1CCN(C(=O)CSc2ccc(-c3ccccc3)nn2)CC1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3939510";"";"None";"443.51";"0";"2.55";"BDBM184086";"Cc1ccc(-n2nccn2)cc1C[C@@H]1COCCN1C(=O)c1cccc(C)c1-n1nccn1";"IC50";"'='";"997.0";"nM";"6.00";"";"332155";"UO_0000065";"13.53";"0.25";"3.45";"6.60";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3905303";"";"None";"413.49";"0";"3.09";"BDBM183961";"O=C(c1ccccc1-n1nccn1)N1CCCC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"332084";"UO_0000065";"19.16";"0.35";"4.83";"9.69";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3916290";"";"None";"463.47";"0";"2.08";"BDBM184057";"COc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"1199.0";"nM";"5.92";"";"332126";"UO_0000065";"12.78";"0.24";"3.84";"5.91";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901878";"";"None";"479.93";"0";"2.59";"BDBM184066";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1Cl";"IC50";"'='";"117.0";"nM";"6.93";"";"332135";"UO_0000065";"14.44";"0.28";"4.34";"6.92";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1342815";"";"None";"337.40";"0";"4.25";"SID14744749";"Cc1cc(SCC(=O)c2ccc3c(c2)OCO3)nc2ccccc12";"IC50";"";"14100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1558506";"";"None";"350.38";"0";"3.01";"SID17504004";"COc1ccc(/C=C/c2nc(N)nc(-c3ccccc3O)n2)cc1OC";"IC50";"";"26900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1557141";"";"None";"386.48";"0";"2.54";"SID24816259";"CCOC(=O)N1CCN(C(=O)CSc2ccc(-c3ccccc3)nn2)CC1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1549099";"";"None";"278.34";"0";"3.33";"SID864252";"N#Cc1c(-c2cccs2)cc(-c2ccccn2)nc1N";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3949161";"";"None";"416.41";"0";"3.44";"BDBM185215";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334132";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3954353";"";"None";"430.43";"0";"3.75";"BDBM185232";"Cc1ccc(-n2cccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334149";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3972328";"";"None";"450.85";"0";"4.10";"BDBM185243";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(Cl)ccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334160";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3895462";"";"None";"362.43";"0";"4.12";"BDBM202963";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"136.0";"nM";"6.87";"";"360489";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920046";"";"None";"361.44";"0";"4.72";"BDBM202969";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc2ccccc12";"IC50";"'='";"291.0";"nM";"6.54";"";"360495";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983793";"";"None";"388.47";"0";"4.63";"BDBM202972";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"360498";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3921814";"";"None";"450.85";"0";"4.10";"BDBM185281";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1cc(Cl)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334198";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3907364";"";"None";"416.41";"0";"3.44";"BDBM185285";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ncccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334202";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3944270";"";"None";"434.40";"0";"3.58";"BDBM185286";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1c(F)cccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334203";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3949011";"";"None";"403.44";"0";"3.88";"BDBM221384";"Cc1ccc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc1";"IC50";"'='";"1851.0";"nM";"5.73";"";"387515";"UO_0000065";"14.21";"0.26";"1.85";"6.03";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981762";"";"None";"475.94";"1";"5.42";"BDBM221411";"COc1cc2c(ccn2CCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)cc1Cl";"IC50";"'='";"40.0";"nM";"7.40";"";"387542";"UO_0000065";"15.54";"0.30";"1.98";"8.49";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933506";"";"None";"424.57";"1";"6.65";"BDBM203107";"Cc1nc(-c2cccc(CN3C(=O)CCC3c3ccccc3-c3ccccc3)c2)cs1";"IC50";"'='";"462.0";"nM";"6.33";"";"360665";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909986";"";"None";"403.45";"1";"5.84";"BDBM203180";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"6.0";"nM";"8.22";"";"360741";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1438417";"";"None";"357.37";"0";"3.26";"SID49667368";"Cc1nn(-c2ccccc2)c2nc(N)c(C#N)c(-c3ccc(O)c(O)c3)c12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3338852";"";"None";"439.52";"1";"5.07";"11";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ccc2-c2ccccc2)nc1OC";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"17.87";"0.33";"2.78";"10.71";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3338848";"";"None";"440.50";"0";"4.46";"7";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2ccccc2)nc1OC";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"17.43";"0.32";"3.22";"8.90";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1513765";"";"None";"462.55";"0";"3.36";"SID49733432";"CN(Cc1ccccc1)C(=O)c1[nH]cnc1C(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2007173";"";"None";"495.40";"0";"4.48";"SID24787776";"O=C(NC(Cc1c[nH]c2ccccc12)C(=O)N/N=C/c1ccc(Br)cc1)c1cccs1";"IC50";"";"14300.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1973904";"";"None";"450.95";"0";"4.37";"SID24782224";"O=C(NC(Cc1c[nH]c2ccccc12)C(=O)N/N=C/c1ccc(Cl)cc1)c1cccs1";"IC50";"";"24000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1364699";"";"None";"322.41";"0";"4.84";"SID4259189";"CCN(CC)c1ccc(NC(=O)c2cc3ccccc3o2)c(C)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1466856";"";"None";"397.41";"0";"3.03";"SID3713616";"Cc1noc(C)c1COC(=O)c1ccc2c(c1)S(=O)(=O)c1ccccc1C2=O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1560993";"";"None";"336.39";"0";"4.14";"SID85146499";"C=CCn1c2ccccc2c(=O)c2cc(C#Cc3ccccn3)ccc21";"IC50";"";"20500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1977808";"";"None";"383.40";"0";"2.97";"SID26665718";"COc1ccc(OC)c(/C=N/NC(=O)c2cc3c(OC)cc(OC)cc3[nH]2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335116";"";"None";"496.62";"0";"2.88";"SID24831241";"CCc1cc2c(SCC(=O)N(CC)c3c(N)n(Cc4ccccc4)c(=O)[nH]c3=O)ncnc2s1";"IC50";"";"31500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL455136";"ALMOREXANT";"3.0";"512.57";"2";"5.74";"2";"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"8100.0";"nM";"5.09";"";"";"UO_0000065";"9.93";"0.19";"-0.65";"10.02";"0";"CHEMBL2424458";"Antagonist activity at OX2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417373";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL454924";"";"None";"520.62";"2";"5.78";"126";"COc1cc2c(cc1OC)C(CCc1ccc(F)c(F)c1)N(C(C(=O)NCC1CC1)c1ccccc1)CC2";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"15.09";"0.28";"2.07";"15.46";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489686";"";"None";"522.64";"2";"6.17";"125";"CCCCNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1CCc1ccc(F)c(F)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"14.77";"0.28";"1.55";"15.20";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL491086";"";"None";"491.59";"0";"3.57";"(+/-)-98";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2cccnc2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.17";"0.19";"1.43";"6.09";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3941361";"";"None";"431.42";"0";"4.22";"BDBM185192";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2ccc(C(F)(F)F)cn2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334109";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3898767";"";"None";"416.41";"0";"3.44";"BDBM185196";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334113";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL1534057";"";"None";"362.43";"0";"4.05";"SID49673460";"CC(=O)Nc1cccc(OCC(=O)NC(C)c2ccc3ccccc3c2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1521046";"";"None";"239.27";"0";"2.82";"SID24819844";"CN(C)/C=C1/Oc2c(ccc3ccccc23)C1=O";"IC50";"";"18300.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1501678";"";"None";"469.59";"1";"5.01";"SID22406356";"CCN(CC)c1ccc(NC(=O)Cn2c(C(C)NC(=O)c3ccccc3)nc3ccccc32)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1981638";"";"None";"399.25";"0";"4.13";"SID24811895";"Cc1ccc(-c2cc(C(=O)N/N=C/C(Br)=C/c3ccccc3)[nH]n2)o1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1565349";"";"None";"459.55";"0";"3.09";"SID14720488";"COc1ccccc1C(=O)Nc1nc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)cs1";"IC50";"";"5930.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1605702";"";"None";"396.53";"0";"4.90";"SID17408202";"Cc1ccccc1N(CC(=O)NC1CCCC1)C(=O)c1oc(C(C)(C)C)cc1C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1572095";"";"None";"482.03";"1";"6.09";"SID17433769";"C=CCn1c(SCc2ccc(C(=O)Nc3nccs3)cc2)nnc1-c1ccc(C)c(Cl)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL487980";"";"None";"406.55";"0";"3.42";"14";"COc1ccc(OCCN(CC(=O)NCC(C)C)Cc2cccs2)cc1OC";"IC50";"'='";"323.59";"nM";"6.49";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL485717";"";"None";"475.01";"0";"4.62";"22";"COc1ccc(OCCN(CC(=O)NCc2ccccc2Cl)Cc2cccs2)cc1OC";"IC50";"'='";"194.98";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3949766";"";"None";"410.40";"0";"3.28";"BDBM185186";"COc1cccc(OC)c1C(=O)N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334103";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3981448";"";"None";"415.42";"0";"3.82";"BDBM185206";"O=C(NC1CCCC1Cc1cc(C(F)(F)F)ccn1)c1ccccc1-n1nccn1";"IC50";"'='";"3800.0";"nM";"5.42";"";"334124";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3894311";"";"None";"409.41";"0";"3.88";"BDBM185211";"COc1cccc(OC)c1C(=O)N[C@H]1CCC[C@@H]1Nc1cccc(C(F)(F)F)n1";"IC50";"'='";"2000.0";"nM";"5.70";"";"334128";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3913231";"";"None";"451.84";"0";"3.49";"BDBM185239";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(Cl)ccc1-n1ccnn1";"IC50";"'>'";"10000.0";"nM";"";"";"334156";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3975385";"";"None";"435.33";"0";"3.55";"BDBM185242";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ncccc1OC(F)(F)F";"IC50";"'>'";"10000.0";"nM";"";"";"334159";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3956915";"";"None";"453.38";"0";"3.12";"BDBM185248";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(F)ccc(F)c1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334165";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL513527";"";"None";"374.51";"0";"3.37";"28";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1cccc(C)c1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL526837";"";"None";"575.11";"2";"5.23";"52";"CCN(C(=O)CN(c1cc2c(C)nsc2cc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1cccc(C)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3907374";"";"None";"445.55";"0";"3.78";"BDBM184155";"Cc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1nccs1";"IC50";"'='";"238.0";"nM";"6.62";"";"332224";"UO_0000065";"14.87";"0.28";"2.84";"9.06";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917353";"";"None";"380.44";"0";"4.41";"BDBM203074";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2oc(C)nc2c1";"IC50";"'='";"223.0";"nM";"6.65";"";"360628";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952013";"";"None";"383.34";"0";"4.41";"BDBM203118";"COc1ccccc1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"568.0";"nM";"6.25";"";"360676";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948062";"";"None";"401.33";"0";"4.54";"BDBM203124";"COc1cc(F)ccc1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"143.0";"nM";"6.84";"";"360682";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978028";"";"None";"413.37";"0";"3.96";"BDBM203131";"CCOc1c(F)cccc1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1680.0";"nM";"5.78";"";"360689";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906516";"";"None";"433.40";"1";"5.56";"BDBM203136";"COc1ccc2ccccc2c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"552.0";"nM";"6.26";"";"360694";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943558";"";"None";"449.86";"1";"5.83";"BDBM203137";"COc1ccc2ccccc2c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1040.0";"nM";"5.98";"";"360695";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938344";"";"None";"427.81";"0";"4.44";"BDBM203141";"O=C1[C@H](Cl)C[C@@H](c2cccc3c2OCCO3)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1480.0";"nM";"5.83";"";"360701";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952476";"";"None";"413.82";"0";"4.98";"BDBM203145";"COc1cccc(C)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"126.0";"nM";"6.90";"";"360705";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980118";"";"None";"410.51";"1";"5.38";"BDBM203181";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1csc(-c2ccc(C)cc2)n1";"IC50";"'='";"49.0";"nM";"7.31";"";"360742";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409874";"";"None";"423.87";"1";"5.81";"BDBM203225";"COc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"360787";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973879";"";"None";"423.43";"0";"4.75";"BDBM203234";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OCC(F)(F)F)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"360796";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923424";"";"None";"423.43";"0";"4.75";"BDBM203235";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OCC(F)(F)F)cc1";"IC50";"'='";"323.0";"nM";"6.49";"";"360797";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935470";"";"None";"405.44";"0";"4.46";"BDBM203237";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OCC(F)F)cc1";"IC50";"'='";"549.0";"nM";"6.26";"";"360799";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908236";"";"None";"449.80";"1";"5.34";"BDBM203252";"CCOc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"360814";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891471";"";"None";"407.47";"0";"4.32";"BDBM202891";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2noc(C)n2)c1";"IC50";"'='";"50.0";"nM";"7.30";"";"360412";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4068004";"";"None";"433.49";"0";"3.52";"10";"CC[C@@H](Cn1ccc(-c2ccc(F)cn2)n1)N(C)C(=O)c1cc(C)ccc1-n1nccn1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4066977";"";"None";"447.52";"0";"3.77";"11";"Cc1ccc(-n2nccn2)c(C(=O)N(C)[C@H](Cn2ccc(-c3ccc(F)cn3)n2)C(C)C)c1";"IC50";"'='";"952.0";"nM";"6.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL487576";"";"None";"400.52";"0";"3.36";"11";"COc1ccc(OCCN(CC(=O)NCC(C)C)Cc2ccccc2)cc1OC";"IC50";"'='";"302.0";"nM";"6.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL487979";"";"None";"436.50";"0";"3.64";"13";"COc1ccc(OCCN(CC(=O)NCC(C)C)Cc2ccc(F)c(F)c2)cc1OC";"IC50";"'='";"229.09";"nM";"6.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL2003606";"";"None";"481.51";"0";"1.59";"SID57262163";"CCN(C(=O)CO/N=C/c1ccc(OC)cc1OC)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O";"IC50";"";"29000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1459603";"";"None";"396.56";"0";"3.51";"SID49715682";"CSc1cccc(NC(=O)C2CCCN(S(=O)(=O)c3cccs3)C2)c1";"IC50";"";"5300.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3338854";"";"None";"464.52";"0";"4.66";"13";"COc1ccc(CNC(=O)c2sc(-c3cncc(C)c3)nc2-c2cccc(F)c2)nc1OC";"IC50";"'='";"1060.0";"nM";"5.97";"";"";"UO_0000065";"12.86";"0.25";"1.31";"6.93";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3338860";"";"None";"459.48";"0";"4.00";"19";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2cncc(F)c2)nc1OC";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"15.77";"0.29";"3.24";"7.31";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3922634";"";"None";"445.61";"1";"6.58";"BDBM203266";"O=C1CCCCC(c2ccccc2-c2cncs2)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360830";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4080625";"";"None";"518.88";"1";"4.17";"13d";"O=C(c1cc(OC(F)(F)F)ccc1-n1nccn1)N1C[C@@H]2CN(c3nc4cc(Cl)ccc4o3)C[C@@H]2C1";"IC50";"'='";"1524.0";"nM";"5.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4098537";"";"None";"444.50";"0";"2.93";"14i";"COc1ccc2oc(N3C[C@H]4CN(C(=O)c5cc(C)ccc5-n5nccn5)C[C@H]4C3)nc2c1";"IC50";"'='";"311.0";"nM";"6.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4079856";"";"None";"414.47";"0";"2.93";"14l";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5ccccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"178.0";"nM";"6.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3426137";"";"None";"388.43";"0";"2.61";"23";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL2347480";"";"None";"496.58";"1";"5.58";"16, diastereomeric mixture";"C=Cc1nc(CC)n2c1C(CCc1ccc(C(F)(F)F)cc1)N([C@@H](C(=O)NC)c1ccccc1)CC2";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1330311";"";"None";"273.31";"0";"3.24";"SID7976621";"Cc1csc(-c2coc3cc(O)cc(C)c3c2=O)n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585859";"";"None";"351.36";"0";"2.83";"SID49642584";"COc1ccc(NC(=O)C(=O)Nc2cccc3cccnc23)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1458435";"";"None";"311.41";"0";"3.72";"SID26664038";"Cc1ccc(NC2=NC(=O)/C(=C/c3cccn3C)S2)cc1C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3959670";"";"None";"378.47";"0";"4.45";"BDBM203072";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc2ccccc2n1C";"IC50";"'='";"41.0";"nM";"7.39";"";"360626";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910919";"";"None";"403.50";"0";"3.36";"BDBM203073";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(S(C)(=O)=O)cc1";"IC50";"'='";"1710.0";"nM";"5.77";"";"360627";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1588256";"";"None";"455.49";"0";"3.65";"SID17504815";"CC(NS(=O)(=O)c1ccc(OCC(=O)Nc2cccc([N+](=O)[O-])c2)cc1)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4082852";"";"None";"439.43";"0";"2.14";"22";"CCN(C(=O)c1cc(F)ccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cn2)n1";"IC50";"'='";"471.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3950157";"";"None";"447.47";"0";"2.86";"BDBM208516";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cn2cc(-c3ccc(F)cc3)cn2)n1";"IC50";"'='";"22.6";"nM";"7.65";"";"368553";"UO_0000065";"17.09";"0.32";"4.79";"8.41";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920093";"";"None";"461.50";"0";"3.11";"BDBM208524";"Cc1ccc(-n2nccn2)c(C(=O)N2CC(C)COC2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"7.7";"nM";"8.11";"";"368569";"UO_0000065";"17.58";"0.33";"5.00";"8.92";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931579";"";"None";"433.47";"0";"3.40";"BDBM221434";"COc1ccnc(NCCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"43.0";"nM";"7.37";"";"387565";"UO_0000065";"16.99";"0.31";"3.97";"6.14";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940596";"";"None";"429.44";"0";"4.32";"BDBM221436";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3nc4ccccc4o3)c2)c1";"IC50";"'='";"941.0";"nM";"6.03";"";"387567";"UO_0000065";"14.03";"0.26";"1.71";"5.57";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947984";"";"None";"385.33";"1";"5.12";"BDBM203053";"O=C1CCCC(c2c(F)cccc2F)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2466.0";"nM";"5.61";"";"360603";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409860";"";"None";"425.40";"0";"4.09";"BDBM203079";"COc1cccc(OC)c1[C@@H]1C[C@H](OC)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"168.0";"nM";"6.78";"";"360633";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409855";"";"None";"413.37";"0";"4.41";"BDBM203084";"COc1cccc(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"360639";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904976";"";"None";"425.45";"1";"6.36";"BDBM203112";"CC1CC(c2ccccc2-c2ccccc2)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"457.0";"nM";"6.34";"";"360670";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893641";"";"None";"411.50";"0";"4.77";"BDBM203178";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-c2ncc(C)s2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"360739";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946703";"";"None";"364.45";"0";"4.29";"BDBM203207";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cc2ccccc2[nH]1";"IC50";"'='";"1190.0";"nM";"5.92";"";"360768";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985473";"";"None";"378.47";"0";"4.31";"BDBM203209";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2c(ccn2C)c1";"IC50";"'='";"529.0";"nM";"6.28";"";"360770";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979225";"";"None";"439.43";"0";"4.72";"BDBM203221";"COc1ccc(CN2C(=O)C(C)CC2c2c(OC)cccc2OC)cc1OC(F)(F)F";"IC50";"'='";"513.0";"nM";"6.29";"";"360783";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892961";"";"None";"405.44";"0";"4.46";"BDBM203236";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OCC(F)F)c1";"IC50";"'='";"173.0";"nM";"6.76";"";"360798";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893390";"";"None";"431.56";"1";"6.18";"BDBM203243";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2sc3ccccc3c2c1";"IC50";"'='";"8.0";"nM";"8.10";"";"360805";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945950";"";"None";"430.43";"0";"3.83";"BDBM185279";"CC1(Nc2ccc(C(F)(F)F)cn2)CCCC1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"1067.0";"nM";"5.97";"";"334196";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3958107";"";"None";"441.49";"0";"4.76";"BDBM221408";"COc1ccc2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"9.0";"nM";"8.05";"";"387539";"UO_0000065";"18.22";"0.33";"3.29";"9.24";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113545";"";"None";"409.40";"0";"4.86";"BDBM50447768";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"94.0";"nM";"7.03";"";"360554";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967832";"";"None";"387.45";"0";"4.31";"BDBM203021";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OCCF)cc1";"IC50";"'='";"61.0";"nM";"7.21";"";"360555";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943680";"";"None";"405.40";"0";"4.28";"BDBM203026";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(c1)OC(F)(F)O2";"IC50";"'='";"178.0";"nM";"6.75";"";"360561";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930770";"";"None";"313.37";"0";"4.09";"BDBM203034";"CCOc1ccccc1C1CCC(=O)N1Cc1ccc(F)cc1";"IC50";"'='";"669.0";"nM";"6.17";"";"360573";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925582";"";"None";"392.40";"0";"3.81";"BDBM203040";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)F)n1";"IC50";"'='";"192.0";"nM";"6.72";"";"360580";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903185";"";"None";"478.51";"0";"3.60";"BDBM221440";"COc1cc(OC)nc(OCCn2nc(C)c(NC(=O)c3ncoc3-c3cccc(C)c3)c2C)n1";"IC50";"'='";"1021.0";"nM";"5.99";"";"387571";"UO_0000065";"12.52";"0.23";"2.39";"4.74";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL486323";"";"None";"468.98";"0";"4.55";"19";"COc1ccc(OCCN(CC(=O)NCc2ccccc2Cl)Cc2ccccc2)cc1OC";"IC50";"'='";"151.36";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL2031507";"";"None";"464.57";"1";"5.89";"51";"Cc1nc(C(=O)N2[C@H](CNc3nc4ccccc4o3)CCC[C@@H]2C)c(-c2ccc(F)cc2)s1";"IC50";"'='";"125.0";"nM";"6.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2396842";"";"None";"532.99";"2";"5.63";"48";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1ccc(OC(F)F)c(F)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4072543";"";"None";"417.52";"0";"2.50";"14c";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc(C)c(C)c(C)n4)C[C@@H]3C2)c1";"IC50";"'='";"4845.0";"nM";"5.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4090815";"";"None";"443.49";"0";"2.87";"14g";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4ncc5cc(F)ccc5n4)C[C@@H]3C2)c1";"IC50";"'='";"108.0";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4105616";"";"None";"450.45";"0";"3.11";"15b";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@]3(F)CN(c4nc5ccccc5o4)C[C@@]3(F)C2)c1";"IC50";"'='";"575.0";"nM";"6.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3937814";"";"None";"443.51";"0";"2.63";"BDBM184034";"Cc1cccc(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@@H]2C)c1-n1nccn1";"IC50";"'='";"2460.0";"nM";"5.61";"";"332103";"UO_0000065";"12.65";"0.23";"2.98";"6.17";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3959470";"";"None";"483.45";"0";"2.95";"BDBM184038";"O=C(c1ccc(C(F)(F)F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"133.0";"nM";"6.88";"";"332107";"UO_0000065";"14.22";"0.27";"3.93";"7.56";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3977273";"";"None";"457.54";"0";"3.02";"BDBM184104";"CC[C@@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"287.0";"nM";"6.54";"";"332173";"UO_0000065";"14.30";"0.26";"3.52";"7.19";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940958";"";"None";"492.94";"0";"3.99";"BDBM184116";"C[C@@H]1CN(C(=O)c2cccc(Cl)c2-n2nccn2)[C@H](Cc2cc(-c3ncccn3)ccc2F)CO1";"IC50";"'='";"447.0";"nM";"6.35";"";"332185";"UO_0000065";"12.88";"0.25";"2.36";"7.38";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3970504";"";"None";"458.50";"0";"3.26";"BDBM184117";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c1";"IC50";"'='";"371.0";"nM";"6.43";"";"332186";"UO_0000065";"14.03";"0.26";"3.17";"7.47";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901113";"";"None";"472.52";"0";"3.64";"BDBM184112";"Cc1cccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c1-n1nccn1";"IC50";"'='";"506.0";"nM";"6.30";"";"332181";"UO_0000065";"13.32";"0.25";"2.66";"7.32";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3965025";"";"None";"486.55";"0";"3.95";"BDBM184113";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c(-n2nccn2)c1C";"IC50";"'='";"818.0";"nM";"6.09";"";"332182";"UO_0000065";"12.51";"0.23";"2.14";"7.08";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3971715";"";"None";"437.44";"1";"5.71";"BDBM203172";"COc1cccc(OC)c1C1CC(F)(F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360732";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964419";"";"None";"394.45";"0";"3.91";"BDBM203199";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"360760";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928080";"";"None";"427.39";"0";"4.35";"BDBM203211";"CC(C)Oc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"77.0";"nM";"7.11";"";"360773";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913912";"";"None";"423.87";"1";"5.81";"BDBM203213";"COc1cccc(F)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"29.0";"nM";"7.54";"";"360775";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3889541";"";"None";"391.41";"0";"4.41";"BDBM203219";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)F)cc1";"IC50";"'='";"621.0";"nM";"6.21";"";"360781";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892988";"";"None";"429.39";"1";"5.18";"BDBM203231";"CC1CC(c2c(F)cccc2OCCF)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"44.0";"nM";"7.36";"";"360793";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895495";"";"None";"408.52";"1";"5.08";"BDBM202881";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc(-c2ccccc2)s1";"IC50";"'='";"366.0";"nM";"6.44";"";"360400";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113748";"";"None";"403.48";"0";"4.41";"BDBM50447808";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"360408";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969634";"";"None";"431.36";"0";"4.55";"BDBM203151";"COc1ccc(F)c(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"296.0";"nM";"6.53";"";"360711";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957444";"";"None";"422.55";"1";"5.47";"BDBM202955";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2cscn2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360481";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113749";"";"None";"409.51";"0";"4.48";"BDBM50447807";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-c2nccs2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"360598";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113536";"";"None";"413.82";"1";"5.50";"BDBM50447778";"COc1cccc(Cl)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"154.0";"nM";"6.81";"";"360600";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986364";"";"None";"413.82";"1";"5.06";"BDBM203125";"CCOc1ccccc1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"129.0";"nM";"6.89";"";"360683";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982812";"";"None";"423.46";"1";"5.48";"BDBM203155";"COc1cccc(OC)c1C1CC(F)(F)C(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"81.0";"nM";"7.09";"";"360715";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970150";"";"None";"436.53";"1";"5.11";"BDBM203263";"COc1ccc2c(c1C1CCCC(=O)N1Cc1cccc(-c3csc(C)n3)c1)OCO2";"IC50";"'='";"11.0";"nM";"7.96";"";"360827";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113745";"";"None";"402.49";"1";"5.02";"BDBM50447811";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"360389";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902408";"";"None";"428.53";"1";"5.60";"BDBM202890";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(c1)c1ccccc1n2C";"IC50";"'='";"132.0";"nM";"6.88";"";"360411";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962071";"";"None";"408.52";"1";"5.08";"BDBM202899";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2cncs2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"360421";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903348";"";"None";"432.47";"0";"4.83";"BDBM202923";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc(OC(F)F)c(C2CC2)c1";"IC50";"'='";"400.0";"nM";"6.40";"";"360449";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977087";"";"None";"417.51";"0";"4.80";"BDBM202936";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360462";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911828";"";"None";"422.55";"1";"5.47";"BDBM202952";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2cncs2)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"360478";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909963";"";"None";"387.48";"1";"5.23";"BDBM202967";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(-c2ccccc2)cc1";"IC50";"'='";"184.0";"nM";"6.74";"";"360493";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913002";"";"None";"394.50";"0";"4.69";"BDBM202977";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"89.0";"nM";"7.05";"";"360503";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965895";"";"None";"394.52";"0";"4.56";"BDBM202981";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(N2CCCCC2)c1";"IC50";"'='";"858.0";"nM";"6.07";"";"360508";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1553774";"";"None";"337.44";"0";"3.99";"SID85146636";"COc1ccc2sc(-c3ccc(N(C)C)cc3)c(C#CCO)c2c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1438417";"";"None";"357.37";"0";"3.26";"SID49667368";"Cc1nn(-c2ccccc2)c2nc(N)c(C#N)c(-c3ccc(O)c(O)c3)c12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1546895";"";"None";"340.40";"0";"4.32";"SID4250611";"COc1cccc(-c2cc(C(=O)Nc3ccccc3SC)no2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493516";"";"None";"323.35";"0";"3.36";"SID17433262";"COc1ccc(/C=C/c2n[nH]c(-c3ccccc3O)n2)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714761";"";"None";"429.35";"1";"5.17";"SID49645954";"O=C(Nc1ccccc1)[C@@H]1CC=C[C@@H]2CCN(Cc3ccc(Cl)c(Cl)c3)C(=O)[C@@H]21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1995726";"";"None";"376.46";"0";"3.10";"SID26725766";"CN(C)S(=O)(=O)c1ccc(-c2csc(N/N=C/c3ccco3)n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2347606";"";"None";"519.01";"2";"6.16";"40";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C(C)C)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347604";"";"None";"519.01";"2";"5.98";"38";"CCCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"60.0";"nM";"7.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347602";"";"None";"541.62";"1";"4.64";"28";"CCc1nc(C(=O)N(C)C)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"111.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347487";"";"None";"516.63";"2";"5.66";"23";"CCc1nc(SC)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1911642";"";"None";"329.83";"0";"4.63";"1c";"Cc1ccc2c(c1)[C@H](C)N(C(=O)c1ccc(Cl)cc1)[C@H](C)CO2";"IC50";"'='";"150.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1082025";"";"None";"430.60";"0";"4.54";"21, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1cccc(C)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1081252";"";"None";"484.57";"1";"5.25";"31(S;R)";"CCn1nc(C)c2c1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1081253";"";"None";"451.01";"0";"4.88";"32, diastereoisomeric mixture";"CCn1nc(C)c2c1CCN(C(C(=O)NC)c1ccccc1)C2CCc1ccc(Cl)cc1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1080571";"";"None";"432.57";"0";"3.99";"33(R;R)";"CCn1nc(C)c2c1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2COc1ccc(C)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL2413523";"";"None";"488.59";"1";"5.23";"12";"Cc1nc(C(=O)N2CCCC[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccc(F)cc2)s1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"15.63";"0.30";"2.41";"10.16";"0";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3667568";"";"None";"374.46";"0";"2.80";"BDBM154941";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(C)c2)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"297232";"UO_0000065";"20.75";"0.41";"4.97";"10.26";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931693";"";"None";"483.45";"0";"2.95";"BDBM184144";"O=C(c1cccc(C(F)(F)F)c1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"371.0";"nM";"6.43";"";"332213";"UO_0000065";"13.30";"0.25";"3.48";"7.07";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3923356";"";"None";"442.52";"0";"3.15";"BDBM184150";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3cccn3)ccc2C)c1";"IC50";"'='";"2130.0";"nM";"5.67";"";"332219";"UO_0000065";"12.82";"0.23";"2.52";"7.26";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3910932";"";"None";"442.52";"0";"3.15";"BDBM184152";"Cc1ccc(-n2cccn2)cc1C[C@@H]1COCCN1C(=O)c1cccc(C)c1-n1nccn1";"IC50";"'='";"3770.0";"nM";"5.42";"";"332221";"UO_0000065";"12.26";"0.22";"2.27";"6.95";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968722";"";"None";"433.45";"0";"2.07";"BDBM184019";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"2736.0";"nM";"5.56";"";"332088";"UO_0000065";"12.83";"0.24";"3.49";"6.12";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3951941";"";"None";"429.48";"0";"2.32";"BDBM184030";"C[C@@H]1COC[C@@H](Cc2cccc(-n3nccn3)c2)N1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"1297.0";"nM";"5.89";"";"332099";"UO_0000065";"13.71";"0.25";"3.57";"6.47";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914144";"";"None";"434.43";"0";"2.54";"BDBM184050";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"893.0";"nM";"6.05";"";"332119";"UO_0000065";"13.92";"0.26";"3.51";"6.10";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3978573";"";"None";"429.48";"0";"2.24";"BDBM184083";"Cc1ccc(-n2nccn2)cc1C[C@@H]1COCCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"1640.0";"nM";"5.79";"";"332152";"UO_0000065";"13.47";"0.25";"3.55";"6.36";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3954732";"";"None";"468.88";"0";"3.19";"BDBM184142";"O=C(c1cccc(Cl)c1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncon2)ccc1F";"IC50";"'='";"830.0";"nM";"6.08";"";"332211";"UO_0000065";"12.97";"0.25";"2.89";"6.13";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667606";"";"None";"388.49";"0";"3.10";"BDBM154980";"COc1ccc(S(=O)(=O)N2CCC[C@@H]2C(=O)Nc2cc(C)cc(C)c2)cc1";"IC50";"'='";"6044.0";"nM";"5.22";"";"297271";"UO_0000065";"13.43";"0.26";"2.12";"6.89";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943937";"";"None";"425.49";"1";"5.06";"BDBM221380";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cc(C)ccc43)c2)c1";"IC50";"'='";"204.0";"nM";"6.69";"";"387511";"UO_0000065";"15.72";"0.29";"1.63";"8.59";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939125";"";"None";"442.48";"0";"4.16";"BDBM221381";"COc1ccc2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2n1";"IC50";"'='";"4.0";"nM";"8.40";"";"387512";"UO_0000065";"18.98";"0.35";"4.24";"8.40";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916785";"";"None";"455.52";"1";"5.15";"BDBM221445";"COc1ccc2ccn(CCCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"47.0";"nM";"7.33";"";"387576";"UO_0000065";"16.09";"0.29";"2.18";"8.41";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966568";"";"None";"425.49";"0";"4.83";"BDBM221361";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCc3cn(C)c4ccccc34)c2)c1";"IC50";"'='";"265.0";"nM";"6.58";"";"387491";"UO_0000065";"15.46";"0.28";"1.75";"8.44";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409851";"";"None";"409.40";"0";"4.71";"BDBM203088";"COc1cccc(OC)c1[C@@H]1C[C@@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"360643";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972041";"";"None";"361.44";"0";"4.72";"BDBM202964";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"113.0";"nM";"6.95";"";"360490";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3967901";"";"None";"447.81";"1";"5.07";"BDBM203140";"COc1ccc(Cl)c(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1020.0";"nM";"5.99";"";"360698";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912041";"";"None";"449.80";"1";"5.34";"BDBM203165";"CCOc1ccc(F)c(F)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"212.0";"nM";"6.67";"";"360725";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918910";"";"None";"410.51";"1";"5.38";"BDBM203182";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"360743";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949744";"";"None";"427.39";"0";"4.21";"BDBM203233";"CC1CC(c2c(F)cccc2OCCO)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"59.0";"nM";"7.23";"";"360795";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919895";"";"None";"392.46";"0";"3.39";"BDBM203005";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"204.0";"nM";"6.69";"";"360533";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986710";"";"None";"392.46";"0";"3.39";"BDBM203006";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-n2cccn2)n1";"IC50";"'='";"1180.0";"nM";"5.93";"";"360534";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113547";"";"None";"417.51";"1";"5.75";"BDBM50447766";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"360543";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113540";"";"None";"439.43";"0";"4.86";"BDBM50447774";"COc1cc(OC)c(C2CCCC(=O)N2Cc2ccc(OC(F)(F)F)cc2)c(OC)c1";"IC50";"'='";"106.0";"nM";"6.97";"";"360551";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925745";"";"None";"417.79";"1";"5.06";"BDBM203123";"COc1cccc(Cl)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"103.0";"nM";"6.99";"";"360681";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952651";"";"None";"417.33";"0";"3.71";"BDBM203134";"COc1c(F)ccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1030.0";"nM";"5.99";"";"360692";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911666";"";"None";"393.40";"0";"4.94";"BDBM203191";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)F)cc1";"IC50";"'='";"65.0";"nM";"7.19";"";"360752";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944292";"";"None";"416.48";"1";"5.25";"BDBM202918";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"1.0";"nM";"9.00";"";"360444";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954609";"";"None";"431.53";"1";"6.14";"BDBM202926";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"187.0";"nM";"6.73";"";"360452";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965481";"";"None";"390.48";"0";"4.90";"BDBM202932";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"82.0";"nM";"7.09";"";"360458";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983362";"";"None";"416.52";"1";"5.41";"BDBM202949";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccncc2)c1";"IC50";"'='";"85.0";"nM";"7.07";"";"360475";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113762";"";"None";"437.46";"1";"5.49";"BDBM50447794";"COc1cccc(OC)c1C1CC(C)(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1080.0";"nM";"5.97";"";"360553";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985046";"";"None";"436.58";"1";"5.78";"BDBM202953";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"360479";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955790";"";"None";"365.43";"0";"4.70";"BDBM203024";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc2ccccc2o1";"IC50";"'='";"170.0";"nM";"6.77";"";"360559";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933331";"";"None";"362.43";"0";"4.12";"BDBM202962";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"44.0";"nM";"7.36";"";"360488";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903138";"";"None";"391.41";"0";"4.41";"BDBM203037";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)F)c1";"IC50";"'='";"96.0";"nM";"7.02";"";"360577";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930977";"";"None";"437.46";"1";"5.66";"BDBM203042";"CCC(c1ccc(OC(F)(F)F)cc1)N1C(=O)C(C)CC1c1c(OC)cccc1OC";"IC50";"'='";"1170.0";"nM";"5.93";"";"360582";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911137";"";"None";"392.40";"0";"3.81";"BDBM203043";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cc(OC(F)F)ccn1";"IC50";"'='";"1260.0";"nM";"5.90";"";"360583";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113546";"";"None";"383.49";"0";"4.75";"BDBM50447767";"CCCOc1ccc(CN2C(=O)CCCC2c2c(OC)cccc2OC)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"360586";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908200";"";"None";"439.43";"0";"4.22";"BDBM203050";"COc1cccc(OCCO)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"85.0";"nM";"7.07";"";"360592";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3891988";"";"None";"419.50";"1";"5.76";"BDBM203062";"COc1cc(F)cc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"232.0";"nM";"6.63";"";"360613";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925974";"";"None";"408.52";"0";"4.94";"BDBM203001";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2cscn2)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"360529";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950159";"";"None";"426.52";"1";"6.07";"BDBM203063";"COc1ccc2c(C)noc2c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"194.0";"nM";"6.71";"";"360614";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925895";"";"None";"380.45";"0";"3.24";"BDBM203069";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(c1)nnn2C";"IC50";"'='";"311.0";"nM";"6.51";"";"360622";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980549";"";"None";"381.50";"1";"5.17";"BDBM203075";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2sccc2c1";"IC50";"'='";"140.0";"nM";"6.85";"";"360629";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985579";"";"None";"433.35";"1";"5.74";"BDBM203077";"O=C1CCCC(c2ccccc2OC(F)(F)F)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2662.0";"nM";"5.58";"";"360631";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962902";"";"None";"472.52";"0";"3.64";"BDBM184111";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"263.0";"nM";"6.58";"";"332180";"UO_0000065";"13.93";"0.26";"2.94";"7.65";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3622330";"";"None";"459.48";"0";"3.43";"9";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc(C(F)(F)F)c(C)n3)CC[C@H]2C)c1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622336";"";"None";"411.90";"0";"2.76";"16";"Cc1cnc(Cl)nc1N1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)CC1";"IC50";"'='";"2600.0";"nM";"5.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2031501";"";"None";"477.56";"1";"5.24";"45";"Cc1nc(C(=O)N2CC(F)CC[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccccc2)s1";"IC50";"'<'";"1.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031492";"";"None";"484.63";"1";"5.34";"27";"Cc1nc(C(=O)N2CCC[C@H](C)[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccccc2)s1";"IC50";"'='";"82.0";"nM";"7.09";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031500";"";"None";"465.55";"0";"4.30";"44";"O=C(NC[C@@H]1CCC(O)CN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3113763";"";"None";"409.40";"0";"4.71";"BDBM50447793";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"133.0";"nM";"6.88";"";"360597";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972945";"";"None";"418.45";"0";"4.19";"BDBM221309";"COc1cccc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)c1";"IC50";"'='";"514.0";"nM";"6.29";"";"387442";"UO_0000065";"15.03";"0.28";"2.10";"6.88";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903258";"";"None";"479.50";"1";"2.74";"BDBM221312";"COc1cc(OC)nc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(N(C)C)c3)cn2)n1";"IC50";"'='";"154.0";"nM";"6.81";"";"387445";"UO_0000065";"14.21";"0.27";"4.07";"5.25";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903513";"";"None";"424.53";"0";"4.18";"BDBM203090";"COc1ncnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"619.0";"nM";"6.21";"";"360648";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920976";"";"None";"403.48";"0";"4.41";"BDBM203091";"COc1ncnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"412.0";"nM";"6.38";"";"360649";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976348";"";"None";"425.53";"1";"5.16";"BDBM203204";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-c2nc(C)cs2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360765";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960262";"";"None";"396.46";"0";"4.44";"BDBM203208";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cc2cc(F)ccc2n1C";"IC50";"'='";"142.0";"nM";"6.85";"";"360769";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1421498";"";"None";"486.41";"0";"3.62";"SID49642404";"CCOc1cc(C(=S)N2CCOCC2)cc(Br)c1OS(=O)(=O)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1980584";"";"None";"294.31";"0";"2.55";"SID7970886";"Cc1ccc2nc(Nc3ccccc3)c(/C=N/O)c(=O)n2c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1565236";"";"None";"363.51";"0";"4.94";"SID4250158";"CSc1nc2ccc3nc(NC(=O)c4cccs4)sc3c2s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1527445";"";"None";"464.60";"1";"5.02";"SID26668282";"Cc1ccc(-c2csc3nnc(SCC(=O)Nc4nsc(-c5ccccc5)n4)n23)cc1";"IC50";"";"177.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1430677";"";"None";"446.87";"0";"4.22";"SID26732463";"Cc1noc(C)c1S(=O)(=O)Nc1ccc(O)c2c(=O)cc(-c3ccccc3Cl)oc12";"IC50";"";"5630.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1304258";"";"None";"301.37";"0";"3.99";"SID24806140";"COc1cc(OC)c(-c2nc3ccccc3s2)cc1OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1416951";"";"None";"336.39";"0";"3.83";"SID845346";"Cc1c(C(=O)Nc2ccc(N3CCOCC3)cc2)oc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1966472";"";"None";"352.45";"0";"3.57";"SID26671021";"Sc1nnc(-c2cc(-c3ccccc3)[nH]n2)n1/N=C/c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342815";"";"None";"337.40";"0";"4.25";"SID14744749";"Cc1cc(SCC(=O)c2ccc3c(c2)OCO3)nc2ccccc12";"IC50";"";"11200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418678";"";"None";"283.76";"0";"3.85";"SID24820516";"Cc1nc2c(-c3ccc(Cl)cc3)cnn2c2c1CCC2";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1733477";"";"None";"313.41";"0";"3.42";"SID24805994";"O=C(NC(=S)Nc1cccc2cccnc12)c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714024";"";"None";"450.00";"0";"4.19";"SID57261318";"CC(NC(C)c1ccccc1Cl)C(=O)Nc1cccc(S(=O)(=O)N2CCCCC2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1728519";"";"None";"558.72";"1";"3.48";"SID85200512";"CC(C)(C)OC(=O)C[C@@H]1C/C=C\C[C@H](CC(=O)N[C@@H](CO)Cc2ccccc2)C(=O)N[C@H](C(C)(C)C)COC1=O";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1478565";"";"None";"290.29";"0";"4.18";"SID17510194";"Cc1c2ccccc2nc2c(F)c(N(C)C)c(F)c(F)c12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518032";"";"None";"365.84";"1";"5.32";"SID17403001";"O=C(Nc1ccc2sc3ccccc3c(=O)c2c1)c1ccccc1Cl";"IC50";"";"1540.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1528787";"";"None";"352.37";"0";"2.97";"SID22408543";"O=C(OCc1cc(=O)n2c(n1)sc1ccccc12)c1cccc(O)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3904030";"";"None";"466.26";"1";"5.86";"BDBM203277";"CCOc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)c(Cl)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"360841";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667549";"";"None";"461.43";"0";"4.02";"20";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)s2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3772009";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3741058";"";"None";"441.00";"1";"5.94";"19";"COc1cccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(C)c2)c1Cl";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3739577";"";"None";"425.00";"1";"6.24";"21";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc(C)c(Cl)c2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL487782";"";"None";"418.51";"0";"3.50";"12";"COc1ccc(OCCN(CC(=O)NCC(C)C)Cc2ccc(F)cc2)cc1OC";"IC50";"'='";"562.34";"nM";"6.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL528990";"";"None";"452.53";"0";"4.04";"16";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccc(F)cc2)cc1OC";"IC50";"'='";"19.5";"nM";"7.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL486117";"";"None";"440.57";"0";"3.96";"18";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2cccs2)cc1OC";"IC50";"'='";"109.65";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL521024";"";"None";"486.97";"0";"4.69";"20";"COc1ccc(OCCN(CC(=O)NCc2ccccc2Cl)Cc2ccc(F)cc2)cc1OC";"IC50";"'='";"138.04";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3895786";"";"None";"430.47";"0";"2.71";"BDBM184043";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncon3)c2)c(-n2nccn2)c1";"IC50";"'='";"212.0";"nM";"6.67";"";"332112";"UO_0000065";"15.50";"0.28";"3.96";"6.73";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940700";"";"None";"463.93";"0";"2.97";"BDBM184146";"C[C@@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"96.0";"nM";"7.02";"";"332215";"UO_0000065";"15.13";"0.29";"4.05";"7.72";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3980856";"";"None";"433.45";"0";"2.47";"BDBM208485";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"18.5";"nM";"7.73";"";"368522";"UO_0000065";"17.84";"0.33";"5.26";"8.50";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933444";"";"None";"423.43";"0";"4.90";"BDBM203071";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OCC(F)(F)F)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"360625";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928054";"";"None";"417.55";"1";"7.27";"BDBM203105";"O=C1CCCC(c2ccccc2-c2ccccc2)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"722.0";"nM";"6.14";"";"360663";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986061";"";"None";"417.55";"1";"7.13";"BDBM203110";"CC1CC(c2ccccc2-c2ccccc2)N(Cc2cccc(-c3ccccc3)c2)C1=O";"IC50";"'='";"596.0";"nM";"6.22";"";"360668";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3987122";"";"None";"399.34";"0";"3.57";"BDBM203117";"COc1cc(F)ccc1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2210.0";"nM";"5.66";"";"360675";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934852";"";"None";"436.94";"1";"5.53";"BDBM203003";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cc(Cl)cc(-c2ccccn2)c1";"IC50";"'='";"270.0";"nM";"6.57";"";"360531";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941842";"";"None";"420.48";"1";"5.01";"BDBM203004";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(F)c(-c2ccccn2)c1";"IC50";"'='";"122.0";"nM";"6.91";"";"360532";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920478";"";"None";"343.40";"0";"4.10";"BDBM203007";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(F)cc1";"IC50";"'='";"231.0";"nM";"6.64";"";"360536";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937707";"";"None";"427.39";"0";"5.00";"BDBM203010";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"18.0";"nM";"7.75";"";"360539";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909991";"";"None";"443.85";"1";"5.51";"BDBM203016";"COc1cc(Cl)cc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"360546";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3889649";"";"None";"449.47";"1";"5.64";"BDBM203048";"COc1cccc(OCC2CC2)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"4137.0";"nM";"5.38";"";"360589";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4065909";"";"None";"420.45";"0";"2.61";"25";"CCN(C(=O)c1ccccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"61.0";"nM";"7.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3942010";"";"None";"434.40";"0";"3.58";"BDBM185288";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334205";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3936699";"";"None";"457.46";"0";"3.72";"BDBM185292";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)nc1C1CC1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334209";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3951993";"";"None";"432.46";"0";"3.08";"BDBM208501";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cc3)n2)c1";"IC50";"'='";"2.4";"nM";"8.62";"";"368543";"UO_0000065";"19.93";"0.37";"5.54";"11.04";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4098119";"";"None";"482.34";"0";"3.07";"10";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccc(Br)nc2-n2nccn2)C1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4089492";"";"None";"419.40";"0";"4.23";"15";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2OC(F)(F)F)C1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4088538";"";"None";"412.49";"0";"4.40";"19";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2cccnc2-c2ccccc2)C1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3426150";"";"None";"399.45";"0";"3.48";"1; MK-8133";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-c1ncccn1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4072715";"";"None";"404.50";"0";"3.32";"25";"C[C@@H]1CC[C@@H](Sc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4099612";"";"None";"421.46";"0";"2.52";"26";"COC(=O)c1cccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096735";"";"None";"437.53";"0";"3.23";"28";"COC(=O)c1cccnc1S[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3394829";"";"None";"413.48";"0";"3.89";"BDBM120778";"C[C@@H]1CC[C@@H](Oc2nccc3ccccc23)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"15.0";"nM";"7.82";"";"321165";"UO_0000065";"18.92";"0.34";"3.93";"10.70";"0";"CHEMBL3705236";"Radioligand Binding Assay: The inhibition constant (Ki) is determined using a radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638431";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3939766";"";"None";"458.50";"0";"3.26";"BDBM184118";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"571.0";"nM";"6.24";"";"332187";"UO_0000065";"13.62";"0.25";"2.98";"7.26";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901217";"";"None";"478.92";"0";"3.60";"BDBM184121";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncccn2)ccc1F";"IC50";"'='";"490.0";"nM";"6.31";"";"332190";"UO_0000065";"13.18";"0.25";"2.71";"7.33";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3977521";"";"None";"447.47";"0";"2.38";"BDBM184089";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1-n1nccn1";"IC50";"'='";"1500.0";"nM";"5.82";"";"332158";"UO_0000065";"13.02";"0.24";"3.44";"6.40";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4113530";"";"None";"391.48";"0";"3.35";"BDBM64582";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](Oc3cccc(C)n3)CC[C@H]2C)c1";"IC50";"'='";"47.0";"nM";"7.33";"";"321163";"UO_0000065";"18.72";"0.35";"3.98";"10.02";"0";"CHEMBL3705236";"Radioligand Binding Assay: The inhibition constant (Ki) is determined using a radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638431";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3940390";"";"None";"418.49";"1";"5.14";"BDBM203033";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(Oc2ccccc2)nc1";"IC50";"'='";"29.0";"nM";"7.54";"";"360571";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899455";"";"None";"376.46";"0";"4.36";"BDBM203167";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"474.0";"nM";"6.32";"";"360727";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965326";"";"None";"415.49";"1";"5.34";"BDBM203272";"COc1ccc2c(c1C1CCCC(=O)N1Cc1cccc(-c3ccccc3)c1)OCO2";"IC50";"'='";"30.0";"nM";"7.52";"";"360836";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964349";"";"None";"449.80";"1";"5.59";"BDBM203276";"CCOc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)c(Cl)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"360840";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2347484";"";"None";"538.54";"2";"5.96";"20";"CCc1nc(C(F)(F)F)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347481";"";"None";"596.44";"2";"5.55";"17, diastereomeric mixture";"CCc1nc(I)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"23.0";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347478";"";"None";"512.62";"2";"6.06";"14";"CCc1nc(C(C)C)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"2904.0";"nM";"5.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347475";"";"None";"484.57";"1";"5.25";"11, diastereomeric mixture";"CCc1nc(C)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"24.0";"nM";"7.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3898558";"";"None";"449.45";"0";"2.59";"BDBM208520";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cc2noc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"6.9";"nM";"8.16";"";"368557";"UO_0000065";"18.16";"0.34";"5.57";"7.28";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916956";"";"None";"484.44";"0";"4.42";"BDBM240114";"Cc1cc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-n2nccn2)cc1C";"IC50";"'='";"5.0";"nM";"8.30";"";"418955";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983998";"";"None";"499.45";"0";"3.86";"BDBM240223";"COc1cc(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c(-n2nccn2)cc1C";"IC50";"'='";"6.0";"nM";"8.22";"";"419066";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4088494";"";"None";"452.88";"0";"3.41";"13b";"O=C(c1cc(F)ccc1-n1nccn1)N1C[C@@H]2CN(c3nc4cc(Cl)ccc4o3)C[C@@H]2C1";"IC50";"'='";"791.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3982470";"";"None";"464.98";"1";"6.03";"BDBM240151";"Cc1cccc(-c2sc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"280.0";"nM";"6.55";"";"418993";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976908";"";"None";"464.98";"1";"6.03";"BDBM240157";"Cc1ccc(-c2sc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"418999";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113770";"";"None";"415.49";"1";"5.71";"BDBM50447786";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"360516";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971859";"";"None";"427.51";"0";"3.45";"BDBM184001";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cccc3)c2)c1";"IC50";"'='";"131.0";"nM";"6.88";"";"332065";"UO_0000065";"16.10";"0.29";"3.43";"10.56";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3954973";"";"None";"429.48";"0";"2.24";"BDBM184016";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cccn3)c2)n1";"IC50";"'='";"3404.0";"nM";"5.47";"";"332080";"UO_0000065";"12.73";"0.23";"3.23";"6.01";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917550";"";"None";"413.49";"0";"3.00";"BDBM183962";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"332083";"UO_0000065";"19.58";"0.36";"5.10";"9.91";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3947761";"";"None";"460.49";"0";"2.72";"BDBM184022";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccc(C)cc2-n2nccn2)cc1-c1ncon1";"IC50";"'='";"34.0";"nM";"7.47";"";"332091";"UO_0000065";"16.22";"0.30";"4.75";"6.89";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3977023";"";"None";"464.46";"0";"2.55";"BDBM184023";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccc(F)cc2-n2nccn2)cc1-c1ncon1";"IC50";"'='";"60.0";"nM";"7.22";"";"332092";"UO_0000065";"15.55";"0.29";"4.67";"6.66";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3904128";"";"None";"434.43";"0";"2.54";"BDBM184044";"O=C(c1cccc(F)c1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"1140.0";"nM";"5.94";"";"332113";"UO_0000065";"13.68";"0.25";"3.40";"5.99";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936592";"";"None";"450.89";"0";"3.05";"BDBM184052";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1ccc(Cl)c(-c2ncon2)c1";"IC50";"'='";"475.0";"nM";"6.32";"";"332121";"UO_0000065";"14.02";"0.27";"3.27";"6.38";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3952515";"";"None";"433.45";"0";"2.34";"BDBM208530";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cc2cnn(-c3ccc(F)cn3)c2)c1";"IC50";"'='";"38.7";"nM";"7.41";"";"368567";"UO_0000065";"17.10";"0.32";"5.07";"8.15";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894788";"";"None";"445.84";"1";"5.59";"BDBM203226";"CC(C)Oc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"360788";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931571";"";"None";"423.52";"1";"5.56";"BDBM203260";"COc1ccc2ccccc2c1C1CCCC(=O)N1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"360824";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897884";"";"None";"392.46";"0";"3.39";"BDBM203000";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"77.0";"nM";"7.11";"";"360528";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113548";"";"None";"417.51";"1";"5.75";"BDBM50447765";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"360558";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917258";"";"None";"437.46";"1";"5.63";"BDBM203059";"COc1cccc(OC(C)C)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"85.0";"nM";"7.07";"";"360609";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903177";"";"None";"427.39";"0";"5.00";"BDBM203060";"COc1cc(F)cc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"27.0";"nM";"7.57";"";"360611";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902987";"";"None";"380.49";"0";"4.32";"BDBM203066";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(c1)CCCN2";"IC50";"'='";"596.0";"nM";"6.22";"";"360619";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409856";"";"None";"413.37";"0";"4.41";"BDBM203080";"COc1cccc(OC)c1[C@@H]1C[C@@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"242.0";"nM";"6.62";"";"360634";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920348";"";"None";"399.34";"0";"3.57";"BDBM203089";"COc1cccc(F)c1[C@@H]1C[C@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1090.0";"nM";"5.96";"";"360644";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929739";"";"None";"416.52";"1";"5.41";"BDBM203096";"COc1cncc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"80.0";"nM";"7.10";"";"360654";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667601";"";"None";"427.35";"0";"4.40";"BDBM154975";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"158.0";"nM";"6.80";"";"297266";"UO_0000065";"15.92";"0.34";"2.40";"10.23";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922632";"";"None";"456.51";"0";"2.82";"BDBM183969";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1cnccn1";"IC50";"'='";"1940.0";"nM";"5.71";"";"332033";"UO_0000065";"12.51";"0.23";"2.89";"6.00";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667574";"";"None";"420.49";"0";"2.50";"BDBM154948";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(OC)cc(OC)c2)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"297239";"UO_0000065";"18.54";"0.37";"5.30";"8.28";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2396836";"";"None";"490.96";"0";"4.99";"37";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(F)c(F)c1F";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347482";"";"None";"504.98";"2";"5.59";"23";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3978354";"";"None";"458.50";"0";"3.74";"BDBM208513";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cn2ccc(-c3ccc(F)cc3)n2)n1";"IC50";"'='";"1.2";"nM";"8.92";"";"368550";"UO_0000065";"19.46";"0.36";"5.18";"10.37";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2396863";"";"None";"506.96";"2";"5.04";"26";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2COc1cccc(C(F)(F)F)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3942444";"";"None";"430.43";"0";"3.75";"BDBM185251";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2ccc(C(F)(F)F)nc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334168";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3952040";"";"None";"472.47";"0";"4.11";"BDBM185314";"CCOc1cnc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"334231";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3918712";"";"None";"451.44";"0";"2.69";"BDBM208514";"O=C(c1cc(F)ccc1-n1nccn1)N1CCCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"368551";"UO_0000065";"18.88";"0.35";"5.83";"9.37";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893831";"";"None";"371.45";"0";"4.73";"BDBM203194";"CCOc1cccc(CN2C(=O)C(C)CC2c2c(F)cccc2OCC)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"360755";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958891";"";"None";"424.54";"1";"5.77";"BDBM203202";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360763";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933036";"";"None";"391.47";"0";"4.14";"BDBM202879";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"360398";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897703";"";"None";"392.46";"0";"3.54";"BDBM202902";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2ccnn2)c1";"IC50";"'='";"239.0";"nM";"6.62";"";"360425";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937008";"";"None";"422.55";"1";"5.47";"BDBM202938";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"360464";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942056";"";"None";"367.40";"0";"3.49";"BDBM203019";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2nonc2c1";"IC50";"'='";"766.0";"nM";"6.12";"";"360549";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113550";"";"None";"401.51";"1";"5.62";"BDBM50447763";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"360568";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914823";"";"None";"418.24";"1";"6.15";"BDBM203057";"O=C1CCCC(c2c(Cl)cccc2Cl)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"456.0";"nM";"6.34";"";"360607";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943747";"";"None";"417.79";"0";"4.81";"BDBM203143";"COc1cccc(F)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1210.0";"nM";"5.92";"";"360703";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962408";"";"None";"421.44";"0";"4.42";"BDBM203242";"COc1cc(CN2C(=O)C(C)CC2c2c(OC)cccc2OC)ccc1OC(F)F";"IC50";"'='";"235.0";"nM";"6.63";"";"360804";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916806";"";"None";"431.36";"0";"4.10";"BDBM203245";"CCOc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"53.0";"nM";"7.28";"";"360807";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917173";"";"None";"423.39";"0";"4.58";"BDBM203264";"COc1ccc2c(c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1)OCO2";"IC50";"'='";"23.0";"nM";"7.64";"";"360828";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3963602";"";"None";"383.49";"0";"4.74";"BDBM203045";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(C)C)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"360585";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893795";"";"None";"415.36";"1";"5.13";"BDBM203054";"COc1cc(F)c(C2CCCC(=O)N2Cc2ccc(OC(F)(F)F)cc2)c(F)c1";"IC50";"'='";"5479.0";"nM";"5.26";"";"360604";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941745";"";"None";"457.00";"1";"6.04";"BDBM203102";"COc1ccc(Cl)c(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"115.0";"nM";"6.94";"";"360660";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909038";"";"None";"410.54";"1";"6.34";"BDBM203109";"O=C1CCC(c2ccccc2-c2ccccc2)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"1370.0";"nM";"5.86";"";"360667";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3622333";"";"None";"461.45";"0";"2.83";"12";"COc1nc(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)ncc1C(F)(F)F";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1464571";"";"None";"353.36";"1";"5.98";"SID49676248";"Cc1ccc(C)c(NP(=O)(Oc2ccccc2)Oc2ccccc2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1541192";"";"None";"447.52";"0";"2.78";"SID7967149";"O=C(C1CCCN1S(=O)(=O)c1cccc2cccnc12)N1CCn2c1nc1ccccc12";"IC50";"";"9680.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1722330";"";"None";"356.42";"0";"2.64";"SID47195117";"CCOc1ccccc1C(=O)NCCNC(=O)c1ccccc1OCC";"IC50";"";"2780.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1375038";"";"None";"482.59";"0";"3.01";"SID56316493";"CSc1cccc(N2CC(C(=O)NCCN3C(=O)S/C(=C\c4cccnc4)C3=O)CC2=O)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335116";"";"None";"496.62";"0";"2.88";"SID24831241";"CCc1cc2c(SCC(=O)N(CC)c3c(N)n(Cc4ccccc4)c(=O)[nH]c3=O)ncnc2s1";"IC50";"";"1710.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1367648";"";"None";"267.36";"0";"3.43";"SID3713837";"N#C/C(=C1\CCCN1)c1nc(-c2ccccc2)cs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342888";"";"None";"383.48";"0";"2.03";"SID24822964";"Nc1nc(-c2sc3nc4c(cc3c2N)CCCC4)nc(N2CCOCC2)n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1382624";"";"None";"408.52";"0";"3.59";"SID4254993";"CSc1cccc(NC(=O)C2CCCN(S(=O)(=O)c3ccc(F)cc3)C2)c1";"IC50";"";"14200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532403";"";"None";"314.41";"0";"2.94";"SID17414686";"CC(=C/c1ccccc1)/C=C1/SC(N2CCOCC2)=NC1=O";"IC50";"";"26000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351929";"";"None";"342.38";"0";"3.33";"SID24815455";"COc1ccccc1C(=O)Nc1nc2cc3c(cc2s1)OCCO3";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1384723";"";"None";"420.48";"0";"2.84";"SID24840225";"C=Cn1ccnc1P(=S)(c1c(C)nn(-c2ccccc2)c1C)c1nccn1C=C";"IC50";"";"170.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1606494";"";"None";"428.56";"0";"4.60";"SID14744388";"CN(C(=O)CSc1nc(-c2ccccc2)cn1N)C(c1ccccc1)c1ccccc1";"IC50";"";"4800.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1590005";"";"None";"395.46";"0";"4.76";"SID85146492";"C=CCn1c2ccccc2c(=O)c2cc(C#Cc3cc(OC)cc(OC)c3)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1549099";"";"None";"278.34";"0";"3.33";"SID864252";"N#Cc1c(-c2cccs2)cc(-c2ccccn2)nc1N";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1333148";"";"None";"472.53";"0";"4.56";"SID24840967";"C=CCn1c(SCC(=O)Nc2cc3oc4ccccc4c3cc2OC)nnc1-c1cnccn1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1590375";"";"None";"310.37";"0";"3.48";"SID85146428";"CC(C)(O)c1cc2ccc(C#Cc3ccsc3)cc2c(=O)o1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1577537";"";"None";"300.47";"0";"3.36";"SID850272";"CCN1C(=O)/C(=C2/SC(C)=C(C)N2CC)SC1=S";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2092888";"";"None";"419.48";"0";"2.68";"4b";"O=C(Nc1ccccc1)N1CCC2(OCCN2S(=O)(=O)c2ccccc2)[C@@H](F)C1";"IC50";"'='";"220.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3898298";"";"None";"415.80";"0";"4.08";"BDBM203115";"COc1cccc(Cl)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"294.0";"nM";"6.53";"";"360673";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927062";"";"None";"395.50";"0";"3.95";"BDBM202982";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(N2CCCCC2)n1";"IC50";"'='";"690.0";"nM";"6.16";"";"360509";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113766";"";"None";"423.43";"1";"5.10";"BDBM50447790";"COc1cccc(OC)c1C1CC(C)(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"252.0";"nM";"6.60";"";"360596";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980990";"";"None";"399.36";"1";"5.43";"BDBM203055";"Cc1ccc(F)c(C2CCCC(=O)N2Cc2ccc(OC(F)(F)F)cc2)c1F";"IC50";"'='";"2437.0";"nM";"5.61";"";"360605";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954899";"";"None";"431.42";"0";"3.15";"BDBM185262";"Cc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334179";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3985911";"";"None";"446.43";"0";"3.93";"BDBM185320";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2ncc(C(F)(F)F)nc2C)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334237";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3918397";"";"None";"460.47";"0";"3.47";"BDBM208510";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cc2noc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"59.1";"nM";"7.23";"";"368547";"UO_0000065";"15.70";"0.29";"3.76";"6.75";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934442";"";"None";"462.46";"0";"3.43";"BDBM208528";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCCOC1Cc1cnn(-c2ccc(F)cn2)c1";"IC50";"'='";"51.8";"nM";"7.29";"";"368565";"UO_0000065";"15.75";"0.29";"3.86";"8.47";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922695";"";"None";"448.46";"0";"2.85";"BDBM184139";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncon3)ccc2F)c1-n1nccn1";"IC50";"'='";"893.0";"nM";"6.05";"";"332208";"UO_0000065";"13.49";"0.25";"3.20";"6.10";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936778";"";"None";"418.43";"0";"2.77";"BDBM208502";"O=C(c1ccccc1-n1nccn1)N1CCOC1Cn1ccc(-c2ccc(F)cc2)n1";"IC50";"'='";"192.2";"nM";"6.72";"";"368539";"UO_0000065";"16.05";"0.30";"3.95";"8.60";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969724";"";"None";"393.40";"1";"5.24";"BDBM203076";"CCOc1ccccc1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"426.0";"nM";"6.37";"";"360630";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409862";"";"None";"425.40";"0";"4.09";"BDBM203086";"COc1cccc(OC)c1[C@@H]1C[C@@H](OC)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"6940.0";"nM";"5.16";"";"360641";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938412";"";"None";"395.38";"0";"3.82";"BDBM203120";"CCOc1ccccc1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"170.0";"nM";"6.77";"";"360678";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936509";"";"None";"415.36";"0";"4.93";"BDBM203150";"CCOc1c(F)cccc1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"434.0";"nM";"6.36";"";"360710";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945398";"";"None";"437.49";"1";"5.87";"BDBM203156";"CCOc1cccc(OC)c1C1CC(F)(F)C(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"63.0";"nM";"7.20";"";"360716";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894403";"";"None";"430.93";"1";"5.72";"BDBM203183";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(-c2nc(Cl)cs2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"360744";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973633";"";"None";"393.40";"0";"4.94";"BDBM203192";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)F)c1";"IC50";"'='";"41.0";"nM";"7.39";"";"360753";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985508";"";"None";"428.53";"1";"5.46";"BDBM203205";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2c(c1)c1ccccc1n2C";"IC50";"'='";"111.0";"nM";"6.96";"";"360766";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935347";"";"None";"364.45";"0";"4.29";"BDBM203210";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2[nH]ccc2c1";"IC50";"'='";"1780.0";"nM";"5.75";"";"360771";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916968";"";"None";"383.49";"0";"4.60";"BDBM203214";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(C)C)cc1";"IC50";"'='";"370.0";"nM";"6.43";"";"360776";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926227";"";"None";"394.52";"0";"4.56";"BDBM203070";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(N2CCCC2)cc1";"IC50";"'='";"132.0";"nM";"6.88";"";"360624";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954049";"";"None";"434.89";"0";"4.17";"BDBM240103";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"418944";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905668";"";"None";"414.47";"0";"3.83";"BDBM240106";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cc(C)ccc3C)no2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"418947";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979585";"";"None";"488.86";"0";"4.89";"BDBM240161";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C(F)(F)F)ccc2-n2nccn2)n1";"IC50";"'='";"390.0";"nM";"6.41";"";"419003";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946611";"";"None";"484.44";"0";"4.42";"BDBM240180";"Cc1cc(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)c(-n2nccn2)cc1C";"IC50";"'='";"3.0";"nM";"8.52";"";"419022";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975924";"";"None";"500.44";"1";"4.12";"BDBM240181";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)c(-n2nccn2)cc1C";"IC50";"'='";"4.0";"nM";"8.40";"";"419023";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4088347";"";"None";"419.46";"0";"3.13";"8a";"Cc1ccc(-n2nccn2)c(C(=O)N(C)[C@@H](C)Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"5.68";"nM";"8.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3957156";"";"None";"423.54";"0";"4.64";"BDBM203170";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccnc(-c2ncc(C)s2)c1";"IC50";"'='";"51.0";"nM";"7.29";"";"360730";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943155";"";"None";"443.96";"0";"4.99";"BDBM203174";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2nc(Cl)cs2)c1";"IC50";"'='";"103.0";"nM";"6.99";"";"360734";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897167";"";"None";"385.48";"1";"5.12";"BDBM203195";"CCCOc1ccc(CN2C(=O)C(C)CC2c2c(F)cccc2OCC)cc1";"IC50";"'='";"95.0";"nM";"7.02";"";"360756";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919889";"";"None";"441.42";"1";"5.05";"BDBM203216";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)C(F)F)cc1";"IC50";"'='";"124.0";"nM";"6.91";"";"360778";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978809";"";"None";"425.42";"1";"5.62";"BDBM203232";"CCCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"291.0";"nM";"6.54";"";"360794";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918463";"";"None";"401.51";"1";"5.48";"BDBM202975";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"360501";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971086";"";"None";"391.47";"0";"4.00";"BDBM202987";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"264.0";"nM";"6.58";"";"360514";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962952";"";"None";"408.52";"0";"4.94";"BDBM202996";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"54.0";"nM";"7.27";"";"360524";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904193";"";"None";"392.40";"0";"3.95";"BDBM203030";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)F)cn1";"IC50";"'='";"70.0";"nM";"7.16";"";"360566";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114472";"";"None";"431.42";"0";"3.23";"BDBM185267";"C[C@@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"1400.0";"nM";"5.85";"";"334184";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3927726";"";"None";"445.45";"0";"3.40";"BDBM185294";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334211";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3914015";"";"None";"450.85";"0";"4.10";"BDBM185289";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1Cl)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334206";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3891497";"";"None";"458.45";"0";"3.11";"BDBM185321";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)nc1C1CC1)c1ncccc1-n1nccn1";"IC50";"'='";"8827.0";"nM";"5.05";"";"334238";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3951318";"";"None";"453.38";"0";"3.12";"BDBM185245";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(F)cc(F)c1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334162";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3919981";"";"None";"385.34";"0";"4.14";"BDBM185256";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1c(F)cccc1F";"IC50";"'>'";"10000.0";"nM";"";"";"334173";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3952886";"";"None";"435.38";"0";"2.98";"BDBM185304";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334221";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3931673";"";"None";"453.38";"0";"3.08";"BDBM185308";"O=C(NC1CC(F)(F)CC1Nc1ncc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334225";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3896959";"";"None";"462.86";"0";"4.37";"BDBM185327";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1Cl)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334244";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3667555";"";"None";"410.95";"0";"3.85";"BDBM154928";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2cccc(Cl)c2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"297219";"UO_0000065";"21.17";"0.46";"4.85";"13.09";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL444602";"";"None";"403.55";"0";"3.25";"47";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1nccs1)C(C)(C)C)CC2";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489893";"";"None";"417.59";"0";"2.98";"46";"CNC1CCCC1CN[C@H](C(=O)N1CCc2cc(OC)c(OC)cc2C1)C(C)(C)C";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL141368";"";"None";"410.56";"0";"3.84";"(+/-)-43";"COc1cc2c(cc1OC)CN(C(=O)C(NCCc1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL139117";"";"None";"382.50";"0";"4.12";"(+/-)-38";"COc1cc2c(cc1OC)CN(C(=O)C(Nc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"2100.0";"nM";"5.68";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL139223";"";"None";"306.41";"0";"1.96";"(+/-)-37";"COc1cc2c(cc1OC)CN(C(=O)C(N)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490489";"";"None";"490.60";"0";"4.18";"(+/-)-91";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccccc2)cc1OC";"IC50";"'='";"8152.0";"nM";"5.09";"";"";"UO_0000065";"10.37";"0.19";"0.91";"7.35";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2031502";"";"None";"485.61";"0";"4.03";"46";"Cc1nc(C(=O)N2CC(N)CC[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccccc2)s1";"IC50";"'='";"2000.0";"nM";"5.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL496993";"";"None";"388.53";"0";"3.62";"18";"CCc1ccc(S(=O)(=O)N(CC(=O)N(CC)CC)c2ccc(C)cc2)cc1";"IC50";"'='";"89.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3113765";"";"None";"409.40";"0";"4.71";"65";"COc1cccc(OC)c1[C@H]1C[C@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113764";"";"None";"409.40";"0";"4.71";"64";"COc1cccc(OC)c1[C@@H]1C[C@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"128.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113763";"";"None";"409.40";"0";"4.71";"63, Stereoisomeric mixture";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"133.0";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113754";"";"None";"426.52";"1";"6.07";"54";"COc1ccc2nc(C)oc2c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"93.0";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL524267";"";"None";"374.51";"0";"3.37";"19";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(C)cc1";"IC50";"'='";"232.0";"nM";"6.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL468964";"";"None";"444.48";"0";"3.96";"24";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1822.0";"nM";"5.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3113536";"";"None";"413.82";"1";"5.50";"18";"COc1cccc(Cl)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"154.0";"nM";"6.81";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL496979";"";"None";"550.08";"1";"3.71";"50";"CCN(C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1cc(C)n(C)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3962927";"";"None";"480.45";"0";"4.72";"BDBM240229";"Cc1ccc(-c2ncccn2)c(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c1";"IC50";"'='";"348.0";"nM";"6.46";"";"419072";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1170803";"";"None";"457.51";"0";"3.54";"rac-9";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC3CCC(C2)N3c2ncc3ccc(F)cc3n2)c1";"IC50";"'='";"175.0";"nM";"6.76";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1170178";"";"None";"457.51";"0";"3.54";"16a";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H]3CC[C@@H]2CCN3c2ncc3ccc(F)cc3n2)c1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1175133";"Antagonist activity at OX2R by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1177797";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL3961068";"";"None";"383.80";"0";"4.52";"BDBM185253";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ccccc1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"334170";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3945012";"";"None";"460.56";"0";"4.09";"BDBM183973";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1cccs1";"IC50";"'='";"31.0";"nM";"7.51";"";"332037";"UO_0000065";"16.30";"0.31";"3.42";"10.81";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3916741";"";"None";"457.53";"0";"4.56";"BDBM221322";"COc1ccc2c(c1)CCN2CCCn1cc(NC(=O)c2ncoc2-c2cccc(C)c2)cn1";"IC50";"'='";"1830.0";"nM";"5.74";"";"387455";"UO_0000065";"12.54";"0.23";"1.18";"6.72";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965024";"";"None";"418.43";"0";"3.66";"BDBM240188";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2noc(-c3cccc(F)c3C)n2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"419030";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959128";"";"None";"430.47";"0";"2.74";"BDBM240216";"CCOc1ncccc1-c1nnc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)[nH]1";"IC50";"'='";"92.0";"nM";"7.04";"";"419059";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972793";"";"None";"469.43";"0";"3.85";"BDBM240221";"Cc1ccc(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c(-n2nccn2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"419064";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897210";"";"None";"484.35";"0";"3.24";"BDBM184133";"O=C(c1cccc(Cl)c1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1Cl";"IC50";"'='";"675.0";"nM";"6.17";"";"332202";"UO_0000065";"12.74";"0.26";"2.93";"6.78";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3972733";"";"None";"481.92";"0";"3.11";"BDBM184135";"C[C@@H]1CN(C(=O)c2cccc(Cl)c2-n2nccn2)[C@H](Cc2cc(-n3nccn3)ccc2F)CO1";"IC50";"'='";"455.0";"nM";"6.34";"";"332204";"UO_0000065";"13.16";"0.25";"3.23";"6.97";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967125";"";"None";"468.88";"0";"3.19";"BDBM184138";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncon2)ccc1F";"IC50";"'='";"240.0";"nM";"6.62";"";"332207";"UO_0000065";"14.12";"0.27";"3.43";"6.68";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968480";"";"None";"462.49";"0";"3.16";"BDBM184141";"Cc1cc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncon3)ccc2F)c(-n2nccn2)cc1C";"IC50";"'='";"34.0";"nM";"7.47";"";"332210";"UO_0000065";"16.15";"0.30";"4.31";"7.53";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2347477";"";"None";"512.62";"2";"5.89";"13";"CCCc1nc(CC)n2c1C(CCc1ccc(C(F)(F)F)cc1)N([C@@H](C(=O)NC)c1ccccc1)CC2";"IC50";"'='";"225.0";"nM";"6.65";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3910216";"";"None";"431.36";"0";"3.91";"BDBM203249";"O=C1[C@H](O)C[C@@H](c2c(F)cccc2OCCF)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"57.0";"nM";"7.24";"";"360811";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955828";"";"None";"448.27";"1";"5.72";"BDBM203254";"CCOc1cccc(Cl)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"46.0";"nM";"7.34";"";"360816";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113755";"";"None";"447.56";"1";"5.83";"BDBM50447801";"COc1ccc2nc(C)oc2c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"360820";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906138";"";"None";"443.85";"1";"5.51";"BDBM203011";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)c(Cl)c1";"IC50";"'='";"62.0";"nM";"7.21";"";"360540";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964922";"";"None";"435.34";"1";"6.00";"BDBM203056";"O=C1CCCC(c2c(F)cccc2C(F)(F)F)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"5896.0";"nM";"5.23";"";"360606";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958542";"";"None";"413.37";"0";"3.96";"BDBM203153";"CCOc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"33.0";"nM";"7.48";"";"360713";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113760";"";"None";"423.43";"1";"5.10";"60, Stereoisomeric mixture";"COc1cccc(OC)c1C1CC(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"297.0";"nM";"6.53";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL2413373";"";"None";"468.53";"0";"4.55";"59";"CN(Cc1ccc(F)cc1)C(=O)Cn1cc(S(=O)(=O)Cc2ccc(F)cc2)c2ccccc21";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2031493";"";"None";"446.58";"1";"5.61";"15";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNc2nc3ccccc3o2)c(-c2ccccc2)s1";"IC50";"'='";"447.0";"nM";"6.35";"";"";"UO_0000065";"14.22";"0.27";"0.74";"8.91";"1";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3982171";"";"None";"420.86";"0";"3.87";"BDBM240163";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2ccccc2-n2nccn2)n1";"IC50";"'='";"74.0";"nM";"7.13";"";"419005";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899022";"";"None";"469.43";"0";"3.85";"BDBM240219";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"419062";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892874";"";"None";"523.40";"1";"4.56";"BDBM240227";"O=C(c1ccc(C(F)(F)F)cc1-n1nccn1)N1CC[C@H]1c1nnc(-c2ccccc2OC(F)(F)F)[nH]1";"IC50";"'='";"17.0";"nM";"7.77";"";"419070";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2347486";"";"None";"514.59";"2";"5.34";"22, diastereomeric mixture";"CCOc1nc(CC)n2c1C(CCc1ccc(C(F)(F)F)cc1)N([C@@H](C(=O)NC)c1ccccc1)CC2";"IC50";"'='";"2746.0";"nM";"5.56";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3426134";"";"None";"391.48";"0";"3.30";"5c";"CCc1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL2347599";"";"None";"495.55";"0";"4.81";"25, diastereomeric mixture";"CCc1nc(C#N)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347479";"";"None";"510.60";"2";"5.82";"15";"CCc1nc(C2CC2)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3409860";"";"None";"425.40";"0";"4.09";"30";"COc1cccc(OC)c1[C@@H]1C[C@H](OC)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"168.0";"nM";"6.78";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2031495";"";"None";"467.54";"1";"5.27";"30";"O=C(NC[C@@H]1C[C@@H](F)CCN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"541.0";"nM";"6.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2396837";"";"None";"522.97";"2";"5.73";"38";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(F)c(C(F)(F)F)c1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396866";"";"None";"520.98";"2";"5.47";"29";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3900899";"";"None";"412.82";"0";"4.22";"BDBM202965";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cnc(OC(F)F)c(Cl)c1";"IC50";"'='";"107.0";"nM";"6.97";"";"360491";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978924";"";"None";"388.47";"0";"4.63";"BDBM202974";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2ccccc2)n1";"IC50";"'='";"105.0";"nM";"6.98";"";"360500";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912173";"";"None";"402.49";"0";"4.88";"BDBM202991";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"73.0";"nM";"7.14";"";"360519";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954220";"";"None";"407.47";"0";"4.17";"BDBM202994";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2noc(C)n2)c1";"IC50";"'='";"46.0";"nM";"7.34";"";"360522";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947861";"";"None";"422.55";"1";"5.25";"BDBM202999";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"21.0";"nM";"7.68";"";"360527";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917615";"";"None";"396.51";"0";"4.73";"BDBM203002";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2nc(C)sc2c1";"IC50";"'='";"703.0";"nM";"6.15";"";"360530";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958937";"";"None";"355.43";"0";"3.97";"BDBM203009";"COc1ccc(CN2C(=O)CCCC2c2c(OC)cccc2OC)cc1";"IC50";"'='";"397.0";"nM";"6.40";"";"360538";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929769";"";"None";"425.47";"1";"5.57";"BDBM203012";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(SC(F)(F)F)cc1";"IC50";"'='";"62.0";"nM";"7.21";"";"360541";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973670";"";"None";"439.48";"0";"4.15";"BDBM221418";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3cnc4ccccc4n3)c2)c1";"IC50";"'='";"286.0";"nM";"6.54";"";"387549";"UO_0000065";"14.89";"0.27";"2.39";"5.91";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113747";"";"None";"392.46";"0";"3.54";"47";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113739";"";"None";"376.46";"0";"4.51";"39";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"217.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL2031488";"";"None";"477.63";"1";"5.11";"23";"COc1cccc(C(=O)NC[C@@H]2[C@H](C)CCCN2C(=O)c2nc(C)sc2-c2ccccc2)c1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3771066";"";"None";"518.65";"1";"4.96";"12";"COc1ccc(CC2c3cc(OC(C)C)c(OC)cc3CCN2CC(=O)NCc2ccccc2)cc1OC";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3113768";"";"None";"443.42";"1";"5.35";"68";"COc1cccc(OC)c1C1c2ccccc2C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113766";"";"None";"423.43";"1";"5.10";"66";"COc1cccc(OC)c1C1CC(C)(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"252.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113746";"";"None";"422.55";"1";"5.39";"46";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113744";"";"None";"402.49";"1";"5.02";"44";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-c2ccccc2)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113547";"";"None";"417.51";"1";"5.75";"30";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3260829";"";"None";"446.52";"0";"2.74";"35";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc(N)c4c(C)coc4n3)CC[C@H]2C)c1";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"15.22";"0.28";"4.06";"5.70";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1911941";"";"None";"449.50";"0";"2.69";"4e";"COc1ccc(S(=O)(=O)N2CCOC23CCN(C(=O)Nc2ccccc2)CC3F)cc1";"IC50";"'='";"87.0";"nM";"7.06";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3099899";"";"None";"494.38";"1";"6.06";"18";"COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3101090";"Antagonist activity at human orexin-2 receptor assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 30 mins by cell-based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3098111";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3977479";"";"None";"451.84";"0";"3.49";"BDBM185303";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1Cl)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334220";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3951456";"";"None";"431.42";"0";"3.15";"BDBM185305";"Cc1cc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334222";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3953789";"";"None";"457.49";"0";"4.46";"BDBM221335";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4ccccc4)cn3)c2cc1OC";"IC50";"'='";"343.0";"nM";"6.46";"";"387468";"UO_0000065";"14.13";"0.26";"2.00";"6.71";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925061";"";"None";"474.55";"0";"4.40";"BDBM221346";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncsc4-c4ccc(OC)nc4)cn3)c2c1";"IC50";"'='";"235.0";"nM";"6.63";"";"387479";"UO_0000065";"13.97";"0.27";"2.23";"6.20";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941436";"";"None";"412.45";"0";"4.15";"BDBM221350";"Cc1nc2ccccc2n1CCn1cc(NC(=O)c2ncoc2-c2ccccc2)cn1";"IC50";"'='";"597.0";"nM";"6.22";"";"387480";"UO_0000065";"15.09";"0.27";"2.07";"6.86";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3597962";"";"None";"432.41";"0";"3.15";"58";"C[C@@H]1CC[C@@H](Oc2cc(C(F)(F)F)ccn2)CN1C(=O)c1ccccc1-n1ncnn1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598905";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced Ca2+ flux preincubated for 5 mins followed by orexin-A induction measured 1 sec interval for 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2347605";"";"None";"520.98";"2";"5.18";"39, diastereomeric mixture";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(COC)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3901915";"";"None";"440.51";"0";"3.12";"BDBM184154";"Cc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ncccn1";"IC50";"'='";"2606.0";"nM";"5.58";"";"332223";"UO_0000065";"12.68";"0.23";"2.46";"6.49";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2396841";"";"None";"534.99";"2";"6.05";"47";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1F";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347607";"";"None";"517.00";"2";"5.91";"44";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396868";"";"None";"522.97";"2";"5.73";"31";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@@H]2CCc1ccc(C(F)(F)F)c(F)c1";"IC50";"'='";"227.0";"nM";"6.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396865";"";"None";"502.99";"2";"5.18";"28";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(OC(F)F)cc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396864";"";"None";"462.00";"0";"4.45";"27";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C#N)cc1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3928551";"";"None";"440.51";"0";"3.12";"BDBM184004";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3cnccn3)c2)c1";"IC50";"'='";"1043.0";"nM";"5.98";"";"332068";"UO_0000065";"13.58";"0.25";"2.86";"6.95";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3909876";"";"None";"443.51";"0";"2.63";"BDBM184035";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@@H]2C)c1";"IC50";"'='";"1850.0";"nM";"5.73";"";"332104";"UO_0000065";"12.93";"0.24";"3.10";"6.30";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914317";"";"None";"443.51";"0";"2.63";"BDBM184064";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@@]2(C)Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"1508.0";"nM";"5.82";"";"332133";"UO_0000065";"13.13";"0.24";"3.19";"6.40";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946019";"";"None";"474.95";"0";"3.85";"BDBM184076";"C[C@@H]1CN(C(=O)c2ccc(Cl)cc2-n2nccn2)[C@H](Cc2cccc(-c3ncccn3)c2)CO1";"IC50";"'='";"83.0";"nM";"7.08";"";"332145";"UO_0000065";"14.91";"0.28";"3.23";"8.23";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3914896";"";"None";"447.47";"0";"2.46";"BDBM184078";"C[C@@H]1CN(C(=O)c2ccccc2-n2nccn2)[C@H](Cc2cc(-n3nccn3)ccc2F)CO1";"IC50";"'='";"899.0";"nM";"6.05";"";"332147";"UO_0000065";"13.51";"0.25";"3.59";"6.65";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3912674";"";"None";"467.89";"0";"2.72";"BDBM184092";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"191.0";"nM";"6.72";"";"332161";"UO_0000065";"14.36";"0.28";"4.00";"7.39";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3923760";"";"None";"478.92";"0";"3.60";"BDBM184122";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncccn2)ccc1F";"IC50";"'='";"268.0";"nM";"6.57";"";"332191";"UO_0000065";"13.72";"0.26";"2.97";"7.64";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3895759";"";"None";"478.92";"0";"3.60";"BDBM184123";"O=C(c1cccc(Cl)c1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncccn2)ccc1F";"IC50";"'='";"655.0";"nM";"6.18";"";"332192";"UO_0000065";"12.91";"0.25";"2.58";"7.19";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3922678";"";"None";"443.51";"0";"2.63";"BDBM184125";"Cc1ccc(C(=O)N2CCO[C@@H](C)[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"1864.0";"nM";"5.73";"";"332194";"UO_0000065";"12.92";"0.24";"3.10";"6.30";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3985846";"";"None";"477.96";"0";"3.20";"BDBM184131";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2Cl)c(-n2nccn2)c1C";"IC50";"'='";"2440.0";"nM";"5.61";"";"332200";"UO_0000065";"11.74";"0.23";"2.41";"6.17";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3938386";"";"None";"481.92";"0";"3.11";"BDBM184148";"C[C@@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)[C@H](Cc2cc(-n3nccn3)ccc2F)CO1";"IC50";"'='";"181.0";"nM";"6.74";"";"332217";"UO_0000065";"13.99";"0.27";"3.63";"7.41";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1572095";"";"None";"482.03";"1";"6.09";"SID17433769";"C=CCn1c(SCc2ccc(C(=O)Nc3nccs3)cc2)nnc1-c1ccc(C)c(Cl)c1";"IC50";"";"18000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1466997";"";"None";"246.27";"0";"4.04";"SID4260863";"c1ccc2nc(-c3nc4ccccc4o3)ccc2c1";"IC50";"";"41700.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1333148";"";"None";"472.53";"0";"4.56";"SID24840967";"C=CCn1c(SCC(=O)Nc2cc3oc4ccccc4c3cc2OC)nnc1-c1cnccn1";"IC50";"";"10400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518566";"";"None";"341.42";"0";"4.57";"SID3714377";"Cc1cnc(NC(=O)c2ccc(-c3nc4ccccc4s3)o2)s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1331281";"";"None";"457.56";"0";"4.61";"SID4258307";"CCn1c(SCC(=O)Nc2ccc3c(c2)c2ccccc2n3CC)nnc1-c1cnccn1";"IC50";"";"38900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1482828";"";"None";"426.45";"0";"2.86";"SID22407760";"Cc1c(C(=O)OCC(=O)NCCN2C(=O)CSC2=O)oc2c1ccc1ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1518032";"";"None";"365.84";"1";"5.32";"SID17403001";"O=C(Nc1ccc2sc3ccccc3c(=O)c2c1)c1ccccc1Cl";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1501678";"";"None";"469.59";"1";"5.01";"SID22406356";"CCN(CC)c1ccc(NC(=O)Cn2c(C(C)NC(=O)c3ccccc3)nc3ccccc32)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1440341";"";"None";"357.49";"0";"4.88";"SID14737997";"CSc1nc2ccc3nc(NC(=O)c4ccccc4)sc3c2s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1520702";"";"None";"311.34";"1";"5.09";"SID49648838";"O=c1c2ccccc2oc2cc(-c3ccc4[nH]ccc4c3)ccc12";"IC50";"";"40000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1460004";"";"None";"501.07";"1";"5.06";"SID24818007";"COc1ccc(OCc2n(CC(=O)OC3CC(C)CCC3C(C)C)c3ccccc3[n+]2C)cc1.[Cl-]";"IC50";"";"8900.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1438621";"";"None";"282.37";"0";"4.37";"SID846962";"N#CC(=C1CCCC1)c1nc(-c2ccccc2O)cs1";"IC50";"";"31600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1713886";"";"None";"217.27";"0";"2.96";"SID14725848";"CCOC(=O)c1ccc2[nH]c(C)c(C)c2c1";"IC50";"";"18800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3914248";"";"None";"437.57";"1";"5.17";"BDBM203095";"COc1cncc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"64.0";"nM";"7.19";"";"360653";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934707";"";"None";"405.49";"1";"5.12";"BDBM203020";"COc1ccc2cc(CN3C(=O)CCCC3c3c(OC)cccc3OC)ccc2c1";"IC50";"'='";"66.0";"nM";"7.18";"";"360550";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893150";"";"None";"449.45";"0";"2.59";"BDBM208522";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cc2noc(-c3ccc(F)cc3)n2)n1";"IC50";"'='";"7.3";"nM";"8.14";"";"368559";"UO_0000065";"18.10";"0.34";"5.55";"7.26";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924823";"";"None";"447.47";"0";"2.73";"BDBM208531";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cc2cnn(-c3ccc(F)cn3)c2)c1";"IC50";"'='";"3.6";"nM";"8.44";"";"368568";"UO_0000065";"18.87";"0.35";"5.71";"9.28";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918788";"";"None";"447.45";"0";"3.78";"BDBM208509";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCOC1Cn1cc(-c2ccc(F)cc2)cn1";"IC50";"'='";"107.0";"nM";"6.97";"";"368546";"UO_0000065";"15.58";"0.29";"3.19";"9.53";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3338850";"";"None";"441.49";"0";"3.86";"9";"COc1ccc(CNC(=O)c2nc(-c3cncc(C)c3)ncc2-c2ccccc2)nc1OC";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"15.68";"0.29";"3.06";"6.98";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3338856";"";"None";"458.49";"0";"4.60";"15";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2cccc(F)c2)nc1OC";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"17.00";"0.31";"3.20";"9.04";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3667552";"";"None";"418.58";"0";"4.15";"BDBM154925";"CCCc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(SC)c2)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"297216";"UO_0000065";"17.51";"0.36";"3.18";"11.02";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667598";"";"None";"460.91";"0";"4.77";"BDBM154972";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C(F)(F)F)cc2Cl)c1";"IC50";"'='";"14.0";"nM";"7.85";"";"297263";"UO_0000065";"17.04";"0.36";"3.08";"11.81";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2107822";"FILOREXANT";"2.0";"420.49";"0";"4.31";"50";"Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3772033";"Antagonist activity at human OX2R expressed in CHO cell membranes assessed as inhibition of orexin-A-induced intracellular calcium release after 120 mins";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL2413374";"";"None";"454.50";"0";"4.21";"60";"O=C(Cn1cc(S(=O)(=O)Cc2ccc(F)cc2)c2ccccc21)NCc1ccc(F)cc1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3976124";"";"None";"439.48";"0";"4.15";"BDBM221424";"Cc1cccc(-c2ocnc2C(=O)Nc2cn(CCNc3ncc4ccccc4n3)cn2)c1";"IC50";"'='";"328.0";"nM";"6.48";"";"387555";"UO_0000065";"14.75";"0.27";"2.33";"5.85";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926636";"";"None";"473.49";"0";"3.56";"BDBM221383";"COc1nc(OC)c2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2n1";"IC50";"'='";"94.0";"nM";"7.03";"";"387514";"UO_0000065";"14.84";"0.27";"3.47";"5.75";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919870";"";"None";"372.43";"0";"4.34";"BDBM221304";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCc3ccccc3)c2)c1";"IC50";"'='";"1277.0";"nM";"5.89";"";"387437";"UO_0000065";"15.83";"0.29";"1.55";"8.08";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3260830";"";"None";"432.49";"0";"2.44";"36";"Cc1coc2nc(N3CC[C@@H](C)N(C(=O)c4ccccc4-n4nccn4)CC3)nc(N)c12";"IC50";"'='";"210.0";"nM";"6.68";"";"";"UO_0000065";"15.44";"0.29";"4.24";"5.60";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3955337";"";"None";"376.46";"0";"4.51";"BDBM202868";"COc1cccc(OC)c1[C@@H]1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"329.0";"nM";"6.48";"";"360382";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3112601";"";"None";"376.46";"0";"4.51";"BDBM50447762";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"58.0";"nM";"7.24";"";"360383";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929583";"";"None";"402.49";"1";"5.02";"BDBM202872";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cncc(-c2ccccc2)c1";"IC50";"'='";"700.0";"nM";"6.16";"";"360387";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908623";"";"None";"407.54";"1";"5.69";"BDBM202878";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(-c2ccccc2)s1";"IC50";"'='";"38.0";"nM";"7.42";"";"360397";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945256";"";"None";"405.29";"0";"4.12";"BDBM202893";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(Br)c1";"IC50";"'='";"1150.0";"nM";"5.94";"";"360415";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949227";"";"None";"420.48";"1";"5.16";"BDBM202897";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(-c2ccccn2)ccc1F";"IC50";"'='";"696.0";"nM";"6.16";"";"360419";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986037";"";"None";"402.49";"1";"5.02";"BDBM202913";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"360439";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927897";"";"None";"389.50";"1";"5.50";"BDBM202929";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc2ccccc12";"IC50";"'='";"27.0";"nM";"7.57";"";"360455";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973773";"";"None";"422.55";"1";"5.47";"BDBM202951";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"360477";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962811";"";"None";"406.49";"0";"3.93";"BDBM202957";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-n2cccn2)n1";"IC50";"'='";"429.0";"nM";"6.37";"";"360483";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969627";"";"None";"403.48";"1";"5.36";"BDBM202971";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(Oc2ccccc2)cc1";"IC50";"'='";"58.0";"nM";"7.24";"";"360497";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3739711";"";"None";"436.58";"1";"5.29";"13";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(C)c2)cc1OC";"IC50";"'='";"3.1";"nM";"8.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4643960";"";"None";"449.45";"0";"2.59";"(-)-6";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cc2noc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"3.6";"nM";"8.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL1083657";"";"None";"417.52";"0";"2.68";"12";"C[C@@H]1CCN(c2ncc3c(n2)CCCC3)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1083659";"SUVOREXANT";"4.0";"450.93";"0";"4.11";"3, MK-4305";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL3667553";"";"None";"447.58";"0";"3.03";"BDBM154926";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc3c(c2)OCCN3C)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"297217";"UO_0000065";"16.91";"0.34";"4.54";"9.59";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3112601";"";"None";"376.46";"0";"4.51";"38, Enantiomer 2";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"329.0";"nM";"6.48";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113545";"";"None";"409.40";"0";"4.86";"28";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"94.0";"nM";"7.03";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL497565";"";"None";"394.92";"0";"3.71";"29";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1cccc(Cl)c1";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL497807";"";"None";"508.95";"1";"4.44";"34";"CCN(CC)C(=O)CN(c1cc(C(F)(F)F)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"48.0";"nM";"7.32";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL495964";"";"None";"484.02";"0";"3.49";"37";"CCN(CC)C(=O)CN(c1ccc(Cl)c(N(C)C)c1)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"789.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL521713";"";"None";"454.98";"0";"3.73";"40";"CCN(CC)C(=O)CN(c1cc(C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL495732";"";"None";"512.05";"1";"4.34";"46";"CCN(CC)C(=O)CN(c1cc2c(C)nsc2cc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"4.5";"nM";"8.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL486116";"";"None";"470.52";"0";"4.18";"17";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccc(F)c(F)c2)cc1OC";"IC50";"'='";"18.62";"nM";"7.73";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL3943607";"";"None";"427.46";"0";"4.52";"BDBM221328";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccccc4)cn3)c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"387461";"UO_0000065";"20.35";"0.37";"4.18";"8.88";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3908794";"";"None";"477.98";"1";"5.64";"BDBM221344";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncsc4-c4cccc(Cl)c4)cn3)c2c1";"IC50";"'='";"20.0";"nM";"7.70";"";"387477";"UO_0000065";"16.11";"0.32";"2.06";"9.08";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4633992";"";"None";"449.52";"0";"3.19";"(-)-3e";"Cc1ccc(-n2nccn2)c(C(=O)N2CCS[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"2300.0";"nM";"5.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4637497";"";"None";"447.47";"0";"2.73";"(-)-5";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cc2cnn(-c3ccc(F)cn3)c2)c1";"IC50";"'='";"2.03";"nM";"8.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL2031478";"";"None";"449.55";"1";"5.33";"4";"O=C(NCC1CCCCN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031480";"";"None";"459.57";"1";"5.29";"6";"Cc1nc(-c2ccccc2)c(C(=O)N2CCCCC2CNC(=O)c2cccc3occc23)s1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031486";"";"None";"487.63";"1";"5.84";"21";"Cc1cc2c(C(=O)NC[C@@H]3[C@H](C)CCCN3C(=O)c3nc(C)sc3-c3ccccc3)cccc2o1";"IC50";"'='";"221.0";"nM";"6.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL342039";"";"None";"368.48";"0";"2.76";"5";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)N(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3939109";"";"None";"408.40";"0";"4.27";"BDBM185250";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(F)cccc1C1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"334167";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3932722";"";"None";"432.41";"0";"2.62";"BDBM185261";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334178";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL2107822";"FILOREXANT";"2.0";"420.49";"0";"4.31";"Filorexant";"Cc1ccc(-c2ncccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"";"UO_0000065";"18.48";"0.34";"3.46";"11.39";"0";"CHEMBL3395400";"Antagonist activity at human OX2R by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393034";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3113742";"";"None";"415.49";"1";"5.86";"42";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113741";"";"None";"396.51";"0";"4.88";"41";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2sc(C)nc2c1";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1911940";"";"None";"449.50";"0";"2.69";"4d";"COc1cccc(S(=O)(=O)N2CCOC23CCN(C(=O)Nc2ccccc2)CC3F)c1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL2031483";"";"None";"460.53";"1";"5.64";"9";"Cc1nc(-c2ccccc2)c(C(=O)N2CCCCC2CNc2ccc(C(F)(F)F)cn2)s1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031489";"";"None";"484.63";"1";"5.34";"24";"Cc1nc(-c2ccccc2)c(C(=O)N2CCC[C@@H](C)[C@H]2CNC(=O)c2cccc3cccnc23)s1";"IC50";"'='";"50.0";"nM";"7.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031496";"";"None";"506.58";"2";"5.34";"31";"Cc1nc(-c2ccccc2)c(C(=O)N2CCC(F)(F)C[C@H]2CNC(=O)c2cccc3cccnc23)s1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3338862";"";"None";"433.51";"0";"3.39";"21";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2N2CCCC2)nc1OC";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"17.14";"0.32";"4.04";"8.31";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3338863";"";"None";"419.49";"0";"3.00";"22";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2N2CCC2)nc1OC";"IC50";"'='";"83.0";"nM";"7.08";"";"";"UO_0000065";"16.88";"0.31";"4.08";"7.91";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3899133";"";"None";"431.42";"0";"3.23";"BDBM185269";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ncccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334186";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3984426";"";"None";"400.35";"0";"3.93";"BDBM185272";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1c(F)cccc1F";"IC50";"'>'";"10000.0";"nM";"";"";"334189";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL1507474";"";"None";"303.41";"0";"2.78";"SID3714103";"Nn1c(-c2cccs2)nc2sc3c(c2c1=O)CCCC3";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1516768";"";"None";"232.31";"0";"2.69";"SID14727402";"Cc1c(/C=C/C(=O)c2cccs2)cnn1C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1714525";"";"None";"351.40";"0";"3.95";"SID85200171";"Cc1c(C(=O)OC(C)C(=O)N(C)Cc2ccccc2)oc2ccccc12";"IC50";"";"5520.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1402931";"";"None";"472.94";"1";"5.33";"SID17407670";"CCSC1=C(C#N)C(c2ccccc2Cl)C(C(=O)c2cccs2)C(O)(C(F)(F)F)N1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3741779";"";"None";"441.00";"1";"5.94";"18";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(C)c2)cc1Cl";"IC50";"'='";"1.8";"nM";"8.74";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667575";"";"None";"408.91";"0";"3.45";"BDBM154949";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)ccc2Cl)cc1";"IC50";"'='";"224.0";"nM";"6.65";"";"297240";"UO_0000065";"16.26";"0.34";"3.20";"8.78";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL435826";"";"None";"402.58";"0";"4.17";"20";"COc1cc2c(cc1OC)CN(C(=O)C(NCC1CCCCC1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3895130";"";"None";"443.51";"0";"2.55";"BDBM184029";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2ccc(C)c(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"274.0";"nM";"6.56";"";"332098";"UO_0000065";"14.80";"0.27";"4.01";"7.21";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3960693";"";"None";"436.42";"0";"2.91";"BDBM208503";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC1Cn1ccc(-c2ccc(F)cc2)n1";"IC50";"'='";"232.7";"nM";"6.63";"";"368540";"UO_0000065";"15.20";"0.28";"3.72";"8.50";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962237";"";"None";"403.48";"0";"4.41";"BDBM202916";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"360442";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3976100";"";"None";"442.56";"1";"5.99";"BDBM202939";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2c(c1)c1ccccc1n2C";"IC50";"'='";"71.0";"nM";"7.15";"";"360465";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113739";"";"None";"376.46";"0";"4.51";"BDBM50447817";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"209.0";"nM";"6.68";"";"360378";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113744";"";"None";"402.49";"1";"5.02";"BDBM50447812";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-c2ccccc2)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"360391";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951889";"";"None";"408.52";"1";"5.08";"BDBM202875";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"360393";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898822";"";"None";"377.44";"0";"3.90";"BDBM202880";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2nccnc2c1";"IC50";"'='";"864.0";"nM";"6.06";"";"360399";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913300";"";"None";"394.52";"0";"4.56";"BDBM202884";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(N2CCCC2)c1";"IC50";"'='";"31.0";"nM";"7.51";"";"360403";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948982";"";"None";"436.94";"1";"5.67";"BDBM202905";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(Cl)cc(-c2ccccn2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"360428";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912213";"";"None";"403.48";"0";"4.41";"BDBM202906";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-c2ccccn2)c1";"IC50";"'='";"119.0";"nM";"6.92";"";"360429";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113752";"";"None";"416.48";"1";"5.25";"BDBM50447804";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"360436";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904636";"";"None";"416.52";"1";"5.41";"BDBM202945";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cncc(-c2ccccc2)c1";"IC50";"'='";"455.0";"nM";"6.34";"";"360471";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955491";"";"None";"425.40";"0";"4.47";"BDBM202961";"COc1cc(OC)c(C2CCC(=O)N2Cc2ccc(OC(F)(F)F)cc2)c(OC)c1";"IC50";"'='";"271.0";"nM";"6.57";"";"360487";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940994";"";"None";"394.52";"0";"4.41";"BDBM202976";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(N2CCCC2)c1";"IC50";"'='";"74.0";"nM";"7.13";"";"360502";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940180";"";"None";"402.49";"0";"4.88";"BDBM202990";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccnc(-c2ccccc2)c1";"IC50";"'='";"172.0";"nM";"6.76";"";"360518";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900083";"";"None";"453.46";"0";"4.61";"BDBM203047";"COc1cccc(OCCCO)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"286.0";"nM";"6.54";"";"360588";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4069535";"";"None";"435.47";"0";"2.31";"9e";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cn2)n1";"IC50";"'='";"17.9";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4069644";"";"None";"438.44";"0";"2.75";"23";"CCN(C(=O)c1cc(F)ccc1-n1nccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"139.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL1911936";"";"None";"410.50";"0";"2.65";"2";"O=S(=O)(c1ccccc1)N1CCOC12CCN(c1cnc3ccccc3n1)CC2";"IC50";"'='";"230.0";"nM";"6.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1727648";"";"None";"374.49";"0";"4.41";"SID49826608";"Cc1ccc(NC2CCCN(C(=O)c3cccc(-c4ncc[nH]4)c3)C2)cc1C";"IC50";"";"4480.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3113761";"";"None";"437.46";"1";"5.49";"61";"COc1cccc(OC)c1C1CCC(C)(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1291.0";"nM";"5.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113548";"";"None";"417.51";"1";"5.75";"31";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1728519";"";"None";"558.72";"1";"3.48";"SID85200512";"CC(C)(C)OC(=O)C[C@@H]1C/C=C\C[C@H](CC(=O)N[C@@H](CO)Cc2ccccc2)C(=O)N[C@H](C(C)(C)C)COC1=O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1330311";"";"None";"273.31";"0";"3.24";"SID7976621";"Cc1csc(-c2coc3cc(O)cc(C)c3c2=O)n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1702133";"";"None";"342.42";"0";"3.68";"SID47201161";"O=C(O)CCn1c(SCCOc2ccccc2)nc2ccccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1433931";"";"None";"733.91";"2";"6.83";"SID87345519";"CC[C@]12c3[nH]c4cc(-c5ccco5)ccc4c3CCN1C(=O)[C@@H](CC(=O)NC/C=C(\C)CCC=C(C)C)C[C@@H]2C(=O)N1CCN(C(=O)c2ccco2)CC1";"IC50";"";"39500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2347476";"";"None";"498.59";"1";"5.50";"12, diastereomeric mixture";"CCc1nc(CC)n2c1C(CCc1ccc(C(F)(F)F)cc1)N([C@@H](C(=O)NC)c1ccccc1)CC2";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3949593";"";"None";"492.94";"0";"3.99";"BDBM184115";"C[C@@H]1CN(C(=O)c2ccc(Cl)cc2-n2nccn2)[C@H](Cc2cc(-c3ncccn3)ccc2F)CO1";"IC50";"'='";"85.0";"nM";"7.07";"";"332184";"UO_0000065";"14.34";"0.28";"3.08";"8.22";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946479";"";"None";"458.52";"0";"3.33";"BDBM184041";"Cc1cc(C(=O)N2CCOC[C@H]2Cc2ccc(C)c(-c3ncon3)c2)c(-n2nccn2)cc1C";"IC50";"'='";"13.0";"nM";"7.89";"";"332110";"UO_0000065";"17.20";"0.32";"4.56";"7.95";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3984705";"";"None";"461.50";"0";"2.77";"BDBM184079";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"107.0";"nM";"6.97";"";"332148";"UO_0000065";"15.10";"0.28";"4.20";"7.66";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3924060";"";"None";"467.89";"0";"2.72";"BDBM184097";"O=C(c1cccc(Cl)c1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"1880.0";"nM";"5.73";"";"332166";"UO_0000065";"12.24";"0.24";"3.01";"6.29";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3948499";"";"None";"448.46";"0";"2.85";"BDBM184136";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncon3)ccc2F)c1";"IC50";"'='";"642.0";"nM";"6.19";"";"332205";"UO_0000065";"13.81";"0.26";"3.34";"6.24";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940238";"";"None";"471.52";"0";"4.77";"BDBM221386";"COc1cc(OC)c2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"9.0";"nM";"8.05";"";"387517";"UO_0000065";"17.06";"0.31";"3.28";"8.35";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972094";"";"None";"446.90";"0";"4.80";"BDBM221394";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4ccc(Cl)nc43)c2)c1";"IC50";"'='";"108.0";"nM";"6.97";"";"387525";"UO_0000065";"15.59";"0.30";"2.17";"7.67";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925170";"";"None";"419.51";"0";"3.78";"BDBM221421";"Cc1cnc(NCCn2cc(NC(=O)c3ncsc3-c3cccc(C)c3)cn2)nc1";"IC50";"'='";"959.0";"nM";"6.02";"";"387552";"UO_0000065";"14.35";"0.27";"2.24";"6.16";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2396839";"";"None";"517.00";"2";"5.91";"45";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1cccc(C(F)(F)F)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3235255";"";"None";"385.47";"0";"3.26";"5c";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cccnc3)CC[C@H]2C)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235258";"";"None";"401.47";"0";"2.97";"5f";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cnccc3O)CC[C@H]2C)c1";"IC50";"'='";"52.0";"nM";"7.28";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3937808";"";"None";"466.85";"0";"3.98";"BDBM185299";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(OC(F)(F)F)cn1)c1cc(Cl)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334216";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3956993";"";"None";"468.39";"0";"3.57";"BDBM185312";"O=C(N[C@H]1CC(F)(F)C[C@@H]1Nc1ccc(OC(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334229";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3945938";"";"None";"449.47";"0";"3.02";"BDBM221430";"COc1cc(OC)nc(NCCn2cnc(NC(=O)c3ncoc3-c3cccc(C)c3)c2)n1";"IC50";"'='";"75.0";"nM";"7.12";"";"387561";"UO_0000065";"15.85";"0.29";"4.10";"5.51";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935731";"";"None";"462.46";"0";"3.57";"BDBM208518";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"6.2";"nM";"8.21";"";"368555";"UO_0000065";"17.75";"0.33";"4.64";"9.54";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL343551";"";"None";"513.42";"1";"4.94";"9";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)NC(=O)c1cc(Cl)cc(Cl)c1)CC2";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"14.50";"0.29";"2.50";"10.97";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3426148";"";"None";"439.52";"0";"4.40";"5q";"C[C@@H]1CC[C@@H](Oc2cc(-c3ccccc3)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"45.0";"nM";"7.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3892369";"NIVASOREXANT";"2.0";"429.48";"0";"2.24";"BDBM183990";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"274.0";"nM";"6.56";"";"332054";"UO_0000065";"15.28";"0.28";"4.32";"7.21";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL139915";"";"None";"396.53";"0";"3.79";"15";"COc1cc2c(cc1OC)CN(C(=O)C(NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"15.23";"0.28";"2.25";"11.89";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3981092";"";"None";"395.50";"0";"4.75";"BDBM203046";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OCC2CC2)cc1";"IC50";"'='";"39.0";"nM";"7.41";"";"360587";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927496";"";"None";"376.46";"0";"4.36";"BDBM203166";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"777.0";"nM";"6.11";"";"360726";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985834";"";"None";"416.48";"1";"5.11";"BDBM203171";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"13.0";"nM";"7.89";"";"360731";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1967431";"";"None";"262.33";"0";"2.32";"SID4243729";"CCn1c(C)cs/c1=N/C(=O)c1ccccc1O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1342888";"";"None";"383.48";"0";"2.03";"SID24822964";"Nc1nc(-c2sc3nc4c(cc3c2N)CCCC4)nc(N2CCOCC2)n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1588363";"";"None";"389.51";"1";"5.55";"SID17514349";"Cc1nc2c(ccc3nc(NC(=O)Cc4cccc5ccccc45)sc32)s1";"IC50";"";"17600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1343392";"";"None";"313.14";"0";"2.67";"SID17402824";"Cc1ccc(C(=O)OCn2ncc(Cl)c(Cl)c2=O)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1583817";"";"None";"435.44";"0";"3.01";"SID14744936";"Cc1noc(C)c1COc1ccc(C(=O)OCC(=O)N2CC(=O)Nc3ccccc32)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1540610";"";"None";"323.40";"0";"2.44";"SID864606";"COC(=O)c1ccccc1NC(=O)c1sc(=S)n(C)c1N";"IC50";"";"1400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1485217";"";"None";"403.48";"0";"3.87";"SID49648089";"COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCc1c[nH]c2ccccc12";"IC50";"";"17200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1335338";"";"None";"363.44";"0";"2.83";"SID24828913";"O=c1cc(CN2CC(O)Cc3ccc4ccccc4c32)nc2sccn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3961858";"";"None";"447.47";"0";"2.86";"BDBM208493";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](Cn3ccc(-c4ccc(F)cn4)n3)OC[C@@H]2C)c1";"IC50";"'='";"41.5";"nM";"7.38";"";"368530";"UO_0000065";"16.50";"0.31";"4.52";"8.12";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902957";"";"None";"437.41";"0";"2.30";"BDBM208496";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"251.4";"nM";"6.60";"";"368534";"UO_0000065";"15.09";"0.28";"4.30";"7.26";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934581";"";"None";"430.44";"0";"3.04";"BDBM208499";"O=C(c1ccccc1-c1ncccn1)N1CCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"224.8";"nM";"6.65";"";"368536";"UO_0000065";"15.45";"0.28";"3.61";"7.73";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924282";"";"None";"448.43";"0";"3.18";"BDBM208500";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"71.7";"nM";"7.14";"";"368537";"UO_0000065";"15.93";"0.30";"3.96";"8.30";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951993";"";"None";"432.46";"0";"3.08";"BDBM208501";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cc3)n2)c1";"IC50";"'='";"46.7";"nM";"7.33";"";"368538";"UO_0000065";"16.95";"0.31";"4.25";"9.39";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1995726";"";"None";"376.46";"0";"3.10";"SID26725766";"CN(C)S(=O)(=O)c1ccc(-c2csc(N/N=C/c3ccco3)n2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1301892";"";"None";"377.44";"0";"3.77";"SID49735429";"CCOc1ccccc1C(=O)Nc1ccc2nc3n(c(=O)c2c1)CCCCC3";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1365949";"";"None";"392.50";"0";"2.27";"SID843476";"O=S(=O)(NC1CC1)c1ccc(S(=O)(=O)N2CCCc3ccccc32)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493493";"";"None";"369.43";"0";"4.13";"SID4250838";"C=CCNc1nc(N(c2ccccc2)c2ccccc2)nc(-n2ccnc2)n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1526293";"";"None";"447.50";"0";"2.32";"SID17509626";"COCCCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1302355";"";"None";"361.49";"0";"4.51";"SID49818091";"Cc1ccc(NC2CCCN(C(=O)c3cn(C)c4ccccc34)C2)cc1C";"IC50";"";"7100.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1981638";"";"None";"399.25";"0";"4.13";"SID24811895";"Cc1ccc(-c2cc(C(=O)N/N=C/C(Br)=C/c3ccccc3)[nH]n2)o1";"IC50";"";"28900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3926906";"";"None";"460.45";"1";"2.58";"BDBM221355";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C#N)c3)cn2)n1";"IC50";"'='";"353.0";"nM";"6.45";"";"387485";"UO_0000065";"14.01";"0.26";"3.87";"4.22";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931705";"";"None";"407.41";"0";"3.71";"BDBM221392";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ccc(F)cn3)c2)c1";"IC50";"'='";"2100.0";"nM";"5.68";"";"387523";"UO_0000065";"13.94";"0.26";"1.97";"5.97";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935842";"";"None";"425.49";"1";"5.14";"BDBM221320";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCCn3ccc4ccccc43)c2)c1";"IC50";"'='";"389.0";"nM";"6.41";"";"387453";"UO_0000065";"15.07";"0.27";"1.27";"8.23";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931546";"";"None";"485.54";"1";"5.08";"BDBM221332";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4ccc(C)c(C)c4)cn3)c2cc1OC";"IC50";"'='";"24.0";"nM";"7.62";"";"387465";"UO_0000065";"15.69";"0.29";"2.54";"7.91";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922730";"";"None";"440.51";"0";"4.77";"BDBM221400";"Cc1cccc(-c2ocnc2C(=O)Nc2c(C)nn(CCn3cnc4ccccc43)c2C)c1";"IC50";"'='";"457.0";"nM";"6.34";"";"387531";"UO_0000065";"14.39";"0.26";"1.57";"6.98";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3739613";"";"None";"407.47";"0";"3.91";"14";"COc1ccc(C[C@@H]2CCCN2C(=O)c2ccccc2-c2nc(C)no2)cc1OC";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3742301";"";"None";"434.56";"1";"5.05";"15";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc3c(c2)OCCO3)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409858";"";"None";"411.38";"0";"3.44";"28";"COc1cccc(OC)c1[C@@H]1C[C@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"670.0";"nM";"6.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409864";"";"None";"410.39";"0";"3.40";"34";"COc1cccc(OC)c1[C@@H]1C[C@@H](N)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"2050.0";"nM";"5.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3426132";"";"None";"377.45";"0";"3.04";"6";"Cc1cccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3942476";"";"None";"387.44";"0";"4.64";"BDBM203101";"COc1ccc2ncoc2c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"1805.0";"nM";"5.74";"";"360659";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964401";"";"None";"424.52";"1";"5.12";"BDBM203113";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(Oc2nc(C)cs2)cc1";"IC50";"'='";"125.0";"nM";"6.90";"";"360671";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964757";"";"None";"401.33";"0";"4.54";"BDBM203122";"COc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"66.0";"nM";"7.18";"";"360680";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949219";"";"None";"397.37";"0";"4.71";"BDBM203144";"COc1cccc(C)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"178.0";"nM";"6.75";"";"360704";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966972";"";"None";"447.81";"0";"4.82";"BDBM203147";"COc1ccc(F)c(OC)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1790.0";"nM";"5.75";"";"360707";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904416";"";"None";"419.45";"1";"5.41";"BDBM203186";"COc1cccc(OC)c1[C@@H]1C[C@@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"40.0";"nM";"7.40";"";"360747";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911067";"";"None";"425.47";"1";"5.43";"BDBM203215";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(SC(F)(F)F)cc1";"IC50";"'='";"428.0";"nM";"6.37";"";"360777";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966605";"";"None";"429.39";"1";"5.32";"BDBM203224";"CC(C)Oc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"360786";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972274";"";"None";"436.58";"1";"5.78";"BDBM202944";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"360470";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895685";"";"None";"405.50";"0";"4.53";"BDBM202947";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cnn(-c2ccccc2)c1";"IC50";"'='";"378.0";"nM";"6.42";"";"360473";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954697";"";"None";"375.47";"0";"4.97";"BDBM202983";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"455.0";"nM";"6.34";"";"360510";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953674";"";"None";"408.52";"0";"4.94";"BDBM202984";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"44.0";"nM";"7.36";"";"360511";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974803";"";"None";"431.36";"0";"4.10";"BDBM203157";"CCOc1ccc(F)c(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"58.0";"nM";"7.24";"";"360717";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982936";"";"None";"415.36";"0";"4.93";"BDBM203163";"CCOc1cc(F)ccc1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"392.0";"nM";"6.41";"";"360723";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3338846";"";"None";"440.50";"0";"4.46";"5";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)cnc2-c2ccccc2)nc1OC";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"17.90";"0.33";"3.43";"9.15";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL142009";"";"None";"397.52";"0";"3.19";"29";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"18.61";"0.35";"4.21";"11.62";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1336039";"";"None";"345.40";"0";"3.50";"SID3711499";"O=C(OC1CCOC1=O)c1ccc(-c2nc3ccccc3s2)s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1377656";"";"None";"501.54";"2";"5.36";"SID22410795";"O=C(Nc1cccc(S(=O)(=O)NCc2ccco2)c1)c1cc(-c2ccc(F)cc2)nc2ccccc12";"IC50";"";"9900.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL521649";"";"None";"532.68";"2";"5.52";"121";"CCCCNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1Cc1ccc(OC)c(OC)c1";"IC50";"'='";"1811.0";"nM";"5.74";"";"";"UO_0000065";"10.78";"0.20";"0.22";"8.29";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL337367";"";"None";"444.53";"0";"3.63";"33";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)CC2";"IC50";"'='";"195.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL140260";"";"None";"401.51";"0";"4.62";"(+/-)-29";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)c1ccccc1)CC2";"IC50";"'='";"395.0";"nM";"6.40";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2031491";"";"None";"484.63";"1";"5.34";"26";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccccc2)s1";"IC50";"'='";"58.0";"nM";"7.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031482";"";"None";"470.60";"1";"5.09";"8";"Cc1nc(-c2ccccc2)c(C(=O)N2CCCCC2CNC(=O)c2cccc3cccnc23)s1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2413367";"";"None";"518.65";"2";"5.13";"ACT-335827";"COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CCN2[C@@H](C(=O)NC(C)C)c2ccccc2)cc1OC";"IC50";"'='";"417.0";"nM";"6.38";"";"";"UO_0000065";"12.30";"0.23";"1.25";"9.21";"1";"CHEMBL2424458";"Antagonist activity at OX2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2417373";"1";"Scientific Literature";"J Med Chem";"2013";"None";"";"";""
"CHEMBL2092734";"";"None";"419.48";"0";"2.68";"4a";"O=C(Nc1ccccc1)N1CCC2(OCCN2S(=O)(=O)c2ccccc2)[C@H](F)C1";"IC50";"'='";"170.0";"nM";"6.77";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1496820";"";"None";"242.30";"0";"3.43";"SID24823370";"Cc1cc(O)cc2c(=O)c3ccccc3sc12";"IC50";"";"9.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468272";"";"None";"379.51";"1";"5.15";"SID14743508";"CCn1c(SCC(=O)c2ccc3ccccc3c2)nnc1-c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1973904";"";"None";"450.95";"0";"4.37";"SID24782224";"O=C(NC(Cc1c[nH]c2ccccc12)C(=O)N/N=C/c1ccc(Cl)cc1)c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1400350";"";"None";"454.62";"0";"4.47";"SID56322360";"CSc1ccc(CN(C)C(=O)c2cc(S(=O)(=O)NCc3ccccc3)ccc2C)cc1";"IC50";"";"16400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1997993";"";"None";"346.46";"0";"4.59";"SID17411216";"Cc1cccc(/C=N/NC(=O)c2cc3c(s2)-c2ccccc2CC3)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1367648";"";"None";"267.36";"0";"3.43";"SID3713837";"N#C/C(=C1\CCCN1)c1nc(-c2ccccc2)cs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1585859";"";"None";"351.36";"0";"2.83";"SID49642584";"COc1ccc(NC(=O)C(=O)Nc2cccc3cccnc23)cc1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1514800";"";"None";"324.38";"0";"3.67";"SID85146498";"Cn1c2ccccc2c(=O)c2cc(C#Cc3cccc(N)c3)ccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1344555";"";"None";"271.35";"0";"3.53";"SID24782548";"CN(C)c1ccc(-c2nnc(-c3cccs3)o2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3235250";"";"None";"407.49";"0";"3.98";"2";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](CCc3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"145.0";"nM";"6.84";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL489097";"";"None";"498.41";"1";"5.64";"(+/-)-34";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)C(=O)c1cc(Cl)cc(Cl)c1)CC2";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3113757";"";"None";"410.39";"0";"3.28";"57";"COc1cccc(OC)c1C1CNCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"589.0";"nM";"6.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113743";"";"None";"402.49";"1";"5.02";"43";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)n1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3112601";"";"None";"376.46";"0";"4.51";"36";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"42.0";"nM";"7.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113551";"";"None";"401.51";"1";"5.62";"34";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccccc1-c1ccccc1";"IC50";"'='";"507.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113534";"";"None";"379.38";"0";"4.85";"16";"COc1ccccc1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"635.0";"nM";"6.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL522574";"";"None";"465.96";"0";"3.29";"33";"CCN(CC)C(=O)CN(c1cc(C#N)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"463.0";"nM";"6.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL526821";"";"None";"498.05";"0";"3.88";"43";"CCN(CC)C(=O)CN(c1cc(N(C)CC)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"433.0";"nM";"6.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL455137";"";"None";"416.59";"0";"4.36";"1";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(C(C)(C)C)cc1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL1405608";"";"None";"461.43";"0";"4.02";"SID14736873";"CSc1cccc(NC(=O)C2CCCN2S(=O)(=O)c2ccc(Br)s2)c1";"IC50";"";"340.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1308855";"";"None";"447.49";"0";"4.85";"SID17509208";"Cc1ccc(C(=O)N/C(=C/c2ccc(-c3cccc([N+](=O)[O-])c3)o2)C(=O)NC(C)(C)C)cc1";"IC50";"";"2420.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2007173";"";"None";"495.40";"0";"4.48";"SID24787776";"O=C(NC(Cc1c[nH]c2ccccc12)C(=O)N/N=C/c1ccc(Br)cc1)c1cccs1";"IC50";"";"11050.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3667586";"";"None";"408.91";"0";"3.45";"BDBM154960";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(Cl)c(C)c2)cc1";"IC50";"'='";"18.0";"nM";"7.75";"";"297251";"UO_0000065";"18.94";"0.39";"4.29";"10.23";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3113751";"";"None";"408.52";"1";"5.08";"51";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113749";"";"None";"409.51";"0";"4.48";"49";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-c2nccs2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113549";"";"None";"401.51";"1";"5.62";"32";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(-c2ccccc2)cc1";"IC50";"'='";"72.0";"nM";"7.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113538";"";"None";"423.43";"1";"5.25";"20";"CCOc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL444602";"";"None";"403.55";"0";"3.25";"24";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1nccs1)C(C)(C)C)CC2";"IC50";"'='";"59.0";"nM";"7.23";"";"";"UO_0000065";"17.91";"0.35";"3.98";"11.35";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL469146";"";"None";"413.49";"0";"2.87";"4";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCN(c3ncc4ccccc4n3)CC2)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1083357";"";"None";"427.51";"0";"3.26";"8";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4ccccc4n3)CC[C@H]2C)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1083358";"";"None";"431.48";"0";"3.09";"10";"C[C@@H]1CCN(c2ncc3cc(F)ccc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1083041";"";"None";"449.46";"0";"3.23";"11";"C[C@@H]1CCN(c2cnc3cc(F)c(F)cc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL1089406";"";"None";"431.48";"0";"3.01";"1a";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCN(c3ncc4cc(F)ccc4n3)CC2)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1091110";"";"None";"425.50";"0";"2.87";"8c, enantiomer-B";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CC(C2)N(c2ncc4ccccc4n2)C3)c1";"IC50";"'='";"6200.0";"nM";"5.21";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1091110";"";"None";"425.50";"0";"2.87";"8c, enantiomer-B";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CC(C2)N(c2ncc4ccccc4n2)C3)c1";"IC50";"'='";"44.0";"nM";"7.36";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1109768";"Antagonist activity at OX2 receptor assessed as inhibition of calcium flux by FLIPR assay";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1156317";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"None";"";"";""
"CHEMBL1465216";"";"None";"364.50";"0";"3.84";"SID24793739";"CCc1c(C)sc(N=C(S)Nc2nc(C)cc(C)n2)c1C(=O)OC";"IC50";"";"15000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1468272";"";"None";"379.51";"1";"5.15";"SID14743508";"CCn1c(SCC(=O)c2ccc3ccccc3c2)nnc1-c1cccs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1735531";"";"None";"498.00";"1";"5.55";"SID56463406";"COc1ccc([C@@H]2CC=C(C(=O)O)[C@H](c3cccc(Cl)c3)N2S(=O)(=O)c2ccccc2C)cc1";"IC50";"";"17100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1388463";"";"None";"277.35";"0";"3.91";"SID47201502";"N#CCSc1nc(-c2ccccc2)nc2ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1706330";"";"None";"482.00";"1";"5.84";"SID85301960";"Cc1ccc([C@@H]2CC=C(C(=O)O)[C@H](c3cccc(Cl)c3)N2S(=O)(=O)c2ccccc2C)cc1";"IC50";"";"3900.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1498924";"";"None";"484.95";"1";"5.49";"SID17507690";"C=CCSC1=C(C#N)C(c2ccccc2Cl)C(C(=O)c2cccs2)C(O)(C(F)(F)F)N1";"IC50";"";"10300.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1459180";"";"None";"359.38";"0";"4.29";"SID17506820";"COc1ccc(C(=O)ON=C2c3ccccc3-c3ccccc32)cc1OC";"IC50";"";"6200.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1496820";"";"None";"242.30";"0";"3.43";"SID24823370";"Cc1cc(O)cc2c(=O)c3ccccc3sc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1575559";"";"None";"440.50";"0";"2.98";"SID24837099";"O=C(c1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1)N1CCN(c2ccccn2)CC1";"IC50";"";"15600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1706285";"";"None";"356.45";"0";"3.41";"SID49817997";"CCc1cc(C(=O)OCC(=O)N2CCC(c3ccccc3)=N2)sc1C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1516768";"";"None";"232.31";"0";"2.69";"SID14727402";"Cc1c(/C=C/C(=O)c2cccs2)cnn1C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1571574";"";"None";"327.34";"0";"3.75";"SID49824531";"COc1cccc2oc3ccc(C#Cc4ccccn4)cc3c(=O)c12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1478565";"";"None";"290.29";"0";"4.18";"SID17510194";"Cc1c2ccccc2nc2c(F)c(N(C)C)c(F)c(F)c12";"IC50";"";"32200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1995997";"";"None";"269.33";"0";"2.83";"SID22415591";"Cc1ccsc1/C=N/N=C1\C(=O)Nc2ccccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1726432";"";"None";"384.48";"0";"3.42";"SID47194607";"CCOc1ccccc1C(=O)NCCCCNC(=O)c1ccccc1OCC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL199868";"";"None";"301.35";"0";"2.60";"SID26667288";"CCN(CC)c1ccc(/C=N/NC(=O)c2ccco2)c(O)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3235252";"";"None";"405.48";"0";"4.06";"4";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](/C=C\c3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"417.0";"nM";"6.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235256";"";"None";"385.47";"0";"3.26";"5d";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccncc3)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235261";"";"None";"415.50";"0";"2.76";"5i";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cc(CO)ccn3)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235265";"";"None";"414.51";"0";"3.36";"5m";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cccc(CO)c3)CC[C@H]2C)c1";"IC50";"'='";"6.3";"nM";"8.20";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2031490";"";"None";"527.57";"2";"6.08";"25";"Cc1nc(C(=O)N2CCC[C@@H](C(F)(F)F)[C@H]2CNC(=O)c2cccc3occc23)c(-c2ccccc2)s1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3918050";"";"None";"402.49";"1";"5.02";"BDBM202882";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(-c2ccccc2)ccn1";"IC50";"'='";"131.0";"nM";"6.88";"";"360401";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912462";"";"None";"420.48";"1";"5.16";"BDBM202894";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccn2)c1F";"IC50";"'='";"64.0";"nM";"7.19";"";"360416";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924691";"";"None";"436.94";"1";"5.67";"BDBM202904";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(-c2ccccn2)ccc1Cl";"IC50";"'='";"625.0";"nM";"6.20";"";"360427";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975042";"";"None";"421.47";"0";"4.55";"BDBM202912";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1ccc(F)c(-c2ccccn2)c1";"IC50";"'='";"135.0";"nM";"6.87";"";"360438";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925275";"";"None";"409.51";"0";"4.48";"BDBM202914";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"360440";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113759";"";"None";"423.43";"1";"5.10";"59, Stereoisomeric mixture";"COc1cccc(OC)c1C1CCC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"894.0";"nM";"6.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1720383";"";"None";"279.28";"0";"3.16";"SID49679688";"Fc1cccc(Nc2nc3ccccc3n3cnnc23)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1978193";"";"None";"446.54";"1";"5.81";"SID24791433";"Sc1nnc(-c2cc(-c3ccccc3)[nH]n2)n1/N=C/c1c2ccccc2cc2ccccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1715597";"";"None";"378.88";"0";"3.44";"SID85268585";"Cc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)cc2)c1";"IC50";"";"1400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1491556";"";"None";"435.51";"0";"3.78";"SID22407370";"CNC(=O)NC(=O)C(C)OC(=O)c1c2c(nc3ccccc13)/C(=C/c1cccs1)CC2";"IC50";"";"8700.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1534057";"";"None";"362.43";"0";"4.05";"SID49673460";"CC(=O)Nc1cccc(OCC(=O)NC(C)c2ccc3ccccc3c2)c1";"IC50";"";"30000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1401331";"";"None";"431.50";"0";"3.08";"SID17509899";"CCCCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2031505";"";"None";"502.62";"2";"5.62";"49";"Cc1nc(C(=O)N2[C@H](CNC(=O)c3cccc4cccnc34)CCC[C@@H]2C)c(-c2ccc(F)cc2)s1";"IC50";"'='";"151.0";"nM";"6.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3409870";"";"None";"419.45";"1";"5.41";"40";"COc1cccc(OC)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL490082";"";"None";"506.65";"2";"6.02";"123";"COc1cc2c(cc1OC)C(Cc1ccc3ccccc3c1)N(C(C(=O)NC1CC1)c1ccccc1)CC2";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.01";"0.26";"1.08";"13.97";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL522927";"";"None";"486.61";"0";"4.66";"106";"COc1cccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC2CCc3ccccc32)c1";"IC50";"'='";"5660.0";"nM";"5.25";"";"";"UO_0000065";"10.78";"0.20";"0.59";"8.74";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489485";"";"None";"499.44";"1";"5.47";"117";"COc1cc2c(cc1OC)C(Cc1ccc(Cl)c(Cl)c1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'='";"281.0";"nM";"6.55";"";"";"UO_0000065";"13.12";"0.26";"1.08";"12.90";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL491278";"";"None";"491.59";"0";"3.57";"(+/-)-99";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccncc2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.17";"0.19";"1.43";"6.09";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1565349";"";"None";"459.55";"0";"3.09";"SID14720488";"COc1ccccc1C(=O)Nc1nc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)cs1";"IC50";"";"8400.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1727648";"";"None";"374.49";"0";"4.41";"SID49826608";"Cc1ccc(NC2CCCN(C(=O)c3cccc(-c4ncc[nH]4)c3)C2)cc1C";"IC50";"";"17100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1477093";"";"None";"426.52";"0";"4.72";"SID14726639";"Cc1cccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2347600";"";"None";"513.56";"1";"4.04";"26, diastereomeric mixture";"CCc1nc(C(N)=O)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"194.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347482";"";"None";"504.98";"2";"5.59";"18";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL140348";"";"None";"396.53";"0";"3.79";"41";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489478";"";"None";"466.53";"0";"4.44";"116";"COc1cc2c(cc1OC)C(Cc1ccc(F)c(F)c1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL524806";"";"None";"378.47";"0";"3.20";"30";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1cccc(F)c1";"IC50";"'='";"839.0";"nM";"6.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL521540";"";"None";"474.58";"0";"2.71";"36";"CCN(CC)C(=O)CN(c1cccc(N(C)C)c1C#N)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL498619";"";"None";"536.05";"1";"3.41";"49";"CCN(C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1)c1ccn(C)n1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL519258";"";"None";"434.54";"0";"3.90";"15";"COc1ccc(OCCN(CC(=O)NCc2ccccc2)Cc2ccccc2)cc1OC";"IC50";"'='";"25.12";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL998534";"Antagonist activity at human OX2 receptor expressed in HEK293 cells assessed as inhibition of human orexin-A-stimulated calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1152230";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3307715";"";"";""
"CHEMBL1402931";"";"None";"472.94";"1";"5.33";"SID17407670";"CCSC1=C(C#N)C(c2ccccc2Cl)C(C(=O)c2cccs2)C(O)(C(F)(F)F)N1";"IC50";"";"20000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1966014";"";"None";"292.39";"0";"2.16";"SID26731595";"Cn1c(N)c(C(=O)N/N=C/c2ccccc2)sc1=S";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1521046";"";"None";"239.27";"0";"2.82";"SID24819844";"CN(C)/C=C1/Oc2c(ccc3ccccc23)C1=O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1430677";"";"None";"446.87";"0";"4.22";"SID26732463";"Cc1noc(C)c1S(=O)(=O)Nc1ccc(O)c2c(=O)cc(-c3ccccc3Cl)oc12";"IC50";"";"16800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1270809";"";"None";"439.50";"1";"5.32";"SID85146457";"O=C(OCC#CCSc1nnc(-c2cccc3ccccc23)o1)c1cccc2[nH]ccc12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1605702";"";"None";"396.53";"0";"4.90";"SID17408202";"Cc1ccccc1N(CC(=O)NC1CCCC1)C(=O)c1oc(C(C)(C)C)cc1C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1445904";"";"None";"374.39";"0";"1.77";"SID49817991";"CCOC(=O)C1=C(COC(=O)/C=C/c2cccc(OC)c2)NC(=O)NC1C";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3741003";"";"None";"403.48";"0";"4.01";"10";"COc1ccc(C[C@@H]2CCCN2C(=O)c2ccccc2-c2ncccn2)cc1OC";"IC50";"'='";"4.7";"nM";"8.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3742040";"";"None";"464.59";"0";"4.92";"28";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2ccc3c(c2)CCO3)cc1OC";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1546895";"";"None";"340.40";"0";"4.32";"SID4250611";"COc1cccc(-c2cc(C(=O)Nc3ccccc3SC)no2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1494796";"";"None";"302.77";"0";"3.11";"SID49649438";"CNc1nc(Nc2ccc(C)c(Cl)c2)c2cnn(C)c2n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979844";"";"None";"397.89";"1";"5.12";"SID17516690";"COc1ccc2c(Cl)c(C(=O)N/N=C/c3c(C)[nH]c4ccccc34)sc2c1";"IC50";"";"23200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3426147";"";"None";"406.49";"0";"2.80";"5p";"C[C@@H]1CC[C@@H](Oc2cc(N(C)C)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3260835";"";"None";"462.58";"0";"3.21";"41";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc(N)c4c(C)csc4n3)CC[C@H]2C)c1";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"15.92";"0.30";"4.16";"6.95";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1704083";"";"None";"499.66";"0";"3.68";"SID56317338";"Cc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NCC(c3cccs3)N3CCOCC3)c2)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3260826";"";"None";"431.50";"0";"3.16";"32";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4c(C)coc4n3)CC[C@H]2C)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"17.31";"0.32";"4.31";"8.02";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113750";"";"None";"392.46";"0";"3.54";"50";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113740";"";"None";"376.46";"0";"4.51";"40";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ncccc2c1";"IC50";"'='";"1002.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113552";"";"None";"375.47";"1";"5.11";"35";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"47.0";"nM";"7.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1536921";"";"None";"454.90";"1";"5.25";"SID24781211";"O=C(N=Nc1c(O)[nH]c2ccccc12)c1cccc(S(=O)(=O)Nc2ccccc2Cl)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1997993";"";"None";"346.46";"0";"4.59";"SID17411216";"Cc1cccc(/C=N/NC(=O)c2cc3c(s2)-c2ccccc2CC3)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1911640";"";"None";"345.83";"0";"4.33";"1a";"COc1ccc2c(c1)[C@H](C)N(C(=O)c1ccc(Cl)cc1)[C@H](C)CO2";"IC50";"'='";"74.0";"nM";"7.13";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1911747";"";"None";"394.70";"1";"5.09";"1j";"C[C@@H]1COc2ccc(Br)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"430.0";"nM";"6.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL2031488";"";"None";"477.63";"1";"5.11";"14";"COc1cccc(C(=O)NC[C@@H]2[C@H](C)CCCN2C(=O)c2nc(C)sc2-c2ccccc2)c1C";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2396867";"";"None";"522.97";"2";"5.73";"30";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)c(F)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4642480";"";"None";"447.47";"0";"2.86";"(-)-4";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"2.21";"nM";"8.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3920218";"";"None";"464.46";"0";"3.37";"BDBM240113";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3OC)no2)c(-n2nccn2)cc1C";"IC50";"'='";"9.0";"nM";"8.05";"";"418954";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957590";"";"None";"500.44";"1";"4.12";"BDBM240123";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-n2nccn2)cc1C";"IC50";"'='";"6.0";"nM";"8.22";"";"418964";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903036";"";"None";"461.48";"0";"3.02";"BDBM240129";"CCOc1ncccc1-c1noc([C@@H]2CCN2C(=O)c2cc(OC)c(C)cc2-n2nccn2)n1";"IC50";"'='";"5.0";"nM";"8.30";"";"418971";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932670";"";"None";"504.47";"2";"5.79";"BDBM240132";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-c2ccccc2F)s1";"IC50";"'='";"59.0";"nM";"7.23";"";"418974";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910736";"";"None";"483.45";"0";"4.16";"BDBM240222";"Cc1cc(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c(-n2nccn2)cc1C";"IC50";"'='";"9.0";"nM";"8.05";"";"419065";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915380";"";"None";"503.87";"1";"4.50";"BDBM240224";"Cc1cc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)cc1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"419067";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4644741";"";"None";"433.45";"0";"2.47";"(-)-3c";"Cc1ccc(-n2nccn2)c(C(=O)N2CCO[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"12.1";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4646361";"";"None";"447.47";"0";"2.86";"(-)-3i";"Cc1ccc(-n2nccn2)c(C(=O)N2COCC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"3.41";"nM";"8.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3925711";"";"None";"470.41";"0";"4.11";"BDBM240111";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"418952";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946962";"";"None";"515.52";"2";"5.41";"BDBM240136";"CN(C)c1nc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-c2ccccc2)s1";"IC50";"'='";"10.0";"nM";"8.00";"";"418978";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922646";"";"None";"472.45";"1";"5.35";"BDBM240137";"O=C(c1ncsc1-c1ccccc1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"266.0";"nM";"6.58";"";"418979";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899504";"";"None";"484.43";"1";"5.49";"BDBM240147";"Cc1cccc(-c2oc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"309.0";"nM";"6.51";"";"418989";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890720";"";"None";"443.48";"0";"3.95";"BDBM208508";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCOC2Cn2cc(-c3ccc(F)cc3)cn2)c1";"IC50";"'='";"26.7";"nM";"7.57";"";"368545";"UO_0000065";"17.08";"0.31";"3.62";"10.35";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941583";"";"None";"471.30";"0";"4.22";"BDBM240213";"COc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2ccc(Cl)cc2-n2nccn2)no1";"IC50";"'='";"4.0";"nM";"8.40";"";"419056";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966888";"";"None";"472.51";"0";"4.17";"BDBM221405";"COc1cc2ncn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2cc1OC";"IC50";"'='";"63.0";"nM";"7.20";"";"387536";"UO_0000065";"15.24";"0.28";"3.03";"6.59";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942226";"";"None";"440.46";"0";"4.12";"BDBM221438";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ncc4ccccc4n3)c2)c1";"IC50";"'='";"226.0";"nM";"6.65";"";"387569";"UO_0000065";"15.09";"0.28";"2.53";"6.16";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895270";"";"None";"441.49";"0";"4.83";"BDBM221360";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"387490";"UO_0000065";"19.70";"0.36";"3.87";"8.88";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956441";"";"None";"442.48";"0";"4.16";"BDBM221368";"COc1ccc2ncn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2c1";"IC50";"'='";"6.0";"nM";"8.22";"";"387498";"UO_0000065";"18.58";"0.34";"4.06";"8.22";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949153";"";"None";"429.46";"0";"4.89";"BDBM221378";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cccc(F)c43)c2)c1";"IC50";"'='";"180.0";"nM";"6.75";"";"387509";"UO_0000065";"15.71";"0.29";"1.85";"8.66";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3260833";"";"None";"462.58";"0";"3.21";"39";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc(N)c4cc(C)sc4n3)CC[C@H]2C)c1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"16.12";"0.31";"4.25";"7.03";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3426152";"";"None";"393.44";"0";"3.20";"6d";"CCOC(=O)c1ccccc1C(=O)N1C[C@H](Oc2cc(C#N)ccn2)CC[C@H]1C";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3908104";"";"None";"431.46";"0";"3.01";"BDBM240192";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)no1";"IC50";"'='";"10.0";"nM";"8.00";"";"419034";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3893903";"";"None";"469.33";"0";"4.83";"BDBM240200";"Cc1cc(-n2nccn2)c(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)cc1Cl";"IC50";"'='";"5.0";"nM";"8.30";"";"419042";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1083659";"SUVOREXANT";"4.0";"450.93";"0";"4.11";"Suvorexant";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1";"IC50";"'='";"138.0";"nM";"6.86";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4060270";"";"None";"434.89";"0";"3.27";"13c";"O=C(c1ccccc1-n1nccn1)N1C[C@@H]2CN(c3nc4cc(Cl)ccc4o3)C[C@@H]2C1";"IC50";"'='";"238.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3925849";"";"None";"454.42";"0";"2.82";"BDBM221311";"COc1cc(OC)nc(OCCn2cc(NC(=O)c3ncoc3-c3cccc(F)c3)cn2)n1";"IC50";"'='";"53.0";"nM";"7.28";"";"387444";"UO_0000065";"16.01";"0.30";"4.46";"5.76";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934744";"";"None";"471.52";"0";"4.77";"BDBM221313";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2cc1OC";"IC50";"'='";"28.0";"nM";"7.55";"";"387446";"UO_0000065";"16.02";"0.29";"2.78";"7.84";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4086531";"";"None";"402.46";"0";"2.91";"6";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3930428";"";"None";"471.52";"0";"4.84";"BDBM221326";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccc(C)c(OC)c4)cn3)c2c1";"IC50";"'='";"146.0";"nM";"6.84";"";"387459";"UO_0000065";"14.50";"0.27";"2.00";"6.38";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4081615";"";"None";"432.48";"0";"2.92";"9";"COc1ccc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(-n2nccn2)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3922620";"";"None";"475.48";"0";"4.60";"BDBM221334";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(F)c4)cn3)c2cc1OC";"IC50";"'='";"146.0";"nM";"6.84";"";"387467";"UO_0000065";"14.38";"0.27";"2.24";"7.10";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917154";"";"None";"487.52";"0";"4.47";"BDBM221336";"COc1ccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cc(OC)c(OC)cc43)c2)cc1";"IC50";"'='";"233.0";"nM";"6.63";"";"387469";"UO_0000065";"13.60";"0.25";"2.16";"6.28";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934185";"";"None";"442.48";"0";"4.16";"BDBM221396";"COc1cc2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2cn1";"IC50";"'='";"230.0";"nM";"6.64";"";"387527";"UO_0000065";"15.00";"0.27";"2.48";"6.64";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949463";"";"None";"412.45";"0";"4.15";"BDBM221406";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4ncccc43)c2)c1";"IC50";"'='";"297.0";"nM";"6.53";"";"387537";"UO_0000065";"15.83";"0.29";"2.38";"7.19";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982714";"";"None";"428.45";"0";"4.35";"BDBM221416";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3nc4ccccc4o3)c2)c1";"IC50";"'='";"235.0";"nM";"6.63";"";"387547";"UO_0000065";"15.47";"0.28";"2.28";"5.97";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899918";"";"None";"463.50";"0";"3.33";"BDBM221427";"COc1nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc(OC)c1C";"IC50";"'='";"180.0";"nM";"6.75";"";"387558";"UO_0000065";"14.55";"0.27";"3.41";"5.22";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899648";"";"None";"422.39";"0";"3.49";"BDBM240107";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cc(F)cc(F)c3)no2)c1";"IC50";"'='";"280.0";"nM";"6.55";"";"418948";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912238";"";"None";"406.42";"0";"4.32";"BDBM221387";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ccc(F)cc3)c2)c1";"IC50";"'='";"973.0";"nM";"6.01";"";"387518";"UO_0000065";"14.79";"0.27";"1.69";"7.32";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984308";"";"None";"412.45";"0";"4.15";"BDBM221391";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cccnc43)c2)c1";"IC50";"'='";"136.0";"nM";"6.87";"";"387522";"UO_0000065";"16.65";"0.30";"2.72";"7.56";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950449";"";"None";"470.53";"0";"4.77";"BDBM221401";"COc1cc2ccn(CCn3nc(C)c(NC(=O)c4ncoc4-c4cccc(C)c4)c3C)c2cn1";"IC50";"'='";"765.0";"nM";"6.12";"";"387532";"UO_0000065";"13.00";"0.24";"1.35";"6.12";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959151";"";"None";"499.57";"1";"5.39";"BDBM221403";"COc1cc2ccn(CCn3nc(C)c(NC(=O)c4ncoc4-c4cccc(C)c4)c3C)c2cc1OC";"IC50";"'='";"472.0";"nM";"6.33";"";"387534";"UO_0000065";"12.66";"0.23";"0.94";"6.57";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113756";"";"None";"411.38";"0";"3.70";"56";"COc1cccc(OC)c1C1COCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"86.0";"nM";"7.07";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3897747";"";"None";"446.41";"0";"3.85";"BDBM185223";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(F)ccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334140";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3978231";"";"None";"434.40";"0";"3.58";"BDBM185231";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(F)ccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334148";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL2347608";"";"None";"531.02";"2";"5.98";"42";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(CC3CC3)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396840";"";"None";"534.99";"2";"6.05";"46";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)c(F)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396838";"";"None";"522.97";"2";"5.73";"39";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1cccc(C(F)(F)F)c1F";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4637711";"";"None";"446.49";"0";"3.47";"(-)-10";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2cc(-c3ccc(F)cc3)cn2)c1";"IC50";"'='";"0.784";"nM";"9.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3956679";"";"None";"420.86";"0";"3.87";"BDBM240110";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3Cl)no2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"418951";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3260832";"";"None";"434.53";"0";"2.60";"38";"C[C@@H]1CCN(c2nc(N)c3ccsc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"17.16";"0.33";"4.86";"7.03";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3394842";"";"None";"431.47";"0";"4.03";"PE-6";"C[C@@H]1CC[C@@H](Oc2ccnc3c(F)cccc23)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"17.95";"0.33";"3.71";"10.59";"0";"CHEMBL3395400";"Antagonist activity at human OX2R by FLIPR assay";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3393034";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4080914";"";"None";"576.67";"1";"3.37";"2; YNT-707";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@@]4(O)[C@@H](C2)N(S(=O)(=O)c2ccccc2)CC[C@]314";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4058250";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 15 mins followed by orexin A addition by Fura 2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052789";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3113769";"";"None";"407.39";"0";"4.32";"69, Stereoisomeric mixture";"COc1cccc(OC)c1C1C2CC2C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1070.0";"nM";"5.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113550";"";"None";"401.51";"1";"5.62";"33";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113773";"";"None";"395.38";"0";"4.47";"13";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"158.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL138091";"";"None";"541.42";"1";"4.53";"11";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)NC(=O)c1ccc(F)c(Br)c1)CC2";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"13.22";"0.28";"2.62";"10.54";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL140547";"";"None";"399.54";"0";"3.13";"23";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1cccn1C)C(C)(C)C)CC2";"IC50";"'='";"28.0";"nM";"7.55";"";"";"UO_0000065";"18.90";"0.36";"4.42";"13.55";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3894144";"";"None";"434.47";"0";"3.64";"BDBM185235";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ncccc1N1CCCCC1";"IC50";"'>'";"10000.0";"nM";"";"";"334152";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL2396870";"";"None";"522.97";"2";"5.73";"33";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1ccc(C(F)(F)F)cc1F";"IC50";"'='";"12.0";"nM";"7.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3113544";"";"None";"423.43";"1";"5.42";"27, Stereoisomeric mixture";"COc1cccc(OC)c1C1CCCC(=O)N1C(C)c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113537";"";"None";"397.37";"0";"4.99";"19";"COc1cccc(F)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"161.0";"nM";"6.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113774";"";"None";"409.40";"0";"4.86";"14";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3959617";"";"None";"470.41";"1";"5.19";"BDBM240144";"Cc1cccc(-c2ocnc2C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"305.0";"nM";"6.52";"";"418986";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958706";"";"None";"504.40";"1";"3.95";"BDBM240182";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)c(-n2nccn2)cc1F";"IC50";"'='";"78.0";"nM";"7.11";"";"419024";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971038";"";"None";"440.51";"0";"4.77";"BDBM221351";"Cc1ccc(-c2ocnc2C(=O)Nc2cnn(CCn3c(C)nc4ccccc43)c2)cc1C";"IC50";"'='";"757.0";"nM";"6.12";"";"387481";"UO_0000065";"13.90";"0.25";"1.35";"6.74";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914811";"";"None";"435.44";"0";"2.71";"BDBM221358";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3ccccc3)cn2)n1";"IC50";"'='";"118.0";"nM";"6.93";"";"387488";"UO_0000065";"15.91";"0.30";"4.22";"5.36";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932318";"";"None";"411.47";"0";"4.82";"BDBM221362";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCc3c[nH]c4ccccc34)c2)c1";"IC50";"'='";"236.0";"nM";"6.63";"";"387492";"UO_0000065";"16.11";"0.29";"1.81";"7.47";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913938";"";"None";"455.52";"0";"4.84";"BDBM221365";"COc1ccc2c(c1)c(CCn1cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn1)cn2C";"IC50";"'='";"22.0";"nM";"7.66";"";"387495";"UO_0000065";"16.81";"0.31";"2.82";"8.79";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985381";"";"None";"448.48";"0";"3.54";"BDBM221370";"COc1cc(OC)nc(CCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"28.0";"nM";"7.55";"";"387501";"UO_0000065";"16.84";"0.31";"4.01";"6.44";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3597963";"";"None";"464.91";"0";"4.18";"BDBM50108621";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)cc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"418965";"UO_0000065";"";"";"";"";"1";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973919";"";"None";"431.46";"0";"3.01";"BDBM240127";"CCOc1ncccc1-c1noc([C@@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)n1";"IC50";"'='";"100.0";"nM";"7.00";"";"418969";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943950";"";"None";"410.39";"0";"3.85";"BDBM185205";"COc1cccc(OC)c1C(=O)N[C@H]1CCC[C@@H]1Oc1cc(C(F)(F)F)ccn1";"IC50";"'='";"6421.0";"nM";"5.19";"";"334122";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3940378";"";"None";"386.32";"0";"3.54";"BDBM185217";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(F)cccc1F";"IC50";"'>'";"10000.0";"nM";"";"";"334134";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3964513";"";"None";"415.42";"0";"3.82";"BDBM185208";"O=C(NC1CCCC1Cc1ccc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334125";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3926359";"";"None";"488.86";"0";"4.89";"BDBM240203";"Cc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2ccc(C(F)(F)F)cc2-n2nccn2)no1";"IC50";"'='";"28.0";"nM";"7.55";"";"419045";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896226";"";"None";"489.85";"0";"4.19";"BDBM240226";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CC[C@H]1c1nnc(-c2ccccc2OC(F)(F)F)[nH]1";"IC50";"'='";"16.0";"nM";"7.80";"";"419069";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951836";"";"None";"384.79";"0";"3.91";"BDBM185254";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cn1)c1ccccc1Cl";"IC50";"'>'";"10000.0";"nM";"";"";"334171";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3896682";"";"None";"431.42";"0";"3.23";"BDBM185277";"CC1(Nc2ncc(C(F)(F)F)cn2)CCCC1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334195";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3905899";"";"None";"460.44";"0";"4.24";"BDBM185325";"CC1(Nc2ncc(C(F)(F)F)cc2F)CCCC1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334242";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL490290";"";"None";"504.63";"1";"4.52";"(+/-)-95";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)N(C)Cc2ccccc2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.91";"0.18";"0.48";"8.27";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3923722";"";"None";"457.49";"0";"3.54";"BDBM240130";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cccnc3OC3CCC3)no2)c1";"IC50";"'='";"71.0";"nM";"7.15";"";"418972";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918089";"";"None";"434.89";"0";"4.17";"BDBM240159";"Cc1cccc(-n2nccn2)c1C(=O)N1CC[C@H]1c1nc(-c2cccc(Cl)c2C)no1";"IC50";"'='";"69.0";"nM";"7.16";"";"419001";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945239";"";"None";"485.33";"0";"4.53";"BDBM240169";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)cc1Cl";"IC50";"'='";"6.0";"nM";"8.22";"";"419011";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970835";"";"None";"461.48";"0";"3.02";"BDBM240187";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2cc(OC)c(C)cc2-n2nccn2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"419029";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982843";"";"None";"520.86";"1";"4.47";"BDBM240189";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)c(-n2nccn2)cc1Cl";"IC50";"'='";"11.0";"nM";"7.96";"";"419031";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965500";"";"None";"420.86";"0";"3.87";"BDBM240195";"Cc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2ccccc2-n2nccn2)no1";"IC50";"'='";"34.0";"nM";"7.47";"";"419037";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929702";"";"None";"443.93";"1";"6.26";"BDBM240208";"Cc1ccc(-c2ccccc2)c(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"419051";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL453134";"";"None";"484.02";"0";"3.49";"32";"CCN(CC)C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3928882";"";"None";"441.49";"0";"4.83";"BDBM221369";"COc1cccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c12";"IC50";"'='";"111.0";"nM";"6.96";"";"387499";"UO_0000065";"15.75";"0.29";"2.12";"7.10";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924766";"";"None";"460.42";"0";"3.93";"BDBM221376";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cc(C(F)(F)F)n(C)n3)c2)c1";"IC50";"'='";"1990.0";"nM";"5.70";"";"387507";"UO_0000065";"12.38";"0.24";"1.77";"5.70";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959140";"";"None";"452.39";"0";"3.69";"BDBM185309";"O=C(NC1CC(F)(F)CC1Nc1ccc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'='";"8753.0";"nM";"5.06";"";"334227";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3968122";"";"None";"446.41";"0";"3.85";"BDBM185326";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334243";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4114837";"";"None";"447.47";"0";"2.86";"BDBM208492";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](C)CO[C@H]2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"460.1";"nM";"6.34";"";"368529";"UO_0000065";"14.16";"0.26";"3.48";"6.97";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916921";"";"None";"397.87";"0";"2.78";"BDBM185193";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(Cl)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334110";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3667556";"";"None";"444.50";"0";"4.22";"BDBM154929";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C(F)(F)F)cc2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"297220";"UO_0000065";"17.48";"0.37";"3.55";"11.69";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1081210";"";"None";"444.62";"0";"4.79";"24(S;R)";"CCc1ccc(CC[C@H]2c3c(C)nn(CC)c3CCN2[C@@H](C(=O)NC)c2ccccc2)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1099401";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1154972";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2010";"CHEMBL3308072";"";"";""
"CHEMBL342363";"";"None";"424.59";"0";"4.23";"19";"COc1cc2c(cc1OC)CN(C(=O)C(NCCCc1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL524139";"";"None";"500.60";"1";"4.38";"108";"COc1cc2c(cc1OC)C(Cc1ccc3c(c1)OCO3)N(CC(=O)NC1CCc3ccccc31)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490291";"";"None";"491.59";"0";"3.57";"(+/-)-97";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccccn2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.17";"0.19";"1.43";"6.09";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3622329";"";"None";"465.87";"0";"3.47";"8";"C[C@@H]1CCN(c2ncc(C(F)(F)F)c(Cl)n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"99.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1083658";"";"None";"416.49";"0";"3.46";"13";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4ccccc4o3)CC[C@H]2C)c1";"IC50";"'='";"57.0";"nM";"7.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1119826";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium mobilization after 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1155457";"1";"Scientific Literature";"J Med Chem";"2010";"CHEMBL3308072";"";"";""
"CHEMBL3622337";"";"None";"461.45";"0";"2.83";"15-(2-methoxypyrimidine variant-2-SORA)";"COc1ncc(C(F)(F)F)c(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)n1";"IC50";"'='";"245.0";"nM";"6.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667569";"";"None";"390.46";"0";"2.50";"BDBM154942";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(OC)c2)cc1";"IC50";"'='";"47.0";"nM";"7.33";"";"297233";"UO_0000065";"18.77";"0.37";"4.83";"8.63";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL490877";"";"None";"430.55";"0";"4.16";"112";"COc1cc2c(cc1OC)C(Cc1ccccc1)N(CC(=O)NCc1ccccc1)CC2";"IC50";"'='";"6103.0";"nM";"5.21";"";"";"UO_0000065";"12.11";"0.22";"1.05";"10.26";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL510425";"";"None";"420.53";"0";"3.08";"129";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL490489";"";"None";"490.60";"0";"4.18";"10";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccccc2)cc1OC";"IC50";"'='";"8152.0";"nM";"5.09";"";"";"UO_0000065";"10.37";"0.19";"0.91";"7.35";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3667588";"";"None";"437.36";"0";"3.86";"BDBM154962";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)cc2)c1";"IC50";"'='";"49.0";"nM";"7.31";"";"297253";"UO_0000065";"16.71";"0.38";"3.45";"11.00";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL139223";"";"None";"306.41";"0";"1.96";"12";"COc1cc2c(cc1OC)CN(C(=O)C(N)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL342363";"";"None";"424.59";"0";"4.23";"19";"COc1cc2c(cc1OC)CN(C(=O)C(NCCCc1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL2031487";"";"None";"538.60";"2";"5.88";"22";"Cc1nc(C(=O)N2CCC[C@@H](C(F)(F)F)[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccccc2)s1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031498";"";"None";"485.53";"1";"5.57";"42";"O=C(NC[C@@H]1CCC(F)(F)CN1C(=O)c1ccccc1-c1ccccc1)c1cccc2cccnc12";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL3260824";"";"None";"445.53";"0";"2.30";"30";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4c(C)nn(C)c4n3)CC[C@H]2C)c1";"IC50";"'='";"85.0";"nM";"7.07";"";"";"UO_0000065";"15.87";"0.29";"4.77";"7.23";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1511752";"";"None";"300.70";"0";"4.17";"SID49641421";"O=[N+]([O-])c1c(O)nc2ccc(Cl)cc2c1-c1ccccc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1542157";"";"None";"321.41";"0";"4.33";"SID17410557";"Cc1[nH]c2ccccc2c1C(=O)CSc1nc2ccccc2[nH]1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1966472";"";"None";"352.45";"0";"3.57";"SID26671021";"Sc1nnc(-c2cc(-c3ccccc3)[nH]n2)n1/N=C/c1cccs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1313229";"";"None";"494.62";"0";"4.59";"SID14725701";"Cc1cc(NC(=O)CCC(=O)N(Cc2cccs2)C(C(=O)NC2CCCC2)c2ccccc2)no1";"IC50";"";"42400.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1400350";"";"None";"454.62";"0";"4.47";"SID56322360";"CSc1ccc(CN(C)C(=O)c2cc(S(=O)(=O)NCc3ccccc3)ccc2C)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1582623";"";"None";"385.36";"1";"5.38";"SID47195785";"COc1cccc(OP(=O)(Nc2ccccc2)Oc2cccc(OC)c2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351110";"";"None";"310.78";"0";"4.13";"SID49680724";"Cc1cc(C(=O)NCc2cccc(Cl)c2)c2ccccc2n1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1967431";"";"None";"262.33";"0";"2.32";"SID4243729";"CCn1c(C)cs/c1=N/C(=O)c1ccccc1O";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1521545";"";"None";"330.39";"0";"3.70";"SID7972582";"c1ccc(N2CCN(c3ncnc4c3oc3ccccc34)CC2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1704083";"";"None";"499.66";"0";"3.68";"SID56317338";"Cc1ccc(N(C)S(=O)(=O)c2cccc(C(=O)NCC(c3cccs3)N3CCOCC3)c2)cc1";"IC50";"";"3350.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1588363";"";"None";"389.51";"1";"5.55";"SID17514349";"Cc1nc2c(ccc3nc(NC(=O)Cc4cccc5ccccc45)sc32)s1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL142009";"";"None";"397.52";"0";"3.19";"52";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL139083";"";"None";"381.52";"0";"4.49";"(+/-)-27";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL455136";"ALMOREXANT";"3.0";"512.57";"2";"5.74";"127";"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"15.80";"0.30";"2.36";"15.94";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL493016";"";"None";"524.66";"2";"5.50";"122";"COCCNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1Cc1ccc2ccccc2c1";"IC50";"'='";"109.0";"nM";"6.96";"";"";"UO_0000065";"13.27";"0.24";"1.46";"11.60";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489288";"";"None";"460.57";"0";"4.17";"114";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NCc2ccccc2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL454125";"";"None";"564.11";"1";"3.71";"133";"CCN(Cc1cc(C)n(C)n1)C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3260823";"";"None";"431.50";"0";"1.99";"29";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc4cnn(C)c4n3)CC[C@H]2C)c1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"16.58";"0.31";"5.16";"7.31";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3667560";"";"None";"424.98";"0";"4.16";"BDBM154933";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C)c(Cl)c2)c1";"IC50";"'='";"3.0";"nM";"8.52";"";"297224";"UO_0000065";"20.05";"0.43";"4.36";"12.82";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL2413367";"";"None";"518.65";"2";"5.13";"19, ACT-335827";"COc1ccc(C[C@H]2c3cc(OC)c(OC)cc3CCN2[C@@H](C(=O)NC(C)C)c2ccccc2)cc1OC";"IC50";"'='";"417.0";"nM";"6.38";"";"";"UO_0000065";"12.30";"0.23";"1.25";"9.21";"1";"CHEMBL3598895";"Antagonist activity at orexin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL1706285";"";"None";"356.45";"0";"3.41";"SID49817997";"CCc1cc(C(=O)OCC(=O)N2CCC(c3ccccc3)=N2)sc1C";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1726432";"";"None";"384.48";"0";"3.42";"SID47194607";"CCOc1ccccc1C(=O)NCCCCNC(=O)c1ccccc1OCC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1501952";"";"None";"416.54";"0";"3.74";"SID49727331";"CCOc1ccc(S(=O)(=O)N2CCCC(C(=O)Nc3cc(C)cc(C)c3)C2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3235251";"";"None";"405.48";"0";"4.06";"3";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](/C=C/c3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235260";"";"None";"415.50";"0";"2.76";"5h";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cccc(CO)n3)CC[C@H]2C)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL2347607";"";"None";"517.00";"2";"5.91";"41";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C3CC3)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347603";"";"None";"490.96";"1";"5.34";"37";"CNC(=O)[C@@H](c1ccccc1)N1CCn2c(C)nc(Cl)c2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2347483";"";"None";"504.98";"2";"5.59";"19";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@@H]2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"107.0";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3235263";"";"None";"415.50";"0";"2.76";"5k";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cncc(CO)c3)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3113546";"";"None";"383.49";"0";"4.75";"29";"CCCOc1ccc(CN2C(=O)CCCC2c2c(OC)cccc2OC)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113540";"";"None";"439.43";"0";"4.86";"22";"COc1cc(OC)c(C2CCCC(=O)N2Cc2ccc(OC(F)(F)F)cc2)c(OC)c1";"IC50";"'='";"106.0";"nM";"6.97";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3113770";"";"None";"415.49";"1";"5.71";"70, Stereoisomeric mixture";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3112599";"";"None";"425.45";"1";"5.34";"23";"COc1cc(OC)c(C2CCCCN2Cc2ccc(OC(F)(F)F)cc2)c(OC)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3119327";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3112474";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL343141";"";"None";"430.55";"0";"3.99";"6";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL3426133";"";"None";"363.42";"0";"2.73";"5a";"C[C@@H]1CC[C@@H](Oc2ccccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3597961";"";"None";"427.53";"0";"3.02";"57";"C[C@@H]1CC[C@@H](Oc2ncccc2C(C)(C)O)CN1C(=O)c1ccsc1-n1nccn1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598905";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced Ca2+ flux preincubated for 5 mins followed by orexin-A induction measured 1 sec interval for 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL2031493";"";"None";"446.58";"1";"5.61";"28";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNc2nc3ccccc3o2)c(-c2ccccc2)s1";"IC50";"'='";"447.0";"nM";"6.35";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL2031506";"";"None";"492.54";"1";"6.17";"50";"Cc1nc(C(=O)N2[C@H](CNc3ccc(C(F)(F)F)cn3)CCC[C@@H]2C)c(-c2ccc(F)cc2)s1";"IC50";"'='";"96.0";"nM";"7.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL1576843";"";"None";"415.46";"0";"2.47";"SID24823196";"C=CCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1418678";"";"None";"283.76";"0";"3.85";"SID24820516";"Cc1nc2c(-c3ccc(Cl)cc3)cnn2c2c1CCC2";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1556270";"";"None";"329.41";"0";"3.53";"SID24786666";"O=C(NC(=S)Nc1nc(-c2ccccc2)cs1)c1ccco1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2006840";"";"None";"350.38";"0";"3.32";"SID24800864";"COc1cccc(/C=N/Nc2cc(C)nc(-c3ccccc3O)n2)c1O";"IC50";"";"11900.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1327720";"";"None";"442.52";"0";"4.42";"SID848125";"COc1ccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)cc1";"IC50";"";"10800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1716146";"";"None";"382.44";"0";"3.07";"SID49817708";"O=C(c1cccc(N2CCNC2=O)c1)N1CCCC(Nc2cccc(F)c2)C1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1575576";"";"None";"344.41";"1";"5.08";"SID17408655";"CCn1c2ccccc2c2cc(NC(=O)c3cccc(OC)c3)ccc21";"IC50";"";"77600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1532403";"";"None";"314.41";"0";"2.94";"SID17414686";"CC(=C/c1ccccc1)/C=C1/SC(N2CCOCC2)=NC1=O";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1577537";"";"None";"300.47";"0";"3.36";"SID850272";"CCN1C(=O)/C(=C2/SC(C)=C(C)N2CC)SC1=S";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1360282";"";"None";"374.44";"1";"5.08";"SID17433838";"CCn1c2ccccc2c2cc(NC(=O)c3cccc(OC)c3OC)ccc21";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1527445";"";"None";"464.60";"1";"5.02";"SID26668282";"Cc1ccc(-c2csc3nnc(SCC(=O)Nc4nsc(-c5ccccc5)n4)n23)cc1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1351929";"";"None";"342.38";"0";"3.33";"SID24815455";"COc1ccccc1C(=O)Nc1nc2cc3c(cc2s1)OCCO3";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1582357";"";"None";"508.48";"2";"5.89";"SID24826880";"CCN(CC)P(=O)(Nc1cccc(C(F)(F)F)c1)c1ccc(N(C)C)cc1NC(=O)c1ccco1";"IC50";"";"5000.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1581581";"";"None";"363.39";"0";"4.53";"SID14725892";"O=C(OCC#CCSc1nc2ccccc2o1)c1cc2ccccc2o1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1970286";"";"None";"384.44";"0";"3.64";"SID17414402";"Cc1nn(-c2ccccc2)c(C)c1/C=N/NC(=O)c1cc(-c2ccccc2)[nH]n1";"IC50";"";"20600.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1988282";"";"None";"447.46";"1";"1.64";"SID49820287";"COc1cccc(/C=N/NC(=O)c2nnn(-c3nonc3N)c2CN(C)c2ccccc2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493516";"";"None";"323.35";"0";"3.36";"SID17433262";"COc1ccc(/C=C/c2n[nH]c(-c3ccccc3O)n2)cc1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1508525";"";"None";"318.45";"0";"4.24";"SID24815779";"O=C(CSc1ccc(-c2cccs2)nn1)c1cccs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1540815";"";"None";"433.49";"0";"4.30";"SID22406208";"COc1ccccc1NS(=O)(=O)c1cccc(NC(=O)c2ccc3ccccc3n2)c1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1733477";"";"None";"313.41";"0";"3.42";"SID24805994";"O=C(NC(=S)Nc1cccc2cccnc12)c1cccs1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1911939";"";"None";"437.47";"0";"2.98";"4c";"O=C(Nc1ccccc1)N1CCC2(OCCN2S(=O)(=O)c2ccccc2)C(F)(F)C1";"IC50";"'='";"1000.0";"nM";"6.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1913449";"Antagonist activity at OX2R expressed in dihydrofolate reductase deficient CHO cells assessed as inhibition of orexin A-induced intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909547";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3426151";"";"None";"379.42";"0";"2.81";"6c";"COC(=O)c1ccccc1C(=O)N1C[C@H](Oc2cc(C#N)ccn2)CC[C@H]1C";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426137";"";"None";"388.43";"0";"2.61";"5f";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"13.0";"nM";"7.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL1422276";"";"None";"324.41";"0";"3.88";"SID24821268";"Cc1cc(O)n2nc(-c3sccc3-n3c(C)ccc3C)cc2n1";"IC50";"";"6480.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1479657";"";"None";"341.37";"1";"5.10";"SID49729299";"COc1cccc2oc3cc(-c4ccc5[nH]ccc5c4)ccc3c(=O)c12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1360282";"";"None";"374.44";"1";"5.08";"SID17433838";"CCn1c2ccccc2c2cc(NC(=O)c3cccc(OC)c3OC)ccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1459603";"";"None";"396.56";"0";"3.51";"SID49715682";"CSc1cccc(NC(=O)C2CCCN(S(=O)(=O)c3cccs3)C2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1520346";"";"None";"347.42";"0";"4.19";"SID7978390";"CCN(CC)c1ccc2cc(-c3nc4ccccc4n3C)c(=O)oc2c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1481095";"";"None";"281.34";"0";"4.32";"SID17409133";"COc1ccc2c(c1)nc(O)c1sc3ccccc3c12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL489685";"";"None";"515.70";"2";"5.57";"124";"CCCCNC(=O)C(c1ccccc1)N1CCc2cc(OC)c(OC)cc2C1Cc1ccc(N(C)C)cc1";"IC50";"'='";"1536.0";"nM";"5.81";"";"";"UO_0000065";"11.27";"0.21";"0.24";"10.76";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL1379934";"";"None";"397.50";"0";"3.01";"SID49674112";"Cc1ccc(S(=O)(=O)N2CCCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1";"IC50";"";"4310.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL510425";"";"None";"420.53";"0";"3.08";"17";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL468968";"";"None";"394.92";"0";"3.71";"26";"CCN(CC)C(=O)CN(c1ccc(C)cc1)S(=O)(=O)c1ccccc1Cl";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL497768";"";"None";"474.58";"0";"2.71";"31";"CCN(CC)C(=O)CN(c1cc(N(C)C)ccc1C#N)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"10.0";"nM";"8.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL1508525";"";"None";"318.45";"0";"4.24";"SID24815779";"O=C(CSc1ccc(-c2cccs2)nn1)c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1556270";"";"None";"329.41";"0";"3.53";"SID24786666";"O=C(NC(=S)Nc1nc(-c2ccccc2)cs1)c1ccco1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1270809";"";"None";"439.50";"1";"5.32";"SID85146457";"O=C(OCC#CCSc1nnc(-c2cccc3ccccc23)o1)c1cccc2[nH]ccc12";"IC50";"";"1390.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1556254";"";"None";"314.39";"0";"4.26";"SID14725382";"Cc1nc2c(-c3ccccc3)c(C)nn2c(N)c1-c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1977763";"";"None";"271.28";"0";"2.77";"SID17506339";"CN(/N=C/c1cc([N+](=O)[O-])ccc1O)c1ccccc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1491556";"";"None";"435.51";"0";"3.78";"SID22407370";"CNC(=O)NC(=O)C(C)OC(=O)c1c2c(nc3ccccc13)/C(=C/c1cccs1)CC2";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1995997";"";"None";"269.33";"0";"2.83";"SID22415591";"Cc1ccsc1/C=N/N=C1\C(=O)Nc2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3235264";"";"None";"415.50";"0";"2.76";"5l";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccnc(CO)c3)CC[C@H]2C)c1";"IC50";"'='";"100.0";"nM";"7.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL1419029";"";"None";"540.64";"1";"3.23";"SID24833540";"Cc1c(NS(=O)(=O)c2cccc(C(=O)OCC(=O)N(C)C3CCCCC3)c2)c(=O)n(-c2ccccc2)n1C";"IC50";"";"800.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1466856";"";"None";"397.41";"0";"3.03";"SID3713616";"Cc1noc(C)c1COC(=O)c1ccc2c(c1)S(=O)(=O)c1ccccc1C2=O";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4094742";"";"None";"379.46";"0";"3.73";"16";"CCOc1ccccc1C(=O)N1C[C@H](Oc2nccc(C#N)c2C)CC[C@H]1C";"IC50";"'='";"6.0";"nM";"8.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4080670";"";"None";"469.55";"0";"4.35";"21";"CC(=O)Nc1cc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(-c2ccccc2)cn1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3426138";"";"None";"421.46";"0";"2.52";"29";"COC(=O)c1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4091661";"";"None";"446.47";"0";"2.39";"30";"COC(=O)c1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3409853";"";"None";"429.82";"0";"4.68";"23";"COc1cccc(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"41.0";"nM";"7.39";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409869";"";"None";"401.46";"1";"5.47";"39";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"20.0";"nM";"7.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1911643";"";"None";"343.85";"0";"4.89";"1d";"CCc1ccc2c(c1)[C@H](C)N(C(=O)c1ccc(Cl)cc1)[C@H](C)CO2";"IC50";"'='";"160.0";"nM";"6.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL3739958";"";"None";"452.58";"0";"4.99";"25";"COc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc(OC)c(OC)c2)c1";"IC50";"'='";"7.8";"nM";"8.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL343786";"";"None";"402.56";"0";"3.85";"49";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccsc1)C(C)(C)C)CC2";"IC50";"'='";"35.0";"nM";"7.46";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL343141";"";"None";"430.55";"0";"3.99";"31";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NCc1ccccc1)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL444407";"";"None";"596.68";"2";"5.97";"120";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2C(C(=O)Nc2ccc3c(c2)OCO3)c2ccccc2)cc1OC";"IC50";"'='";"1814.0";"nM";"5.74";"";"";"UO_0000065";"9.62";"0.18";"-0.23";"6.55";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL489303";"";"None";"486.61";"0";"4.66";"107";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)NC2CCc3ccccc32)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL522443";"";"None";"516.64";"1";"4.45";"(+/-)-96";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)N2CCc3ccccc3C2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"9.68";"0.18";"0.55";"8.27";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL139158";"";"None";"382.50";"0";"3.40";"21";"COc1cc2c(cc1OC)CN(C(=O)C(NCc1ccccc1)C(C)C)CC2";"IC50";"'='";"3300.0";"nM";"5.48";"";"";"UO_0000065";"14.33";"0.27";"2.08";"10.79";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL138717";"";"None";"410.51";"0";"3.43";"14";"COc1cc2c(cc1OC)CN(C(=O)C(NC(=O)c1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1571574";"";"None";"327.34";"0";"3.75";"SID49824531";"COc1cccc2oc3ccc(C#Cc4ccccn4)cc3c(=O)c12";"IC50";"";"820.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1482828";"";"None";"426.45";"0";"2.86";"SID22407760";"Cc1c(C(=O)OCC(=O)NCCN2C(=O)CSC2=O)oc2c1ccc1ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1979844";"";"None";"397.89";"1";"5.12";"SID17516690";"COc1ccc2c(Cl)c(C(=O)N/N=C/c3c(C)[nH]c4ccccc34)sc2c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2396835";"";"None";"540.96";"2";"5.87";"36";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2CCc1cc(F)c(C(F)(F)F)c(F)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2396862";"";"None";"506.96";"2";"5.04";"25";"CCc1nc(Cl)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)[C@H]2COc1ccc(C(F)(F)F)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL455136";"ALMOREXANT";"3.0";"512.57";"2";"5.74";"ACT-078573";"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL2400168";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2396638";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL1966014";"";"None";"292.39";"0";"2.16";"SID26731595";"Cn1c(N)c(C(=O)N/N=C/c2ccccc2)sc1=S";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1327720";"";"None";"442.52";"0";"4.42";"SID848125";"COc1ccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1526729";"";"None";"252.30";"0";"2.87";"SID24821640";"N#Cc1cccn1-c1nccc(-c2cccs2)n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1479951";"";"None";"492.56";"0";"3.83";"SID852774";"O=C(c1ccco1)N1CCCC(c2nc(-c3ccc(S(=O)(=O)NCc4ccccc4)cc3)no2)C1";"IC50";"";"5510.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1575559";"";"None";"440.50";"0";"2.98";"SID24837099";"O=C(c1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1)N1CCN(c2ccccn2)CC1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1409330";"";"None";"300.43";"0";"4.95";"SID3711668";"N#CC(=C1SC=CS1)c1nc(-c2ccccc2)cs1";"IC50";"";"4310.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1348119";"";"None";"398.45";"1";"5.27";"SID17515708";"O=C(Nc1nnc(-c2ccccc2)o1)c1cc(-c2cccs2)nc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1480014";"";"None";"426.52";"0";"4.72";"SID14726667";"Cc1ccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1583817";"";"None";"435.44";"0";"3.01";"SID14744936";"Cc1noc(C)c1COc1ccc(C(=O)OCC(=O)N2CC(=O)Nc3ccccc32)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1594672";"";"None";"459.96";"0";"4.06";"SID17515972";"Cc1cc(Cl)ccc1OCCCC(=O)NCCN1C(=O)S/C(=C\c2cccnc2)C1=O";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1536921";"";"None";"454.90";"1";"5.25";"SID24781211";"O=C(N=Nc1c(O)[nH]c2ccccc12)c1cccc(S(=O)(=O)Nc2ccccc2Cl)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1582357";"";"None";"508.48";"2";"5.89";"SID24826880";"CCN(CC)P(=O)(Nc1cccc(C(F)(F)F)c1)c1ccc(N(C)C)cc1NC(=O)c1ccco1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1343392";"";"None";"313.14";"0";"2.67";"SID17402824";"Cc1ccc(C(=O)OCn2ncc(Cl)c(Cl)c2=O)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1465216";"";"None";"364.50";"0";"3.84";"SID24793739";"CCc1c(C)sc(N=C(S)Nc2nc(C)cc(C)n2)c1C(=O)OC";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1388463";"";"None";"277.35";"0";"3.91";"SID47201502";"N#CCSc1nc(-c2ccccc2)nc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493493";"";"None";"369.43";"0";"4.13";"SID4250838";"C=CCNc1nc(N(c2ccccc2)c2ccccc2)nc(-n2ccnc2)n1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL2413370";"";"None";"446.57";"0";"4.42";"56";"Cc1c(S(=O)(=O)Cc2ccccc2)c2ccccn2c1CC(=O)N(C)Cc1ccccc1";"IC50";"'='";"1.0";"nM";"9.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL2031484";"";"None";"502.62";"2";"5.48";"13";"Cc1nc(C(=O)N2CCC[C@@H](C)[C@H]2CNC(=O)c2cccc3cccnc23)c(-c2ccc(F)cc2)s1";"IC50";"'='";"658.0";"nM";"6.18";"";"";"UO_0000065";"12.30";"0.23";"0.70";"8.22";"1";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL2413372";"";"None";"451.52";"0";"3.65";"58";"CN(Cc1ccc(F)cc1)C(=O)Cc1nc(S(=O)(=O)Cc2ccccc2)c2ccccn12";"IC50";"'='";"194.0";"nM";"6.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL139915";"";"None";"396.53";"0";"3.79";"(+/-)-40";"COc1cc2c(cc1OC)CN(C(=O)C(NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"910.0";"nM";"6.04";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL138091";"";"None";"541.42";"1";"4.53";"(+/-)-36";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)NC(=O)c1ccc(F)c(Br)c1)CC2";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL140700";"";"None";"513.42";"1";"4.94";"35";"COc1cc2c(cc1OC)CN(C(=O)[C@H](Cc1ccccc1)NC(=O)c1cc(Cl)cc(Cl)c1)CC2";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL2413369";"";"None";"466.59";"0";"3.36";"55";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC2CNC(=O)c2c(N)nc3sccn23)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3971640";"";"None";"449.80";"1";"5.34";"BDBM203158";"CCOc1ccc(F)c(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"35.0";"nM";"7.46";"";"360718";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904643";"";"None";"400.44";"0";"3.52";"BDBM240099";"Cc1ccc(-c2noc([C@@H]3CCN3C(=O)c3cc(C)ccc3-n3nccn3)n2)cc1";"IC50";"'='";"180.0";"nM";"6.75";"";"418940";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909062";"";"None";"468.94";"1";"5.86";"BDBM240150";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-c2ccccc2F)s1";"IC50";"'='";"218.0";"nM";"6.66";"";"418992";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927468";"";"None";"448.91";"1";"5.56";"BDBM240166";"Cc1cccc(-c2oc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"555.0";"nM";"6.26";"";"419008";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952601";"";"None";"470.41";"0";"4.11";"BDBM240179";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)c1";"IC50";"'='";"11.0";"nM";"7.96";"";"419021";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894851";"";"None";"445.48";"0";"3.32";"BDBM240186";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2cc(C)c(C)cc2-n2nccn2)no1";"IC50";"'='";"0.6";"nM";"9.22";"";"419028";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934595";"";"None";"432.46";"0";"3.97";"BDBM240117";"Cc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3C)no2)c(-n2nccn2)cc1C";"IC50";"'='";"4.0";"nM";"8.40";"";"418958";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952851";"";"None";"378.45";"0";"4.88";"BDBM203197";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"71.0";"nM";"7.15";"";"360758";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890906";"";"None";"425.53";"1";"5.16";"BDBM203198";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-c2ncc(C)s2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360759";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949230";"";"None";"450.56";"1";"5.15";"BDBM203258";"COc1ccc2c(c1C1CCCC(=O)N1Cc1cccc(-c3csc(C)n3)c1)OCCO2";"IC50";"'='";"13.0";"nM";"7.89";"";"360822";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957500";"";"None";"413.37";"0";"3.96";"BDBM203154";"CCOc1cc(F)ccc1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1360.0";"nM";"5.87";"";"360714";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971640";"";"None";"449.80";"1";"5.34";"BDBM203158";"CCOc1ccc(F)c(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"462.0";"nM";"6.33";"";"360724";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986272";"";"None";"423.54";"0";"4.64";"BDBM203168";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"360728";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL522975";"";"None";"496.65";"0";"4.65";"(+/-)-101";"COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2CC(=O)N(C)C2CCCCC2)cc1OC";"IC50";"'='";"10000.0";"nM";"5.00";"";"";"UO_0000065";"10.07";"0.19";"0.35";"8.27";"0";"CHEMBL1007909";"Inhibition of OX2 receptor";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL453134";"";"None";"484.02";"0";"3.49";"130";"CCN(CC)C(=O)CN(c1cc(N(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007911";"Antagonist activity at OX2 receptor by FLIPR";"F";"BAO_0000019";"assay format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL342039";"";"None";"368.48";"0";"2.76";"(+/-)-30";"COc1cc2c(cc1OC)CN(C(=O)C(Cc1ccccc1)N(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL1007898";"Antagonist activity at human OX2 receptor";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1140924";"1";"Scientific Literature";"J Med Chem";"2009";"None";"";"";""
"CHEMBL3922074";"";"None";"431.81";"1";"5.20";"BDBM203160";"CCOc1cc(F)ccc1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1630.0";"nM";"5.79";"";"360720";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897027";"";"None";"402.49";"0";"4.88";"BDBM203173";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"113.0";"nM";"6.95";"";"360733";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948479";"";"None";"364.42";"0";"4.49";"BDBM203176";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"1260.0";"nM";"5.90";"";"360737";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973182";"";"None";"411.39";"1";"5.23";"BDBM203189";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360750";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895491";"";"None";"424.54";"1";"5.77";"BDBM203201";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1csc(-c2ccc(C)cc2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"360762";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917566";"";"None";"425.86";"1";"5.07";"BDBM203218";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)F)c(Cl)c1";"IC50";"'='";"155.0";"nM";"6.81";"";"360780";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978321";"";"None";"447.81";"0";"4.61";"BDBM203246";"CCOc1cccc(F)c1C1CC(O)C(=O)N1Cc1ccc(OC(F)(F)F)c(Cl)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"360808";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3597957";"";"None";"410.48";"0";"2.59";"53";"Cc1oc([C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3ncnn3)C2)nc1C(C)(C)O";"IC50";"'='";"13.5";"nM";"7.87";"";"";"UO_0000065";"19.17";"0.36";"5.28";"7.14";"0";"CHEMBL3598895";"Antagonist activity at orexin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3622331";"";"None";"475.48";"0";"3.13";"10";"COc1nc(N2CC[C@@H](C)N(C(=O)c3cc(C)ccc3-n3nccn3)CC2)ncc1C(F)(F)F";"IC50";"'='";"43.0";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667589";"";"None";"408.52";"0";"4.25";"BDBM154963";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2cccc3ccccc23)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"297254";"UO_0000065";"18.57";"0.36";"3.34";"11.41";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3955752";"";"None";"408.41";"0";"3.81";"51";"O=C(c1cccn2cncc12)N1CCC(F)(F)[C@@H](Oc2ccc3ccccc3n2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3868342";"Antagonist activity at human OX2 receptor expressed on CHO cell membrane assessed as inhibition of Ala-6,12 orexin-A-induced calcium increase preincubated for 5 mins prior to Ala-6,12 orexin-A addition measured at 1 sec intervals for 1 min by Fluo-4AM dye-based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3867477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3667591";"";"None";"418.52";"0";"3.11";"BDBM154965";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1OC";"IC50";"'='";"101.0";"nM";"7.00";"";"297256";"UO_0000065";"16.72";"0.33";"3.89";"8.24";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL141368";"";"None";"410.56";"0";"3.84";"18";"COc1cc2c(cc1OC)CN(C(=O)C(NCCc1ccccc1)C(C)(C)C)CC2";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL139634";"";"None";"397.52";"0";"3.19";"28";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1cccnc1)C(C)(C)C)CC2";"IC50";"'='";"240.0";"nM";"6.62";"";"";"UO_0000065";"16.65";"0.31";"3.43";"10.39";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL4740509";"";"None";"475.56";"0";"2.82";"26";"COC(=O)N1[C@H](C)C[C@H](NS(=O)(=O)NCF)[C@@H]1CO[C@H]1CC[C@@H](c2cccc(F)c2)CC1";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL3941690";"";"None";"431.42";"0";"3.23";"BDBM185265";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334182";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3930702";"";"None";"449.41";"0";"3.37";"BDBM185268";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1cc(F)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334185";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3971206";"";"None";"417.39";"0";"2.84";"BDBM185284";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334201";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3932153";"";"None";"450.40";"0";"3.27";"BDBM185335";"O=C(N[C@H]1CC(F)(F)C[C@@H]1Nc1ccc(OC(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334252";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3963632";"";"None";"432.41";"0";"2.54";"BDBM185260";"Cc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334177";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3974993";"";"None";"430.43";"0";"3.75";"BDBM185291";"Cc1cc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334208";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3950052";"";"None";"377.45";"0";"2.38";"BDBM185297";"CCc1cnc(N[C@H]2CCC[C@@H]2NC(=O)c2ccccc2-n2nccn2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334214";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3971938";"";"None";"470.38";"0";"3.83";"BDBM185313";"O=C(N[C@H]1CC(F)(F)C[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334230";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3923506";"";"None";"442.45";"0";"4.11";"BDBM185334";"CC1(Nc2ccc(C(F)(F)F)cn2)CCCC1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334251";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL2347485";"";"None";"500.57";"1";"4.95";"21, diastereomeric mixture";"CCc1nc(OC)c2n1CCN([C@@H](C(=O)NC)c1ccccc1)C2CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"73.0";"nM";"7.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2350730";"Antagonist activity at human OX2 receptor expressed in CHO cells assessed as inhibition of orexin A-induced calcium influx by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2346521";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL3978623";"";"None";"418.43";"0";"3.66";"BDBM240098";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3C)no2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"418939";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935511";"";"None";"468.88";"0";"4.01";"BDBM240120";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)cc1F";"IC50";"'='";"25.0";"nM";"7.60";"";"418961";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956526";"";"None";"448.46";"0";"3.67";"BDBM240124";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3C)no2)c(-n2nccn2)cc1C";"IC50";"'='";"4.0";"nM";"8.40";"";"418966";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915969";"";"None";"486.48";"1";"5.65";"BDBM240135";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-c2ccccc2)s1";"IC50";"'='";"41.0";"nM";"7.39";"";"418977";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958954";"";"None";"500.50";"2";"5.96";"BDBM240140";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-c2ccccc2C)s1";"IC50";"'='";"416.0";"nM";"6.38";"";"418982";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965076";"";"None";"471.37";"1";"6.06";"BDBM240156";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2ncsc2-c2cccc(Cl)c2)n1";"IC50";"'='";"367.0";"nM";"6.43";"";"418998";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932896";"";"None";"450.95";"1";"5.72";"BDBM240164";"Cc1cccc(-c2scnc2C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"240.0";"nM";"6.62";"";"419006";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932276";"";"None";"432.46";"0";"3.97";"BDBM240184";"Cc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(F)c3C)n2)c(-n2nccn2)cc1C";"IC50";"'='";"3.0";"nM";"8.52";"";"419026";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965816";"";"None";"448.91";"0";"4.48";"BDBM240197";"Cc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c(-n2nccn2)cc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"419039";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932611";"";"None";"445.91";"1";"5.05";"BDBM240211";"Cc1ccc(-c2ncccn2)c(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"419054";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960019";"";"None";"463.50";"0";"3.41";"BDBM221428";"COc1cc(OC)nc(N[C@H](C)Cn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"354.0";"nM";"6.45";"";"387559";"UO_0000065";"13.92";"0.26";"3.04";"4.99";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4096258";"";"None";"387.45";"0";"2.64";"24";"C[C@@H]1CC[C@@H](Nc2cc(C#N)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4093272";"";"None";"427.51";"0";"2.67";"14b";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5ccccc5n4C)C[C@@H]3C2)c1";"IC50";"'='";"775.0";"nM";"6.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3963773";"";"None";"500.50";"2";"5.96";"BDBM240133";"Cc1cccc(-c2sc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"119.0";"nM";"6.92";"";"418975";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945488";"";"None";"470.41";"0";"4.11";"BDBM240141";"Cc1cccc(-n2nccn2)c1C(=O)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"115.0";"nM";"6.94";"";"418983";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923037";"";"None";"540.38";"1";"4.70";"BDBM240142";"O=C(c1cc(OC(F)(F)F)ccc1-n1nccn1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"727.0";"nM";"6.14";"";"418984";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970228";"";"None";"433.90";"0";"3.91";"BDBM240218";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nnc(-c3cccc(Cl)c3C)[nH]2)c1";"IC50";"'='";"238.0";"nM";"6.62";"";"419061";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912470";"";"None";"419.42";"0";"2.16";"BDBM208495";"O=C(c1ccccc1-n1nccn1)N1CCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"252.0";"nM";"6.60";"";"368532";"UO_0000065";"15.73";"0.29";"4.44";"7.25";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902957";"";"None";"437.41";"0";"2.30";"BDBM208496";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"170.9";"nM";"6.77";"";"368533";"UO_0000065";"15.47";"0.29";"4.47";"7.44";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939214";"";"None";"401.33";"0";"4.54";"BDBM203278";"COc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"93.0";"nM";"7.03";"";"360842";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920334";"";"None";"451.84";"0";"3.49";"BDBM185224";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(Cl)cccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334141";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3898815";"";"None";"432.41";"0";"3.62";"BDBM185228";"Cc1nnc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"334145";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3909223";"";"None";"472.52";"0";"3.64";"BDBM184109";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c1";"IC50";"'='";"171.0";"nM";"6.77";"";"332178";"UO_0000065";"14.32";"0.26";"3.13";"7.87";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3947571";"";"None";"454.53";"0";"3.42";"BDBM184002";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3nccc(C)n3)c2)c1";"IC50";"'='";"231.0";"nM";"6.64";"";"332066";"UO_0000065";"14.60";"0.27";"3.22";"7.71";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3959904";"";"None";"460.49";"0";"2.72";"BDBM184020";"COc1ccc(C[C@@H]2COCCN2C(=O)c2cc(C)ccc2-n2nccn2)cc1-c1ncon1";"IC50";"'='";"42.0";"nM";"7.38";"";"332089";"UO_0000065";"16.02";"0.30";"4.66";"6.81";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3924228";"";"None";"443.51";"0";"2.63";"BDBM184031";"Cc1ccc(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@H]2C)c(-n2nccn2)c1";"IC50";"'='";"314.0";"nM";"6.50";"";"332100";"UO_0000065";"14.66";"0.27";"3.87";"7.15";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3975507";"";"None";"446.47";"0";"2.41";"BDBM184021";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ncon1";"IC50";"'='";"80.0";"nM";"7.10";"";"332090";"UO_0000065";"15.90";"0.29";"4.69";"6.55";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3956556";"";"None";"457.54";"0";"3.02";"BDBM184106";"CC[C@@H]1CN(C(=O)c2ccc(C)cc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"104.0";"nM";"6.98";"";"332175";"UO_0000065";"15.26";"0.28";"3.96";"7.68";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917812";"";"None";"409.41";"0";"3.36";"BDBM185214";"CCOc1ccc(C)nc1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334131";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL291536";"";"None";"319.32";"0";"3.72";"139";"Cc1nc2ccc(NC(=O)Nc3ccnc4cccnc34)cc2o1";"IC50";"'='";"835000.0";"nM";"";"Outside typical range";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4415170";"Antagonist activity at human OX2R expressed in CHOK1 cells by Syto62 probe based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414553";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL2031503";"";"None";"478.52";"1";"5.59";"47";"Cc1nc(C(=O)N2CC(F)CC[C@H]2CNc2ccc(C(F)(F)F)cn2)c(-c2ccccc2)s1";"IC50";"'='";"7.0";"nM";"8.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2034510";"Antagonist activity at OX2 receptor expressed in CHO cells assessed as inhibition of OXA-stimulated intracellular calcium mobilization after 30 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2029290";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2012";"CHEMBL3308072";"";"";""
"CHEMBL4592258";"";"None";"480.62";"0";"4.44";"4; V2a";"CC[C@@]12CCCN3CCc4c([nH]c5ccccc45)[C@]31N(Cc1cn(Cc3ccccc3)nn1)C(=O)C2";"IC50";"'='";"2260.0";"nM";"5.65";"";"";"UO_0000065";"11.75";"0.21";"1.21";"8.06";"0";"CHEMBL4344232";"Antagonist activity at human Gq-coupled HCRTR2 expressed in CHOK1 cells assessed as inhibition in Orexin A-induced beta-arrestin 2 recruitment incubated for 30 mins followed by Orexin A addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4342456";"1";"Scientific Literature";"J Med Chem";"2020";"None";"";"";""
"CHEMBL1911749";"";"None";"399.80";"1";"5.22";"1l";"C[C@@H]1COc2ccc(OC(F)(F)F)cc2[C@H](C)N1C(=O)c1ccc(Cl)cc1";"IC50";"'='";"140.0";"nM";"6.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1914018";"Antagonist activity at human OX2R expressed in CHO cells assessed intracellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1909552";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2011";"CHEMBL3308072";"";"";""
"CHEMBL1083659";"SUVOREXANT";"4.0";"450.93";"0";"4.11";"39";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"16.08";"0.31";"3.14";"9.03";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL4213974";"";"None";"558.66";"1";"4.18";"13a";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC=C4[C@@H](C2)N(S(=O)(=O)c2ccccc2)CC[C@]431";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5133796";"Antagonist activity at OX2R (unknown origin) by cell-based calcium assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131444";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"";""
"CHEMBL3924447";"";"None";"442.48";"0";"2.51";"BDBM184157";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1ccc(O)c(-c2ncccn2)c1";"IC50";"'='";"2010.0";"nM";"5.70";"";"332086";"UO_0000065";"12.87";"0.24";"3.19";"5.36";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3968141";"";"None";"467.89";"0";"2.72";"BDBM184091";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"188.0";"nM";"6.73";"";"332160";"UO_0000065";"14.37";"0.28";"4.01";"7.39";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3986684";"";"None";"431.53";"1";"6.14";"BDBM202927";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"98.0";"nM";"7.01";"";"360453";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985172";"";"None";"416.52";"1";"5.41";"BDBM202934";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccnc(-c2ccccc2)c1";"IC50";"'='";"58.0";"nM";"7.24";"";"360460";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL495965";"";"None";"445.54";"0";"2.95";"38";"CCN(CC)C(=O)CN(c1ccc(C)cc1C#N)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL495973";"";"None";"483.03";"0";"4.54";"41";"CCN(CC)C(=O)CN(c1cc(C(C)C)ccc1Cl)S(=O)(=O)c1ccc(OC)c(OC)c1";"IC50";"'='";"90.0";"nM";"7.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL1006173";"Inhibition of human OX2 receptor expressed in CHO cells assessed as intercellular calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1143438";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2008";"CHEMBL3308072";"";"";""
"CHEMBL3894723";"";"None";"454.53";"0";"3.50";"BDBM184071";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-c3ncccn3)c2)c1";"IC50";"'='";"105.0";"nM";"6.98";"";"332140";"UO_0000065";"15.35";"0.28";"3.48";"8.11";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1512498";"";"None";"247.30";"0";"3.58";"SID49648071";"Cc1cccc2c3nc4ccccc4nc3n(C)c12";"IC50";"";"5760.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1438621";"";"None";"282.37";"0";"4.37";"SID846962";"N#CC(=C1CCCC1)c1nc(-c2ccccc2O)cs1";"IC50";"";"19800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1493746";"";"None";"455.01";"1";"6.21";"SID17516553";"C=CCn1c(SCc2csc(-c3ccc(Cl)cc3)n2)nnc1-c1ccccc1OC";"IC50";"";"2700.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1721724";"";"None";"356.45";"0";"3.99";"SID47200781";"Cc1cccc(OCCSc2nc3ccccc3n2CCC(=O)O)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1477093";"";"None";"426.52";"0";"4.72";"SID14726639";"Cc1cccc(-c2cc3nc(-c4ccccc4)cc(N4CCC5(CC4)OCCO5)n3n2)c1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1612190";"";"None";"312.42";"0";"4.18";"SID24816433";"O=C(CSc1ccc(-c2ccccc2)nn1)c1cccs1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1514800";"";"None";"324.38";"0";"3.67";"SID85146498";"Cn1c2ccccc2c(=O)c2cc(C#Cc3cccc(N)c3)ccc21";"IC50";"";"70.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3944494";"";"None";"457.51";"0";"4.34";"BDBM208525";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cn2ccc(-c3ccc(F)cc3)n2)c1";"IC50";"'='";"1.0";"nM";"9.00";"";"368562";"UO_0000065";"19.67";"0.36";"4.66";"12.31";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935533";"";"None";"457.51";"0";"4.34";"BDBM208527";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cn2cc(-c3ccc(F)cc3)cn2)c1";"IC50";"'='";"3.2";"nM";"8.49";"";"368564";"UO_0000065";"18.57";"0.34";"4.15";"11.61";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3933736";"";"None";"497.92";"0";"2.73";"BDBM184101";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)cc1Cl";"IC50";"'='";"191.0";"nM";"6.72";"";"332170";"UO_0000065";"13.49";"0.26";"3.99";"6.71";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3409875";"";"None";"405.43";"0";"4.57";"45";"COc1cccc(F)c1C1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"5.0";"nM";"8.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409876";"";"None";"405.43";"0";"4.57";"46-(trans)";"COc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"20.71";"0.38";"3.83";"13.35";"0";"CHEMBL3413700";"Binding affinity to human OX2R";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL4756711";"";"None";"429.55";"0";"3.65";"47";"CC[C@](C)(O)c1nc([C@@H]2CC[C@@H](C)N(C(=O)c3cscc3-n3nccn3)C2)oc1C";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL140348";"";"None";"396.53";"0";"3.79";"16";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccccc1)C(C)(C)C)CC2";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"17.37";"0.32";"3.10";"13.56";"0";"CHEMBL757348";"Inhibitory concentration against human orexin-2 receptor (hOX2R)";"B";"BAO_0000357";"single protein format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1136503";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2003";"None";"";"";""
"CHEMBL1584180";"";"None";"483.55";"1";"5.23";"SID22409822";"O=C(Nc1cccc(S(=O)(=O)NCc2ccco2)c1)c1cc(-c2ccccc2)nc2ccccc12";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1440953";"";"None";"568.93";"2";"6.24";"SID24782357";"O=C(CSc1ccc(Br)c2cccc(Cl)c12)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1307031";"";"None";"249.27";"0";"0.77";"SID857884";"CN1C(=O)C2(N=c3ccccc3=N2)c2ccccc21";"IC50";"'>'";"50000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1964010";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3904880";"";"None";"469.43";"0";"2.35";"BDBM184099";"O=C(c1cc(F)c(F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"202.0";"nM";"6.70";"";"332168";"UO_0000065";"14.26";"0.27";"4.34";"7.36";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3925326";"";"None";"492.94";"0";"3.99";"BDBM184114";"C[C@@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)[C@H](Cc2cc(-c3ncccn3)ccc2F)CO1";"IC50";"'='";"129.0";"nM";"6.89";"";"332183";"UO_0000065";"13.98";"0.27";"2.90";"8.01";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3622335";"";"None";"445.45";"0";"3.13";"15";"Cc1ncc(C(F)(F)F)c(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1083358";"";"None";"431.48";"0";"3.09";"1";"C[C@@H]1CCN(c2ncc3cc(F)ccc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622332";"";"None";"445.45";"0";"3.13";"11";"Cc1nc(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)ncc1C(F)(F)F";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3667571";"";"None";"388.49";"0";"3.10";"BDBM154944";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(C)c(C)c2)cc1";"IC50";"'='";"29.0";"nM";"7.54";"";"297235";"UO_0000065";"19.40";"0.38";"4.44";"9.96";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667600";"";"None";"460.90";"0";"4.77";"BDBM154974";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"297265";"UO_0000065";"16.75";"0.35";"2.95";"11.61";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL1083659";"SUVOREXANT";"4.0";"450.93";"0";"4.11";"2";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1";"IC50";"'='";"0.4";"nM";"9.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1479657";"";"None";"341.37";"1";"5.10";"SID49729299";"COc1cccc2oc3cc(-c4ccc5[nH]ccc5c4)ccc3c(=O)c12";"IC50";"";"10000.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1594672";"";"None";"459.96";"0";"4.06";"SID17515972";"Cc1cc(Cl)ccc1OCCCC(=O)NCCN1C(=O)S/C(=C\c2cccnc2)C1=O";"IC50";"";"17500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1434457";"";"None";"465.58";"0";"3.85";"SID57256579";"CCOc1ccccc1N1CCN(C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)CC1";"IC50";"";"42500.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL490082";"";"None";"506.65";"2";"6.02";"14";"COc1cc2c(cc1OC)C(Cc1ccc3ccccc3c1)N(C(C(=O)NC1CC1)c1ccccc1)CC2";"IC50";"'='";"80.0";"nM";"7.10";"";"";"UO_0000065";"14.01";"0.26";"1.08";"13.97";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3972749";"";"None";"458.50";"0";"3.26";"BDBM184119";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c1-n1nccn1";"IC50";"'='";"2590.0";"nM";"5.59";"";"332188";"UO_0000065";"12.18";"0.22";"2.33";"6.49";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957175";"";"None";"443.51";"0";"2.63";"BDBM184130";"Cc1ccc(C(=O)N2CCO[C@H](C)[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"3505.0";"nM";"5.46";"";"332199";"UO_0000065";"12.30";"0.23";"2.83";"6.00";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667557";"";"None";"410.95";"0";"3.85";"BDBM154930";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)cc2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"297221";"UO_0000065";"19.58";"0.42";"4.20";"12.10";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3597953";"";"None";"424.54";"1";"5.72";"33";"Cc1nc(C(=O)N2CCCC[C@H]2CCOc2ccc(F)cc2)c(-c2ccccc2)s1";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"18.50";"0.36";"2.13";"18.51";"0";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3770745";"";"None";"404.47";"0";"3.32";"34";"CCN(CCN(C)c1nc2ccccc2o1)C(=O)c1cc(C)ccc1-n1nccn1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"19.15";"0.35";"4.42";"9.65";"0";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL3338866";"MK-1064";"1.0";"461.91";"0";"4.20";"66; MK-1064";"COc1ccc(CNC(=O)c2cc(-c3cncc(Cl)c3)cnc2-c2ccccn2)nc1OC";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"16.77";"0.32";"3.54";"7.81";"0";"CHEMBL3772037";"Antagonist activity at human OX2R expressed in CHO cells by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3586412";"";"None";"431.95";"0";"4.32";"35";"COc1cccc(OC)c1C(=O)N1CCCN(c2nc3ccc(Cl)cc3s2)CC1";"IC50";"'='";"98.0";"nM";"7.01";"";"";"UO_0000065";"16.23";"0.33";"2.69";"12.77";"0";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL455136";"ALMOREXANT";"3.0";"512.57";"2";"5.74";"15";"CNC(=O)[C@@H](c1ccccc1)N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(C(F)(F)F)cc1";"IC50";"'='";"8.0";"nM";"8.10";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3772001";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium release";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3597952";"ACT-462206";"1.0";"388.49";"0";"3.10";"22; ACT-462206";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1";"IC50";"'='";"11.0";"nM";"7.96";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL3772009";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3941085";"";"None";"445.55";"0";"3.78";"BDBM184006";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3nccs3)c2)c1";"IC50";"'='";"273.0";"nM";"6.56";"";"332070";"UO_0000065";"14.73";"0.28";"2.78";"8.97";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3967251";"";"None";"431.52";"0";"3.47";"BDBM184007";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"457.0";"nM";"6.34";"";"332071";"UO_0000065";"14.69";"0.28";"2.87";"8.67";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3906374";"";"None";"444.56";"0";"4.39";"BDBM184008";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3cccs3)c2)c1";"IC50";"'='";"119.0";"nM";"6.92";"";"332072";"UO_0000065";"15.58";"0.30";"2.53";"11.49";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3973412";"";"None";"485.39";"0";"3.86";"BDBM185229";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(C(F)(F)F)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334146";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3980229";"";"None";"395.39";"0";"3.05";"BDBM185244";"CCOc1cccnc1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334161";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3978999";"";"None";"451.44";"0";"2.21";"BDBM184098";"O=C(c1c(F)cccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-n2nccn2)ccc1F";"IC50";"'='";"574.0";"nM";"6.24";"";"332167";"UO_0000065";"13.82";"0.26";"4.03";"6.86";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4790356";"";"None";"473.61";"0";"2.86";"67";"[2H][C@@H]1C[C@@H](OC[C@H]2[C@@H](NS(=O)(=O)N(C)C)C[C@@H](C)N2C(=O)OC)CC[C@@]1([2H])c1cccc(F)c1";"IC50";"'='";"0.46";"nM";"9.34";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL3667570";"";"None";"403.50";"0";"2.55";"BDBM154943";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(N(C)C)c2)cc1";"IC50";"'='";"19.0";"nM";"7.72";"";"297234";"UO_0000065";"19.14";"0.38";"5.17";"9.78";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667562";"";"None";"445.39";"0";"4.51";"BDBM154935";"CSc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(Cl)c2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"297226";"UO_0000065";"19.53";"0.44";"4.19";"13.09";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667597";"";"None";"460.91";"0";"4.77";"BDBM154971";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2cc(C(F)(F)F)ccc2Cl)c1";"IC50";"'='";"36.0";"nM";"7.44";"";"297262";"UO_0000065";"16.15";"0.34";"2.67";"11.20";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426155";"";"None";"403.40";"0";"4.13";"6f";"C[C@@H]1CC[C@@H](Oc2cc(C#N)ccn2)CN1C(=O)c1ccccc1CC(F)(F)F";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3409854";"";"None";"429.82";"0";"4.68";"24";"COc1cccc(OC)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"563.0";"nM";"6.25";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622325";"";"None";"425.92";"0";"3.07";"4";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc(Cl)c(C)n3)CC[C@H]2C)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622326";"";"None";"425.92";"0";"3.07";"5";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc(C)c(Cl)n3)CC[C@H]2C)c1";"IC50";"'='";"30.0";"nM";"7.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622328";"";"None";"479.89";"0";"3.78";"7";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3ncc(C(F)(F)F)c(Cl)n3)CC[C@H]2C)c1";"IC50";"'='";"120.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3740505";"";"None";"404.51";"0";"4.21";"(+/-)-6";"COc1cccc(CCC2CCCCN2C(=O)c2cc(C)ccc2-n2nccn2)c1";"IC50";"'='";"243.0";"nM";"6.61";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3742235";"";"None";"436.58";"1";"5.29";"17";"COc1cc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2cccc(C)c2)cc(OC)c1";"IC50";"'='";"4.3";"nM";"8.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3338849";"";"None";"441.49";"0";"3.86";"8";"COc1ccc(CNC(=O)c2nc(-c3cncc(C)c3)cnc2-c2ccccc2)nc1OC";"IC50";"'='";"31.0";"nM";"7.51";"";"";"UO_0000065";"17.01";"0.31";"3.65";"7.58";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3338858";"";"None";"442.48";"0";"3.25";"17";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2cnccn2)nc1OC";"IC50";"'='";"109.0";"nM";"6.96";"";"";"UO_0000065";"15.74";"0.29";"3.71";"6.22";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3964151";"";"None";"418.43";"0";"3.66";"BDBM240104";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3c(C)cccc3F)no2)c1";"IC50";"'='";"115.0";"nM";"6.94";"";"418945";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968605";"";"None";"452.42";"0";"3.50";"BDBM240121";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3C)no2)c(-n2nccn2)cc1F";"IC50";"'='";"27.0";"nM";"7.57";"";"418962";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900012";"";"None";"443.93";"1";"6.26";"BDBM240152";"Cc1ccc(-c2ccccc2)c(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"418994";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901710";"";"None";"449.90";"0";"3.61";"BDBM240220";"COc1c(Cl)cccc1-c1nnc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)[nH]1";"IC50";"'='";"170.0";"nM";"6.77";"";"419063";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938546";"";"None";"400.44";"0";"3.52";"BDBM240109";"Cc1cccc(-c2noc([C@@H]3CCN3C(=O)c3cc(C)ccc3-n3nccn3)n2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"418950";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981923";"";"None";"431.46";"0";"3.01";"BDBM240125";"CCOc1ncccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)n1";"IC50";"'='";"10.0";"nM";"8.00";"";"418967";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982981";"";"None";"524.38";"1";"4.82";"BDBM240143";"O=C(c1cc(C(F)(F)F)ccc1-n1nccn1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"239.0";"nM";"6.62";"";"418985";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939052";"";"None";"415.53";"1";"6.01";"BDBM202931";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccccc1-c1ccccc1";"IC50";"'='";"806.0";"nM";"6.09";"";"360457";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941481";"";"None";"408.54";"0";"4.80";"BDBM202986";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(N2CCCCC2)c1";"IC50";"'='";"157.0";"nM";"6.80";"";"360513";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948940";"";"None";"402.49";"0";"4.88";"BDBM202992";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2cccnc2)c1";"IC50";"'='";"28.0";"nM";"7.55";"";"360520";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113774";"";"None";"409.40";"0";"4.86";"BDBM50447782";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"22.0";"nM";"7.66";"";"360535";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3932504";"";"None";"368.46";"0";"4.18";"BDBM202980";"COc1cccc(OC)c1C1CCC(=O)N1Cc1nc2ccccc2s1";"IC50";"'='";"2050.0";"nM";"5.69";"";"360507";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929234";"";"None";"392.40";"0";"3.95";"BDBM203022";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)F)nc1";"IC50";"'='";"92.0";"nM";"7.04";"";"360556";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956786";"";"None";"391.41";"0";"4.56";"BDBM203023";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(OC(F)F)c1";"IC50";"'='";"78.0";"nM";"7.11";"";"360557";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113551";"";"None";"401.51";"1";"5.62";"BDBM50447819";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccccc1-c1ccccc1";"IC50";"'='";"507.0";"nM";"6.29";"";"360569";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113743";"";"None";"402.49";"1";"5.02";"BDBM50447813";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)n1";"IC50";"'='";"43.0";"nM";"7.37";"";"360390";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113549";"";"None";"401.51";"1";"5.62";"BDBM50447764";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(-c2ccccc2)cc1";"IC50";"'='";"72.0";"nM";"7.14";"";"360623";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409854";"";"None";"429.82";"0";"4.68";"BDBM203081";"COc1cccc(OC)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"563.0";"nM";"6.25";"";"360636";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409852";"";"None";"423.43";"1";"5.10";"BDBM203087";"CC[C@H]1C[C@@H](c2c(OC)cccc2OC)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"3610.0";"nM";"5.44";"";"360642";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113758";"";"None";"424.42";"0";"3.62";"BDBM50447798";"COc1cccc(OC)c1C1CN(C)CC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"410.0";"nM";"6.39";"";"360647";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931687";"";"None";"438.60";"1";"6.90";"BDBM203111";"Cc1nc(-c2cccc(CN3C(=O)C(C)CC3c3ccccc3-c3ccccc3)c2)cs1";"IC50";"'='";"455.0";"nM";"6.34";"";"360669";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898606";"";"None";"427.81";"0";"4.44";"BDBM203128";"O=C1[C@@H](Cl)C[C@@H](c2cccc3c2OCCO3)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"397.0";"nM";"6.40";"";"360686";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896893";"";"None";"407.42";"1";"5.55";"BDBM203212";"COc1cccc(F)c1[C@@H]1C[C@@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"7.0";"nM";"8.15";"";"360774";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409873";"";"None";"407.42";"1";"5.55";"BDBM203223";"COc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360785";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951644";"";"None";"425.41";"1";"5.84";"BDBM203227";"COc1cccc(F)c1C1CC(F)(F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"12.0";"nM";"7.92";"";"360789";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917482";"";"None";"425.42";"1";"5.62";"BDBM203230";"CC(C)Oc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"68.0";"nM";"7.17";"";"360792";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954128";"";"None";"387.45";"0";"4.16";"BDBM203238";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OCCF)c1";"IC50";"'='";"237.0";"nM";"6.62";"";"360800";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930793";"";"None";"387.45";"0";"4.16";"BDBM203239";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OCCF)cc1";"IC50";"'='";"1040.0";"nM";"5.98";"";"360801";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907804";"";"None";"399.34";"0";"3.57";"BDBM203247";"COc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"152.0";"nM";"6.82";"";"360809";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936096";"";"None";"413.37";"0";"3.96";"BDBM203250";"CCOc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccccc1OC(F)(F)F";"IC50";"'='";"3920.0";"nM";"5.41";"";"360812";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4577444";"";"None";"409.40";"0";"3.43";"140";"O=C(c1nccc2[nH]cnc12)N1CCC(F)(F)C(Oc2ccc3ccccc3n2)C1";"IC50";"'>'";"5868.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4415170";"Antagonist activity at human OX2R expressed in CHOK1 cells by Syto62 probe based fluorescence assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4414553";"1";"Scientific Literature";"Eur J Med Chem";"2019";"None";"";"";""
"CHEMBL3921151";"";"None";"461.50";"0";"3.25";"BDBM208523";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](Cn3cc(-c4ccc(F)cn4)cn3)OCC[C@@H]2C)c1";"IC50";"'='";"46.6";"nM";"7.33";"";"368560";"UO_0000065";"15.89";"0.29";"4.08";"8.06";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3920093";"";"None";"461.50";"0";"3.11";"BDBM208524";"Cc1ccc(-n2nccn2)c(C(=O)N2CC(C)COC2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"1.4";"nM";"8.85";"";"368561";"UO_0000065";"19.18";"0.36";"5.74";"9.73";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972040";"";"None";"460.49";"0";"2.72";"BDBM184025";"COc1ccc(C[C@@H]2COCCN2C(=O)c2c(C)cccc2-n2nccn2)cc1-c1ncon1";"IC50";"'='";"49.0";"nM";"7.31";"";"332094";"UO_0000065";"15.87";"0.29";"4.59";"6.74";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4115063";"";"None";"443.51";"0";"2.55";"BDBM184026";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2ccc(C)c(-n3nccn3)c2)c1";"IC50";"'='";"261.0";"nM";"6.58";"";"332096";"UO_0000065";"14.84";"0.27";"4.03";"7.24";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3898874";"";"None";"444.50";"0";"3.02";"BDBM184051";"Cc1cc(C)c(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncon3)c2)c1";"IC50";"'='";"420.0";"nM";"6.38";"";"332120";"UO_0000065";"14.35";"0.26";"3.36";"6.43";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3916665";"";"None";"449.90";"0";"2.59";"BDBM184069";"O=C(c1cccc(Cl)c1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"435.0";"nM";"6.36";"";"332138";"UO_0000065";"14.14";"0.27";"3.77";"6.99";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4531556";"";"None";"484.57";"0";"3.79";"8";"COc1ccc(N(CC(=O)NC(C)c2ccccc2)S(=O)(=O)c2ccc(OC)c(OC)c2)cc1";"IC50";"'='";"70.0";"nM";"7.16";"";"";"UO_0000065";"14.77";"0.29";"3.36";"7.60";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3946045";"";"None";"468.88";"0";"3.19";"BDBM184140";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cc(-c2ncon2)ccc1F";"IC50";"'='";"165.0";"nM";"6.78";"";"332209";"UO_0000065";"14.47";"0.28";"3.59";"6.84";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3909224";"";"None";"463.93";"0";"2.97";"BDBM184147";"C[C@@H]1CN(C(=O)c2ccc(Cl)cc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"39.0";"nM";"7.41";"";"332216";"UO_0000065";"15.97";"0.31";"4.44";"8.15";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917431";"";"None";"416.44";"0";"3.22";"BDBM240100";"COc1ccccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)n1";"IC50";"'='";"38.0";"nM";"7.42";"";"418941";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929858";"";"None";"444.50";"0";"4.00";"BDBM240102";"CCCOc1ccccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)n1";"IC50";"'='";"115.0";"nM";"6.94";"";"418943";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL1590375";"";"None";"310.37";"0";"3.48";"SID85146428";"CC(C)(O)c1cc2ccc(C#Cc3ccsc3)cc2c(=O)o1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1337585";"";"None";"522.95";"2";"5.56";"SID49646422";"COc1ccc(CN2CC[C@H]3C=CC[C@@H](C(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)[C@H]3C2=O)cc1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1520346";"";"None";"347.42";"0";"4.19";"SID7978390";"CCN(CC)c1ccc2cc(-c3nc4ccccc4n3C)c(=O)oc2c1";"IC50";"";"32000.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1304258";"";"None";"301.37";"0";"3.99";"SID24806140";"COc1cc(OC)c(-c2nc3ccccc3s2)cc1OC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1363571";"";"None";"452.92";"0";"3.53";"SID24806388";"NS(=O)(=O)c1ccc(CNC(=O)c2cc(-c3ccccn3)nc3ccc(Cl)cc23)cc1";"IC50";"";"30100.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1562279";"";"None";"408.45";"0";"2.76";"SID49716630";"COc1cccc(/C=C2/Oc3ccccc3N(CC(=O)NCC3CCCO3)C2=O)c1";"IC50";"";"3820.0";"nM";"";"";"active";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1722330";"";"None";"356.42";"0";"2.64";"SID47195117";"CCOc1ccccc1C(=O)NCCNC(=O)c1ccccc1OCC";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1576843";"";"None";"415.46";"0";"2.47";"SID24823196";"C=CCNC(=O)CCC(=O)NNc1nc2ccccc2c2nc(-c3ccccc3)nn12";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL3338855";"";"None";"458.49";"0";"4.60";"14";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2ccccc2F)nc1OC";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"16.58";"0.31";"3.00";"8.82";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3667594";"";"None";"384.50";"0";"3.74";"BDBM154968";"C=Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cc(C)cc(C)c2)cc1";"IC50";"'='";"92.0";"nM";"7.04";"";"297259";"UO_0000065";"18.30";"0.36";"3.30";"10.58";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946806";"";"None";"433.53";"1";"5.52";"BDBM203270";"COc1ccc2ncoc2c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"102.0";"nM";"6.99";"";"360834";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3398475";"";"None";"391.41";"0";"2.40";"4a";"Cc1ccc(-n2nccn2)c(C(=O)NCCn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"198.0";"nM";"6.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3902291";"";"None";"477.50";"0";"2.39";"BDBM184096";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)cc1C";"IC50";"'='";"336.0";"nM";"6.47";"";"332165";"UO_0000065";"13.56";"0.25";"4.08";"6.46";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3944467";"";"None";"445.48";"0";"3.32";"BDBM240126";"CCOc1ncccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)c(C)cc2-n2nccn2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"418968";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983377";"";"None";"468.88";"0";"4.01";"BDBM240191";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(F)c3C)n2)c(-n2nccn2)cc1Cl";"IC50";"'='";"3.0";"nM";"8.52";"";"419033";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL469146";"";"None";"413.49";"0";"2.87";"36";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCN(c3ncc4ccccc4n3)CC2)c1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"18.30";"0.33";"4.70";"9.46";"1";"CHEMBL3771845";"Antagonist activity at OX2R (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3769367";"1";"Scientific Literature";"J Med Chem";"2016";"None";"";"";""
"CHEMBL1565236";"";"None";"363.51";"0";"4.94";"SID4250158";"CSc1nc2ccc3nc(NC(=O)c4cccs4)sc3c2s1";"IC50";"'>'";"88800.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL1328144";"";"None";"403.46";"0";"2.58";"SID3712546";"COC(=O)c1ccccc1NC(=O)CSc1nc(O)cc(=O)n1C1CCCC1";"IC50";"";"56200.0";"nM";"";"";"inactive";"UO_0000065";"";"";"";"";"0";"CHEMBL1963974";"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Fluorescence-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ";"F";"BAO_0000219";"cell-based format";"None";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL1201862";"7";"PubChem BioAssays";"";"";"None";"";"";""
"CHEMBL4070275";"";"None";"562.69";"1";"4.00";"14; YNT-817";"COc1ccc2c(c1)[C@]13CCN(S(=O)(=O)c4ccccc4)[C@H](C2)[C@]1(O)CC[C@@H](N(C)C(=O)/C=C/c1ccoc1)C3";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4058250";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 15 mins followed by orexin A addition by Fura 2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052789";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4548914";"";"None";"402.46";"1";"5.57";"9";"Cc1cccc2c1[nH]c1nc(N/N=C\c3c4ccccc4cc4ccccc34)nnc12";"IC50";"'='";"300.0";"nM";"6.52";"";"";"UO_0000065";"16.21";"0.29";"0.95";"8.27";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3985942";"";"None";"447.47";"0";"2.86";"BDBM208487";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"1.2";"nM";"8.92";"";"368524";"UO_0000065";"19.94";"0.37";"6.06";"9.81";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4445194";"";"None";"424.51";"0";"4.92";"6";"CC(/C=C/c1ccccc1)=N/Nc1nc(Nc2ccccc2)nc(-n2nc(C)cc2C)n1";"IC50";"'='";"11800.0";"nM";"4.93";"";"";"UO_0000065";"11.61";"0.21";"0.01";"5.30";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3667572";"";"None";"410.50";"0";"3.64";"BDBM154945";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc3ccccc23)cc1";"IC50";"'='";"171.0";"nM";"6.77";"";"297236";"UO_0000065";"16.48";"0.32";"3.13";"8.94";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667563";"";"None";"415.33";"0";"3.30";"BDBM154936";"O=C(Nc1ccccc1)[C@@H]1CCCN1S(=O)(=O)c1ccc(Br)s1";"IC50";"'='";"164.0";"nM";"6.79";"";"297227";"UO_0000065";"16.34";"0.40";"3.49";"10.21";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667554";"";"None";"406.53";"0";"3.21";"BDBM154927";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(SC)c2)cc1";"IC50";"'='";"3.0";"nM";"8.52";"";"297218";"UO_0000065";"20.96";"0.43";"5.31";"11.26";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3932886";"";"None";"447.47";"0";"2.86";"BDBM208488";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"3.2";"nM";"8.49";"";"368525";"UO_0000065";"18.98";"0.35";"5.63";"9.34";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3338859";"";"None";"442.48";"0";"3.25";"18";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2-c2ccnnc2)nc1OC";"IC50";"'='";"1450.0";"nM";"5.84";"";"";"UO_0000065";"13.20";"0.24";"2.59";"5.21";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3667558";"";"None";"436.56";"0";"3.22";"BDBM154931";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(SC)c2)cc1OC";"IC50";"'='";"3.0";"nM";"8.52";"";"297222";"UO_0000065";"19.52";"0.40";"5.30";"10.03";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3409852";"";"None";"423.43";"1";"5.10";"22";"CC[C@H]1C[C@@H](c2c(OC)cccc2OC)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"3610.0";"nM";"5.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409863";"";"None";"410.39";"0";"3.40";"33";"COc1cccc(OC)c1[C@@H]1C[C@H](N)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"9490.0";"nM";"5.02";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3972713";"";"None";"439.52";"1";"5.37";"BDBM221399";"Cc1cccc(-c2ocnc2C(=O)Nc2c(C)nn(CCn3ccc4ccccc43)c2C)c1";"IC50";"'='";"183.0";"nM";"6.74";"";"387530";"UO_0000065";"15.33";"0.28";"1.37";"8.65";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928156";"";"None";"470.53";"0";"4.77";"BDBM221402";"COc1cc2c(ccn2CCn2nc(C)c(NC(=O)c3ncoc3-c3cccc(C)c3)c2C)cn1";"IC50";"'='";"207.0";"nM";"6.68";"";"387533";"UO_0000065";"14.21";"0.26";"1.91";"6.68";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890034";"";"None";"504.55";"2";"3.31";"BDBM221318";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(N4CCCC4)c3)cn2)n1";"IC50";"'='";"201.0";"nM";"6.70";"";"387451";"UO_0000065";"13.27";"0.25";"3.39";"5.06";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907876";"";"None";"449.47";"0";"3.02";"BDBM221321";"COc1cnc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc1OC";"IC50";"'='";"870.0";"nM";"6.06";"";"387454";"UO_0000065";"13.48";"0.25";"3.04";"4.69";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985205";"";"None";"463.50";"0";"3.41";"BDBM221429";"COc1cc(OC)nc(N[C@@H](C)Cn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"270.0";"nM";"6.57";"";"387560";"UO_0000065";"14.17";"0.26";"3.16";"5.08";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954630";"";"None";"449.47";"0";"3.02";"BDBM221432";"COc1cc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)nc(OC)n1";"IC50";"'='";"30.0";"nM";"7.52";"";"387563";"UO_0000065";"16.74";"0.31";"4.50";"5.82";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910923";"";"None";"406.42";"0";"3.75";"BDBM221306";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3ccc(F)cn3)c2)c1";"IC50";"'='";"471.0";"nM";"6.33";"";"387439";"UO_0000065";"15.57";"0.29";"2.58";"6.46";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912271";"";"None";"427.51";"0";"4.55";"BDBM221314";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCCN3CCc4ccccc43)c2)c1";"IC50";"'='";"502.0";"nM";"6.30";"";"387447";"UO_0000065";"14.73";"0.27";"1.75";"8.27";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983991";"";"None";"437.42";"1";"1.50";"BDBM221324";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3ccncn3)cn2)n1";"IC50";"'='";"9020.0";"nM";"5.04";"";"387457";"UO_0000065";"11.53";"0.22";"3.54";"3.25";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962597";"";"None";"443.53";"0";"4.99";"BDBM221343";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncsc4-c4ccccc4)cn3)c2c1";"IC50";"'='";"65.0";"nM";"7.19";"";"387476";"UO_0000065";"16.20";"0.31";"2.20";"8.47";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946638";"";"None";"429.46";"0";"4.96";"BDBM221366";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCc3c[nH]c4ccc(F)cc34)c2)c1";"IC50";"'='";"98.0";"nM";"7.01";"";"387496";"UO_0000065";"16.32";"0.30";"2.05";"7.90";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952452";"";"None";"429.46";"0";"4.89";"BDBM221377";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4ccc(F)cc43)c2)c1";"IC50";"'='";"67.0";"nM";"7.17";"";"387508";"UO_0000065";"16.70";"0.31";"2.28";"9.21";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949553";"";"None";"472.51";"0";"4.17";"BDBM221395";"COc1cc(OC)c2ccn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2n1";"IC50";"'='";"65.0";"nM";"7.19";"";"387526";"UO_0000065";"15.21";"0.28";"3.02";"6.58";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667550";"";"None";"499.33";"0";"4.20";"BDBM154923";"O=C(Nc1cccc(OC(F)(F)F)c1)[C@@H]1CCCN1S(=O)(=O)c1ccc(Br)s1";"IC50";"'='";"104.0";"nM";"6.98";"";"297214";"UO_0000065";"13.98";"0.34";"2.78";"9.22";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3948019";"";"None";"434.43";"0";"3.36";"BDBM240112";"COc1c(F)cccc1-c1noc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)n1";"IC50";"'='";"17.0";"nM";"7.77";"";"418953";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902440";"";"None";"470.41";"0";"4.11";"BDBM240174";"Cc1ccc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-n2nccn2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"419016";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978561";"";"None";"481.90";"0";"3.36";"BDBM240193";"CCOc1ncccc1-c1nc([C@@H]2CCN2C(=O)c2cc(OC)c(Cl)cc2-n2nccn2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"419035";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894407";"";"None";"434.89";"0";"4.17";"BDBM240196";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"419038";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904615";"";"None";"475.94";"1";"5.06";"BDBM240210";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c(-c2ncccn2)cc1C";"IC50";"'='";"5.0";"nM";"8.30";"";"419053";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113747";"";"None";"392.46";"0";"3.54";"BDBM50447809";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"360423";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113750";"";"None";"392.46";"0";"3.54";"BDBM50447806";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(-n2cccn2)c1";"IC50";"'='";"80.0";"nM";"7.10";"";"360431";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947845";"";"None";"416.52";"1";"5.41";"BDBM202937";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccccn2)c1";"IC50";"'='";"7.0";"nM";"8.15";"";"360463";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980334";"";"None";"440.87";"0";"5.00";"BDBM202942";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cnc(OC(F)F)c(Cl)c1";"IC50";"'='";"85.0";"nM";"7.07";"";"360468";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958111";"";"None";"410.54";"1";"5.27";"BDBM202948";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2sc(C)nc2c1";"IC50";"'='";"29.0";"nM";"7.54";"";"360474";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986127";"";"None";"406.49";"0";"3.93";"BDBM202954";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"360480";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917655";"";"None";"453.46";"0";"4.87";"BDBM203049";"COCCOc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"664.0";"nM";"6.18";"";"360590";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965518";"";"None";"345.44";"1";"5.10";"BDBM203064";"COc1ccccc1C1CCCC(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"369.0";"nM";"6.43";"";"360615";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113552";"";"None";"375.47";"1";"5.11";"BDBM50447818";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ccccc2c1";"IC50";"'='";"47.0";"nM";"7.33";"";"360617";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935942";"";"None";"378.47";"0";"4.45";"BDBM203067";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(ccn2C)c1";"IC50";"'='";"275.0";"nM";"6.56";"";"360620";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925639";"";"None";"399.80";"0";"4.67";"BDBM203119";"COc1ccccc1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"901.0";"nM";"6.04";"";"360677";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3235249";"";"None";"409.47";"0";"3.43";"1";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](COc3ccc(F)cn3)CC[C@H]2C)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235257";"";"None";"401.47";"0";"2.97";"5e";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3cccnc3O)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3235262";"";"None";"415.50";"0";"2.76";"5j";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C#Cc3ccc(CO)nc3)CC[C@H]2C)c1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL3240642";"Antagonist activity at human OX2 receptor assessed as Ca2+ flux by FLIPR assay";"F";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3232758";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"None";"";"";""
"CHEMBL3667579";"";"None";"404.49";"0";"2.89";"BDBM154953";"CCOc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(OC)cc2)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"297244";"UO_0000065";"18.34";"0.36";"4.53";"8.74";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943446";"";"None";"410.50";"0";"3.87";"BDBM203092";"COc1ncnc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"256.0";"nM";"6.59";"";"360650";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916581";"";"None";"423.54";"0";"4.87";"BDBM203098";"COc1cncc(OC)c1C1CCCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"182.0";"nM";"6.74";"";"360656";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954632";"";"None";"410.50";"0";"4.82";"BDBM203103";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(Oc2nccs2)cc1";"IC50";"'='";"213.0";"nM";"6.67";"";"360661";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901212";"";"None";"435.78";"0";"4.95";"BDBM203279";"COc1c(F)ccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"219.0";"nM";"6.66";"";"360699";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943140";"";"None";"410.51";"0";"3.79";"BDBM202877";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(N2CCOCC2)c1";"IC50";"'='";"661.0";"nM";"6.18";"";"360396";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913461";"";"None";"409.51";"0";"4.48";"BDBM202917";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1csc(-c2ccccc2)n1";"IC50";"'='";"246.0";"nM";"6.61";"";"360443";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931438";"";"None";"359.85";"0";"4.61";"BDBM203008";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(Cl)cc1";"IC50";"'='";"154.0";"nM";"6.81";"";"360537";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113544";"";"None";"423.43";"1";"5.42";"BDBM50447769";"COc1cccc(OC)c1C1CCCC(=O)N1C(C)c1ccc(OC(F)(F)F)cc1";"IC50";"'='";"6.0";"nM";"8.22";"";"360563";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969984";"";"None";"433.45";"0";"2.07";"BDBM183989";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"822.0";"nM";"6.08";"";"332053";"UO_0000065";"14.04";"0.26";"4.02";"6.69";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3890222";"";"None";"463.47";"0";"2.08";"BDBM183996";"COc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1F";"IC50";"'='";"1200.0";"nM";"5.92";"";"332060";"UO_0000065";"12.77";"0.24";"3.84";"5.91";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3903196";"";"None";"449.41";"0";"3.00";"BDBM185258";"CN(c1cnc(C(F)(F)F)cn1)[C@H]1CCC[C@@H]1NC(=O)c1cc(F)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334175";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3937876";"";"None";"447.45";"0";"3.78";"BDBM208505";"O=C(c1cc(F)ccc1-c1ncccn1)N1CCOC1Cn1ccc(-c2ccc(F)cc2)n1";"IC50";"'='";"234.1";"nM";"6.63";"";"368542";"UO_0000065";"14.82";"0.27";"2.85";"9.07";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3950355";"";"None";"440.51";"0";"3.12";"BDBM184010";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3cccnn3)c2)c1";"IC50";"'='";"2380.0";"nM";"5.62";"";"332074";"UO_0000065";"12.77";"0.23";"2.50";"6.54";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3913644";"";"None";"456.51";"0";"2.82";"BDBM184013";"COc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncccn3)c2)c1";"IC50";"'='";"942.0";"nM";"6.03";"";"332077";"UO_0000065";"13.20";"0.24";"3.21";"6.33";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3927349";"";"None";"433.45";"0";"2.07";"BDBM184017";"O=C(c1cccc(F)c1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"1824.0";"nM";"5.74";"";"332081";"UO_0000065";"13.24";"0.24";"3.67";"6.31";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3920867";"";"None";"429.91";"1";"5.95";"BDBM240168";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2ccccc2-c2ccccc2)n1";"IC50";"'='";"20.0";"nM";"7.70";"";"419010";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978378";"";"None";"469.33";"0";"4.83";"BDBM240177";"Cc1cc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)cc1Cl";"IC50";"'='";"10.0";"nM";"8.00";"";"419019";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5181823";"";"None";"647.78";"2";"5.82";"42b";"CN(C)c1ccccc1C(=O)Nc1cccc([C@]2(C)O[C@H]3CO[C@@H]4N3[C@H]2O[C@@]4(C)c2cccc(NC(=O)c3ccccc3N(C)C)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5173055";"";"None";"647.78";"2";"5.82";"47b";"CN(C)c1ccc(C(=O)Nc2cccc([C@@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@]5(C)c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL4062167";"";"None";"420.47";"0";"2.55";"27";"COC(=O)c1cccnc1N[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2nccn2)C1";"IC50";"'='";"38.0";"nM";"7.42";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4059661";"";"None";"406.49";"0";"3.61";"8";"COc1ccc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(C2CC2)n1";"IC50";"'='";"32.0";"nM";"7.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4098714";"";"None";"412.49";"0";"4.40";"20";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccncc2-c2ccccc2)C1";"IC50";"'='";"69.0";"nM";"7.16";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4096217";"";"None";"462.94";"0";"4.11";"7";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCC3CN(c4nc5cc(Cl)ccc5o4)CC32)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3409856";"";"None";"413.37";"0";"4.41";"26";"COc1cccc(OC)c1[C@@H]1C[C@@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"242.0";"nM";"6.62";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409861";"";"None";"439.43";"0";"4.48";"31";"CCO[C@H]1C[C@@H](c2c(OC)cccc2OC)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409868";"";"None";"438.45";"0";"4.01";"38";"COc1cccc(OC)c1[C@@H]1C[C@@H](N(C)C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3426145";"";"None";"409.52";"0";"3.46";"5n";"CSc1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"6.7";"nM";"8.17";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL4641191";"";"None";"451.44";"0";"2.69";"(-)-11";"O=C(c1cc(F)ccc1-n1nccn1)N1CCCO[C@H]1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"1.96";"nM";"8.71";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3985696";"";"None";"409.51";"0";"4.48";"BDBM202908";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"360432";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980919";"";"None";"397.50";"0";"4.27";"BDBM202911";"COc1ccnc(OC)c1C1CCCC(=O)N1Cc1ccc2nc(C)sc2c1";"IC50";"'='";"1530.0";"nM";"5.82";"";"360437";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978443";"";"None";"415.53";"1";"6.01";"BDBM202925";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"12.0";"nM";"7.92";"";"360451";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3972122";"";"None";"415.53";"1";"6.01";"BDBM202930";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc(-c2ccccc2)cc1";"IC50";"'='";"188.0";"nM";"6.73";"";"360456";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910207";"";"None";"429.52";"1";"6.25";"BDBM202943";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"360469";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938814";"";"None";"434.51";"1";"5.55";"BDBM202959";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-c2ccccn2)c1F";"IC50";"'='";"60.0";"nM";"7.22";"";"360485";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3894979";"";"None";"403.48";"1";"5.36";"BDBM202970";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"360496";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903988";"";"None";"377.44";"0";"3.75";"BDBM202979";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"839.0";"nM";"6.08";"";"360505";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902652";"";"None";"427.85";"1";"5.59";"BDBM203193";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)F)c(Cl)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"360754";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409876";"";"None";"405.43";"0";"4.57";"BDBM203229";"COc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"360791";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3977119";"";"None";"408.52";"0";"4.94";"BDBM202998";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2cncs2)c1";"IC50";"'='";"114.0";"nM";"6.94";"";"360526";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3900701";"";"None";"393.40";"0";"4.98";"BDBM203013";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(C(F)(F)F)cc1";"IC50";"'='";"171.0";"nM";"6.77";"";"360542";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969853";"";"None";"440.87";"1";"5.17";"BDBM203028";"COc1cccc(OC)c1C1CCCC(=O)N1C(C)c1cnc(OC(F)F)c(Cl)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"360564";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113537";"";"None";"397.37";"0";"4.99";"BDBM50447777";"COc1cccc(F)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"156.0";"nM";"6.81";"";"360599";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409858";"";"None";"411.38";"0";"3.44";"BDBM203078";"COc1cccc(OC)c1[C@@H]1C[C@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"670.0";"nM";"6.17";"";"360632";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948541";"";"None";"399.34";"0";"3.57";"BDBM203114";"COc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"338.0";"nM";"6.47";"";"360672";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3987155";"";"None";"397.37";"0";"4.80";"BDBM203121";"CCOc1ccccc1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"98.0";"nM";"7.01";"";"360679";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916592";"";"None";"431.41";"0";"4.58";"BDBM203133";"COc1ccc2ccccc2c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"826.0";"nM";"6.08";"";"360691";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913072";"";"None";"431.81";"1";"5.20";"BDBM203162";"CCOc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"15.0";"nM";"7.82";"";"360722";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3975066";"";"None";"417.48";"1";"6.23";"BDBM203200";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360761";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939066";"";"None";"420.48";"1";"5.01";"BDBM202997";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ccccn2)c1F";"IC50";"'='";"230.0";"nM";"6.64";"";"360525";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904115";"";"None";"390.48";"0";"4.75";"BDBM203018";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(-n2cccc2)cc1";"IC50";"'='";"190.0";"nM";"6.72";"";"360548";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981188";"";"None";"381.50";"1";"5.17";"BDBM203025";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc2ccccc2s1";"IC50";"'='";"252.0";"nM";"6.60";"";"360560";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941158";"";"None";"464.27";"1";"5.34";"BDBM203139";"COc1ccc(Cl)c(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"444.0";"nM";"6.35";"";"360697";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3906541";"";"None";"455.52";"0";"3.42";"BDBM183966";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ccccn1";"IC50";"'='";"3340.0";"nM";"5.48";"";"332030";"UO_0000065";"12.02";"0.22";"2.06";"6.65";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3920320";"";"None";"455.52";"0";"3.42";"BDBM183967";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1cccnc1";"IC50";"'='";"1880.0";"nM";"5.73";"";"332031";"UO_0000065";"12.57";"0.23";"2.31";"6.95";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3912376";"";"None";"461.55";"0";"3.48";"BDBM183971";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1nccs1";"IC50";"'='";"335.0";"nM";"6.47";"";"332035";"UO_0000065";"14.03";"0.27";"2.99";"7.86";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3981412";"";"None";"447.47";"0";"2.38";"BDBM183992";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1F";"IC50";"'='";"333.0";"nM";"6.48";"";"332056";"UO_0000065";"14.48";"0.27";"4.10";"7.12";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3949919";"";"None";"445.48";"0";"1.94";"BDBM183995";"COc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"489.0";"nM";"6.31";"";"332059";"UO_0000065";"14.17";"0.26";"4.37";"6.30";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3904243";"";"None";"430.43";"0";"3.75";"BDBM185190";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2ccc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334107";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3912383";"";"None";"435.39";"0";"2.98";"BDBM185216";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(F)cccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334133";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3930194";"";"None";"417.40";"0";"2.84";"BDBM185219";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-n1ccnn1";"IC50";"'>'";"10000.0";"nM";"";"";"334136";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3912268";"";"None";"428.42";"0";"3.72";"BDBM185222";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334139";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3911399";"";"None";"431.42";"0";"3.15";"BDBM185226";"Cc1ccc(-n2ccnn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334143";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3963082";"";"None";"446.43";"0";"3.45";"BDBM185234";"COc1cccc(-n2cccn2)c1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334151";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3916349";"";"None";"478.47";"1";"5.93";"BDBM240228";"Cc1ccc(-c2ccccc2)c(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3OC(F)(F)F)[nH]2)c1";"IC50";"'='";"39.0";"nM";"7.41";"";"419071";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4544095";"";"None";"415.32";"0";"4.99";"12";"Cc1ccc(C(O)(C(=O)NNc2cc(Cl)ccc2Cl)c2ccc(C)cc2)cc1";"IC50";"'='";"800.0";"nM";"6.10";"";"";"UO_0000065";"14.68";"0.30";"1.11";"9.94";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3409866";"";"None";"424.42";"0";"3.66";"36";"CN[C@@H]1C[C@@H](c2c(OC)cccc2OC)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'='";"5810.0";"nM";"5.24";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409876";"";"None";"405.43";"0";"4.57";"46-(trans)";"COc1cccc(F)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"3.0";"nM";"8.52";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3409877";"";"None";"405.43";"0";"4.57";"47-(trans)";"COc1cccc(F)c1[C@H]1C[C@H](O)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"315.0";"nM";"6.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3338861";"";"None";"449.51";"0";"2.63";"20";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)ncc2N2CCOCC2)nc1OC";"IC50";"'='";"3502.0";"nM";"5.46";"";"";"UO_0000065";"12.14";"0.23";"2.83";"5.53";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3968960";"";"None";"429.45";"0";"4.13";"BDBM185210";"Cc1ccc(-n2nccn2)c(C(=O)NC2CCCC2Cc2ccc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334127";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3667584";"";"None";"392.45";"0";"2.93";"BDBM154958";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(F)c(C)c2)cc1";"IC50";"'='";"28.0";"nM";"7.55";"";"297249";"UO_0000065";"19.25";"0.38";"4.62";"9.98";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3966611";"";"None";"427.43";"0";"4.32";"BDBM185197";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334114";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3926014";"";"None";"417.40";"0";"2.84";"BDBM185202";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334119";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3919723";"";"None";"433.45";"0";"2.47";"BDBM208486";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"18.6";"nM";"7.73";"";"368523";"UO_0000065";"17.83";"0.33";"5.26";"8.50";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4475736";"";"None";"529.82";"2";"5.47";"5";"COC(=O)CN(C(C)=O)C(c1ccccc1)c1cc(Br)ccc1NC(=O)c1ccccc1Cl";"IC50";"'='";"1700.0";"nM";"5.77";"";"";"UO_0000065";"10.89";"0.24";"0.30";"7.62";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3923638";"";"None";"418.43";"0";"3.66";"BDBM240118";"Cc1ccc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3C)no2)c(-n2nccn2)c1";"IC50";"'='";"23.0";"nM";"7.64";"";"418959";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909762";"";"None";"465.43";"1";"5.89";"BDBM240149";"O=C(c1ccccc1-c1ccccc1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"10.0";"nM";"8.00";"";"418991";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986606";"";"None";"455.31";"0";"4.52";"BDBM240171";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2ccc(Cl)cc2-n2nccn2)n1";"IC50";"'='";"11.0";"nM";"7.96";"";"419013";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667566";"";"None";"394.88";"0";"3.14";"BDBM154939";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(Cl)c2)cc1";"IC50";"'='";"31.0";"nM";"7.51";"";"297230";"UO_0000065";"19.01";"0.39";"4.37";"9.92";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667565";"";"None";"428.43";"0";"3.51";"BDBM154938";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(C(F)(F)F)c2)cc1";"IC50";"'='";"9.0";"nM";"8.05";"";"297229";"UO_0000065";"18.78";"0.38";"4.54";"10.63";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667605";"";"None";"471.80";"0";"4.51";"BDBM154979";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(Br)cc2Cl)c1";"IC50";"'='";"106.0";"nM";"6.97";"";"297270";"UO_0000065";"14.78";"0.35";"2.46";"10.49";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931170";"";"None";"457.49";"0";"4.94";"BDBM221441";"Cc1cccc(-c2ocnc2C(=O)Nc2c(C)nn(CCOc3nc4ccccc4o3)c2C)c1";"IC50";"'='";"966.0";"nM";"6.01";"";"387572";"UO_0000065";"13.15";"0.24";"1.08";"5.56";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898665";"";"None";"418.41";"0";"3.51";"BDBM221349";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccon4)cn3)c2c1";"IC50";"'='";"53.0";"nM";"7.28";"";"387579";"UO_0000065";"17.39";"0.32";"3.77";"5.87";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4096073";"";"None";"405.44";"0";"2.79";"7a";"Cc1ccc(-n2nccn2)c(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"58.4";"nM";"7.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4068766";"";"None";"405.44";"0";"2.79";"7b";"Cc1ccc(-n2nccn2)c(C(=O)N[C@@H](C)Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"840.0";"nM";"6.08";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4088212";"";"None";"446.49";"0";"3.19";"20";"CCN(C(=O)c1cc(C)ccc1-c1ncccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cn2)n1";"IC50";"'='";"129.0";"nM";"6.89";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3597959";"";"None";"425.56";"0";"3.67";"55";"Cc1sc([C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)nc1C(C)(C)O";"IC50";"'='";"14.0";"nM";"7.85";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3598905";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of human orexin-A-induced Ca2+ flux preincubated for 5 mins followed by orexin-A induction measured 1 sec interval for 5 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3597956";"";"None";"435.53";"0";"3.77";"52";"C[C@@H]1CC[C@@H](c2nc(C(C)(C)O)c(C3CC3)o2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"19.0";"nM";"7.72";"";"";"UO_0000065";"17.73";"0.33";"3.95";"7.94";"0";"CHEMBL3598895";"Antagonist activity at orexin-2 receptor (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3596142";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"None";"";"";""
"CHEMBL3338853";"";"None";"481.51";"0";"4.60";"12";"COc1ccc(CNC(=O)c2cc(-c3cncc(C)c3)nc3onc(-c4ccccc4)c23)nc1OC";"IC50";"'='";"420.0";"nM";"6.38";"";"";"UO_0000065";"13.24";"0.24";"1.78";"5.68";"0";"CHEMBL3387581";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of Ala-6,12-orexinA-induced effect after 5 mins by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3352684";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3741099";"";"None";"420.53";"1";"5.00";"16";"Cc1cccc(-c2sc(C)nc2C(=O)N2CCC[C@H]2Cc2ccc3c(c2)OCO3)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3741194";"";"None";"466.56";"0";"4.71";"27";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nc(C)sc2-c2ccc3c(c2)OCO3)cc1OC";"IC50";"'='";"6.6";"nM";"8.18";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3938144";"";"None";"431.49";"1";"5.47";"BDBM203273";"COc1ccc2c(c1C1CCCC(=O)N1Cc1cccc(Oc3ccccc3)c1)OCO2";"IC50";"'='";"14.0";"nM";"7.85";"";"360837";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4068314";"";"None";"403.40";"0";"4.35";"14";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2C(F)(F)F)C1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4090936";"";"None";"476.97";"0";"4.36";"3";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@]3(C)CN(c4nc5cc(Cl)ccc5o4)C[C@@]3(C)C2)c1";"IC50";"'='";"5988.0";"nM";"5.22";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4097880";"";"None";"482.47";"0";"3.94";"14m";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(C(F)(F)F)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"508.0";"nM";"6.29";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3409873";"";"None";"407.42";"1";"5.55";"43";"COc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4799832";"";"None";"475.56";"0";"2.66";"21";"CNS(=O)(=O)N[C@H]1C[C@@H](C)N(C(=O)OC)[C@H]1CO[C@H]1CC[C@@H](c2cc(F)ccc2F)CC1";"IC50";"'='";"0.47";"nM";"9.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL4102998";"";"None";"462.94";"0";"3.97";"2";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CN(c4nc5cc(Cl)ccc5o4)CC3(C)C2)c1";"IC50";"'='";"1093.0";"nM";"5.96";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4069952";"";"None";"448.91";"0";"3.72";"4";"Cc1ccc(-n2nccn2)c(C(=O)N2CC3CCN(c4nc5cc(Cl)ccc5o4)C3C2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3667551";"";"None";"406.53";"0";"3.21";"BDBM154924";"COc1cccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(SC)c2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"297215";"UO_0000065";"19.92";"0.41";"4.89";"10.69";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4079177";"";"None";"412.52";"0";"3.46";"12";"COc1ccc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(SC)n1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4060310";"";"None";"403.45";"0";"2.31";"18";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2-n2ncnn2)C1";"IC50";"'='";"7.7";"nM";"8.11";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3622322";"";"None";"391.48";"0";"2.42";"17";"Cc1ncc(C)c(N2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)CC2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3622323";"";"None";"432.32";"0";"3.11";"18";"C[C@@H]1CCN(c2nc(Cl)ncc2Cl)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"3200.0";"nM";"5.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3625146";"Antagonist activity at human orexin 2 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced intracellular calcium level after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3621132";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3973097";"";"None";"409.40";"0";"3.43";"47";"O=C(c1nccc2[nH]cnc12)N1CCC(F)(F)[C@@H](Oc2ccc3ccccc3n2)C1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3868342";"Antagonist activity at human OX2 receptor expressed on CHO cell membrane assessed as inhibition of Ala-6,12 orexin-A-induced calcium increase preincubated for 5 mins prior to Ala-6,12 orexin-A addition measured at 1 sec intervals for 1 min by Fluo-4AM dye-based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3867477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3394848";"";"None";"435.43";"0";"3.74";"10";"O=C(c1ccccc1-n1nccn1)N1CCC(F)(F)[C@@H](Oc2ccc3ccccc3n2)C1";"IC50";"'='";"4184.0";"nM";"5.38";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3868342";"Antagonist activity at human OX2 receptor expressed on CHO cell membrane assessed as inhibition of Ala-6,12 orexin-A-induced calcium increase preincubated for 5 mins prior to Ala-6,12 orexin-A addition measured at 1 sec intervals for 1 min by Fluo-4AM dye-based FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3867477";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3739682";"";"None";"392.46";"0";"3.13";"8";"COc1ccc(C[C@@H]2CCCN2C(=O)c2ccccc2-n2nccn2)cc1OC";"IC50";"'='";"3.5";"nM";"8.46";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3739859";"";"None";"417.51";"0";"4.32";"12";"COc1ccc(C[C@@H]2CCCN2C(=O)c2nccnc2-c2cccc(C)c2)cc1OC";"IC50";"'='";"4.0";"nM";"8.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3745065";"Inhibition of human orexin-2 receptor expressed in CHO cells assessed as calcium release preincubated for 120 mins followed by addition of orexin-A by fluo-4 AM based-FLIPR analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3739395";"1";"Scientific Literature";"Medchemcomm";"2015";"CHEMBL3308072";"";"";""
"CHEMBL4471376";"";"None";"665.79";"3";"5.07";"11";"CCOC(=O)c1c(NC(=O)C(C)Sc2nnc(CNC(=O)c3cc(OC)cc(OC)c3)n2-c2ccccc2OC)sc2c1CCC2";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"9.24";"0.18";"1.08";"4.31";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3903190";"";"None";"422.55";"1";"5.39";"BDBM202900";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"6.0";"nM";"8.22";"";"360422";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113538";"";"None";"423.43";"1";"5.25";"BDBM50447776";"CCOc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"360591";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901353";"";"None";"365.43";"0";"3.61";"BDBM203068";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cn2ccccc2n1";"IC50";"'='";"1390.0";"nM";"5.86";"";"360621";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968171";"";"None";"402.49";"1";"5.02";"BDBM202871";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2cccnc2)c1";"IC50";"'='";"55.0";"nM";"7.26";"";"360386";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981203";"";"None";"434.24";"1";"5.33";"BDBM203127";"COc1cccc(Cl)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"108.0";"nM";"6.97";"";"360685";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3904896";"";"None";"447.47";"0";"2.86";"BDBM208489";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](C)O[C@H]2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"11.5";"nM";"7.94";"";"368526";"UO_0000065";"17.74";"0.33";"5.08";"8.73";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4114541";"";"None";"447.47";"0";"2.86";"BDBM208491";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](C)CO[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"54.9";"nM";"7.26";"";"368528";"UO_0000065";"16.23";"0.30";"4.40";"7.98";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910238";"";"None";"444.47";"0";"3.35";"BDBM208498";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"9.5";"nM";"8.02";"";"368535";"UO_0000065";"18.05";"0.33";"4.67";"9.32";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4060971";"";"None";"445.50";"0";"3.80";"21";"CCN(C(=O)c1cc(C)ccc1-c1ncccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"36.0";"nM";"7.44";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4089194";"";"None";"433.49";"0";"3.52";"3";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@H](C)Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"250.0";"nM";"6.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4087602";"";"None";"546.65";"1";"3.36";"5; YNT-1745";"CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4cccc5c4[C@@]2(CCN3S(=O)(=O)c2ccccc2)[C@H]1O5";"IC50";"'>='";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4058250";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 15 mins followed by orexin A addition by Fura 2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052789";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4076262";"";"None";"576.67";"1";"3.37";"8; YNT-1369";"COc1ccc2c3c1O[C@H]1[C@@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@@]4(O)[C@@H](C2)N(S(=O)(=O)c2ccccc2)CC[C@]314";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4058250";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 15 mins followed by orexin A addition by Fura 2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4052789";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3931654";"";"None";"454.53";"0";"3.50";"BDBM184072";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-c3ncccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"176.0";"nM";"6.75";"";"332141";"UO_0000065";"14.86";"0.27";"3.25";"7.85";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3900153";"";"None";"454.53";"0";"3.50";"BDBM184073";"Cc1cccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-c3ncccn3)c2)c1-n1nccn1";"IC50";"'='";"983.0";"nM";"6.01";"";"332142";"UO_0000065";"13.22";"0.24";"2.51";"6.98";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3973202";"";"None";"417.79";"0";"4.81";"BDBM203129";"COc1cc(F)ccc1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"585.0";"nM";"6.23";"";"360687";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946411";"";"None";"445.48";"0";"3.01";"BDBM183972";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ncco1";"IC50";"'='";"468.0";"nM";"6.33";"";"332036";"UO_0000065";"14.21";"0.26";"3.32";"6.63";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3901346";"";"None";"415.46";"0";"1.93";"BDBM183975";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"1235.0";"nM";"5.91";"";"332039";"UO_0000065";"14.22";"0.26";"3.98";"6.50";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667590";"";"None";"408.52";"0";"4.25";"BDBM154964";"Cc1cc(C)cc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc3ccccc3c2)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"297255";"UO_0000065";"18.61";"0.36";"3.35";"11.44";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3956436";"";"None";"397.37";"0";"4.01";"BDBM185255";"COc1cccc(F)c1C(=O)N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1";"IC50";"'='";"7600.0";"nM";"5.12";"";"334172";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3915860";"";"None";"442.45";"0";"4.11";"BDBM185275";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334192";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3958727";"";"None";"389.46";"0";"2.70";"BDBM185295";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C2CC2)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334212";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3969035";"";"None";"457.33";"0";"3.20";"BDBM185301";"COc1cc(Br)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"7800.0";"nM";"5.11";"";"334218";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3902140";"";"None";"411.39";"1";"5.23";"BDBM203188";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"30.0";"nM";"7.52";"";"360749";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3980818";"";"None";"378.45";"0";"4.88";"BDBM203196";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1cnc2ccccc2c1";"IC50";"'='";"690.0";"nM";"6.16";"";"360757";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918728";"";"None";"423.43";"1";"5.16";"BDBM203061";"COc1cc(C)cc(OC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"107.0";"nM";"6.97";"";"360612";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955473";"";"None";"409.40";"0";"4.71";"BDBM203222";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccccc1OC(F)(F)F";"IC50";"'='";"87.0";"nM";"7.06";"";"360784";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3953548";"";"None";"447.38";"1";"5.62";"BDBM203228";"CC(C)Oc1cccc(F)c1C1CC(F)(F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"98.0";"nM";"7.01";"";"360790";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3969988";"";"None";"383.49";"0";"4.60";"BDBM203240";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OC(C)C)c1";"IC50";"'='";"93.0";"nM";"7.03";"";"360802";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983331";"";"None";"433.35";"1";"5.07";"BDBM203251";"CCOc1cccc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"21.0";"nM";"7.68";"";"360813";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922326";"";"None";"442.48";"0";"4.23";"BDBM221367";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c2n1";"IC50";"'='";"15.0";"nM";"7.82";"";"387497";"UO_0000065";"17.68";"0.32";"3.59";"7.06";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4071500";"";"None";"432.46";"0";"3.06";"14h";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(F)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"131.0";"nM";"6.88";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3950689";"";"None";"422.39";"0";"3.49";"BDBM240108";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccc(F)c(F)c3)no2)c1";"IC50";"'='";"187.0";"nM";"6.73";"";"418949";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3955074";"";"None";"469.33";"1";"5.90";"BDBM240167";"Cc1onc(-c2ccccc2Cl)c1C(=O)N1CC[C@H]1c1nc(-c2cccc(Cl)c2C)no1";"IC50";"'='";"666.0";"nM";"6.18";"";"419009";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3946635";"";"None";"457.54";"0";"2.94";"BDBM184036";"Cc1cc(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@@H]2C)c(-n2nccn2)cc1C";"IC50";"'='";"355.0";"nM";"6.45";"";"332105";"UO_0000065";"14.10";"0.26";"3.51";"7.09";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946888";"";"None";"449.90";"0";"2.59";"BDBM184039";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"96.0";"nM";"7.02";"";"332108";"UO_0000065";"15.60";"0.30";"4.43";"7.72";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3963262";"";"None";"444.50";"0";"3.02";"BDBM184047";"Cc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncon3)c2)c(-n2nccn2)cc1C";"IC50";"'='";"21.0";"nM";"7.68";"";"332116";"UO_0000065";"17.27";"0.32";"4.66";"7.74";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3952970";"";"None";"443.51";"0";"2.55";"BDBM184054";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1C";"IC50";"'='";"2633.0";"nM";"5.58";"";"332123";"UO_0000065";"12.58";"0.23";"3.03";"6.13";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3930115";"";"None";"445.48";"0";"1.94";"BDBM184055";"COc1ccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"2086.0";"nM";"5.68";"";"332124";"UO_0000065";"12.75";"0.24";"3.74";"5.67";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3940721";"";"None";"461.50";"0";"2.77";"BDBM184080";"Cc1cccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1-n1nccn1";"IC50";"'='";"728.0";"nM";"6.14";"";"332149";"UO_0000065";"13.30";"0.25";"3.37";"6.75";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3946996";"";"None";"443.51";"0";"2.63";"BDBM184124";"Cc1ccc(-n2nccn2)c(C(=O)N2CCO[C@@H](C)[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"2530.0";"nM";"5.60";"";"332193";"UO_0000065";"12.62";"0.23";"2.97";"6.15";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3426149";"";"None";"403.44";"0";"3.38";"6a";"Cc1nc(-c2ccccc2C(=O)N2C[C@H](Oc3cc(C#N)ccn3)CC[C@H]2C)no1";"IC50";"'='";"25.0";"nM";"7.60";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426146";"";"None";"441.51";"0";"2.14";"5o";"C[C@@H]1CC[C@@H](Oc2cc(S(C)(=O)=O)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"16.0";"nM";"7.80";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426143";"";"None";"489.32";"0";"3.34";"5l";"C[C@@H]1CC[C@@H](Oc2cc(I)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"7.2";"nM";"8.14";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426135";"";"None";"431.42";"0";"3.75";"5d";"C[C@@H]1CC[C@@H](Oc2cc(C(F)(F)F)ccn2)CN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3426130";"";"None";"377.45";"0";"3.04";"4";"Cc1ccc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)nc1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL1481561";"";"None";"422.45";"0";"2.04";"14";"COc1ccc(CCNC(=O)Cn2c(-c3nonc3N)nc3ccccc32)cc1OC";"IC50";"'='";"500.0";"nM";"6.30";"";"";"UO_0000065";"14.92";"0.28";"4.26";"4.84";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3946963";"";"None";"434.43";"0";"3.36";"BDBM240115";"COc1c(F)cccc1-c1noc([C@@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)n1";"IC50";"'='";"9.0";"nM";"8.05";"";"418956";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3938169";"";"None";"479.46";"1";"6.20";"BDBM240134";"Cc1ccc(-c2ccccc2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"4.0";"nM";"8.40";"";"418976";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3890542";"";"None";"456.38";"0";"3.80";"BDBM240145";"O=C(c1ccccc1-n1nccn1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"91.0";"nM";"7.04";"";"418987";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941877";"";"None";"434.88";"1";"5.25";"BDBM240162";"Cc1cccc(-c2ocnc2C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c1";"IC50";"'='";"631.0";"nM";"6.20";"";"419004";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3966231";"";"None";"448.91";"0";"4.48";"BDBM240165";"Cc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)cc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"419007";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939929";"";"None";"501.33";"1";"4.23";"BDBM240206";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3OC)n2)c(-n2nccn2)cc1Cl";"IC50";"'='";"1.0";"nM";"9.00";"";"419049";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3667573";"";"None";"385.45";"0";"2.36";"BDBM154946";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(C#N)c2)cc1";"IC50";"'='";"98.0";"nM";"7.01";"";"297237";"UO_0000065";"18.18";"0.35";"4.65";"7.04";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3113740";"";"None";"376.46";"0";"4.51";"BDBM50447816";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2ncccc2c1";"IC50";"'='";"1002.0";"nM";"6.00";"";"360380";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3956662";"";"None";"382.49";"0";"4.57";"BDBM202889";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1nc2ccccc2s1";"IC50";"'='";"858.0";"nM";"6.07";"";"360410";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917893";"";"None";"409.51";"0";"4.48";"BDBM202896";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2nccs2)n1";"IC50";"'='";"147.0";"nM";"6.83";"";"360418";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3934682";"";"None";"408.52";"1";"5.08";"BDBM202901";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2cscn2)c1";"IC50";"'='";"17.0";"nM";"7.77";"";"360424";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3922489";"";"None";"461.91";"1";"5.18";"BDBM221340";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(Cl)c4)cn3)c2c1";"IC50";"'='";"2.0";"nM";"8.70";"";"387473";"UO_0000065";"18.83";"0.36";"3.52";"8.88";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935985";"";"None";"495.46";"1";"5.54";"BDBM221342";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4ccc(C(F)(F)F)cc4)cn3)c2c1";"IC50";"'='";"594.0";"nM";"6.23";"";"387475";"UO_0000065";"12.57";"0.24";"0.69";"6.36";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964827";"";"None";"456.51";"0";"4.47";"BDBM221352";"COc1cc(-c2ocnc2C(=O)Nc2cnn(CCn3c(C)nc4ccccc43)c2)ccc1C";"IC50";"'='";"3800.0";"nM";"5.42";"";"387482";"UO_0000065";"11.87";"0.22";"0.95";"5.42";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899892";"";"None";"441.49";"0";"4.83";"BDBM221347";"COc1ccc2[nH]cc(CCn3cnc(NC(=O)c4ncoc4-c4cccc(C)c4)c3)c2c1";"IC50";"'='";"27.0";"nM";"7.57";"";"387500";"UO_0000065";"17.14";"0.31";"2.74";"7.73";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901996";"";"None";"432.44";"0";"3.91";"BDBM221372";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ccc4c(c3)OCO4)c2)c1";"IC50";"'='";"414.0";"nM";"6.38";"";"387503";"UO_0000065";"14.76";"0.27";"2.47";"6.34";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3899184";"";"None";"437.50";"1";"5.27";"BDBM221412";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc(-c4ccccc4)c3)c2)c1";"IC50";"'='";"864.0";"nM";"6.06";"";"387543";"UO_0000065";"13.86";"0.25";"0.79";"7.79";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984152";"";"None";"389.42";"0";"3.00";"BDBM221422";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3ncccn3)c2)c1";"IC50";"'='";"1160.0";"nM";"5.94";"";"387553";"UO_0000065";"15.24";"0.28";"2.94";"5.36";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3971093";"";"None";"417.47";"0";"3.62";"BDBM221426";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3nc(C)cc(C)n3)c2)c1";"IC50";"'='";"262.0";"nM";"6.58";"";"387557";"UO_0000065";"15.77";"0.29";"2.96";"5.94";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910282";"";"None";"445.50";"1";"5.03";"BDBM221373";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCSc3nc4ccccc4o3)c2)c1";"IC50";"'='";"110.0";"nM";"6.96";"";"387504";"UO_0000065";"15.62";"0.30";"1.93";"7.03";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3905525";"";"None";"417.47";"0";"4.19";"BDBM221389";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cc(C)cc(C)n3)c2)c1";"IC50";"'='";"474.0";"nM";"6.32";"";"387520";"UO_0000065";"15.15";"0.28";"2.13";"6.65";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3943151";"";"None";"444.46";"0";"2.95";"BDBM221398";"COc1ncnc2ncn(CCn3cc(NC(=O)c4ncoc4-c4cccc(C)c4)cn3)c12";"IC50";"'='";"492.0";"nM";"6.31";"";"387529";"UO_0000065";"14.19";"0.26";"3.36";"5.02";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937131";"";"None";"442.48";"0";"4.16";"BDBM221404";"COc1cc2c(ccn2CCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)cn1";"IC50";"'='";"29.0";"nM";"7.54";"";"387535";"UO_0000065";"17.03";"0.31";"3.38";"7.54";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3924473";"";"None";"437.54";"1";"6.89";"BDBM203262";"COc1ccc2ccccc2c1C1CCCC(=O)N1Cc1cccc(Oc2ccccc2)c1";"IC50";"'='";"92.0";"nM";"7.04";"";"360826";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981734";"";"None";"469.46";"0";"3.58";"BDBM203051";"COc1cccc(OCC(O)CO)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"735.0";"nM";"6.13";"";"360593";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113534";"";"None";"379.38";"0";"4.85";"BDBM50447780";"COc1ccccc1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"635.0";"nM";"6.20";"";"360616";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929633";"";"None";"383.41";"1";"6.11";"BDBM203065";"O=C1CCCC(c2ccccc2C(F)(F)F)N1Cc1ccc2ccccc2c1";"IC50";"'='";"3585.0";"nM";"5.45";"";"360618";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984889";"";"None";"429.39";"1";"5.37";"BDBM203190";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"115.0";"nM";"6.94";"";"360751";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4645974";"";"None";"431.48";"0";"3.28";"(-)-3a";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"3.15";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3980766";"";"None";"448.46";"0";"2.85";"BDBM184137";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncon3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"359.0";"nM";"6.45";"";"332206";"UO_0000065";"14.37";"0.27";"3.59";"6.50";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3910447";"";"None";"481.92";"0";"3.11";"BDBM184149";"C[C@@H]1CN(C(=O)c2ccc(Cl)cc2-n2nccn2)[C@H](Cc2cc(-n3nccn3)ccc2F)CO1";"IC50";"'='";"58.0";"nM";"7.24";"";"332218";"UO_0000065";"15.02";"0.29";"4.13";"7.96";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3942815";"";"None";"447.47";"0";"2.38";"BDBM184018";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1";"IC50";"'='";"837.0";"nM";"6.08";"";"332087";"UO_0000065";"13.58";"0.25";"3.70";"6.68";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3972999";"";"None";"429.48";"0";"2.24";"BDBM184028";"Cc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-n1nccn1";"IC50";"'='";"992.0";"nM";"6.00";"";"332097";"UO_0000065";"13.98";"0.26";"3.76";"6.60";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3929585";"";"None";"443.51";"0";"2.63";"BDBM184032";"Cc1cccc(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@H]2C)c1-n1nccn1";"IC50";"'='";"2610.0";"nM";"5.58";"";"332101";"UO_0000065";"12.59";"0.23";"2.95";"6.14";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936704";"";"None";"443.51";"0";"2.63";"BDBM184033";"Cc1ccc(C(=O)N2[C@H](Cc3cccc(-n4nccn4)c3)COC[C@@H]2C)c(-n2nccn2)c1";"IC50";"'='";"2190.0";"nM";"5.66";"";"332102";"UO_0000065";"12.76";"0.23";"3.03";"6.22";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3932708";"";"None";"472.52";"0";"3.56";"BDBM184120";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3ncccn3)ccc2F)c(-n2nccn2)c1C";"IC50";"'='";"2260.0";"nM";"5.65";"";"332189";"UO_0000065";"11.95";"0.22";"2.09";"6.56";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3907310";"";"None";"458.50";"0";"3.26";"BDBM184128";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-c3cccnn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"1395.0";"nM";"5.86";"";"332197";"UO_0000065";"12.77";"0.24";"2.60";"6.81";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3937108";"";"None";"468.56";"0";"3.81";"BDBM184074";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-c3ncccn3)c2)c(-n2nccn2)c1C";"IC50";"'='";"839.0";"nM";"6.08";"";"332143";"UO_0000065";"12.97";"0.24";"2.27";"7.06";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3667567";"";"None";"439.33";"0";"3.25";"BDBM154940";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2cccc(Br)c2)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"297231";"UO_0000065";"16.92";"0.39";"4.18";"9.82";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4069949";"";"None";"502.88";"1";"4.29";"13f";"O=C(c1cc(C(F)(F)F)ccc1-n1nccn1)N1C[C@@H]2CN(c3nc4cc(Cl)ccc4o3)C[C@@H]2C1";"IC50";"'='";"1044.0";"nM";"5.98";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3980751";"";"None";"364.42";"0";"4.49";"BDBM203177";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"334.0";"nM";"6.48";"";"360738";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957833";"";"None";"427.39";"0";"4.85";"BDBM203217";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc(OC(F)(F)F)c(F)c1";"IC50";"'='";"183.0";"nM";"6.74";"";"360779";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3962013";"";"None";"439.43";"0";"4.72";"BDBM203220";"COc1ccc(OC(F)(F)F)cc1CN1C(=O)C(C)CC1c1c(OC)cccc1OC";"IC50";"'='";"449.0";"nM";"6.35";"";"360782";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973440";"";"None";"455.31";"0";"4.52";"BDBM240175";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2cc(Cl)ccc2-n2nccn2)n1";"IC50";"'='";"49.0";"nM";"7.31";"";"419017";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3944230";"";"None";"403.44";"0";"3.88";"BDBM221393";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cc(C)ccn3)c2)c1";"IC50";"'='";"2020.0";"nM";"5.70";"";"387524";"UO_0000065";"14.12";"0.26";"1.81";"5.99";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3914331";"";"None";"419.45";"0";"3.01";"BDBM221423";"COc1ccnc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn2)n1";"IC50";"'='";"78.0";"nM";"7.11";"";"387554";"UO_0000065";"16.95";"0.31";"4.10";"5.92";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930216";"";"None";"432.44";"0";"3.82";"BDBM221348";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cc(C)no4)cn3)c2c1";"IC50";"'='";"17.0";"nM";"7.77";"";"387578";"UO_0000065";"17.97";"0.33";"3.95";"6.27";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3918063";"";"None";"520.55";"2";"2.55";"BDBM221319";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3cccc(N4CCOCC4)c3)cn2)n1";"IC50";"'='";"134.0";"nM";"6.87";"";"387452";"UO_0000065";"13.20";"0.25";"4.32";"4.85";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892255";"";"None";"457.53";"0";"4.56";"BDBM221323";"COc1ccc2c(c1)N(CCCn1cc(NC(=O)c3ncoc3-c3cccc(C)c3)cn1)CC2";"IC50";"'='";"247.0";"nM";"6.61";"";"387456";"UO_0000065";"14.44";"0.27";"2.05";"7.74";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959036";"";"None";"501.54";"1";"4.78";"BDBM221333";"COc1cc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cc(OC)c(OC)cc43)c2)ccc1C";"IC50";"'='";"110.0";"nM";"6.96";"";"387466";"UO_0000065";"13.87";"0.26";"2.18";"6.59";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979268";"";"None";"422.55";"1";"5.25";"BDBM202985";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"24.0";"nM";"7.62";"";"360512";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3974018";"";"None";"486.48";"1";"5.65";"BDBM240146";"Cc1cccc(-c2scnc2C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c1";"IC50";"'='";"342.0";"nM";"6.47";"";"418988";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3915192";"";"None";"464.98";"1";"6.03";"BDBM240158";"Cc1nc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-c2ccccc2C)s1";"IC50";"'='";"448.0";"nM";"6.35";"";"419000";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3954052";"";"None";"504.86";"1";"4.76";"BDBM240160";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2cc(OC(F)(F)F)ccc2-n2nccn2)n1";"IC50";"'='";"676.0";"nM";"6.17";"";"419002";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979471";"";"None";"464.91";"0";"4.18";"BDBM240198";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c(-n2nccn2)cc1C";"IC50";"'='";"2.0";"nM";"8.70";"";"419040";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3912551";"";"None";"506.89";"2";"6.00";"BDBM240138";"O=C(c1ncsc1-c1cccc(Cl)c1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"357.0";"nM";"6.45";"";"418980";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3979924";"";"None";"504.85";"2";"5.84";"BDBM240148";"Cc1onc(-c2ccccc2Cl)c1C(=O)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"1190.0";"nM";"5.92";"";"418990";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3929213";"";"None";"500.50";"2";"5.96";"BDBM240139";"Cc1ccc(-c2sc(C)nc2C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)cc1";"IC50";"'='";"73.0";"nM";"7.14";"";"418981";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949525";"";"None";"436.92";"1";"5.41";"BDBM240155";"Cc1c(Cl)cccc1-c1noc([C@@H]2CCN2C(=O)c2ncsc2-c2ccccc2)n1";"IC50";"'='";"500.0";"nM";"6.30";"";"418997";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916868";"";"None";"520.86";"1";"4.47";"BDBM240170";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-n2nccn2)cc1Cl";"IC50";"'='";"12.0";"nM";"7.92";"";"419012";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3959304";"";"None";"462.90";"1";"5.01";"BDBM221415";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3nc4cc(Cl)ccc4o3)c2)c1";"IC50";"'='";"5074.0";"nM";"5.29";"";"387546";"UO_0000065";"11.44";"0.22";"0.28";"4.77";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409851";"";"None";"409.40";"0";"4.71";"2";"COc1cccc(OC)c1[C@@H]1C[C@@H](C)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"119.0";"nM";"6.92";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL3113746";"";"None";"422.55";"1";"5.39";"BDBM50447810";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360395";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113742";"";"None";"415.49";"1";"5.86";"BDBM50447814";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2oc3ccccc3c2c1";"IC50";"'='";"4.0";"nM";"8.40";"";"360409";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3897223";"";"None";"423.54";"0";"4.78";"BDBM202915";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"33.0";"nM";"7.48";"";"360441";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3916366";"";"None";"393.45";"0";"2.93";"BDBM202919";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-n2cccn2)n1";"IC50";"'='";"3700.0";"nM";"5.43";"";"360445";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3892317";"";"None";"429.82";"0";"4.47";"BDBM203244";"CCOc1cccc(Cl)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"75.0";"nM";"7.12";"";"360806";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113757";"";"None";"410.39";"0";"3.28";"BDBM50447799";"COc1cccc(OC)c1C1CNCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"589.0";"nM";"6.23";"";"360646";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902339";"";"None";"431.81";"1";"5.20";"BDBM203148";"CCOc1c(F)cccc1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"528.0";"nM";"6.28";"";"360708";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4103978";"";"None";"448.91";"0";"3.72";"5";"Cc1ccc(-n2nccn2)c(C(=O)N2CCC3CN(c4nc5cc(Cl)ccc5o4)CC32)c1";"IC50";"'='";"354.0";"nM";"6.45";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4068943";"";"None";"469.33";"0";"3.92";"13a";"O=C(c1cc(Cl)ccc1-n1nccn1)N1C[C@@H]2CN(c3nc4cc(Cl)ccc4o3)C[C@@H]2C1";"IC50";"'='";"1269.0";"nM";"5.90";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4082033";"";"None";"498.47";"0";"3.82";"14j";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(OC(F)(F)F)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"4710.0";"nM";"5.33";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3909701";"";"None";"450.89";"0";"3.05";"BDBM184046";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"246.0";"nM";"6.61";"";"332115";"UO_0000065";"14.66";"0.28";"3.56";"6.66";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3938822";"";"None";"484.44";"0";"3.42";"BDBM184049";"O=C(c1ccc(C(F)(F)F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"227.0";"nM";"6.64";"";"332118";"UO_0000065";"13.71";"0.26";"3.22";"6.70";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3963023";"";"None";"443.51";"0";"2.55";"BDBM184085";"Cc1ccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2C)c(-n2nccn2)c1";"IC50";"'='";"939.0";"nM";"6.03";"";"332154";"UO_0000065";"13.59";"0.25";"3.48";"6.63";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957620";"";"None";"463.47";"0";"2.08";"BDBM184093";"COc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1";"IC50";"'='";"1131.0";"nM";"5.95";"";"332162";"UO_0000065";"12.83";"0.24";"3.87";"5.94";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3956147";"";"None";"415.45";"0";"3.01";"BDBM184005";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncco2)c1";"IC50";"'='";"2009.0";"nM";"5.70";"";"332069";"UO_0000065";"13.71";"0.25";"2.69";"6.60";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3941635";"";"None";"458.50";"0";"3.26";"BDBM184012";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncccn3)c2)c1F";"IC50";"'='";"582.0";"nM";"6.24";"";"332076";"UO_0000065";"13.60";"0.25";"2.98";"7.25";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3929240";"";"None";"430.47";"0";"2.71";"BDBM183965";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-c3ncon3)c2)c1";"IC50";"'='";"406.0";"nM";"6.39";"";"332029";"UO_0000065";"14.85";"0.27";"3.68";"6.44";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3951681";"";"None";"429.48";"0";"2.24";"BDBM183974";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"196.0";"nM";"6.71";"";"332038";"UO_0000065";"15.62";"0.29";"4.47";"7.37";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936446";"";"None";"444.50";"0";"2.55";"BDBM183977";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-n1cccn1";"IC50";"'='";"905.0";"nM";"6.04";"";"332041";"UO_0000065";"13.60";"0.25";"3.49";"6.92";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3982154";"";"None";"428.50";"0";"2.85";"BDBM183982";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3cccn3)c2)c1";"IC50";"'='";"369.0";"nM";"6.43";"";"332046";"UO_0000065";"15.01";"0.27";"3.58";"8.24";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943785";"";"None";"432.46";"0";"2.68";"BDBM183983";"O=C(c1cc(F)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"1527.0";"nM";"5.82";"";"332047";"UO_0000065";"13.45";"0.25";"3.14";"7.45";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3963637";"";"None";"431.42";"0";"2.86";"BDBM185257";"CN(c1cnc(C(F)(F)F)cn1)[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334174";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3939249";"";"None";"461.50";"0";"2.77";"BDBM184103";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-n3ccnn3)ccc2F)c(-n2nccn2)c1";"IC50";"'='";"429.0";"nM";"6.37";"";"332172";"UO_0000065";"13.80";"0.26";"3.60";"7.00";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3943170";"";"None";"463.93";"0";"2.97";"BDBM184134";"C[C@@H]1CN(C(=O)c2cccc(Cl)c2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"93.0";"nM";"7.03";"";"332203";"UO_0000065";"15.16";"0.29";"4.06";"7.73";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3927258";"";"None";"442.45";"0";"4.02";"BDBM185263";"Cc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334180";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3902166";"";"None";"465.87";"0";"3.88";"BDBM185271";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1c(Cl)cccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334188";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3959140";"";"None";"452.39";"0";"3.69";"BDBM185309";"O=C(NC1CC(F)(F)CC1Nc1ccc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334226";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3969411";"";"None";"396.88";"0";"3.39";"BDBM185189";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2ccc(Cl)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334106";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3955953";"";"None";"415.42";"0";"4.05";"BDBM185195";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1ccccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334112";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3981397";"";"None";"417.40";"0";"2.84";"BDBM185227";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ncccc1-n1cccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334144";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3986449";"";"None";"459.27";"0";"4.03";"BDBM185233";"COc1cccc(Br)c1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334150";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3967022";"";"None";"457.46";"0";"3.72";"BDBM185241";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(C2CC2)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334158";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3953804";"";"None";"445.61";"1";"6.58";"BDBM203267";"O=C1CCCCC(c2ccccc2-c2cscn2)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"360831";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3936905";"";"None";"417.79";"0";"4.81";"BDBM203275";"COc1cccc(F)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1cccc(OC(F)(F)F)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"360839";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4065091";"";"None";"433.47";"0";"2.32";"7";"COc1ccc(C(=O)N2C[C@H](Oc3nccc(C#N)c3C)CC[C@H]2C)c(-n2nccn2)n1";"IC50";"'='";"21.0";"nM";"7.68";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4067287";"";"None";"404.51";"0";"3.93";"17";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2N2CCCC2)C1";"IC50";"'='";"29.0";"nM";"7.54";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL3893826";"";"None";"439.48";"0";"4.15";"BDBM221414";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3ncc4ccccc4n3)c2)c1";"IC50";"'='";"133.0";"nM";"6.88";"";"387545";"UO_0000065";"15.65";"0.28";"2.73";"6.21";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964074";"";"None";"440.46";"0";"4.12";"BDBM221439";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3cnc4ccccc4n3)c2)c1";"IC50";"'='";"627.0";"nM";"6.20";"";"387570";"UO_0000065";"14.08";"0.26";"2.08";"5.75";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3981316";"";"None";"412.45";"0";"4.15";"BDBM221379";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3cnc4ccccc43)c2)c1";"IC50";"'='";"65.0";"nM";"7.19";"";"387510";"UO_0000065";"17.43";"0.32";"3.04";"7.92";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930019";"";"None";"425.49";"1";"5.06";"BDBM221388";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCn3ccc4cccc(C)c43)c2)c1";"IC50";"'='";"376.0";"nM";"6.42";"";"387519";"UO_0000065";"15.10";"0.27";"1.36";"8.25";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949044";"";"None";"413.48";"0";"4.16";"BDBM221317";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCN3CCc4ccccc43)c2)c1";"IC50";"'='";"368.0";"nM";"6.43";"";"387450";"UO_0000065";"15.56";"0.28";"2.27";"8.44";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3978828";"";"None";"431.42";"0";"3.15";"BDBM185187";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2ncc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334104";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3970401";"";"None";"378.47";"0";"4.31";"BDBM203206";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cc2ccccc2n1C";"IC50";"'='";"132.0";"nM";"6.88";"";"360767";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973636";"";"None";"445.42";"0";"4.46";"BDBM185198";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1)c1cc(F)ccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334115";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3940335";"";"None";"432.41";"0";"3.62";"BDBM185199";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334116";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3964513";"";"None";"415.42";"0";"3.82";"BDBM185208";"O=C(NC1CCCC1Cc1ccc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334126";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3921425";"";"None";"450.56";"1";"5.15";"BDBM203259";"COc1ccc2c(c1C1CCCC(=O)N1Cc1cccc(-c3ncc(C)s3)c1)OCCO2";"IC50";"'='";"8.0";"nM";"8.10";"";"360823";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3965358";"";"None";"442.58";"1";"6.53";"BDBM203261";"COc1ccc2ccccc2c1C1CCCC(=O)N1Cc1cccc(-c2ncc(C)s2)c1";"IC50";"'='";"59.0";"nM";"7.23";"";"360825";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945078";"";"None";"439.58";"1";"6.52";"BDBM203265";"O=C1CCCCC(c2ccccc2-c2ccncc2)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"15.0";"nM";"7.82";"";"360829";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3957489";"";"None";"400.44";"0";"3.52";"BDBM240097";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3C)no2)c1";"IC50";"'='";"19.0";"nM";"7.72";"";"418938";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3945314";"";"None";"416.44";"0";"3.22";"BDBM240101";"COc1cccc(-c2noc([C@@H]3CCN3C(=O)c3cc(C)ccc3-n3nccn3)n2)c1";"IC50";"'='";"25.0";"nM";"7.60";"";"418942";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3960974";"";"None";"504.40";"1";"3.95";"BDBM240119";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)c(-n2nccn2)cc1F";"IC50";"'='";"39.0";"nM";"7.41";"";"418960";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3895717";"";"None";"386.42";"0";"3.21";"BDBM240131";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3)no2)c1";"IC50";"'='";"287.0";"nM";"6.54";"";"418973";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3986689";"";"None";"504.86";"1";"4.76";"BDBM240190";"Cc1cc(-n2nccn2)c(C(=O)N2CC[C@H]2c2noc(-c3ccccc3OC(F)(F)F)n2)cc1Cl";"IC50";"'='";"6.0";"nM";"8.22";"";"419032";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968500";"";"None";"434.89";"0";"4.17";"BDBM240201";"Cc1ccc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c(-n2nccn2)c1";"IC50";"'='";"9.0";"nM";"8.05";"";"419043";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3910117";"";"None";"457.54";"0";"2.94";"BDBM184060";"Cc1cc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1C";"IC50";"'='";"24.0";"nM";"7.62";"";"332129";"UO_0000065";"16.65";"0.31";"4.68";"8.38";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3936519";"";"None";"443.51";"0";"2.55";"BDBM184081";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2C)c1";"IC50";"'='";"593.0";"nM";"6.23";"";"332150";"UO_0000065";"14.04";"0.26";"3.68";"6.85";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3893504";"";"None";"461.50";"0";"2.69";"BDBM184090";"Cc1cc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c(-n2nccn2)cc1C";"IC50";"'='";"30.0";"nM";"7.52";"";"332159";"UO_0000065";"16.30";"0.30";"4.83";"8.27";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4472213";"";"None";"589.25";"2";"5.51";"7";"COc1ccc(Nc2nc(NCc3ccco3)nc(N/N=C\c3cc(Br)c(O)c(Br)c3)n2)cc1";"IC50";"";"";"";"";"";"Not Determined";"";"";"";"";"";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3962086";"";"None";"434.43";"0";"3.36";"BDBM240116";"COc1c(F)cccc1-c1noc([C@H]2CCN2C(=O)c2ccc(C)cc2-n2nccn2)n1";"IC50";"'='";"33.0";"nM";"7.48";"";"418957";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925873";"";"None";"490.83";"0";"4.46";"BDBM240172";"O=C(c1ccc(Cl)cc1-n1nccn1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"28.0";"nM";"7.55";"";"419014";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3948694";"";"None";"450.89";"0";"3.87";"BDBM240204";"COc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2cc(C)ccc2-n2nccn2)no1";"IC50";"'='";"3.0";"nM";"8.52";"";"419046";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911945";"";"None";"485.33";"0";"4.53";"BDBM240207";"COc1c(Cl)cccc1-c1nc([C@@H]2CCN2C(=O)c2cc(Cl)c(C)cc2-n2nccn2)no1";"IC50";"'='";"1.0";"nM";"9.00";"";"419050";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983392";"";"None";"392.45";"0";"4.61";"BDBM202885";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cc(-c2ccccc2)on1";"IC50";"'='";"902.0";"nM";"6.04";"";"360404";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3949346";"";"None";"346.45";"0";"3.72";"BDBM202924";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1csc(C)n1";"IC50";"'='";"6190.0";"nM";"5.21";"";"360450";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927882";"";"None";"434.51";"1";"5.55";"BDBM202960";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc(F)c(-c2ccccn2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"360486";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3917613";"";"None";"403.48";"0";"4.27";"BDBM202993";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2ncccn2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"360521";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964719";"";"None";"416.44";"0";"2.40";"BDBM183964";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"803.0";"nM";"6.09";"";"332028";"UO_0000065";"14.64";"0.27";"3.70";"6.15";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3960391";"";"None";"415.46";"0";"1.93";"BDBM183976";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"4439.0";"nM";"5.35";"";"332040";"UO_0000065";"12.88";"0.24";"3.42";"5.88";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3981349";"";"None";"504.86";"1";"4.76";"BDBM240178";"Cc1cc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nc(-c3ccccc3OC(F)(F)F)no2)cc1Cl";"IC50";"'='";"13.0";"nM";"7.89";"";"419020";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3919098";"";"None";"385.43";"0";"2.95";"BDBM240214";"Cc1ccc(-n2nccn2)c(C(=O)N2CC[C@H]2c2nnc(-c3ccccc3)[nH]2)c1";"IC50";"'='";"450.0";"nM";"6.35";"";"419057";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927724";"";"None";"426.85";"0";"4.61";"BDBM202869";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnc(OC(F)F)c(Cl)c1";"IC50";"'='";"38.0";"nM";"7.42";"";"360384";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939364";"";"None";"395.50";"0";"3.95";"BDBM202892";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccnc(N2CCCC2)c1";"IC50";"'='";"2060.0";"nM";"5.69";"";"360413";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3968360";"";"None";"410.54";"1";"5.27";"BDBM202958";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1ccc2nc(C)sc2c1";"IC50";"'='";"258.0";"nM";"6.59";"";"360484";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983237";"";"None";"387.48";"1";"5.23";"BDBM202966";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"34.0";"nM";"7.47";"";"360492";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4112780";"";"None";"437.46";"1";"5.81";"BDBM203029";"CCC(c1ccc(OC(F)(F)F)cc1)N1C(=O)CCCC1c1c(OC)cccc1OC";"IC50";"'='";"5650.0";"nM";"5.25";"";"360565";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3913204";"";"None";"417.51";"1";"5.75";"BDBM203032";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccccc1Oc1ccccc1";"IC50";"'='";"50.0";"nM";"7.30";"";"360570";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113535";"";"None";"393.40";"1";"5.16";"BDBM50447779";"COc1cccc(C)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"268.0";"nM";"6.57";"";"360601";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3952014";"";"None";"376.46";"0";"4.51";"BDBM202867";"COc1cccc(OC)c1[C@H]1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"41.0";"nM";"7.39";"";"360381";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3982929";"";"None";"424.52";"1";"5.21";"BDBM203099";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1csc(Oc2ccccc2)n1";"IC50";"'='";"172.0";"nM";"6.76";"";"360657";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3985659";"";"None";"401.47";"0";"4.95";"BDBM203100";"COc1ccc2nc(C)oc2c1C1CCCC(=O)N1Cc1ccc2ccccc2n1";"IC50";"'='";"1030.0";"nM";"5.99";"";"360658";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3935599";"";"None";"438.60";"1";"7.04";"BDBM203104";"Cc1nc(-c2cccc(CN3C(=O)CCCC3c3ccccc3-c3ccccc3)c2)cs1";"IC50";"'='";"548.0";"nM";"6.26";"";"360662";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931515";"";"None";"445.82";"0";"4.09";"BDBM203135";"COc1ccc(Cl)c(OC)c1[C@@H]1C[C@@H](O)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"920.0";"nM";"6.04";"";"360693";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3931037";"";"None";"431.81";"1";"5.20";"BDBM203152";"CCOc1cccc(F)c1[C@@H]1C[C@@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"184.0";"nM";"6.74";"";"360712";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3903997";"";"None";"433.35";"1";"5.07";"BDBM203159";"CCOc1ccc(F)c(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"17.0";"nM";"7.77";"";"360719";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3926444";"";"None";"423.54";"0";"4.64";"BDBM203169";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1csc(-c2ccc(C)cc2)n1";"IC50";"'='";"51.0";"nM";"7.29";"";"360729";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3958622";"";"None";"423.54";"0";"4.64";"BDBM203281";"COc1ccnc(OC)c1C1CC(C)C(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"113.0";"nM";"6.95";"";"360735";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923606";"";"None";"411.50";"0";"4.77";"BDBM203184";"COc1cccc(F)c1C1CC(C)C(=O)N1Cc1ccnc(-c2nc(C)cs2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"360745";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3984287";"";"None";"444.96";"1";"6.11";"BDBM203203";"CCOc1cccc(F)c1C1CC(C)C(=O)N1Cc1cccc(-c2nc(Cl)cs2)c1";"IC50";"'='";"2.0";"nM";"8.70";"";"360764";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3951985";"";"None";"433.35";"1";"5.07";"BDBM203255";"CCOc1cc(F)cc(F)c1[C@@H]1C[C@H](F)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"37.0";"nM";"7.43";"";"360817";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3964578";"";"None";"391.47";"0";"4.14";"BDBM202886";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1cnn(-c2ccccc2)c1";"IC50";"'='";"115.0";"nM";"6.94";"";"360405";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902382";"";"None";"441.42";"1";"5.05";"BDBM203241";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1cccc(OC(F)(F)C(F)F)c1";"IC50";"'='";"13.0";"nM";"7.89";"";"360803";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927832";"";"None";"398.36";"0";"3.41";"BDBM185315";"COc1cccc(F)c1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334232";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3946398";"";"None";"442.45";"0";"4.02";"BDBM185316";"Cc1cc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334233";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3980821";"";"None";"469.47";"0";"3.99";"BDBM185322";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)nc1C1CC1)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334239";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3910747";"";"None";"443.43";"0";"3.50";"BDBM185323";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ncccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334240";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3938008";"";"None";"446.43";"0";"4.01";"BDBM185338";"Cc1nnc(-c2ccccc2C(=O)N[C@H]2CCC[C@]2(C)Nc2cnc(C(F)(F)F)cn2)o1";"IC50";"'>'";"10000.0";"nM";"";"";"334255";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3909380";"";"None";"443.51";"0";"2.71";"BDBM184105";"CC[C@@H]1CN(C(=O)c2ccccc2-n2nccn2)[C@H](Cc2cccc(-n3nccn3)c2)CO1";"IC50";"'='";"485.0";"nM";"6.31";"";"332174";"UO_0000065";"14.24";"0.26";"3.60";"6.94";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3934850";"";"None";"458.50";"0";"3.74";"BDBM208515";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCOC2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"7.3";"nM";"8.14";"";"368552";"UO_0000065";"17.75";"0.33";"4.40";"9.46";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911191";"";"None";"405.42";"0";"3.92";"BDBM185273";"C[C@]1(Nc2cnc(C(F)(F)F)cn2)CCC[C@@H]1NC(=O)c1ncccc1C1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"334190";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3949597";"";"None";"446.43";"0";"3.71";"BDBM185280";"CC1(Nc2ccc(OC(F)(F)F)cn2)CCCC1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"1356.0";"nM";"5.87";"";"334197";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3966483";"";"None";"459.48";"0";"3.96";"BDBM185293";"CC(C)c1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ccccc1-n1nccn1";"IC50";"'='";"3549.0";"nM";"5.45";"";"334210";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3922313";"";"None";"391.48";"0";"2.94";"BDBM185296";"CC(C)c1cnc(N[C@H]2CCC[C@@H]2NC(=O)c2ccccc2-n2nccn2)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334213";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3913315";"";"None";"432.41";"0";"3.32";"BDBM185298";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(OC(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334215";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3939470";"";"None";"427.31";"0";"3.19";"BDBM185300";"O=C(N[C@H]1CCC[C@@H]1Nc1ccc(Br)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334217";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3973203";"";"None";"409.41";"0";"3.44";"BDBM185270";"CCOc1cccnc1C(=O)N[C@H]1CCC[C@]1(C)Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334187";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4639148";"";"None";"445.50";"0";"3.67";"(-)-3b";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCC[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"1.64";"nM";"8.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4646165";"";"None";"464.46";"0";"1.35";"(-)-9";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2ncn(-c3ccc(F)cn3)c2=O)c1";"IC50";"'='";"5.4";"nM";"8.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4633158";"";"None";"433.45";"0";"2.55";"(-)-12";"O=C(c1ccccc1-n1nccn1)N1CCCO[C@H]1Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"2.62";"nM";"8.58";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL4644984";"";"None";"458.50";"0";"3.74";"(-)-13";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCCO[C@H]2Cn2ccc(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"3.18";"nM";"8.50";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3398482";"";"None";"405.44";"0";"2.83";"1";"CCN(CCn1ccc(-c2ccc(F)cn2)n1)C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"38.7";"nM";"7.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL3975104";"";"None";"431.42";"0";"3.15";"BDBM185191";"Cc1ccc(-n2nccn2)c(C(=O)N[C@H]2CCC[C@@H]2Nc2cnc(C(F)(F)F)cn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"334108";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3986621";"";"None";"432.41";"0";"3.62";"BDBM185200";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2ncc(C(F)(F)F)cn2)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334117";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3901476";"";"None";"418.38";"0";"2.81";"BDBM185203";"O=C(N[C@H]1CCC[C@H]1Oc1cnc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'='";"6105.0";"nM";"5.21";"";"334120";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3910360";"";"None";"394.40";"0";"3.58";"BDBM185221";"COc1ccc(C)cc1C(=O)N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334138";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3986569";"";"None";"435.39";"0";"2.98";"BDBM185225";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(F)ccc1-n1ccnn1";"IC50";"'>'";"10000.0";"nM";"";"";"334142";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3409865";"";"None";"424.42";"0";"3.66";"35";"CN[C@H]1C[C@@H](c2c(OC)cccc2OC)N(Cc2ccc(OC(F)(F)F)cc2)C1=O";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3413696";"Antagonist activity at human orexin 1 receptor expressed in CHO cells assessed as inhibition of orexin-A-induced calcium mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3407375";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3308072";"";"";""
"CHEMBL1083659";"SUVOREXANT";"4.0";"450.93";"0";"4.11";"1, Suvorexant";"Cc1ccc(-n2nccn2)c(C(=O)N2CCN(c3nc4cc(Cl)ccc4o3)CC[C@H]2C)c1";"IC50";"'='";"56.0";"nM";"7.25";"";"";"UO_0000065";"16.08";"0.31";"3.14";"9.03";"1";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3909306";"";"None";"460.44";"0";"4.16";"BDBM185264";"Cc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1cc(F)ccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334181";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4073607";"";"None";"433.49";"0";"3.52";"9b";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cn1cc(-c2ccc(F)cn2)cn1";"IC50";"'='";"5.87";"nM";"8.23";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4060868";"";"None";"434.48";"0";"2.92";"9c";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cn1cc(-c2ccc(F)cn2)nn1";"IC50";"'='";"22.8";"nM";"7.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4081186";"";"None";"438.44";"0";"3.69";"15";"CCN(C(=O)c1cc(F)ccc1-n1nccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"23.6";"nM";"7.63";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3979271";"";"None";"447.47";"0";"2.86";"BDBM208494";"Cc1ccc(-n2nccn2)c(C(=O)N2[C@H](Cn3cc(-c4ccc(F)cn4)cn3)OC[C@@H]2C)c1";"IC50";"'='";"273.4";"nM";"6.56";"";"368531";"UO_0000065";"14.67";"0.27";"3.70";"7.22";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL4107152";"";"None";"391.48";"0";"3.35";"BDBM64581";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@H](Oc3ncccc3C)CC[C@H]2C)c1";"IC50";"'='";"32.0";"nM";"7.50";"";"321161";"UO_0000065";"19.14";"0.35";"4.14";"10.25";"0";"CHEMBL3705236";"Radioligand Binding Assay: The inhibition constant (Ki) is determined using a radioligand binding assay (described in Bergman et. al. Bioorg. Med. Chem. Lett. 2008, 18, 1425-1430).";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638431";"37";"BindingDB Database";"";"2013";"None";"";"";""
"CHEMBL3938211";"";"None";"443.51";"0";"2.63";"BDBM184126";"Cc1cccc(C(=O)N2CCO[C@@H](C)[C@H]2Cc2cccc(-n3nccn3)c2)c1-n1nccn1";"IC50";"'='";"4040.0";"nM";"5.39";"";"332195";"UO_0000065";"12.16";"0.22";"2.76";"5.93";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3905808";"";"None";"399.46";"0";"2.70";"BDBM183963";"O=C(c1ccccc1-n1nccn1)N1CCC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"40.0";"nM";"7.40";"";"332082";"UO_0000065";"18.52";"0.34";"4.70";"9.05";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3933467";"";"None";"429.48";"0";"2.24";"BDBM60732";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1-n1nccn1";"IC50";"'='";"784.0";"nM";"6.11";"";"332095";"UO_0000065";"14.22";"0.26";"3.87";"6.71";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3952666";"";"None";"449.90";"0";"2.59";"BDBM183993";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-n2nccn2)c1";"IC50";"'='";"199.0";"nM";"6.70";"";"332057";"UO_0000065";"14.89";"0.29";"4.11";"7.37";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3917412";"";"None";"475.51";"0";"1.95";"BDBM183997";"COc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1OC";"IC50";"'='";"1230.0";"nM";"5.91";"";"332061";"UO_0000065";"12.43";"0.23";"3.96";"5.40";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3913869";"";"None";"443.51";"0";"2.55";"BDBM183998";"Cc1cc(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)cc1C";"IC50";"'='";"25.0";"nM";"7.60";"";"332062";"UO_0000065";"17.14";"0.31";"5.05";"8.36";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4060107";"";"None";"419.46";"0";"3.13";"8b";"Cc1ccc(-n2nccn2)c(C(=O)N(C)[C@@H](C)Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"21.2";"nM";"7.67";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4096766";"";"None";"446.49";"0";"4.13";"12";"CCN(C(=O)c1cc(C)ccc1-c1ncccn1)[C@@H](C)Cc1noc(-c2ccc(F)cn2)n1";"IC50";"'='";"43.2";"nM";"7.37";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4095852";"";"None";"449.46";"0";"4.57";"16";"CCN(C(=O)c1cc(F)ccc1-c1ncccn1)[C@@H](C)Cc1noc(-c2ccc(F)cc2)n1";"IC50";"'='";"80.1";"nM";"7.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3667581";"";"None";"388.49";"0";"3.05";"BDBM154955";"CCc1cccc(NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(OC)cc2)c1";"IC50";"'='";"8.0";"nM";"8.10";"";"297246";"UO_0000065";"20.84";"0.41";"5.05";"10.69";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3957941";"";"None";"417.40";"0";"2.84";"BDBM185201";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334118";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3977257";"";"None";"451.84";"0";"3.49";"BDBM185236";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(Cl)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334153";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3895735";"";"None";"453.38";"0";"3.12";"BDBM185240";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1c(-n2nccn2)ccc(F)c1F";"IC50";"'>'";"10000.0";"nM";"";"";"334157";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3965933";"";"None";"391.40";"0";"3.53";"BDBM185247";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1ncccc1C1CC1";"IC50";"'>'";"10000.0";"nM";"";"";"334164";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4111139";"";"None";"447.47";"0";"2.86";"BDBM208490";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H](C)O[C@H]2Cn2cc(-c3ccc(F)cn3)cn2)c1";"IC50";"'='";"9.8";"nM";"8.01";"";"368527";"UO_0000065";"17.90";"0.33";"5.15";"8.80";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3909943";"";"None";"443.48";"0";"3.95";"BDBM208504";"Cc1ccc(-c2ncccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cc3)n2)c1";"IC50";"'='";"100.8";"nM";"7.00";"";"368541";"UO_0000065";"15.78";"0.29";"3.05";"9.57";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3987121";"";"None";"409.41";"0";"3.88";"BDBM185185";"COc1cccc(OC)c1C(=O)N[C@H]1CCC[C@@H]1Nc1ccc(C(F)(F)F)cn1";"IC50";"'>'";"10000.0";"nM";"";"";"334102";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3943280";"";"None";"391.48";"0";"2.69";"BDBM185188";"CCc1cnc(N[C@H]2CCC[C@@H]2NC(=O)c2cc(C)ccc2-n2nccn2)nc1";"IC50";"'>'";"10000.0";"nM";"";"";"334105";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3967667";"";"None";"435.39";"0";"2.98";"BDBM185220";"O=C(N[C@H]1CCC[C@@H]1Nc1cnc(C(F)(F)F)cn1)c1cc(F)ccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334137";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL5207891";"";"None";"647.78";"2";"5.82";"46b";"CN(C)c1cccc(C(=O)Nc2cccc([C@@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@]5(C)c3cccc(NC(=O)c4cccc(N(C)C)c4)c3)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL3983155";"";"None";"433.45";"0";"2.47";"BDBM208511";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cn2ccc(-c3ccc(F)cc3)n2)n1";"IC50";"'='";"3.0";"nM";"8.52";"";"368548";"UO_0000065";"19.66";"0.36";"6.05";"9.37";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3907843";"";"None";"447.47";"0";"2.86";"BDBM208512";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cn2ccc(-c3ccc(F)cc3)n2)n1";"IC50";"'='";"4.0";"nM";"8.40";"";"368549";"UO_0000065";"18.77";"0.35";"5.54";"9.23";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3896560";"";"None";"433.45";"0";"2.34";"BDBM208529";"Cc1ccc(-n2nccn2)c(C(=O)N2CCOC2Cc2ccn(-c3ccc(F)cn3)n2)c1";"IC50";"'='";"12.1";"nM";"7.92";"";"368566";"UO_0000065";"18.27";"0.34";"5.58";"8.70";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5197041";"";"None";"561.64";"2";"5.69";"31b";"C[C@]1(c2cccc(NC(=O)c3ccccc3)c2)O[C@H]2CO[C@@H]3N2[C@H]1O[C@]3(C)c1cccc(NC(=O)c2ccccc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL3915231";"";"None";"443.51";"0";"2.55";"BDBM184037";"Cc1cc(C)c(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)c1";"IC50";"'='";"547.0";"nM";"6.26";"";"332106";"UO_0000065";"14.12";"0.26";"3.71";"6.88";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3931057";"";"None";"452.42";"0";"2.68";"BDBM184042";"O=C(c1cc(F)c(F)cc1-n1nccn1)N1CCOC[C@H]1Cc1cccc(-c2ncon2)c1";"IC50";"'='";"645.0";"nM";"6.19";"";"332111";"UO_0000065";"13.68";"0.26";"3.51";"6.24";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3915416";"";"None";"443.51";"0";"2.63";"BDBM184063";"Cc1ccc(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cccc(-n3nccn3)c2)c(-n2nccn2)c1";"IC50";"'='";"155.0";"nM";"6.81";"";"332132";"UO_0000065";"15.35";"0.28";"4.18";"7.49";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3921658";"";"None";"461.50";"0";"2.77";"BDBM184077";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H](C)OC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1";"IC50";"'='";"146.0";"nM";"6.84";"";"332146";"UO_0000065";"14.81";"0.27";"4.07";"7.52";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL5171804";"";"None";"647.78";"2";"5.82";"44b";"CN(C)c1ccc(C(=O)Nc2cccc([C@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@@]5(C)c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5191943";"";"None";"563.61";"1";"4.48";"52b";"C[C@]1(c2cccc(NC(=O)c3cccnc3)c2)O[C@H]2CO[C@@H]3N2[C@H]1O[C@]3(C)c1cccc(NC(=O)c2cccnc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5192110";"";"None";"621.69";"2";"5.71";"(+/-)-41b";"COc1ccc(C(=O)Nc2cccc(C3(C)OC4COC5N4C3OC5(C)c3cccc(NC(=O)c4ccc(OC)cc4)c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL4739975";"";"None";"471.60";"0";"2.86";"37";"COC(=O)N1[C@H](C)C[C@H](NS(=O)(=O)N(C)C)[C@@H]1CO[C@H]1CC[C@@H](c2cccc(F)c2)CC1";"IC50";"'='";"0.23";"nM";"9.64";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4731353";"Agonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as increase in intracellular Ca2+ mobilization by measuring IP3 production incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4725461";"1";"Scientific Literature";"ACS Med Chem Lett";"2020";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL3260825";"";"None";"431.50";"0";"1.99";"31";"Cc1nn(C)c2nc(N3CC[C@@H](C)N(C(=O)c4ccccc4-n4nccn4)CC3)ncc12";"IC50";"'='";"280.0";"nM";"6.55";"";"";"UO_0000065";"15.19";"0.28";"4.56";"6.70";"0";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL1083358";"";"None";"431.48";"0";"3.09";"2";"C[C@@H]1CCN(c2ncc3cc(F)ccc3n2)CCN1C(=O)c1ccccc1-n1nccn1";"IC50";"'='";"27.0";"nM";"7.57";"";"";"UO_0000065";"17.54";"0.32";"4.48";"9.46";"1";"CHEMBL3267684";"Antagonist activity at human orexin-2 receptor expressed in CHO cells assessed as inhibition of Ala-6, 12-induced responses by FLIPR assay";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3259632";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2014";"CHEMBL3308072";"";"";""
"CHEMBL3426138";"";"None";"421.46";"0";"2.52";"5g";"COC(=O)c1ccnc(O[C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3429485";"Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3425449";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2015";"CHEMBL3307512";"";"";""
"CHEMBL3938842";"";"None";"463.93";"0";"2.89";"BDBM184065";"Cc1cc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cccc(-n3nccn3)c2)cc1Cl";"IC50";"'='";"47.0";"nM";"7.33";"";"332134";"UO_0000065";"15.80";"0.30";"4.44";"8.06";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3954756";"";"None";"463.93";"0";"2.89";"BDBM184084";"Cc1cccc(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2Cl)c1-n1nccn1";"IC50";"'='";"1610.0";"nM";"5.79";"";"332153";"UO_0000065";"12.49";"0.24";"2.90";"6.37";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3974582";"";"None";"481.46";"0";"2.22";"BDBM184095";"COc1ccc(-n2nccn2)c(C(=O)N2CCOC[C@H]2Cc2cc(-n3nccn3)ccc2F)c1F";"IC50";"'='";"2600.0";"nM";"5.58";"";"332164";"UO_0000065";"11.60";"0.22";"3.37";"5.57";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3919273";"";"None";"456.51";"0";"2.82";"BDBM183968";"COc1ccc(C[C@@H]2COCCN2C(=O)c2ccccc2-n2nccn2)cc1-c1ncccn1";"IC50";"'='";"2950.0";"nM";"5.53";"";"332032";"UO_0000065";"12.11";"0.22";"2.71";"5.81";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3930099";"";"None";"448.46";"0";"3.20";"BDBM208521";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCOC2Cc2noc(-c3ccc(F)cc3)n2)c1";"IC50";"'='";"1.7";"nM";"8.77";"";"368558";"UO_0000065";"19.55";"0.36";"5.57";"8.84";"0";"CHEMBL3888032";"Antagonistic Activity Assay: The antagonistic activities of the test compounds on human orexin-1 receptor (hOX1R) and orexin-2 receptor (hOX2R) were measured by modifying from the method described in literature (Toshikatsu Okumura et al., Biochemical and Biophysical Research Communications 280, 976-981, 2001). Chinese hamster ovary (CHO) cells forcibly expressing the hOX1R and hOX2R were seeded into a 96 well Black clear bottom plate (Nunc) at 20,000 cells per well, which were cultured in Ham's F-12 medium containing 0.1 mM MEM non-essential amino acids, 0.5 mg/ml G418, 10% fetal bovine serum (all by Invitrogen) for 16 hours under the conditions of 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the medium, 100 uL of 0.5 uM Fluo-4AM ester (Dojin) in an assay buffer (25 mM HEPES (Dojin), Hank's balanced salt solution (Invitrogen), 0.1% bovine serum albumin, 2.5 mM probenecid, 200 ug/ml Amaranth (all by Sigma-Aldrich), pH 7.4) was added and the cells were incubated for 60 minutes at 37° C., 5% CO2. After removing the assay buffer containing fluo-3AM ester, the test compound was dissolved in dimethyl sulfoxide to be 10 mM and diluted with the assay buffer, 150 uL of which was added and incubated for 30 minutes.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886545";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL2413371";"";"None";"464.56";"0";"4.56";"57";"Cc1c(S(=O)(=O)Cc2ccccc2)c2ccccn2c1CC(=O)N(C)Cc1ccc(F)cc1";"IC50";"'='";"0.8";"nM";"9.10";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL2416548";"Antagonist activity at human orexin receptor 2 expressed in CHO cells assessed as inhibition of orexin-A-induced calcium flux by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"CHEMBL3308072";"";"";""
"CHEMBL4578783";"";"None";"454.53";"0";"4.15";"10";"O=C(CSc1nnc(-c2cccs2)n1Cc1ccco1)Nc1ccc2c(c1)OCCO2";"IC50";"'='";"130.0";"nM";"6.89";"";"";"UO_0000065";"15.15";"0.30";"2.74";"7.53";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL5190821";"";"None";"481.62";"0";"2.49";"15";"CC1CC(NS(=O)(=O)N(C)C)C2COC3CCC(CC3)c3cccc(c3)OCCOC(=O)N12";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL4100428";"";"None";"433.49";"0";"3.52";"2";"CCN(C(=O)c1cc(C)ccc1-n1nccn1)[C@@H](C)Cn1ccc(-c2ccc(F)cn2)n1";"IC50";"'='";"1.61";"nM";"8.79";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL4090659";"";"None";"449.47";"0";"3.63";"24";"CCN(C(=O)c1cc(F)ccc1-c1ncccn1)[C@@H](C)Cn1nnc(-c2ccc(F)cc2)n1";"IC50";"'='";"532.0";"nM";"6.27";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4046293";"Antagonist activity at human OX2R expressed in CHO cells assessed as reduction in [Ala6,12]orexin-A-induced intracellular Ca2+ mobilization incubated for 30 mins by Fluo-4AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4043177";"1";"Scientific Literature";"Bioorg Med Chem";"2017";"None";"";"";""
"CHEMBL3932544";"";"None";"433.45";"0";"2.07";"BDBM184107";"O=C(c1ccccc1-n1nccn1)N1CCOC[C@H]1Cc1cc(F)cc(-n2nccn2)c1";"IC50";"'='";"1514.0";"nM";"5.82";"";"332176";"UO_0000065";"13.43";"0.25";"3.75";"6.40";"0";"CHEMBL3887325";"OX Inhibition Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/mL G418, 100 U/mL penicillin, 100 ug/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886276";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL3958101";"";"None";"446.44";"0";"2.80";"BDBM185306";"CCc1nc(C(F)(F)F)cnc1N[C@H]1CCC[C@@H]1NC(=O)c1ncccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334223";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3961425";"";"None";"453.38";"0";"3.08";"BDBM185307";"O=C(NC1CC(F)(F)CC1Nc1cnc(C(F)(F)F)cn1)c1ccccc1-n1nccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334224";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3985002";"";"None";"445.42";"0";"4.46";"BDBM185317";"O=C(N[C@H]1CCC[C@@H]1Nc1ncc(C(F)(F)F)cc1F)c1ccccc1-c1ncccn1";"IC50";"'>'";"10000.0";"nM";"";"";"334234";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL4797142";"";"None";"449.51";"0";"3.33";"3";"COC(=O)C1(C)CC1c1coc([C@@H]2CC[C@@H](C)N(C(=O)c3ccccc3-n3nccn3)C2)n1";"IC50";"'='";"18.0";"nM";"7.75";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4720027";"Antagonist activity at human OX2R expressed in CHO cells assessed as inhibition of orexin A-induced intracellular Ca2+ release by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4715811";"1";"Scientific Literature";"ACS Med Chem Lett";"2016";"None";"";"ANTAGONIST";""
"CHEMBL3667578";"";"None";"412.87";"0";"3.28";"BDBM154952";"COc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)Nc2ccc(F)c(Cl)c2)cc1";"IC50";"'='";"34.0";"nM";"7.47";"";"297243";"UO_0000065";"18.09";"0.38";"4.19";"9.86";"0";"CHEMBL3707946";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 ug/ml G418, 100 U/ml penicillin, 100 ug/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 C. in 5% CO2.Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH: water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 ul of staining buffer.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3638718";"37";"BindingDB Database";"";"2015";"None";"";"";""
"CHEMBL4080914";"";"None";"576.67";"1";"3.37";"10a";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@@]4(O)[C@@H](C2)N(S(=O)(=O)c2ccccc2)CC[C@]314";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"1";"CHEMBL5133796";"Antagonist activity at OX2R (unknown origin) by cell-based calcium assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131444";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"";""
"CHEMBL5177846";"";"None";"489.54";"0";"2.31";"82";"CC1CC(NS(C)(=O)=O)C2COC3CCC(CC3)c3nc(c(F)cc3F)OCCOC(=O)N12";"IC50";"'='";"0.07";"nM";"10.15";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL142009";"";"None";"397.52";"0";"3.19";"35";"COc1cc2c(cc1OC)CN(C(=O)[C@@H](NCc1ccncc1)C(C)(C)C)CC2";"IC50";"'='";"40.0";"nM";"7.40";"";"";"UO_0000065";"18.61";"0.35";"4.21";"11.62";"1";"CHEMBL2416556";"Binding affinity to orexin receptor 2 (unknown origin)";"B";"BAO_0000357";"single protein format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL2412971";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2013";"None";"";"";""
"CHEMBL3798017";"(R)-Carvedilol";"None";"406.48";"0";"3.74";"4";"COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12";"IC50";"'='";"900.0";"nM";"6.05";"";"";"UO_0000065";"14.87";"0.28";"2.31";"7.98";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL4078722";"";"None";"448.91";"0";"3.58";"1";"Cc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(Cl)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"206.0";"nM";"6.69";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL4473709";"";"None";"411.46";"0";"4.15";"13";"C=CCN1C(=O)C2(Nc3ccccc3C(=O)N2c2ccccc2OC)c2ccccc21";"IC50";"'='";"700.0";"nM";"6.16";"";"";"UO_0000065";"14.96";"0.27";"2.00";"9.95";"0";"CHEMBL4429656";"Displacement of [125I]-orexin A from human OX2 receptor expressed in CHO cell membranes after 90 mins by scintillation counting";"B";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4428072";"1";"Scientific Literature";"J Med Chem";"2016";"CHEMBL3308072";"";"";""
"CHEMBL3969685";"";"None";"369.46";"0";"4.36";"BDBM203044";"CCOc1ccc(CN2C(=O)CCCC2c2c(OC)cccc2OC)cc1";"IC50";"'='";"65.0";"nM";"7.19";"";"360584";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5202688";"";"None";"563.61";"1";"4.48";"51b";"C[C@]1(c2cccc(NC(=O)c3ccccn3)c2)O[C@H]2CO[C@@H]3N2[C@H]1O[C@]3(C)c1cccc(NC(=O)c2ccccn2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL4097192";"";"None";"375.47";"0";"4.21";"13";"Cc1c(C#N)ccnc1O[C@@H]1CC[C@@H](C)N(C(=O)c2ccccc2C2CC2)C1";"IC50";"'='";"9.0";"nM";"8.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999720";"Antagonist activity at human OX2R expressed in CHOK1 cells assessed as reduction in orexin A-induced calcium flux preincubated followed by orexin A addition by FLIPR assays";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997828";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"None";"";"";""
"CHEMBL4098665";"";"None";"464.91";"0";"3.28";"13e";"COc1ccc(-n2nccn2)c(C(=O)N2C[C@@H]3CN(c4nc5cc(Cl)ccc5o4)C[C@@H]3C2)c1";"IC50";"'='";"387.0";"nM";"6.41";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL3999730";"Antagonist activity at human orexin 2 receptor expressed in HEK293 cells assessed as inhibition of orexin-induced calcium mobilization after 60 mins by FLIPR assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"HEK293";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3997829";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2017";"CHEMBL3307715";"";"";""
"CHEMBL3113539";"";"None";"437.46";"1";"5.64";"BDBM50447775";"CCOc1cccc(OCC)c1C1CCCC(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"395.0";"nM";"6.40";"";"360610";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3942258";"";"None";"449.41";"0";"4.36";"BDBM185319";"Cc1noc(-c2ccccc2C(=O)N[C@H]2CCC[C@@H]2Nc2ncc(C(F)(F)F)cc2F)n1";"IC50";"'>'";"10000.0";"nM";"";"";"334236";"UO_0000065";"";"";"";"";"0";"CHEMBL3887338";"Fluorescent Imaging Plate Reader (FLIPR) Assay: Orexin antagonist activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in fluorescent signal were monitored by Fluorescent Imaging Plate Reader (FLIPR®) technology available from Molecular Devices, LLC, U.S.A. Orexin mediated increases in intracellular Ca2+ concentration were readily detected upon activation with orexin-A. Twenty-four hours prior to the assay, RBL-2H3 cells stably expressing either human orexin receptor 1 or human orexin receptor 2 were seeded in cell culture medium in black, clear-bottom 384-well plates (commercially available from Corning Inc., U.S.A.) and grown overnight at 37 °C., 5% CO2. On the day of the assay, cell culture media was removed and cells were loaded with Calcium 5 Dye (commercially sold by Molecular Devices, LLC, U.S.A.) for 1 hour at 37 °C., 5% CO2.";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"RBL-2H3";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886283";"37";"BindingDB Database";"";"2015";"CHEMBL3307666";"";"";""
"CHEMBL3915976";"";"None";"409.36";"0";"3.19";"BDBM203116";"O=C1[C@H](O)C[C@@H](c2cccc3c2OCCO3)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"5010.0";"nM";"5.30";"";"360674";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3113771";"";"None";"396.51";"0";"4.73";"BDBM50447785";"COc1cccc(OC)c1C1CC(C)C(=O)N1Cc1ccc2sc(C)nc2c1";"IC50";"'='";"121.0";"nM";"6.92";"";"360772";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3973346";"";"None";"447.81";"0";"4.82";"BDBM203149";"COc1ccc(F)c(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"197.0";"nM";"6.71";"";"360709";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3409853";"";"None";"429.82";"0";"4.68";"BDBM203085";"COc1cccc(OC)c1[C@@H]1C[C@H](Cl)C(=O)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"41.0";"nM";"7.39";"";"360640";"UO_0000065";"";"";"";"";"1";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898857";"";"None";"479.50";"1";"3.03";"BDBM221354";"COc1cc(OC)nc(NCCn2cc(NC(=O)c3ncoc3-c3ccc(C)c(OC)c3)cn2)n1";"IC50";"'='";"238.0";"nM";"6.62";"";"387484";"UO_0000065";"13.81";"0.26";"3.59";"4.78";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3940263";"";"None";"406.42";"0";"3.75";"BDBM221315";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCNc3cc(F)ccn3)c2)c1";"IC50";"'='";"379.0";"nM";"6.42";"";"387448";"UO_0000065";"15.80";"0.29";"2.67";"6.56";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3898855";"";"None";"445.45";"0";"4.66";"BDBM221327";"COc1ccc2[nH]cc(CCn3cc(NC(=O)c4ncoc4-c4cccc(F)c4)cn3)c2c1";"IC50";"'='";"6.0";"nM";"8.22";"";"387460";"UO_0000065";"18.46";"0.34";"3.56";"8.39";"0";"CHEMBL3888294";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 120 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3937214";"";"None";"443.46";"0";"4.63";"BDBM221374";"Cc1cccc(-c2ocnc2C(=O)Nc2cnn(CCOc3ccc4nc(C)oc4c3)c2)c1";"IC50";"'='";"949.0";"nM";"6.02";"";"387505";"UO_0000065";"13.58";"0.25";"1.39";"5.57";"0";"CHEMBL3888293";"In Vitro Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20'000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37 °C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37 °C. in 5% CO2 followed by equilibration at RT for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μl/well, incubated for 10 min and finally 10 μl/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"B";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886640";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3902815";"";"None";"405.50";"0";"4.53";"BDBM202950";"COc1cccc(OC)c1C1CCCCC(=O)N1Cc1cccc(-n2cccn2)c1";"IC50";"'='";"20.0";"nM";"7.70";"";"360476";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3928451";"";"None";"408.52";"0";"5.00";"BDBM202978";"COc1cccc(OC)c1C1CCC(=O)N1Cc1cccc(-c2csc(C)n2)c1";"IC50";"'='";"82.0";"nM";"7.09";"";"360504";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3930068";"";"None";"468.42";"0";"3.20";"BDBM240122";"COc1cc(C(=O)N2CC[C@H]2c2nc(-c3cccc(F)c3OC)no2)c(-n2nccn2)cc1F";"IC50";"'='";"26.0";"nM";"7.58";"";"418963";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3970650";"";"None";"465.45";"0";"2.85";"BDBM240128";"CCOc1ncccc1-c1noc([C@@H]2CCN2C(=O)c2cc(OC)c(F)cc2-n2nccn2)n1";"IC50";"'='";"27.0";"nM";"7.57";"";"418970";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3901328";"";"None";"434.89";"0";"4.17";"BDBM240173";"Cc1ccc(C(=O)N2CC[C@H]2c2nc(-c3cccc(Cl)c3C)no2)c(-n2nccn2)c1";"IC50";"'='";"22.0";"nM";"7.66";"";"419015";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3911441";"";"None";"490.83";"0";"4.46";"BDBM240176";"O=C(c1cc(Cl)ccc1-n1nccn1)N1CC[C@H]1c1nc(-c2ccccc2OC(F)(F)F)no1";"IC50";"'='";"47.0";"nM";"7.33";"";"419018";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3947062";"";"None";"485.33";"0";"4.53";"BDBM240199";"COc1cc(C(=O)N2CC[C@H]2c2noc(-c3cccc(Cl)c3C)n2)c(-n2nccn2)cc1Cl";"IC50";"'='";"2.0";"nM";"8.70";"";"419041";"UO_0000065";"";"";"";"";"0";"CHEMBL3888842";"Intracellular Calcium Assay: Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 μg/mL G418, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES for use in the assay at a final concentration of 3 nM. Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/L and 20 mM HEPES. On the day of the assay, 50 μL of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/L, 5 mM probenecid (Sigma) and 3 μM of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at rt for 30 min before measurement. Within the Fluorescent Imaging Plate Reader (FLIPR Tetra, Molecular Devices), antagonists are added to the plate in a volume of 10 μL/well, incubated for 120 min and finally 10 μL/well of agonist is added. Fluorescence is measured for each well at 1 second intervals, and the height of each fluorescence peak is compared to the height of the fluorescence peak induced by 3 nM orexin-A with vehicle in place of antagonist.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886856";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5181668";"";"None";"647.78";"2";"5.82";"43b";"CN(C)c1cccc(C(=O)Nc2cccc([C@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@@]5(C)c3cccc(NC(=O)c4cccc(N(C)C)c4)c3)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5194793";"";"None";"467.59";"0";"2.42";"61";"CC1CC(NS(C)(=O)=O)C2COC3CCC(CC3)c3cccc(n3)OCCCOC(=O)N12";"IC50";"'='";"0.05";"nM";"10.30";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL5206338";"";"None";"467.59";"0";"2.34";"79";"Cc1ccc2nc1C1CCC(CC1)OCC1C(NS(C)(=O)=O)CC(C)N1C(=O)OCCO2";"IC50";"'='";"0.1";"nM";"10.00";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL4637671";"";"None";"448.46";"0";"2.26";"(-)-8";"Cc1ccc(-n2nccn2)c(C(=O)N2CCCO[C@H]2Cn2cc(-c3ccc(F)cn3)nn2)c1";"IC50";"'='";"3.07";"nM";"8.51";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL4624029";"Antagonist activity at human recombinant OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intracellular Ca2+ release preincubated for 30 mins followed by orexin-A stimulation by Fluo-4AM dye based fluorescence analysis";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL4622874";"1";"Scientific Literature";"Bioorg Med Chem";"2020";"CHEMBL3307512";"";"";""
"CHEMBL5207082";"";"None";"621.69";"2";"5.71";"40b";"COc1cccc(C(=O)Nc2cccc([C@@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@]5(C)c3cccc(NC(=O)c4cccc(OC)c4)c3)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5190162";"";"None";"647.78";"2";"5.82";"45b";"CN(C)c1ccccc1C(=O)Nc1cccc([C@@]2(C)O[C@H]3CO[C@@H]4N3[C@H]2O[C@]4(C)c2cccc(NC(=O)c3ccccc3N(C)C)c2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5180400";"";"None";"563.61";"1";"4.48";"53b";"C[C@]1(c2cccc(NC(=O)c3ccncc3)c2)O[C@H]2CO[C@@H]3N2[C@H]1O[C@]3(C)c1cccc(NC(=O)c2ccncc2)c1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL5170308";"";"None";"621.69";"2";"5.71";"(+)-41b";"COc1ccc(C(=O)Nc2cccc([C@]3(C)O[C@@H]4CO[C@H]5N4[C@@H]3O[C@@]5(C)c3cccc(NC(=O)c4ccc(OC)cc4)c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
"CHEMBL3943538";"";"None";"407.52";"1";"5.79";"BDBM203271";"O=C1CCCC(c2ccnn2-c2ccccc2)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"716.0";"nM";"6.14";"";"360835";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3939381";"";"None";"439.58";"1";"6.52";"BDBM203268";"O=C1CCCCC(c2ccccc2-c2cccnc2)N1Cc1cccc(-c2nccs2)c1";"IC50";"'='";"93.0";"nM";"7.03";"";"360832";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3983645";"";"None";"420.48";"1";"5.16";"BDBM202898";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc(F)c(-c2ccccn2)c1";"IC50";"'='";"26.0";"nM";"7.58";"";"360420";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3925796";"";"None";"396.51";"0";"4.88";"BDBM202903";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2nc(C)sc2c1";"IC50";"'='";"165.0";"nM";"6.78";"";"360426";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5208227";"";"None";"601.73";"1";"4.24";"13b";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC=C4[C@@H](C2)N(S(=O)(=O)c2ccccc2N(C)C)CC[C@]431";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5133796";"Antagonist activity at OX2R (unknown origin) by cell-based calcium assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131444";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"";""
"CHEMBL4215362";"";"None";"560.67";"1";"4.26";"21a";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@H]4[C@@H](C2)N(S(=O)(=O)c2ccccc2)CC[C@@]341";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5133796";"Antagonist activity at OX2R (unknown origin) by cell-based calcium assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131444";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"";""
"CHEMBL5207350";"";"None";"603.74";"1";"4.32";"21b";"COc1ccc2c3c1O[C@H]1[C@H](N(C)C(=O)/C=C/c4ccoc4)CC[C@H]4[C@@H](C2)N(S(=O)(=O)c2ccccc2N(C)C)CC[C@@]341";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5133796";"Antagonist activity at OX2R (unknown origin) by cell-based calcium assay";"T";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5131444";"1";"Scientific Literature";"Bioorg Med Chem Lett";"2022";"None";"";"";""
"CHEMBL5195414";"";"None";"463.60";"0";"3.08";"1";"C[C@@H]1C[C@H](NS(=O)(=O)N(C)C)[C@@H]2COC3CCC(CC3)c3ccccc3/C=C/OC(=O)N12";"IC50";"'='";"0.09";"nM";"10.05";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL3894400";"";"None";"402.49";"1";"5.02";"BDBM202921";"COc1cncc(OC)c1C1CCCC(=O)N1Cc1cccc(-c2ccccc2)c1";"IC50";"'='";"31.0";"nM";"7.51";"";"360447";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3927627";"";"None";"369.42";"0";"3.69";"BDBM203015";"COc1cccc(OC)c1C1CCCC(=O)N1Cc1ccc2c(c1)OCO2";"IC50";"'='";"549.0";"nM";"6.26";"";"360545";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3923331";"";"None";"329.37";"0";"3.71";"BDBM203036";"COc1cccc(OC)c1C1CCC(=O)N1Cc1ccc(F)cc1";"IC50";"'='";"1305.0";"nM";"5.88";"";"360576";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL3941716";"";"None";"401.79";"1";"5.63";"BDBM203058";"O=C1CCCC(c2c(F)cccc2Cl)N1Cc1ccc(OC(F)(F)F)cc1";"IC50";"'='";"1193.0";"nM";"5.92";"";"360608";"UO_0000065";"";"";"";"";"0";"CHEMBL3887887";"In Vitro Assay: Intracellular Calcium Measurements : In Vitro Assay: Intracellular Calcium Measurements:Chinese hamster ovary (CHO) cells expressing the human orexin-1 receptor and the human orexin-2 receptor, respectively, are grown in culture medium (Ham F-12 with L-Glutamine) containing 300 g/ml G418, 100 U/ml penicillin, 100 g/ml streptomycin and 10% heat inactivated fetal calf serum (FCS). The cells are seeded at 20,000 cells/well into 384-well black clear bottom sterile plates (Greiner). The seeded plates are incubated overnight at 37° C. in 5% CO2. Human orexin-A as an agonist is prepared as 1 mM stock solution in MeOH:water (1:1), diluted in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES for use in the assay at a final concentration of 3 nM.Antagonists are prepared as 10 mM stock solution in DMSO, then diluted in 384-well plates using DMSO followed by a transfer of the dilutions into in HBSS containing 0.1% bovine serum albumin (BSA), NaHCO3: 0.375 g/l and 20 mM HEPES. On the day of the assay, 50 μl of staining buffer (HBSS containing 1% FCS, 20 mM HEPES, NaHCO3: 0.375 g/l, 5 mM probenecid (Sigma) and 3 M of the fluorescent calcium indicator fluo-4 AM (1 mM stock solution in DMSO, containing 10% pluronic) is added to each well. The 384-well cell-plates are incubated for 50 min at 37° C. in 5% CO2 followed by equilibration at RT for 30 min before measurement.";"F";"BAO_0000019";"assay format";"Homo sapiens";"None";"None";"None";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL3886487";"37";"BindingDB Database";"";"2016";"None";"";"";""
"CHEMBL5196538";"";"None";"453.56";"0";"2.03";"60";"CC1CC(NS(C)(=O)=O)C2COC3CCC(CC3)c3cccc(n3)OCCOC(=O)N12";"IC50";"'='";"0.04";"nM";"10.40";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5149864";"Agonist activity at human OX2R expressed in CHO cells incubated for 2 hrs by IP-one detection reagent based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5143751";"1";"Scientific Literature";"ACS Med Chem Lett";"2022";"None";"TIME = 2.0 hr";"AGONIST";""
"CHEMBL5194980";"";"None";"621.69";"2";"5.71";"(-)-41b; 41b";"COc1ccc(C(=O)Nc2cccc([C@@]3(C)O[C@H]4CO[C@@H]5N4[C@H]3O[C@]5(C)c3cccc(NC(=O)c4ccc(OC)cc4)c3)c2)cc1";"IC50";"'>'";"10000.0";"nM";"";"";"";"UO_0000065";"";"";"";"";"0";"CHEMBL5118353";"Antagonist activity at human OX2R expressed in CHO-K1 cells assessed as inhibition of orexin-A-induced increase in calcium mobilization preincubated for 15 mins followed orexin-A stimulation by Fura-2-AM dye based fluorescence assay";"F";"BAO_0000219";"cell-based format";"Homo sapiens";"None";"None";"CHO-K1";"None";"";"";"";"CHEMBL4792";"Orexin receptor 2";"Homo sapiens";"SINGLE PROTEIN";"CHEMBL5113495";"1";"Scientific Literature";"Eur J Med Chem";"2022";"None";"TIME = 0.25 hr";"";""
